# Pennystocks.news > Penny stock news covering OTC, Nasdaq small caps and Canadian listings. Company profiles, live charts and a free screener, updated every day. Public Ghost content for AI and LLM tooling. This file includes a bounded export of public pages first, then recent public posts. Append `.md` to any post or page URL to get the content in Markdown (for example, `/example-post.md`). ## Pages ### About this site URL: https://www.pennystocks.news/about/ Last updated: 2026-08-03T08:57:51.000Z Pennystocks is an independent publication launched in August 2026 by Alan Rashid. If you subscribe today, you'll get full access to the website as well as email newsletters about new content when it's available. Your subscription makes this site possible, and allows Pennystocks to continue to exist. Thank you! ### Access all areas By signing up, you'll get access to the full archive of everything that's been published before and everything that's still to come. Your very own private library. ### Fresh content, delivered Stay up to date with new content sent straight to your inbox! No more worrying about whether you missed something because of a pesky algorithm or news feed. ### Meet people like you Join a community of other subscribers who share the same interests. --- ### Start your own thing Enjoying the experience? Get started for free and set up your very own subscription business using [Ghost](https://ghost.org/?ref=pennystocks.news), the same platform that powers this website. ### Charts URL: https://www.pennystocks.news/charts/ Last updated: 2026-08-03T20:02:09.000Z Price chart Load Predictiv AI SoundHound AI BigBear.ai Rigetti Computing D-Wave Quantum Intuitive Machines Plug Power Opendoor CleanSpark TeraWulf Riot Platforms WELL Health Bitfarms Denison Mines NexGen Energy Propel Holdings Dye & Durham NFI Group Lightspeed Commerce BlackBerry Watchlists Charts and data by [TradingView](https://www.tradingview.com/?ref=pennystocks.news). Quotes are delayed. Nothing on this page is investment advice. ### Screener URL: https://www.pennystocks.news/screener/ Last updated: 2026-08-03T19:51:09.000Z Live screens across US and Canadian markets. Sort any column; click a row to open the full chart. Quotes are delayed. All US US movers All Canada Canada movers Data supplied by TradingView. Screens cover all listed securities — sort by price to narrow the list to low-priced names. Nothing here is investment advice. ### Disclaimer URL: https://www.pennystocks.news/disclaimer/ Last updated: 2026-08-03T21:41:35.000Z #### Not investment advice pennystocks.news is published by Pennystocks.news, Utrecht, Netherlands. Everything here is journalism and general information. None of it is investment advice, a recommendation, or an offer to buy or sell any security. We are not a broker-dealer, investment adviser, or licensed financial professional. We don't know your circumstances and can't assess whether anything we write about is suitable for you. Speak to a licensed adviser in your own country before acting on what you read here. #### Payment from companies we cover Most of our coverage is unpaid and chosen by our team. We do sometimes receive payment from companies, or from third parties acting for them, to produce and distribute content about those companies. Where that happens, the article carries a disclosure at the end stating who paid and how much. Read it. Paid content is promotional. It is written to be accurate, but it is not independent. #### Accuracy We draw on press releases, regulatory filings, data providers, and other public sources. We take reasonable care but do not independently audit everything we report, and we give no warranty of accuracy, completeness, or timeliness. Articles can be out of date by the time you read them, and we are not obliged to update them. Content may include forward-looking statements — projections, plans, and expectations, ours or an issuer's. These are not facts and frequently turn out wrong. #### Market data Quotes and charts come from TradingView. Data is delayed and provided for information only. #### Liability To the fullest extent permitted by law, Pennystocks.news accepts no liability for any loss arising from your use of this site or reliance on anything published on it. Questions: \[EMAIL\] ### Privacy URL: https://www.pennystocks.news/privacy/ Last updated: 2026-08-03T21:42:43.000Z #### Who we are pennystocks.news is published by Pennystocks.news, Salamancapad 315, 3584 DX Utrecht, Netherlands. We are the controller of the data described below under the GDPR. Reach us at \[EMAIL\]. #### What we collect **Your email address**, when you subscribe to the newsletter. We use it to send you the newsletter and nothing else. Legal basis: your consent (Art. 6(1)(a) GDPR), which you can withdraw any time via the unsubscribe link. **Delivery statistics** — whether emails were delivered, opened, and clicked — so we can tell the newsletter is working and clear out dead addresses. Legal basis: legitimate interests (Art. 6(1)(f) GDPR). **Server logs** — IP address, browser, referring page, time of request — kept for security and troubleshooting for 30 days. Legal basis: legitimate interests (Art. 6(1)(f) GDPR). **Emails you send us**, kept for 24 months so we can reply and keep a record. Legal basis: legitimate interests (Art. 6(1)(f) GDPR). We don't collect payment information. Nothing here is sold to readers and we will never ask you for card details. #### Cookies and analytics We set a session cookie when a subscriber signs in, which keeps you signed in until you sign out. That's it. We run no analytics, no advertising cookies, and no tracking of our own. #### Embedded content Our charts come from TradingView, and articles may embed videos or social posts. Embedded content behaves as if you had visited that site directly: your browser contacts their servers, they receive your IP address, and they may set their own cookies and record your interaction with the embed. That's governed by their privacy policies, not ours. TradingView's policy: [https://www.tradingview.com/privacy-policy/](https://www.tradingview.com/privacy-policy/?ref=pennystocks.news) #### Who processes your data Ghost(Pro) hosts the site and manages subscriptions. Mailgun delivers the newsletter. Both are established in the United States; transfers outside the EEA rely on standard contractual clauses. We don't sell your data, don't share it with advertisers, and don't share it with the companies we write about — including ones that have paid us. #### How long we keep it Subscription data lasts as long as you stay subscribed. If you unsubscribe we keep a suppression record — your address and the fact you opted out — so we don't contact you again. #### Your rights You can ask us to give you a copy of your data, correct it, delete it, restrict or stop our use of it, or send it to you in a portable format. You can withdraw consent at any time. Email \[EMAIL\] and we'll respond within a month. You can also complain to the Dutch data protection authority, the Autoriteit Persoonsgegevens (autoriteitpersoonsgegevens.nl), or to the authority in the country where you live. #### Children This site isn't directed at anyone under 16 and we don't knowingly collect their data. #### Changes We may update this policy. The date at the top shows when it last changed. ### Contact URL: https://www.pennystocks.news/contact/ Last updated: 2026-08-03T21:41:55.000Z pennystocks.news is published by Pennystocks.news, Salamancapad 315, 3584 DX Utrecht, Netherlands. **\[EMAIL\]** Story tips, questions about our coverage, corrections, privacy requests, and enquiries from companies all reach us at that address. **Corrections.** If we've published something inaccurate, tell us. We fix errors of fact promptly and note the correction on the article. **Companies.** Paying for coverage doesn't buy favourable coverage, and gives no approval rights over what we publish beyond factual accuracy. See our Disclaimer. We aim to reply within three business days. ### Subscribe URL: https://www.pennystocks.news/subscribe/ Last updated: 2026-08-03T21:46:34.000Z pennystocks.news newsletter ## The small-cap moves that matter, every morning OTC, Nasdaq, and the Canadian venues — what moved, what filed, and what's worth a second look. In your inbox before the open. Email address Subscribe free Free, always. Unsubscribe in one click from any issue. See our [Privacy Policy](https://www.pennystocks.news/privacy/). Check your inbox — we've sent a confirmation link. Click it and you're in. That didn't go through. Check the address and try again. **Free, and staying free.** No paid tier, no subscriptions, and we'll never ask you for payment details. Your email is used to send you the newsletter and nothing else — we don't sell it, rent it, or pass it to the companies we cover. Please read our [Disclaimer](https://www.pennystocks.news/disclaimer/) — nothing we publish is investment advice, and some articles are paid for by the companies they cover, disclosed on each one. ### The AI company working where the real money is made URL: https://www.pennystocks.news/predictiv-ai/ Last updated: 2026-09-05T15:41:26.000Z **August 26, 2026 – Toronto, ON – Forget the hype cycle around chatbots. While the market focuses on AI that writes emails and poems, Predictiv AI Inc. (FWB: 7IT) (CSE: PAI) (the “Company” or “Predictiv AI”) is quietly embedding artificial intelligence directly into the industries that keep the world running: global logistics, healthcare, aviation and local commerce. This is AI with a direct line to the P&L – not a demo.** Predictiv AI operates four brands: - Shift AI (fleet and logistics intelligence) - CloudRep AI (AI-powered voice, SMS and chat automation) - CloudMD AI (AI for healthcare) - TireGPT (AI-powered tire marketplace) **Shift AI: Global Logistics Push – Launched and Underway** In April 2026, Shift Technologies (Shift AI) entered a joint venture with Arcasia Holdings to deploy its AI-powered transportation management platform across first-, middle- and last-mile logistics networks worldwide. This is not a company trying to build market share from zero. It is a company moving directly into networks that already move freight at scale. Results came quickly. By June 2026, the Arcasia joint venture had produced Shift AI’s first major commercial deployment: a multi-phase contract with Prompt Xpress, one of Sri Lanka’s largest courier and logistics networks. Shift AI’s transportation management system, together with proprietary Shiftmatics hardware, is now being integrated end to end into Prompt Xpress’s middle-mile and last-mile operations. The model is working exactly as intended: technology paired with an established operator enables rapid scaling under real-world conditions – not a slow grind to adoption. **CloudRep AI: Direct Access to More Than 1,500 Clinics – Already Proven in Practice** In May 2026, Predictiv AI signed a strategic reseller agreement with ADDATech Systems, the company behind Clinicmaster. The practice management and EMR platform is used by more than 15,000 healthcare professionals across over 1,500 clinics in physiotherapy, rehabilitation, chiropractic and multidisciplinary care. That company is handing Predictiv AI the keys to its entire distribution network. Under the agreement, ADDATech will market, implement and resell CloudRep AI within its Canadian clinic network. The platform handles every front-desk function: AI-powered call answering, real-time appointment booking, caller authentication, SMS reminders, chatbot interactions, bilingual English and French support, and real-time sentiment analysis. Critically, this agreement was not signed off a pitch deck. It followed completed pilot projects across multiple clinics and production-level integration testing. The technology had already proven itself in practice before the ink was dry on the contract. **Aviation: The Platform Proves Itself Where the Stakes Could Hardly Be Higher** If you want to know whether a fleet intelligence platform really delivers what it promises, you test it in one of the most demanding operating environments in the world: the live operations of an international airport. That is exactly what happened when Shift AI was selected for Innovate Calgary’s Soaring Higher Challenge. The program was designed to stress-test promising technologies inside live aviation operations and is run in direct partnership with Calgary International Airport (YYC) and WestJet. This was not a lab demonstration. Shift AI’s asset and fleet intelligence platform was deployed in live operations, giving airport teams real-time visibility into where high-value ground equipment is located, how it is being used, and where action is needed. The solution was purpose-built around YYC’s airport layout rather than running on a generic template. The result: a validated, aviation-specific solution built hand in hand with one of Canada’s busiest airports and one of the country’s leading airlines. It is also worth noting that in early 2026, Shift AI completed a paid proof of concept for Air Canada, the country’s largest airline, at Canada’s largest airport, Toronto Pearson. Shareholders would undoubtedly benefit significantly should this successful POC convert into a commercial contract in the coming months. **Global Reach and Deployment by the United Nations** At the institutional level, Shift AI was awarded a fleet management software contract by the United Nations Development Programme in Africa. The contract was won through a competitive RFP process. A global institution put Shift AI up against dozens of competing bids – in an environment where compliance, reporting and end-to-end asset traceability are absolutely non-negotiable. And the customer list continues to grow across the North American economy: tire retail and vehicle service through Tire Warehouse.ca and TrailTire Auto Centers; health and wellness through PhysioMed and Anytime Fitness; travel and mobility through Expedia TAAP – supported by ongoing pilots and proofs of concept with Canadian municipalities and Air Canada. Aviation. Public sector. Healthcare. Retail. Fitness. Travel. Fleets. A global organization. This is not a start-up leaning on one lucky reference customer. This is a company building real, cross-industry momentum in almost every corner of the real economy. **Why This Matters for Investors** With reseller partnerships opening established distribution channels, enterprise implementations already underway and expansion across multiple industries, Predictiv AI is positioning itself to scale well beyond the traditional start-up playbook. And if execution continues at its current pace, today’s valuation could be just the beginning. ## Posts ### A Failed Phase 3 Drug Shows Signs of Life in Follow-On Data URL: https://www.pennystocks.news/vtgn-a-failed-phase-3-drug-shows-signs-of-life-in-follow-on/ Last updated: 2026-09-24T23:00:34.000Z Vistagen's randomized Phase 3 trial of fasedienol **failed its primary endpoint in June**. Three months later, data from patients who kept taking the drug without a control arm to compare against shows their anxiety scores steadily improving. The extension enrolled 322 patients who chose to continue using the nasal spray after the controlled trial ended, taking it as needed in everyday situations. Over four months, their mean score on a standard social anxiety scale — where the group started at 99.3, in the most severe category on a 0-to-144 range — **fell by about 31 points**. By month four, 65% of participants had improved by at least 20 points. Vistagen Therapeutics, Inc. NASDAQ: VTGN The limitation is plain. A controlled trial includes a placebo arm precisely because patients in open-label studies — where everyone knows they are taking the drug — tend to improve for reasons unrelated to the drug itself. The Phase 3 that failed was designed to account for that; the extension was not. Vistagen says the data adds to the case for fasedienol, and the company says it is preparing to **meet with the FDA this quarter to propose a new registrational trial**. Safety data from the extension showed a 1.6% rate of discontinuation due to adverse events — five patients among the 322 — with none attributed to fasedienol. More than 95% of side effects were mild or moderate. Headache was the most common complaint. Shares closed **46.54% higher at $0.3684** after the company released the open-label data, on dollar volume of about $241 million. Vistagen has no approved products. The FDA meeting has not been scheduled, and the company has not said what design or endpoints it would propose for a new trial. ### A Tiny Energy-Storage Stock Is Shrinking Its Share Count to Stay Listed URL: https://www.pennystocks.news/gcdt-a-tiny-energy-storage-stock-is-shrinking-its-share-coun/ Last updated: 2026-09-24T19:40:26.000Z Green Circle Decarbonize Technology's shares had been trading well below a dollar. The company said that put its NYSE American listing at risk. On October 7, every six of its shares will become one. Green Circle Decarbonize Technology Limited NYSEAMERICAN: GCDT The company made the announcement on September 23, stating the primary purpose is to lift the per-share price and **maintain its NYSE American listing**, according to a GlobeNewswire release. Shareholders had voted in favour at an extraordinary general meeting on **August 10**. For every six shares a holder owns before October 7, they will receive one after. Their proportional stake in the company stays the same; only the count changes. Outstanding options, warrants and other convertible securities adjust on the same **1-for-6 basis**, the company said. Shares **closed 50.03% higher at $0.5110** on September 24, on dollar volume of about $111 million across 333,124 trades. The company did not say what price threshold NYSE American requires, or how far the current price falls short of it. The free float is about 7.2 million shares, or 53.1% of shares outstanding. In the session following the announcement, **short volume came to about 70.4 million shares**. ### This Coffee Chain Has Until November to Convince Nasdaq It Can Stay Listed URL: https://www.pennystocks.news/rebn-this-coffee-chain-has-until-november-to-convince-nasdaq/ Last updated: 2026-09-24T16:20:01.000Z One problem closed on September 16\. Another opened the same day. Reborn Coffee had been warned in early September that a late quarterly report threatened its Nasdaq listing. It filed that report on September 14, and Nasdaq confirmed two days later that the matter was resolved. The same day, according to an 8-K filed with the SEC on September 22, Nasdaq sent a second letter: the company's **stockholders' equity of $735,642** — the net assets left after liabilities — falls well short of the **$2.5 million minimum** Nasdaq requires for continued listing. Reborn Coffee, Inc. NASDAQ: REBN That gap is what matters to anyone holding the stock. Nasdaq's rules give Reborn Coffee **until November 2 to submit a compliance plan**. If the plan is accepted, the exchange can grant **up to 180 calendar days** from the date of the notice to actually close the shortfall. If it is rejected, the company can appeal to a Nasdaq hearings panel. The 8-K notes the notice has no immediate effect on the listing of the stock. The filing also disclosed that Reborn Coffee does not currently meet either of the two alternative routes to compliance — through the market value of its listed securities or through net income from continuing operations — without giving figures for either. That removes the fallback options and leaves the equity figure as the only path the company is working against. Reborn Coffee said in the filing it intends to submit a plan on time and is evaluating its options, but acknowledged **no assurance the plan will be accepted** or that compliance can be regained. The filing does not say where the money to close the gap would come from. Shares closed 16.60% higher at $1.0900 after the filing, on dollar volume of about $338,634. The compliance plan is due in roughly six weeks. The filing is silent on what it will contain. ### A Convicted Founder's Claims Could Vanish Into Thin Air URL: https://www.pennystocks.news/benf-a-convicted-founder-s-claims-could-vanish-into-thin-air/ Last updated: 2026-09-24T13:00:03.000Z Brad Heppner founded Beneficient and ran it as chief executive until a federal jury convicted him of fraud this past spring. Now the company wants his debt and equity interests gone. What it is offering him in return is a handful of shares. Beneficient NASDAQ: BENF According to a press release attached to an 8-K filed with the SEC on September 23, the proposed deal would cancel **about $130 million in contested debt held by HCLP Nominees** — an entity the company says Heppner secretly controlled and used to fabricate a claim against the company. It would also convert preferred equity with **a stated liquidation preference of about $850 million into just 162,132 shares** of Class A common stock. A third piece would terminate other agreements and extinguish **about $88 million in other amounts** the company calls purportedly owed. For a holder of the stock, two things stand out. Heppner holds Class B shares that carry **super-voting, board-appointment, and consent rights** — the kind of structural control that leaves other shareholders with limited ability to force change. And the preferred equity represents a potential dilution overhang: a large unconverted claim that, depending on how it is eventually resolved, could produce far more common shares than currently exist. The proposed deal would end both. Shares **closed 438.73% higher at $2.9000** after the announcement, on turnover of about $598 million. The free float stands at about 1.4 million shares. The company's case rests on the conviction. According to the press release, **Heppner was found guilty on May 7, 2026, of securities fraud, wire fraud and related charges**. The criminal trial, the company says, produced evidence that he concealed his control of HCLP and fabricated the debt it now claims to be owed. On that basis, the company calls the HCLP debt invalid and unenforceable. The company says it is trying to complete a consensual deal before Heppner's sentencing, **scheduled for October 21, 2026**. **No definitive agreement has been signed**, and the company said in the release there is no assurance one will be reached. If negotiations fail, it says, it is prepared to pursue all available claims and remedies through litigation. Whether Heppner agrees before October 21, and on what terms, is now the largest single unresolved item on Beneficient's balance sheet. ### A Tiny Biotech Says Its Ebola Drug Beat Remdesivir in the Lab URL: https://www.pennystocks.news/dcoy-a-tiny-biotech-says-its-ebola-drug-beat-remdesivir-in-t/ Last updated: 2026-09-23T23:00:02.000Z The drug was designed by an algorithm. In cell tests against live Ebola virus, it **outperformed remdesivir by a factor of seven**, the company says. That is the claim; the work ahead is proving it holds in animals. Decoy Therapeutics Inc. NASDAQ: DCOY Shares in Decoy Therapeutics **closed 21.09% higher at $3.10** after the company published the results, on dollar volume of about $559 million. For holders, the core question is whether the lab data survives animal testing — and whether government funding will pay for that next stage. Decoy's AI platform produced the candidate against filoviruses — the viral family that includes Ebola and Marburg — in what the company calls a single optimization cycle. In cell-based assays, the compound hit a potency reading of **1.56 μM against wild-type Ebola Zaire**. That measures the concentration needed to block half the virus's activity in a dish; lower means the drug works at a smaller dose. The same compound hit **1.04 μM against Marburg virus**. The company plans to seek approval through the FDA's Animal Rule, a pathway that lets drugs targeting lethal pathogens win regulatory clearance through animal studies rather than human efficacy trials. Decoy says it is pursuing **non-dilutive government grants** and biodefense partnerships to fund the work — meaning it does not plan to issue new shares to pay for it. There is a second potential payoff. A successful filovirus approval would make Decoy eligible for a Priority Review Voucher — a certificate that speeds the FDA's review of any later drug application and can be sold to another pharmaceutical company. The company says recent voucher transactions have ranged **between $100 million and $180 million**. The program remains at the preclinical stage. No animal data has been published, no government grant has been announced, and the company has not given a timeline. The distance from a cell assay to an approved drug is long, and what sits at the start of that road is an AI-designed molecule that worked in a dish. ### A Freight Broker Is Spending Tens of Millions on GPU Servers URL: https://www.pennystocks.news/qnme-a-freight-broker-is-spending-tens-of-millions-on-gpu-se/ Last updated: 2026-09-23T19:40:34.000Z In August 2026, Lakeside Holding Limited — a cross-border freight broker — renamed itself Quanome Technologies and said it was moving into quantum and AI computing. Six weeks later, it **agreed to buy 32 GPU servers from Compal Electronics for about $18.8 million**. The filing does not say where that money is coming from. Quanome Technologies, Inc. NASDAQ: QNME Shares closed 33.04% higher at $0.8509 on September 23, on dollar volume of about $159.7 million across roughly 326,000 trades, after the company filed an 8-K disclosing the purchase agreement on September 21. For a company that spent the fiscal year ended June 2025 booking cross-border shipping and pharmaceutical distribution revenue — about $15 million combined from freight alone, according to the annual report filed with the SEC — an $18.8 million hardware commitment is a significant step. Who will use the servers, where they will be housed beyond "a designated data center location in the United States," and how the purchase will be financed are not addressed in the filing. ## Payment terms and conditions Under the agreement, **20% of the purchase price is due after the order is accepted**, with the remaining 80% payable before Compal ships the units. The agreement covers delivery, inspection, warranties, and refund rights in certain circumstances, but the filing warns that the purchase remains conditional on the company meeting its payment obligations, Compal completing production, and supply-chain requirements being satisfied. There is no stated completion deadline. The SEC still classifies Quanome under industrial code 4731 — arrangement of transportation of freight and cargo. The company says it intends to deploy the servers as part of an artificial intelligence computing infrastructure business, but has not disclosed a customer, a revenue model, or a contract. ## Board change on the same day On the same day the GPU filing was made, the company replaced a board member. **Xiaoou Li resigned as a director, and Chao Liu was elected to fill the vacancy**, effective immediately. The filing says Li's departure was not the result of any disagreement with the company. Liu, 44, brings a background in real estate investment and non-profit work; she has run The HLW Investment USA since 2013 and has served as president of a United Nations-affiliated organization in Singapore since 2025\. The board now has five members, a majority of them independent under Nasdaq rules. Short volume on September 23 was about 19,985,089 shares, equal to 51.6% of reported volume on the session. The purchase agreement itself will not be filed as an exhibit until the quarterly report for the period ending September 30, 2026\. Until then, the key question — how a company with a freight-brokerage operating history pays for $18.8 million of computing hardware — has no public answer. ### The FDA Unblocked This Drug Trial. Nasdaq May Delist the Company Anyway. URL: https://www.pennystocks.news/flna-the-fda-unblocked-this-drug-trial-nasdaq-may-delist-the/ Last updated: 2026-09-23T16:20:34.000Z On September 17, Nasdaq warned Filana Therapeutics its shares had spent a month below the exchange's minimum price. Five days later, the FDA **lifted the block on its main drug program**. Filana Therapeutics, Inc. NASDAQ: FLNA The FDA cleared the company to advance **simufilam toward a mid-stage human trial** targeting tuberous sclerosis complex — TSC, a rare genetic condition that causes seizures in 80% to 90% of the people it affects, according to the company's September 22 announcement. Simufilam is an oral drug designed to act on a protein called filamin A. The case for it rests on animal studies; no human efficacy data exist yet. Shares **closed 39.28% higher at $1.0300** on September 23, after the announcement, on dollar volume of about $100 million across 186,415 trades. For anyone holding the stock, the two events pull in opposite directions. The FDA news clears a regulatory obstacle that had stopped the trial program from moving forward. The Nasdaq notice starts a clock: to stay listed, the stock must **close above $1.00 for at least ten consecutive business days before March 16, 2027**. That deadline arrived because the shares had closed below that floor for **thirty consecutive business days** — a count the September 23 close has started, but not yet resolved. The company says it completed trial-readiness work while the hold was in place, including engaging a clinical research organization and identifying sites. The planned study is a **16-week trial at 13 sites in the U.S.**, targeting **40 participants aged 12 to 55** whose seizures have not responded to existing treatments. Those who complete it are eligible for a 48-week follow-on study. Patient screening is expected to start by the first quarter of 2027\. The Nasdaq compliance window runs to the same month. ### A Well-Known Canadian Mining Investor Just Took a Stake in This Junior Gold Explorer URL: https://www.pennystocks.news/gaymf-a-well-known-canadian-mining-investor-just-took-a-stak/ Last updated: 2026-09-23T13:00:34.000Z **Michael Gentile, one of Canada's better-known names in resource investing, is committing to a new $14 million share offering in Galway Metals** — and agreeing not to sell for a year. GALWAY METALS INC OTC: GAYMF Gentile has agreed to take **17.15 million units at $0.72 each**, according to a September 22 announcement by Galway Metals. That would give him **about 11% of the company** once the deal closes. Shares **closed 31.16% higher at $0.6250 on September 23**, on dollar volume of about $956,000. The placement uses flow-through shares — a Canadian tax structure where the company passes its exploration spending to investors, who can deduct those costs against their own taxable income. Galway commits to spending the proceeds on **exploration at its Clarence Stream gold project in New Brunswick** by the end of 2027, and to formally handing the tax deductions to subscribers by December 31, 2026. Each unit also carries a warrant, giving the holder the right to buy one additional share at **$0.80, exercisable for three years after closing**. If Gentile exercises all his warrants, the company says his stake would grow to **close to 20% of outstanding shares**. Every new share issued in that scenario makes existing holders' stakes a smaller portion of the same company. The **12-month lock-up** is the most concrete commitment in the release. A strategic investor who cannot sell for a year is at least nominally aligned with holders who bought in the open market. Beacon Securities is acting as sole agent on a best-efforts basis, meaning the total raised could fall short of the target. The deal is expected to close around October 14, subject to TSX Venture Exchange approval. Robert Hinchcliffe, Galway's president and chief executive, said in the release that Galway will present alongside other companies in Gentile's portfolio at his inaugural investor forum in London on October 19. The placement is priced at $0.72 per unit. On announcement day, after the shares had already risen, the stock still closed at $0.6250 — below what Gentile agreed to pay. ### Innventure Halves Its Own Costs and Bets Everything on One Subsidiary URL: https://www.pennystocks.news/inv-innventure-halves-its-own-costs-and-bets-everything-on-o/ Last updated: 2026-09-22T23:00:02.000Z The parent company is cutting costs by more than half and narrowing its focus to a single subsidiary. Everything else is being shed. Innventure, Inc. NASDAQ: INV Innventure said in a **September 21 press release** that it expects quarterly parent-level cash spending to fall from **$7.5 million to about $3.2 million** by year-end — a drop of about 56%, according to the release. The company says nearly all of what remains will go toward supporting Accelsius, a subsidiary that makes direct-to-chip liquid cooling systems for data centres — meaning technology that pulls heat away from processors by running liquid directly over the chips themselves. The stated figures exclude debt service, severance, litigation, and certain other one-off costs; the release does not say how large those excluded items are. For a shareholder, the company is now effectively a single-asset vehicle. If Accelsius wins customers in the data-centre market, the stake is worth something. The press release does not disclose **Accelsius's revenue or any sales figures**, so where it stands commercially is not clear from this filing. Shares closed 47.26% higher at $0.8800 after the announcement, on dollar volume of about $72.8 million across 143,525 trades. The company is also changing its finance chief. **David Yablunosky steps down on October 19**, when Eric Stober takes the role. Stober spent nine years as CFO of Astrotech Corporation, where he managed the sale of its satellite business to Lockheed Martin, according to the press release. His base salary is **$525,000** a year, and he receives a grant of restricted stock units valued at **$600,000** on his start date. Two board members, **Michael Otworth and John Hewitt, resigned on September 18** to allow the board to add more independent directors. Hewitt will continue as CEO of Accelsius itself. Michael Madon, currently chief revenue officer at secure-printing firm ABCorp, fills Otworth's seat. Six of the seven remaining directors will be independent, according to the release. The release says Innventure is "evaluating funding alternatives" but does not say what form those might take or when a decision is expected. ### A Tiny Optics Maker Just Landed Its Biggest Defense Order Ever URL: https://www.pennystocks.news/optx-a-tiny-optics-maker-just-landed-its-biggest-defense-ord/ Last updated: 2026-09-22T19:40:34.000Z Syntec Optics has fewer than 200 people at its Rochester, New York factory. On Sunday it said it is supplying optics for U.S. National Reconnaissance Office satellite constellations and Space Force infrastructure — **what CFO Dean Rudy called the most significant order in the company's 25-year history**, according to a September 21 company announcement. Syntec Optics Holdings, Inc. NASDAQ: OPTX Shares closed **16.20% higher at $7.8900** on September 22, after the announcement, on dollar volume of about $10.7 million. No contract value was given. What the release did offer was a projection: Rudy said Syntec is beginning to build a forecast for its space product lines with **a backlog exceeding $100 million**. That is a projected figure, not booked revenue. The release gave no timeline for when, or whether, it would be earned. The NRO is building out a constellation of **hundreds of low-flying satellites**, the company said. Having hundreds of smaller satellites in orbit, rather than fewer larger ones, is designed to raise how often any given location can be imaged, increase overall coverage, and remove single points of failure if individual satellites are disabled. Syntec's job is to make the optics that go inside them — components the company says can handle the temperature extremes of space and track objects on the ground in real time. Matt Carey, a vice president at Syntec and a former Marine, said in the release that the company already produces optics for communications satellites in volume. Syntec said it has built **thousands of laser connections** allowing satellites to relay data directly to each other in orbit, without routing through ground stations that could be knocked out. The constellation is still in its early stages. The $100 million figure is where Rudy expects the program to take the company — not where it stands now. ### New Era Signed a Power Deal with Vistra. The Bill Arrives First. URL: https://www.pennystocks.news/nuai-new-era-signed-a-power-deal-with-vistra-the-bill-arrive/ Last updated: 2026-09-22T16:20:34.000Z New Era Energy & Digital has a 20-year deal for the power its planned Texas data center needs. It has weeks to post the bond that keeps the deal alive. New Era Energy & Digital, Inc. NASDAQ: NUAI On September 18, 2026, New Era's subsidiary TCDC PowerCo LLC signed a power purchase agreement — a contract to buy electricity at set terms over a fixed period — with Luminant ET Services Company LLC, a subsidiary of Vistra Corp., according to an 8-K filed with the SEC. Luminant will supply **up to 207 MW** from a 1,180-MW natural gas plant in Odessa, Texas, situated next to the planned data center site. The company's September 21 press release puts first delivery in the third quarter of 2027. The credit obligations fall on New Era. Within 15 business days of signing, it must post **a $116 million letter of credit**. Before power flows, it must also provide **up to $82.8 million in additional agreed security**. If a required substation purchase agreement goes unsigned and New Era does not pay related construction invoices, Luminant's affiliate may draw on that $116 million directly. The filing lists the ability to arrange credit support on commercially reasonable terms as a key risk to the project's completion. The company does not say where the funds will come from. A companion development agreement signed at the same time adds further obligations. Once power flows, **New Era must give Vistra a 5% non-voting equity stake** in the portion of the project company it supplies. Vistra also gets first claim on any expansion at the Texas site from April 2028 onward. The filing gives no dollar value for the equity provisions. Shares **closed 30.55% higher at $7.6500** after the filing, on dollar volume of about $191.7 million. CEO Charlie Nelson said in the company's September 21 press release that the agreement turns the site "from a site with a power plan into permitted powered land." The letter of credit deadline is the first test of that claim. ### Priority's CEO Already Runs the Company. Now He's Buying It. URL: https://www.pennystocks.news/prth-priority-s-ceo-already-runs-the-company-now-he-s-buying/ Last updated: 2026-09-22T13:00:04.000Z Thomas Priore chairs Priority Technology Holdings' board, runs it as chief executive, and controls roughly 61% of its shares alongside allied stockholders. On September 18, he signed an agreement to buy the remaining shares and take the company off the public markets. Priority Technology Holdings, Inc. NASDAQ: PRTH The deal offers public shareholders **$8.05 per share in cash**, according to a merger agreement filed with the SEC. Priore's group — the same stockholders already locked into voting yes — won't receive that cash. They are contributing their shares into the private holding company in exchange for equity in it. The public minority gets the exit; Priore and his supporters stay invested. Shares closed 33.79% higher at $7.80 on September 22, after the announcement, on dollar volume of about $145 million across 28,097 trades. The stock settled below the $8.05 offer, a gap that reflects the distance between signing and closing. ## Financing and deal security The buyer expects to fund the transaction through a combination of **up to $160 million in equity from Searchlight Capital Partners**, borrowings on Priority's existing revolving credit line with Truist Bank, and the company's own cash. The deal is not conditioned on the financing being in place, meaning Priore cannot walk away solely because the money falls short. ## Two votes, one still in doubt Closing requires two separate shareholder approvals. The first is a straight majority of all outstanding shares — with **61.4% already committed** by the supporting stockholders, that hurdle is close to cleared before a vote is called. The second is harder: a majority of votes cast by disinterested shareholders, a group that explicitly excludes Priore, his supporters, company officers, and board members who are not on the special committee. That is the vote where public holders actually decide. A committee of independent directors, advised by Barclays Capital as financial adviser, negotiated the terms and unanimously recommended the deal. Priore and one other director recused themselves from the board vote. ## Fees and conditions The deal carries a deadline of December 18, 2027\. If Priority walks away to accept a competing offer, it owes the buyer **about $15.75 million**. If the buyer fails to close when required, it owes Priority **about $35.25 million**. Closing also requires regulatory approval of Priority's money-transmitter licences across the states where it operates — a condition with some flexibility through alternative arrangements or limited withdrawals, so long as any states from which it pulls back did not account for more than 10% of relevant fee revenue. The disinterested-holder vote — the count Priore cannot determine — is the only question not yet settled. ### NuRAN Wireless Opens a Share Tap to Fund Its African Build URL: https://www.pennystocks.news/nur-nuran-wireless-opens-a-share-tap-to-fund-its-african-bui/ Last updated: 2026-09-21T23:00:05.000Z NuRAN Wireless signed an agreement on September 15 giving itself the ability to **sell up to $50 million worth of new shares on Nasdaq at prevailing market prices**, whenever its management chooses. Nuran Wireless Inc. NASDAQ: NUR The structure — letting a company drip shares into the open market over time rather than running a fixed-price block sale — means each sale happens at the going price and the company controls the pace. **H.C. Wainwright & Co. acts as sales agent and keeps 3% of whatever is raised.** For existing holders, the consequence is straightforward: every share NuRAN sells creates a new claim on the same company, making each existing share a smaller piece. With a free float of about 13 million shares, a $50 million ceiling is a large ceiling relative to what currently trades. The company says it intends to use the net proceeds primarily to **build and connect additional telecommunications infrastructure sites across Africa**, with the remainder going toward operating costs and working capital. NuRAN describes itself as a network-as-a-service provider that finances, builds, owns and operates 2G, 3G and 4G mobile infrastructure for carriers wanting coverage outside cities. According to the September 15 release, **the company has more than 5,000 sites under contract.** Shares closed 15.09% higher at $1.2200 on September 21, six days after the announcement, on dollar volume of about $331,552 across 1,178 trades. The agreement does not commit NuRAN to sell anything. **Whether it sells, how much, and when, are decisions management makes at its own discretion** — so the full $50 million may never reach the market. ### A 3D Perception Company Is Building a Full Autonomous Stack for Drones and Ground Robots URL: https://www.pennystocks.news/frsx-a-3d-perception-company-is-building-a-full-autonomous-s/ Last updated: 2026-09-21T19:40:13.000Z Foresight Autonomous Holdings makes systems that let machines see in three dimensions. This week it said it wants to make the ones that drive themselves. The company's automotive subsidiary announced on September 18 a shift from perception-only tools to a complete autonomous driving platform — one that handles sensing, real-time AI decisions, and **direct control of brakes and steering**. The targets are operators of unmanned ground and aerial vehicles working in defense, agriculture, and heavy machinery. Foresight Autonomous Holdings Ltd. NASDAQ: FRSX **Shares closed 16.04% higher at $1.2300** on September 21, on dollar volume of about $4.1 million. For someone holding the stock, that shift is the thing to register. Foresight has been a sensor and perception company — a supplier of one layer of what autonomous vehicles need. **A full autonomous stack puts it in a different business**: responsible for the whole system working, not just one part of it. That is a larger market and a harder problem. The new platform has three layers, according to the company's September 18 announcement: 3D sensing using visible light and thermal cameras; AI-driven decision-making in real time; and actuator control — meaning brakes and steering. **A customer evaluation kit is targeted for the first half of 2027.** To lead the effort, Foresight Automotive named **Shlomo Hillel as chief technology officer**. The previous CTO, Levy Zruya, had resigned effective September 15\. The company says Hillel brings **25 years of experience** spanning computer vision, AI, sensor fusion, electro-optics, and autonomous platforms. The announcement names no customers, discloses no budget for the programme, and gives no price for the kit. ### Canaan Cashed Out Its Crypto Treasury to Buy Back Its Own Shares URL: https://www.pennystocks.news/can-canaan-cashed-out-its-crypto-treasury-to-buy-back-its-ow/ Last updated: 2026-09-21T16:20:34.000Z In late August, Canaan sold its entire Ethereum position and part of its Bitcoin holdings while prices were running high, **generating about $13.9 million in cash**. It then put a portion of that to work buying back its own shares. Canaan Inc. NASDAQ: CAN The company sold **3,952 ETH at roughly $2,400 each and 54 BTC at roughly $79,000 each**, according to a September 14 company press release. It then **deployed $5.4 million to repurchase about 13.6 million American Depositary Shares** — the units that trade on Nasdaq — bringing its **year-to-date total to about 16.4 million ADSs repurchased**. The board authorized the conversion on August 4, saying it believed the share price did not fully reflect the company's underlying assets and performance, the release said. For shareholders, a buyback on that premise means the company is treating its own shares as a better use of capital than holding digital assets at current prices — and each share retired makes the remaining ones a slightly larger stake in the same company. Shares closed 16.79% higher at $0.3728 on September 21, after the release, on dollar volume of about $14.9 million. Canaan **still held 1,868 BTC** at month-end after the sales. During August it **mined 44 BTC**, kept its non-joint-venture installed hashrate at **10.05 EH/s**, and ran at an average all-in power cost of **$0.043 per kilowatt-hour**, the release said. The authorization to draw on the digital asset treasury for further buybacks remains active, the release said. The pile it could draw on is many times what it has already sold. ### $6 Million in Revenue. A $200 Million Mandate. URL: https://www.pennystocks.news/cd-6-million-in-revenue-a-200-million-mandate/ Last updated: 2026-09-21T13:00:02.000Z Top Wealth Group sells sturgeon caviar and aged wine out of Hong Kong. Last week it **appointed a small New York broker-dealer as exclusive agent for a $200 million share-sale program** — with no minimum, no set timeline, and no guarantee that a single share will change hands. Chaince Digital Holdings Inc. NASDAQ: CD The broker is Chaince Securities, a wholly owned subsidiary of Chaince Digital Holdings. Under a sales agreement dated September 8, Chaince becomes the sole channel through which Top Wealth may sell Class A ordinary shares at prevailing market prices, in whatever amounts and at whatever times the company chooses. Top Wealth makes the decision; Chaince carries out the instructions. The company said in a September 17 announcement on GlobeNewswire that it may use any proceeds for general corporate purposes, including possible acquisitions. The $200 million figure is the ceiling on the program, not a commitment. **Top Wealth reported first-half 2026 revenue of $6.1 million**, according to a company press release published on Nasdaq's website in August. The offering cap is far larger than that revenue run rate, though how much of the program gets drawn depends on whether Top Wealth decides to sell shares at all, and at what price it is prepared to do so. Shares of Chaince Digital **closed 20.27% higher at $3.50** on September 21, after the announcement, on dollar volume of about $1.5 million. The structure of the deal is straightforward. Rather than raising money all at once in a traditional offering, Top Wealth can sell newly issued shares gradually into the open market over time. **Chaince is not required to sell any specific number or dollar amount of shares**, and the agreement sets no floor. The shares are being offered under a shelf registration that the SEC declared effective in June 2026. No commission rate or fee arrangement was disclosed in the announcement. Whether Chaince earns anything from the mandate depends on whether Top Wealth decides to sell — and that decision belongs entirely to the company. ### A Solana Treasury Company Just Opened a New Preferred Stock Funding Engine URL: https://www.pennystocks.news/dfdv-a-solana-treasury-company-just-opened-a-new-preferred-s/ Last updated: 2026-09-20T23:00:08.000Z DeFi Development Corp. has set up a standing program to sell shares of its CHAD preferred stock into the open market over time, with all proceeds earmarked for Solana purchases. The program has a ceiling of **$300 million**, according to an 8-K filed with the SEC on September 14. DeFi Development Corp. NASDAQ: DFDV An at-the-market program lets a company sell stock on any trading day, in whatever size the market will absorb, without going back to investors for a fresh offering each time. R.F. Lafferty & Co., Inc. is named as the sole sales agent. The company says it intends to issue CHAD shares at or above **$10.00 per share**, which is CHAD's par value, and is not obligated to sell any shares under the arrangement. The company's SOL holdings grew to **nearly 2.4 million SOL** as of September 11, after adding about 55,500 SOL between August 27 and September 11, according to the same filing. Those holdings are deployed through staking and the company's own validator infrastructure. Shares of the common stock **closed 21.20% higher at $6.0600** after the filings, on dollar volume of about $52.4 million across roughly 52,500 trades. CHAD carries an annual dividend rate of **13%**, paid daily. Holders asking where those payments come from should read the September 16 SEC filing carefully: the company disclosed it has no accumulated earnings and profits and does not expect to generate them in the current year or the foreseeable future. For U.S. holders, that means distributions are more likely to be treated as a return of capital — reducing a holder's cost basis rather than triggering ordinary income tax — than as taxable dividends. ### After Buying an AI Firm, Zenta Wants a Reverse Split It Can Run Without Another Vote URL: https://www.pennystocks.news/ztg-after-buying-an-ai-firm-zenta-wants-a-reverse-split-it-c/ Last updated: 2026-09-20T19:40:34.000Z Last week Zenta Group roughly doubled its share count to buy an AI company. This week shareholders vote on compressing those shares back down — and on giving the board authority to compress them further, without a second vote, if the price drops. Zenta Group Company Limited NASDAQ: ZTG Zenta Group, a Macau consulting firm listed on Nasdaq, **completed its acquisition of 100% of ZentoAI Intelligent Technology Company Limited** on September 11, according to a 6-K filed with the SEC. The price was **HKD 10 million in cash, plus about 12.3 million new Class A ordinary shares** issued to ZentoAI's former owners. Those new shares roughly doubled the total share count, which now stands at about 24 million. The filing gives no revenue, no asset figures, and no explanation of how the deal was priced. Shares **closed 50.83% higher at $1.8100** on September 20, on dollar volume of about $111.7 million across 251,326 trades. A separate 6-K filed September 14 called an extraordinary general meeting for September 30\. Shareholders face two consolidation proposals. The first would **combine every 12 existing shares into one**. A holder's proportional stake stays the same; the share count falls and the per-share price adjusts in line with the ratio. Fractional entitlements are rounded up to the next whole share. The second proposal goes further. It would give the board **standing authority to run a separate 20-for-1 consolidation without calling another meeting**, if the share price **stays consecutively below $1 for more than eight trading days**. A yes vote on Proposal 2 is a pre-authorisation: when the trigger fires, the board acts and shareholders have no further say. The stock closed at $1.81 on September 20 — above the $1 floor — but that is a backstop condition, not a present one. The pre-approved authority would remain on the table for as long as shareholders grant it. The September 30 meeting will determine whether the board leaves that second trigger loaded. ### The Stock Was at $0.44. The Investor Agreed to Pay $1.05. URL: https://www.pennystocks.news/gipr-the-stock-was-at-0-44-the-investor-agreed-to-pay-1-05/ Last updated: 2026-09-20T16:20:05.000Z An investor agreed to exercise warrants at a price well above where the stock was trading. The sweetener: twice as many new warrants at that same price. Generation Income Properties announced on September 18 that the investor agreed to exercise warrants — originally issued in June 2026 — covering **about 4.1 million shares at $1.05 each**, bringing the company **roughly $4.3 million in gross proceeds before fees**. Maxim Group LLC advised on the transaction. Generation Income Properties Inc. NASDAQ: GIPR In return, the investor receives reload warrants covering **about 8.1 million shares — twice the original count** — at the same $1.05 exercise price. Those warrants are **not exercisable until shareholders vote to approve them**; the September 18 announcement named no date for that vote. If it passes and the reload warrants are later exercised, the new shares would outnumber the entire free float of about 5.5 million shares. Every share issued makes the existing ones a smaller slice of the same company. The company says it will file a registration statement with the SEC covering resale of those shares; the reload warrants expire **five years after stockholder approval**. Shares **closed 63.44% higher at $0.7183 on September 20** after the announcement, on dollar volume of about $328 million. Even at that close, $1.05 was above where the stock traded. Shareholders have yet to be asked. ### From Rounding Error to Top Revenue Line URL: https://www.pennystocks.news/atch-from-rounding-error-to-top-revenue-line/ Last updated: 2026-09-20T13:00:34.000Z A year ago, AtlasClear barely earned anything from helping broker-dealers locate shares their clients wanted to borrow for short selling. Last fiscal year, the company says it generated **about $6.8 million from that business**, up from about $0.3 million the year before, making it the single largest driver of an **85% jump in total revenue**. AtlasClear Holdings, Inc. NYSEAMERICAN: ATCH AtlasClear issued preliminary unaudited results on September 17 for the fiscal year ended June 30, 2026, showing **total revenue of about $20.1 million**. The locate business alone accounted for roughly 34% of that, according to the release. Two years ago the company says the service barely existed. For a shareholder, two things frame what that growth produced. The company says it earned **net income of about $2.0 million** — its second straight profitable year, though the figure includes non-cash gains from changes in the fair value of financial instruments. And it did so without printing new shares: **no dilutive capital raise since October 2025**, the company says. Cash roughly doubled, from about $7.5 million to **about $15.4 million** at June 30, 2026\. Stockholders' equity swung from a deficit to **about $21.1 million positive**. The release does not itemise what drove the cash increase; the full 10-K is expected by September 28, 2026. Shares closed 16.01% higher at $0.2000 on September 20, on dollar volume of about $428,000 across 3,304 trades. The company has also signed agreements with **six new correspondent broker-dealers** — firms that outsource their clearing to AtlasClear — who are still in various stages of onboarding and conversion. None of their revenue appears in the fiscal 2026 figures. The company says it expects them to begin contributing during fiscal 2027, but those results are not yet in hand. ### A Tiny Nasdaq Miner Is Buying a Century-Old Borate Operation Out of Bankruptcy URL: https://www.pennystocks.news/feam-a-tiny-nasdaq-miner-is-buying-a-century-old-borate-oper/ Last updated: 2026-09-19T19:40:34.000Z Searles Valley Minerals and its predecessors have mined boron from California's Searles Lake without interruption since the nineteenth century. **In June, it filed for bankruptcy.** Last week, 5E Advanced Materials agreed to buy most of what it owns. 5E Advanced Materials, Inc. NASDAQ: FEAM The deal covers two processing plants, **about 9,000 acres of Searles Lake brine deposits**, the Trona Railway short-line railroad, and a water utility that serves the surrounding Trona community in California's Mojave Desert. The purchase price comes in three parts: **about $3.4 million in cash, 8.3 million new shares of 5E stock, and a note of about $6.2 million.** To fund the deal and cover working capital, 5E secured **$10 million in bridge financing** from Searles Valley Minerals' own ultimate parent company, according to the September 15 announcement — the seller's parent is lending the buyer the cash to make the purchase. The share component is what existing holders need to understand. 5E will issue 8.3 million new shares as part of this deal. The company's free float — the shares currently available to trade — stands at about 11.1 million. Every new share issued means the same company is divided into more pieces, making each existing piece smaller. **Shares closed 21.36% higher at $2.5000** after the deal was announced, on dollar volume of about $6.9 million. The transaction still requires approval from the Delaware bankruptcy court and, separately, federal authorization for the transfer of the railroad. **Closing is expected in October.** The announcement does not name Searles Valley Minerals' ultimate parent. The same company whose subsidiary went into bankruptcy is now the one providing the funds for someone else to buy it out. ### The Bid SkyAI's Board Has Been Avoiding for Three Months URL: https://www.pennystocks.news/fwdi-the-bid-skyai-s-board-has-been-avoiding-for-three-month/ Last updated: 2026-09-19T16:20:34.000Z Three months ago, Forward Industries went public with a proposal to buy SkyAI. SkyAI's board said nothing, and the offer expired. On September 15, Forward went public again. Forward Industries, Inc. NASDAQ: FWDI The updated proposal carries a **50% premium** to SkyAI's closing price on September 14\. Each SkyAI share would convert at a fixed ratio of **0.306 Forward shares**, implying **$2.13 per SkyAI share** against SkyAI's close of $1.42 that day. Unlike the first approach — an all-stock offer that Forward disclosed in a June Globe Newswire release — this one lets SkyAI shareholders choose cash, Forward stock, or a mix of both. The ratio is fixed and does not adjust if either company's stock moves, so the real value of a stock election could differ from what the implied price is today. Shares of Forward closed **24.19% higher at $7.70** after the filing, on dollar volume of about $49 million. For SkyAI shareholders, the 50% premium is a concrete number. The catch is that it is not a firm offer. The proposal is non-binding and depends on due diligence, a signed merger agreement, regulatory clearance, and a vote of SkyAI's own shareholders. Any of those could fail, and none has started, because SkyAI's board has not agreed to engage. That refusal to engage is what makes the September 15 filing significant. Forward's chief investment officer, Ryan Navi, said in the release: "SkyAI's stockholders have waited long enough. We're ready to move quickly — the next step is for the Board to engage." Publishing an offer a board has not agreed to negotiate is one way to apply pressure directly on the shareholders who would vote on any eventual deal. Forward has set a response deadline of **5:00 p.m. Eastern on September 25**. The June offer also had a deadline, and it passed without a reply. The filing does not explain why a Solana blockchain treasury company is pursuing an AI firm, what SkyAI generates in revenue, or what Forward intends to do with it if the acquisition closes. Both companies are listed on Nasdaq, and the combined entity would sit across two sectors — Solana-focused crypto assets and AI — without a stated rationale for why those belong together. What happens if SkyAI's board goes quiet again, Forward has not said. ### The Supplier That Makes This Smart-Glass Tech Is Back in Business URL: https://www.pennystocks.news/refr-the-supplier-that-makes-this-smart-glass-tech-is-back-i/ Last updated: 2026-09-19T13:00:34.000Z Gauzy makes the film that sits inside Research Frontiers' smart glass. A debt crisis had stopped production. On September 8, a court in Tel Aviv approved the deal that clears the path back. Research Frontiers Inc NASDAQ: REFR Shares closed **68.49% higher at $0.6513** after Research Frontiers released the news on September 18, on dollar volume of about $70 million. Research Frontiers holds the patents and signs the licensing deals, but it does not make the film that its licensees put in cars, aircraft and buildings. Gauzy does. When Gauzy's debts overwhelmed it and production stopped, every licensee waiting on film was waiting on Gauzy — and Research Frontiers' royalty stream went with it. The settlement that ends that wait had near-unanimous backing. **Creditors holding 98.96% of voting claims approved the plan, and 100% of Gauzy's secured lenders voted in favour**, according to the Research Frontiers release. Gauzy said in its own September 18 announcement on GlobeNewswire that the settlement resolves **about $61 million in pre-petition debt** and that **$7 million in new capital has been committed** to support operations going forward. Film production at Gauzy's German factory and emulsion production at its Israeli site are both restarting. Research Frontiers CEO Joseph M. Harary said in the release that **"activities and funding" are already flowing** to both locations. The restart also removes the block on products that were waiting behind the shutdown. Harary said production needed to resume before **black SPD film and products aimed at the architectural retrofit market** could move forward. Both can now. ### $38,000 in Cash. A $100 Million Share Offering. URL: https://www.pennystocks.news/mkdw-38-000-in-cash-a-100-million-share-offering/ Last updated: 2026-09-12T19:40:33.000Z The financial statements showed **$38,252 in cash** and raised doubt about whether the company could keep operating without new money — what auditors call a going-concern warning. Three days later, MKDWELL Tech opened **a program to sell up to $100 million of new shares** into the market. MKDWELL Tech Inc. NASDAQ: MKDW The half-year results, filed as a 6-K on September 8, showed a **net loss of $6.52 million** for the six months ended June 30 — nearly four times the $1.70 million loss in the same period a year earlier. The filing says **$5.22 million of that came from share-based compensation** paid to four consultants in April. Revenue for the period was about $1.5 million. For anyone holding the stock, the share-sale program is the part that affects them directly. In an at-the-market offering, a company can sell new shares into the trading session on any day it chooses, at prevailing prices — **every new share issued makes the existing ones a smaller slice of the same company**. With a free float of roughly 3.1 million shares, even a fraction of the $100 million ceiling would be large relative to what already trades. Shares **closed 51.96% higher at $7.75** on September 12, on dollar volume of about $10.6 million, after the results and the **at-the-market offering agreement with Maxim Group LLC** were filed. **Working capital was in deficit by about $6 million** as of June 30, and **accumulated losses stood at $22.6 million**. The filing says the company has historically depended on bank borrowing and related-party financing to keep running, and cannot assure profitability. The September 11 filing says proceeds are intended for general corporate purposes, including working capital, with no current plans for specific acquisitions or investments disclosed. One balance sheet item from June 30 had not resolved when the results were filed: **a $3.3 million unsecured loan to a Chinese manufacturing firm**, with repayment due July 31\. The September 8 filing noted **the loan had not been collected**. ### A Used-Car Dealer Is Racing a September 18 Default Deadline URL: https://www.pennystocks.news/crmt-a-used-car-dealer-is-racing-a-september-18-default-dead/ Last updated: 2026-09-12T16:20:34.000Z The lenders moved the deadline once. Then they moved it again. **September 18 is now when the default waiver expires**, according to an 8-K filed with the SEC on September 11, and America's Car-Mart says it is close to a deal. America's Car Mart Inc NASDAQ: CRMT Two days before the deadline extension, the company filed its first-quarter results. It reported a net loss of about **$69 million** for the quarter ended July 31, 2026\. **Retail units sold were down 81.9%** from a year ago, to 2,450 cars. CEO Doug Campbell attributed the collapse to the same problem driving the lender talks: "This is a capital structure story, not a demand story." Shares closed 19.50% higher at $1.9000 on September 12 after the filings, on dollar volume of about $5.8 million. For anyone holding the stock, the September 11 filing sets out what happens if no deal gets done. The company says there is no assurance talks will produce any outcome favourable to shareholders. It names bankruptcy protection as a possibility. Common stockholders, the filing says, "could experience a significant or complete loss of their investment." ## A business running on fumes The lender holding the company to this deadline is Silver Point Finance, which stepped in under a credit agreement signed in October 2025\. Silver Point first set the waiver expiry at September 7, then extended it to September 11, then extended it again to September 18\. The company says in the filing that discussions "remain active" with Silver Point, its other lenders, and unidentified third parties. **Unrestricted cash — the money available for day-to-day operations — stood at $27.5 million** at the end of July, down from $47.0 million three months earlier. With little capital to buy inventory, there was little inventory to sell. During fiscal 2026 the company consolidated 60 of its dealerships, cutting its count to 94. Credit performance deteriorated alongside the sales collapse. **Loans written off after failed collection attempts ran at 9.5% of average finance receivables** for the quarter, up from 6.6% a year earlier. The company attributes the rise to three factors: a smaller loan book against which the ratio is measured, cost-of-living pressure on customers, and disruption during a transition to centralised collections — which it says is now complete. On top of the operating loss, the quarter included about **$13.7 million in charges that the company describes as non-recurring**: professional fees tied to the capital structure review and retention bonuses for staff. The special committee overseeing the strategic review has not disclosed what a transaction would look like. The filing lists refinancing, recapitalisation, and potential mergers and acquisitions as possibilities. What it makes clear is that September 18 is not another extension in an open-ended process — it is where Silver Point's patience, for now, runs out. ### Copart Is Buying the Online Wholesale Car Auction Upstart URL: https://www.pennystocks.news/acva-copart-is-buying-the-online-wholesale-car-auction-upsta/ Last updated: 2026-09-12T13:00:12.000Z Copart, which built its business buying and reselling salvaged and total-loss vehicles, has agreed to acquire ACV Auctions — a company that does something quite different: running an online wholesale market where working used cars change hands between dealers. The deal, signed on September 10, 2026, moves Copart into a corner of the used-car market it did not previously occupy. ACV Auctions Inc. NYSE: ACVA The price is **$10.50 per share in cash**, with no financing condition attached, meaning Copart is not relying on borrowed money to close. For holders, that removes one of the usual ways a deal like this falls apart. The ACV board recommended that shareholders accept. Shares closed 44.18% higher at $10.41 on dollar volume of about $1.2 billion across about 112,000 trades after the announcement, settling just below the offer price — the small gap reflecting the market's view that the deal is not yet certain. Whether it closes depends first on shareholders. Copart must receive valid tenders from holders representing more than half of ACV's outstanding shares, and the offer must remain open for at least **10 business days** from the date it formally commences. Separately, the deal requires regulatory clearance under U.S. antitrust law. That is the piece the termination fees are written around: if a court blocks the transaction or the parties miss the regulatory deadline, Copart owes ACV a **reverse break fee of about $115.3 million**. If ACV instead walks away to take a better offer, ACV pays Copart **about $57.7 million**. The asymmetry matters. Copart's potential penalty is roughly double ACV's, which typically signals that the buyer accepted more regulatory risk than usual to get the deal done. The filing does not explain why; it states the figures without attributing a reason. A group of existing ACV stockholders, holding **about 4.1%** of outstanding shares as of September 8, have already signed support agreements committing them to tender. That is a thin base — the deal still needs most of the rest of the float to participate. Once the tender clears the 50%-plus-one threshold, Delaware law allows Copart to complete the merger immediately without a separate shareholder vote. Holders who do not tender in time receive the same $10.50 in cash at the merger's effective date. Employee stock options with exercise prices above $10.50 are cancelled for nothing. Vested options priced below the offer get cashed out at the spread. Unvested options, restricted stock units, and performance-based awards convert into equivalent Copart equity on the same vesting schedule, so employees remain exposed to Copart's stock price rather than receiving an immediate payout. The 8-K does not disclose what drew Copart to ACV, what a combined company would look like operationally, or what either party expects to pay in antitrust remedies if regulators demand concessions before approving the deal. ### Pay the Notes or Watch Them Convert at a Discount. Tenon Paid. URL: https://www.pennystocks.news/tnon-pay-the-notes-or-watch-them-convert-at-a-discount-tenon/ Last updated: 2026-09-11T23:00:34.000Z The notes were due Thursday. On Tuesday, Tenon Medical paid them off in full — two days before the deadline, and with a stated reason: to stop the holders from converting the debt into new shares at a price set below what the stock was trading. Tenon Medical, Inc. NASDAQ: TNON According to an amended 8-K filed with the SEC, the notes were convertible into common stock at a price equal to 80% of the average trading price over the prior three days — meaning every share issued through conversion would carry **a 20% discount to market**. Each discounted share makes the ones already outstanding worth a smaller slice of the same company. Tenon's early cash repayment, announced in an 8-K filed with the SEC on September 9, ended that possibility. The notes carried an aggregate principal of about **$5.16 million** and had been issued six months earlier, in March 2026, according to the filing. For an existing shareholder, the difference between cash repayment and conversion is concrete: cash leaves the share count unchanged; conversion hands a discounted stake to the note holders at everyone else's expense. The company chose to pay. **Shares closed 117.21% higher at $5.3000** on the maturity date after the announcement, on dollar volume of about $584 million across roughly 933,000 trades. "By proactively addressing this obligation, we are reducing potential dilution for our shareholders," said Steven M. Foster, chief executive officer and president, in the company's September 9 press release. The free float stands at about **534,000 shares**, roughly 80% of shares outstanding. Short volume on the session — the number of shares sold short during Thursday's trading, not total outstanding short positions — was about **32 million shares**, or about 59% of reported volume. Both figures come from the same session: a free float of about 534,000 shares, and roughly 32 million shares of short-side activity. The same filing's boilerplate lists the company's ability to continue as a going concern and its ability to regain compliance with Nasdaq listing standards among the subjects it has made forward-looking statements about. Neither is addressed in the press release. ### Aterian's New CEO Holds a Stake That Could Dwarf the Float URL: https://www.pennystocks.news/ater-aterian-s-new-ceo-holds-a-stake-that-could-dwarf-the-fl/ Last updated: 2026-09-11T19:40:34.000Z On July 17, Aterian sold its consumer brand portfolio and brought in a new chief executive. **David Lazar paid $7 million for preferred stock that, once converted, gives him 95.7% of the company.** Six weeks later, Nasdaq told Aterian its stock had been below the minimum price for 30 straight trading days. Aterian, Inc. NASDAQ: ATER Shares closed 20.70% higher at $0.8570 on September 11, on dollar volume of about $5.2 million, the session after Lazar filed a Schedule 13D with the SEC disclosing the full terms of his stake. For anyone holding common shares, the two facts belong together. **Lazar's preferred stock can convert into about 250 million common shares.** About 18 million common shares are currently outstanding. Every share created on conversion makes the ones already issued worth a smaller slice of the same company. The investment came in two equal payments. **In April, Lazar paid $3.5 million for Series AA preferred stock,** each share of which converts into 7.7 common shares. Stockholders approved the second stage at a July meeting, and Lazar paid another $3.5 million for Series AAA preferred — which converts at 135.1 common shares per preferred share, the far higher rate that accounts for most of the potential new stock. In August he converted half his Series AA shares **into about 6.7 million common shares, which carry voting rights.** The remaining preferred generally does not. **On September 2, Nasdaq sent Aterian a bid-price deficiency notice:** the stock had closed below the required $1.00 for 30 consecutive business days. **The company has until March 1, 2027 to regain compliance,** which requires the closing price to hold at or above $1.00 for ten consecutive business days. Stockholders approved a reverse stock split at the July meeting, according to the Schedule 13D. Under the preferred stock terms, conversion prices adjust for reverse splits, so consolidating the share count would not change Lazar's ownership share after conversion. **As of September 4, Lazar is also the company's interim chief financial officer,** after the previous CFO was terminated under a transition agreement. He holds both executive roles at a company that has sold its main business, has no permanent finance chief, and must get its stock above $1.00 to stay listed — all while holding preferred stock he can convert to common at any time of his choosing. ### Synergy Filed for Bankruptcy. Four of Its Five Directors Quit the Same Day. URL: https://www.pennystocks.news/snyr-synergy-filed-for-bankruptcy-four-of-its-five-directors/ Last updated: 2026-09-11T16:20:34.000Z The petition was filed on September 4\. By the end of that same day, four of the five members of the board were gone. Synergy CHC Corp. filed a voluntary Chapter 11 petition — the form of bankruptcy that keeps a company trading while it works out what comes next — with the US Bankruptcy Court for the District of Columbia. **Four directors resigned immediately after the filing**: Alfred Baumeler, Nitin Kaushal, J. Paul SoRelle, and Teresa Thompson. The sole person left on the board is Jack Ross, who signed the 8-K the company filed with the SEC four days later. Synergy CHC Corp. NASDAQ: SNYR For anyone holding shares, the position is this: the company's assets are now under court supervision, a single director is running the board, and the company says it expects to put forward a plan — either to restructure or to wind down — **within 120 days**. Which of those two it will be, the filing does not say. The departures had been building for days before the filing. Baumeler had already stepped down as president on August 31\. A week before that, on August 26, **the company brought in Lauren P. Berret of Eisner Advisory Group** as chief restructuring officer. The VerStandig Law Firm is acting as bankruptcy counsel, the filing states, pending court approval. The 8-K says the four directors resigned "in connection with the company's chapter 11 filing" and not over any dispute about operations or policy. Shares closed 30.59% higher at $0.1080 on September 11, on dollar volume of about $42 million. Short volume on the session was about **50.7 million shares, or 54.68% of reported volume**, according to the stock note. The free float is about 8.1 million shares. Whether the company reorganises or liquidates, the answer is due within 120 days. Jack Ross is the one who will have to decide which way to push it. ### Six Metals in the Same Core: Talon Sets a Project Record in Minnesota URL: https://www.pennystocks.news/tloff-six-metals-in-the-same-core-talon-sets-a-project-recor/ Last updated: 2026-09-11T13:00:27.000Z The record at Tamarack is not just about length. On September 9, Talon Metals published assay results from the longest drill interval in the project's history — and the six metals it returned made the grades the story. TALON METAL CORP NEW OTC: TLOFF The interval runs **46.43 metres, grading 13.37% nickel and 16.54% copper**. Those two figures alone would constitute a notable result. Across the same stretch of core, **platinum came back at 14.49 grams per tonne, palladium at 7.85 grams per tonne and gold at 8.56 grams per tonne**, according to Talon's September 9 release. Cobalt was also present throughout. Buried within that interval is a tighter section: **26.22 metres grading 14.95% nickel and 17.85% copper**, with platinum and gold also higher than the broader average. Shares closed 33.79% higher at $8.0945, on dollar volume of about $12.9 million. The hole was drilled **about 50 metres southwest of the original Vault Zone discovery hole**, confirmed in May 2025\. That step-out matters: it shows the mineralised system reaches laterally, not just downward, and that grades like these are not confined to the single hole that first found them. "Any one of these grades will get your attention," said Brian Goldner, Talon's Chief Exploration Officer, in the release. "To see nickel, copper, cobalt, platinum, palladium, and gold all concentrated at these levels in the same rock is particularly significant." The Vault Zone sits below Tamarack's existing resource estimate, so any confirmed extension of it adds ground the current resource numbers do not yet capture. Talon says further step-out drilling is under way, guided by borehole electromagnetic surveys. How far the zone extends — sideways and at depth — is the question that will determine whether this intercept changes the resource picture or remains a particularly rich corner of it. ### United Arab Emirates Pledges 40 Billion Euros of Investment in Germany URL: https://www.pennystocks.news/uae-40-billion-euro-investment-germany/ Last updated: 2026-09-11T09:37:50.000Z The United Arab Emirates said it will **invest 40 billion euros in Germany**, with the money directed at data centres, artificial intelligence, energy and defence. The pledge was set out in a joint statement by UAE President Mohamed bin Zayed Al Nahyan and German Chancellor Friedrich Merz during a visit to Berlin. **A quarter of the sum, 10 billion euros, is earmarked for Bavaria**. An investment council will also be set up to strengthen trade between the two countries. The figure is an addition rather than a restatement: it comes **on top of 34 billion euros the UAE has already invested in Germany**. Alongside the government announcement, German and Emirati companies signed **more than 9 billion euros in further commercial agreements** during the visit. The report gives no further detail: no breakdown of how the 40 billion euros splits between the four named sectors, which entities on the Emirati side will supply the capital, or over what period it will be deployed. **No timetable and no named projects were reported**. ## Part of a wider European push The German package follows similar commitments elsewhere in Europe. The UAE has previously **promised 50 billion euros of investment in France** and tens of billions more in Italy. Taken together, the moves point to a strategy of broadening ties with European economies rather than relying on the relationship with the United States alone. The direction of travel suits Berlin. Merz travelled to the Gulf himself in February, with the stated aim of strengthening energy and defence links and reducing Germany's dependence on the United States and China. Sultan Ahmed Al Jaber, the UAE's minister of industry and technology and chief executive of the state oil company Abu Dhabi National Oil Company, said Germany has been a strategic and economic partner of the Emirates for decades. He described the investment as long-term in nature and said the 40 billion euros reflects the country's ambition in the relationship. Those remarks came from the Emirati side of the announcement and are framing rather than a financial commitment with defined terms. ## Where the money is pointed Of the four sectors named, energy and defence are the two Germany had already singled out: strengthening those links was the stated aim of Merz's own trip to the Gulf in February. The two countries have been partners for more than fifty years. Which companies will eventually receive contracts from the programme is **not stated in the report**. Source: [www.nu.nl](https://www.nu.nl/economie/6409376/emiraten-willen-sterkere-band-met-europa-en-investeren-40-miljard-in-duitsland.html?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### A Liver Biotech Drops Its Name and Reinvents Itself Around Gut Surgery URL: https://www.pennystocks.news/glmd-a-liver-biotech-drops-its-name-and-reinvents-itself-aro/ Last updated: 2026-09-10T23:00:34.000Z For years, Galmed Pharmaceuticals chased a drug for liver disease. On September 9, it scrapped the name, the ticker, and the corporate identity. Galmed Pharmaceuticals Ltd. NASDAQ: GLMD The company is now **EoCene Ltd., trading on Nasdaq under the symbol EOCN**. At the centre of the rebrand is **Colospan, a subsidiary Galmed acquired in June**, which makes a device called CG-100\. Designed to protect the surgical join made during colorectal operations, it sits inside the bowel to shield that join while it heals — reducing the need for surgeons to route the bowel through a temporary opening in the abdomen. The device is **approved for sale in Europe and Israel** but is not approved for commercial use in the United States, where it is running a pivotal trial and holds an FDA designation for expedited development and review. For shareholders, the company they own has shifted character. Chief Executive Allen Baharaff said in the announcement that because CG-100 is already commercial-ready in Europe and Israel, the company believes Colospan may generate revenue faster than a conventional drug programme. The company said it held about **$11.4 million in cash and short-term investments as of June 30**, which it called a sufficient foundation to execute the transition. In the same announcement, the company cut off its equity line with investor YA II PN, Ltd., known as Yorkville, effective September 8\. That facility had offered up to **$20 million in funding**; before termination, **the company had drawn about $7.3 million**, issuing 437,947 ordinary shares in the process. The announcement gave no reason for the termination. The rebrand also arrived alongside the end of a separate problem. Nasdaq had warned the company in January 2026 that its shares had failed to hold the exchange's required minimum price of $1.00 per share, triggering a compliance notice. The company missed its first deadline and received an extension. It cleared the bar by holding above $1.00 for **10 consecutive trading days** between August 20 and September 2, and Nasdaq confirmed compliance on September 3. Shares **closed 21.05% higher at $4.6300** on September 10, after the rebrand was announced, on dollar volume of about $1.25 million. The drug that Galmed was originally built around — Aramchol, a compound being tested in liver disease and certain cancers — stays in the pipeline. Whether a company that spent years as a pre-revenue liver biotech can convert a colorectal device into commercial sales is the question the new name does not answer. ### A Singapore Ship Fueler Nearly Doubled Its Revenue in Six Months URL: https://www.pennystocks.news/ufg-a-singapore-ship-fueler-nearly-doubled-its-revenue-in-si/ Last updated: 2026-09-10T19:40:05.000Z The revenue nearly doubled. The stock trades at less than a fifth of what investors paid at the IPO. Uni-Fuels Holdings reported **$197 million in revenue for the six months ended June 30, 2026**, against about $115 million a year earlier — growth of roughly 72%. **Net income was $1.4 million**, according to an unaudited 6-K filed with the SEC on September 9\. In the same period a year earlier the company was barely profitable; the first-half 2026 result is a meaningful step up in scale. Uni-Fuels Holdings Limited NASDAQ: UFG Shares **closed 24.97% higher at $0.7196**, on dollar volume of about $72 million, after the results were filed. The company listed on Nasdaq at $4 per share in January 2025. For a Class A shareholder, the half-year numbers offer the clearest sign yet that the business is working. The open question — which the filing does not answer — is what it takes for that operating progress to close the distance between the current share price and the listing price. The day before the results appeared, shareholders met and voted to change the rules for passing decisions by written resolution. Written resolutions let a company act without convening a formal meeting. Under the previous rules, every eligible shareholder had to sign; a single holder could block anything put to a written vote. The new standard requires only a majority of votes. The voting structure gives that change its weight. Each Class A share carries one vote; each Class B share carries 100\. There are 9,815,000 Class A shares — all of them in the public float — and about 22.65 million Class B shares, which were not offered in the IPO. With 100 votes apiece, the Class B shares control the overwhelming majority of eligible votes. Under the new majority standard, whoever holds those shares can pass any written resolution without Class A holder agreement. Previously, any single Class A holder could veto one. **That right is now gone.** Shareholders also voted to add an exclusive Cayman Islands jurisdiction clause for certain legal disputes, concentrating any challenge to company decisions in its place of incorporation. The filing gives no reason for either governance change. A Class A holder who bought at the IPO has watched the stock fall to less than a fifth of the entry price. The half-year results show the underlying business growing fast. Now that holder also has no veto over the next decision the company wants to pass without a meeting. ### A Rare Eye Disease Gene Therapy Shows Vision Gains in Every Patient Treated URL: https://www.pennystocks.news/ird-a-rare-eye-disease-gene-therapy-shows-vision-gains-in-ev/ Last updated: 2026-09-10T16:20:25.000Z Five patients enrolled in the first group of Opus Genetics' gene therapy trial for a rare inherited retinal disease. **All five showed clinically meaningful gains in visual function,** and none experienced a serious adverse event, the company said in a September 9 announcement. Opus Genetics, Inc. NASDAQ: IRD The therapy, OPGx-BEST1, is delivered beneath the retina in a single procedure. It carries a working copy of the BEST1 gene to the retinal pigment epithelium — the cell layer that keeps photoreceptors alive. Mutations in BEST1 damage that layer progressively, causing vision loss. No approved treatment currently addresses the genetic root cause. Three of the five patients improved on standard visual acuity testing. **Three of four evaluable patients showed better retinal sensitivity on microperimetry,** a test that maps how well the central retina detects light across a defined area. Structural improvements — including reductions in the abnormal deposits that define the most common form of the disease — appeared in four of the five. The company notes that the largest gains occurred in patients with less advanced disease, where viable retinal tissue remained. **Shares closed 32.03% higher at $5.7300** after the announcement, on dollar volume of about $332 million. The FDA's position, reached in a meeting last month, makes the clinical finding more consequential. The agency aligned with Opus Genetics on a potential endpoint for a confirmatory trial: a gain of **at least 3 decibels on microperimetry** across five pre-specified measurement points, combined with a patient-reported outcome, in a randomised controlled design. The company says it expects to complete Phase 3 manufacturing requirements in early 2027 and to begin participant dosing that year. Ahead of that, the company has advanced to a higher-dose second group. **Eight patients enrolled** — three more than originally planned — and dosing is expected to wrap up in the fourth quarter of 2026, with three-month results due in the second quarter of 2027. New epidemiology research commissioned by the company estimates roughly **23,600 symptomatic BEST1 patients in the US** — including both diagnosed and undiagnosed cases — and about 45,400 worldwide, figures the company says are substantially larger than earlier estimates. Cash on hand is expected to cover operations into 2029, the company says, long enough to reach multiple clinical milestones. Higher-dose Cohort 2 results and the start of Phase 3 enrolment are both expected in the same quarter. ### America's Only Solar Cell Maker Is Building a Second Factory URL: https://www.pennystocks.news/sune-america-s-only-solar-cell-maker-is-building-a-second-fa/ Last updated: 2026-09-10T13:00:01.000Z The building shell in Laurens County, South Carolina is already up. On September 8, Suniva said it has the money to put a factory inside it. SUNation Energy, Inc. NASDAQ: SUNE Suniva says it **closed $835 million in combined debt and equity financing**, according to a press release filed with the SEC. The package includes senior secured credit facilities from funds managed by Goldman Sachs Alternatives and I Squared Capital, a second lien facility from JBA Asset Management, and equity from Electron Capital Partners, Orion Infrastructure Capital, and Rubric Capital Management, among others. The new plant is designed for **4.5 GW of annual solar cell production capacity**, adding to an existing factory in Norcross, Georgia that already runs at 1 GW. At 5.5 GW combined, the company would go from a niche domestic producer to a scale that could supply a material share of U.S. solar demand. A gigawatt is roughly the generating output of a large power station; the jump from 1 to 5.5 is not incremental. The company says the Laurens County project will cost about **$600 million** and is expected to create 564 manufacturing jobs in South Carolina's Upstate region. Completion is expected in late 2027, with a full production ramp in 2028\. The building shell is already complete. The financing is tied to a pending merger. Suniva agreed in June to combine with SUNation Energy in a reverse merger — where Suniva, the private company, effectively takes over SUNation's Nasdaq listing — with the combined entity operating under the Suniva name. Before the deal can close, SUNation stockholders must vote on several items, including raising **the authorized share count from 1 billion to 1.5 billion**. A registration statement covering the full terms has not yet been filed with the SEC. Shares **closed 90.30% higher at $4.5100**, on dollar volume of about $460 million across 614,014 trades. The free float was about 3.5 million shares; reported short volume for the session was about 41.2 million. The company says long-term offtake agreements with U.S. solar buyers already cover the majority of planned output from the new plant. No customers are named in the release, and no dollar value is given for those agreements — which are what the expansion's revenue case rests on. ### The Radar Chip Chosen for Eyes-Off Driving in China URL: https://www.pennystocks.news/arbe-the-radar-chip-chosen-for-eyes-off-driving-in-china/ Last updated: 2026-09-09T23:00:21.000Z One of the world's largest automotive groups has chosen Arbe Robotics' radar chipset for a **Level 3 automated driving program covering multiple brands in China**. Series-production radar deliveries are set to begin in the **fourth quarter of 2027**, Arbe and its partner announced September 8. Arbe Robotics Ltd. NASDAQ: ARBE The contract runs through Hirain Technologies, a Beijing-based automotive electronics supplier founded in 2003 that will manufacture, integrate and validate the complete radar system. Level 3 means the car handles the driving in defined conditions and the driver can take their eyes off the road — a standard that demands sensors deliver far more precise data than ordinary driver-assistance radars. Arbe's chipset generates that denser picture, according to the announcement. Hirain builds the system around it. The automotive group is not named. The announcement, and an accompanying Form 6-K filed with the SEC on September 8, describe it only as "one of the world's largest automotive groups," with the program spanning multiple brands under that group. Shares closed 16.93% higher at $0.7431 after the announcement, on dollar volume of about $86 million across roughly 236,000 trades. The win matters most as a commercial milestone rather than an immediate revenue event. In the six months ended June 30, 2026, Arbe recorded **about $1.2 million in revenue** — compared with about $314,000 in the same period a year earlier — the majority from chipset sales, according to financial statements filed with the SEC on September 4\. The **net loss in that period was about $18.5 million**. At June 30, the company held about $5 million in cash and roughly $36.6 million in short-term bank deposits. Every new share issued makes the existing ones a smaller slice of the same company, and Arbe has been issuing: the share count rose from about 109 million at the start of 2026 to about 127 million by June 30, according to the same filing. In January 2026, Arbe raised roughly $17 million net in a public offering, selling shares **at $1.40 each**. The September 8 filing's own risk disclosure names the possibility of Nasdaq delisting **if the share price stays below $1.00** — which, at Tuesday's close, it did. The Q4 2027 delivery schedule is set ahead of vehicle start of production, meaning Hirain needs the chipsets validated and ready before cars begin rolling off the line. Arbe's own risk language in the September 8 filing named the core uncertainty plainly: the program might "not advance to start of production on the anticipated schedule or at all." ### Patrick Soon-Shiong's Nant Takes Board Seats at PDS Biotech URL: https://www.pennystocks.news/pdsb-patrick-soon-shiong-s-nant-takes-board-seats-at-pds-bio/ Last updated: 2026-09-09T19:40:18.000Z Patrick Soon-Shiong's Nant Capital is joining PDS Biotechnology's board of directors. Alongside a capital injection expected to close within days, it secured the sole right to negotiate a license to one of the company's cancer programs — for an entire year. PDS Biotechnology Corporation NASDAQ: PDSB The deal was signed September 7 and disclosed in an 8-K filed with the SEC the following morning. For shareholders, it means a new investor with significant resources has taken board-level influence and holds an exclusive path to one of the company's programs — one that no competing bidder is now permitted to approach. **Shares closed 36.36% higher at $0.3000**, on dollar volume of about $210 million across about 671,000 trades. The capital arrives in two tranches. At an initial closing expected around September 11, the company will raise roughly **$11.5 million** from a group of accredited investors in a private placement. Buyers receive shares or pre-funded warrants, each unit paired with additional warrants exercisable at **$0.22 per share** for one year. A second tranche of about **$11 million** is contingent on a clinical milestone. PDS Biotech must submit a registrational Phase 3 trial protocol for its tumor-targeting program PDS0301 to the FDA — a protocol the filing says will be designed in collaboration with Nant. Once submitted, Nant Capital and a co-investor called AB Group are obligated to fund the second tranche. **Nant has the right to designate two directors**, one of whom must be Dr. Patrick Soon-Shiong himself. That right holds as long as Nant owns at least **15%** of the company's outstanding shares. If Nant's stake falls below that threshold, its designees must offer to resign. Separate from the equity deal, Nant's subsidiary NantWorks is taking an exclusive option to negotiate a license over PDS0101, the company's HPV-targeted cancer vaccine. The price for that option is **$25,000**. In return, PDS Biotech cannot reach any competing licensing agreement on PDS0101 for the full year ahead, and cannot enter one at all without NantWorks' written consent. The full placement — including all warrants and milestone securities — could produce up to about **111 million new shares**. The company's free float entering the deal stood at about 47.6 million shares, so the ceiling on potential new issuance is roughly double what currently trades. What NantWorks ultimately pays for PDS0101, if it reaches an agreement at all, is what the next year of negotiations will decide. The $25,000 buys the conversation, not the program. ### Ottawa Keeps a List of Approved AI Suppliers. A Toronto Company Just Got On It. URL: https://www.pennystocks.news/predictiv-ai-canada-government-ai/ Last updated: 2026-09-09T17:46:37.000Z Canada spent this year learning how much of its economy hangs on decisions made in Washington. **Tariffs came, and then they were suspended.** The answer has been the same everywhere: make it at home instead. With technology that gets expensive. The Canadian government is one of the biggest technology buyers in the country. Now there is pressure to keep that money in the country. ## You have to be on the list Selling software to the Canadian government is not something you just do. The government keeps a list of approved suppliers. **Only companies on it get to bid on the work.** If you are not on it, you never even see the job. Predictiv AI Inc. (CSE:PAI / FWB:7IT) is now on it — at all three levels, including the top one. **That band covers requirements of up to $37.5 million before taxes.** The announcement does not say which dollar. The procurement agency's letter is dated August 26\. The Toronto company made it public on September 9\. The stock is listed in Canada and trades in Frankfurt under the ticker 7IT. Being on the list is not the same as being paid. The company says so itself: the qualification "does not constitute a contract award or guarantee future revenue." Nothing has been won so far. It is permission to try. ## Why a Canadian company has a shot now The argument is not price. It is about where the data ends up. "Organizations need the benefits of advanced AI without giving up control over where sensitive data resides, how it is processed or how it is governed," said Suman Pushparajah, who runs the company. **The announcement makes that point twice.** Once in the text, once in the chief executive's quote. With the tariff question open, Canadian suppliers are betting the argument works in their favour. ## What the company does Predictiv AI builds AI for vehicle fleets and for customer communication: software for managing vehicles, AI agents for voice, chat and SMS, tools for structured workflows. **The company says it is actively pursuing provincial, municipal and airport authority customers** — pursuing them, not yet holding them. ## What counts next Being on the list means the contracts get shown to you. It does not mean any of them get won. What to watch for is a signed contract. Until then Predictiv AI has a letter dated August 26 and a place in a room it could not get into in July. ### A Chinese Meat Company Sold Two-Thirds of Itself to Three People URL: https://www.pennystocks.news/wyhg-a-chinese-meat-company-sold-two-thirds-of-itself-to-thr/ Last updated: 2026-09-09T16:20:21.000Z Three individuals now own roughly two-thirds of Wing Yip Food Holdings. **Wang Tingfeng, Wong Sio Chan and Zhao Jin Hua paid a combined HKD 195 million for 23 million newly issued shares** — placed directly with them at a fixed price, not sold in the open market. Wing Yip Food Holdings Group Limited NASDAQ: WYHG The shares were issued on August 7, 2026 and **listed on the Korea Exchange on September 7**, according to a Form 6-K filed with the SEC on September 8\. After the issuance, the company had about 35.6 million shares outstanding, with the placement shares making up roughly two-thirds of that total. For existing shareholders, this is the central fact: every share held before August 7 now represents a smaller portion of the same company than it did. The three buyers paid **KRW 1,600 per share**, a price approved at a shareholder meeting on August 6. **Wang Tingfeng took the largest position — 13 million shares for about HKD 110 million.** Wong Sio Chan and Zhao Jin Hua each received 5 million shares. The company says the proceeds will go toward procurement costs, marketing and research and development. Shares **closed 44.83% higher at $5.8800** on September 9, on dollar volume of about $112.8 million. All 23 million placement shares are **subject to a lock-up until September 6, 2027**. For a year, roughly two-thirds of the company cannot be sold by the people who hold it. ### A Junior Copper Miner Is Buying Its Own Office to Ready an Arizona Mine URL: https://www.pennystocks.news/cpfxf-a-junior-copper-miner-is-buying-its-own-office-to-read/ Last updated: 2026-09-09T13:00:34.000Z Copper Fox Metals has agreed to buy the Miami, Arizona building it currently uses as an office and core storage for **US$290,000**. The deal is expected to close this month, the company said in a September 2 release. COPPER FOX METALS INC OTC: CPFXF The facility covers **about 0.86 acres** and includes an office, a core preparation room and an outbuilding. As a transaction it is small. It comes as the company finalises both an underground development plan for its Van Dyke copper project in Gila County and an updated economic study of that project — a permanent base near the mine site is the kind of infrastructure that precedes ground being broken. Van Dyke uses in-situ copper recovery: solution is injected underground to dissolve the metal, and the resulting liquid is pumped to surface for processing, without blasting or open-pit excavation. The updated preliminary economic assessment — an early study that estimates whether a project is worth developing — has progressed far enough that the company has now defined a complete excavation plan. That plan calls for **roughly 4,900 metres of tunnelling in two phases**. Phase one covers the **first six years** and targets the higher-grade sections of the deposit first, which the company says is designed to generate copper production earlier and accelerate recovery of capital costs. Phase two, covering **years seven through seventeen**, moves into lower-grade material. Both phases will use a roadheader — a mechanical cutting machine — rather than conventional drill-and-blast methods. The company says this avoids the gases that explosives produce and is expected to maintain the structural integrity of the rock above the workings. A groundwater flow model for the project has been **completed and calibrated**, a step required before the company can model how water moves through the deposit and the surrounding geology. Shares **closed 16.64% higher at $0.5670** on dollar volume of about **$769,000**. The economic assessment has not been published. The release does not say when it will be. ### A Cancer Diagnostics Company Is Buying a Humanoid Robot Maker URL: https://www.pennystocks.news/onco-a-cancer-diagnostics-company-is-buying-a-humanoid-robot/ Last updated: 2026-09-05T19:40:14.000Z Onconetix makes a test that screens for prostate cancer, approved for sale in the European Union. It is in the process of buying a company that makes humanoid robots. On September 3, the robot company announced its latest development. Onconetix, Inc. NASDAQ: ONCO Realbotix, the acquisition target, said it has **launched a pilot with a European telecommunications company** — which it did not name — to deploy its humanoid robots as presenters, hosts, and brand ambassadors at live events. The program tests the robots holding interactive conversations with full audiences, not just one-on-one exchanges. **No dollar value was disclosed**, and the partner was not identified. Shares **closed 38.02% higher at $1.0200** on September 5, on dollar volume of about $6.2 million across 18,828 trades. Onconetix relayed the Realbotix announcement to its own shareholders on the same day it was released. According to the announcement, possible roles for the robots include corporate event hosting, live product demonstrations, education and training support, and reception and concierge functions. The pilot is also intended to test how the Realbotix platform can be configured to a partner's specific workflows, the company says. **Onconetix agreed in February 2026 to acquire 100% of Realbotix LLC**, a wholly-owned subsidiary of Realbotix Corp., in an all-stock transaction. The combined company is expected to trade on Nasdaq after closing, which Onconetix says it anticipates in the **second half of 2026**, subject to shareholder approval, required regulatory approvals, and other conditions. The all-stock structure means existing holders would own shares in a company that has become something quite different from the one they bought into: a humanoid robotics business rather than a cancer diagnostics one. The announcement does not say what would happen to Proclarix under the combined company. ### Immuron Brings a Decade-Old Swedish Gut Health Device to the US URL: https://www.pennystocks.news/imrn-immuron-brings-a-decade-old-swedish-gut-health-device-t/ Last updated: 2026-09-05T16:20:01.000Z Immuron has struck an exclusive deal to bring PROIBS — a gut-health medical device that has been sold in Swedish pharmacies for more than a decade — to the United States. The agreement is with Calmino group AB, the Swedish company that developed the product, extending an arrangement that began when Immuron launched PROIBS in Australia. Immuron Limited NASDAQ: IMRN Shares **closed 62.16% higher at $1.8000** after the announcement, on dollar volume of about $217 million. The deal adds a product with a long commercial track record to Immuron's US lineup. The announcement gives no financial terms, no minimum order commitments, and no date for when PROIBS will reach US shelves. Holders know a new product is coming; the rest is still open. PROIBS is classified as a medical device, not a supplement, and is indicated for abdominal pain, bloating and irregular bowel movements. It works through a gel-forming compound drawn from the Aloe barbadensis plant, which Calmino says supports the intestinal lining. In a usability study of **1,003 people run by Calmino itself**, **94% said the product was helpful** and 98% said they would recommend it to others. Chief Commercial Officer Flavio Palumbo said in the announcement that the move follows what the release described as rapid growth of Travelan, Immuron's existing US product, and forms part of a broader plan to build a gut-health portfolio. No revenue figures for either product were given. During the session, **57.38% of reported volume was short**, according to exchange data — more than half of all volume on the day the deal was disclosed. The release did not address the product's regulatory status in the United States or say when it would be available to US consumers. ### A Heart Drug Failed Its Trial — But the Investor Who Bet on It Says It's Fine URL: https://www.pennystocks.news/nvs-a-heart-drug-failed-its-trial-but-the-investor-who-bet-o/ Last updated: 2026-09-05T13:00:34.000Z The trial failed. Novartis's drug pelacarsen, studied in patients with high levels of a blood protein linked to heart disease, did not reduce cardiovascular events compared to placebo. The investor that had **put $150 million on it** says the deal will still make money. Novartis AG NYSE: NVS That investor is Royalty Pharma, which in January 2023 put **$500 million into a funding deal with Ionis Pharmaceuticals**. The structure of that deal is why Royalty Pharma is not calling it a disaster. Only $150 million rode on pelacarsen. The remaining **$350 million bought royalties on Spinraza**, a treatment for spinal muscular atrophy — and the Spinraza money keeps flowing regardless of what happened in the HORIZON cardiovascular trial. Under the terms of the deal, Royalty Pharma holds 25% of Ionis' Spinraza royalty stream through 2027, rising to 45% from 2028\. The arrangement ends once **royalty payments reach $550 million**, which Royalty Pharma says represents **a 1.1x return on the total amount funded**. Because the trial failed, the company also confirmed it will make no further milestone payments to Ionis. Novartis shares closed 1.90% lower at $159.99 on September 5, on dollar volume of about $203 million. Novartis said it plans to present the full HORIZON data at an upcoming medical congress, according to its September 4 press release. That release noted pelacarsen did lower lipoprotein(a) — the blood protein the drug was designed to target — among participants already receiving standard heart disease treatments. The drug lowered the protein. It just could not turn that into fewer deaths or hospitalisations. ### A Nasdaq Company Holds Eight Percent of All Worldcoin in Circulation URL: https://www.pennystocks.news/orbs-a-nasdaq-company-holds-eight-percent-of-all-worldcoin-i/ Last updated: 2026-09-04T23:00:34.000Z Eightco Holdings says it owns **nearly 302 million Worldcoin tokens — about 8.3% of the token's circulating supply**, the largest publicly disclosed institutional position in the asset, according to a press release the company filed with the SEC on September 3. Eightco Holdings Inc. NASDAQ: ORBS The company put its **total treasury at roughly $380 million** as of September 2, spread across four positions: **about $90 million invested indirectly in OpenAI** through special purpose vehicles, an **$18 million equity stake in Beast Industries** (the holding company behind MrBeast's YouTube operation), roughly $122 million in cash and stablecoins, and the Worldcoin holding. The Worldcoin figure uses a stated price of $0.37 per token as of that evening, per Coinbase. For a shareholder, the company functions as a publicly traded wrapper around assets that are otherwise difficult to access: a liquid token, two private-company stakes, and cash. Two of the four positions — the OpenAI stake and the Beast Industries equity — have no liquid market price, and the release does not explain how either valuation was determined. The OpenAI exposure is held through third-party vehicles, not direct equity, which means Eightco has no involvement in how OpenAI is run and no guaranteed path to liquidity from that stake. Shares closed 15.78% higher at $0.9698 on September 4, on dollar volume of about $28.5 million. The company also said it **bought back more than 25 million of its own shares** over the past month under a previously announced **$125 million repurchase program**. Board member Tom Lee was quoted in the release saying the company "judged that accretively acquiring shares is a high return use of capital." Holding 8.3% of a token's circulating supply is a concentrated position. The release does not say **what Eightco paid for those tokens**, when it accumulated them, or whether any restrictions apply to selling them. ### Chegg Exits Its Debt, But Barely Has Cash Left to Show for It URL: https://www.pennystocks.news/chgg-chegg-exits-its-debt-but-barely-has-cash-left-to-show-f/ Last updated: 2026-09-04T19:40:15.000Z The debt is gone. But so is nearly half the cash. CHEGG, INC. NYSE: CHGG Chegg **repaid $33.9 million in convertible notes** on September 1, the day they came due, according to an 8-K filed with the SEC the same day. The notes carried no interest — the filing describes them as 0% convertible senior notes — and with that payment, Chegg says it **carries no outstanding debt**. The cash position tells the other half of the story. As of June 30, Chegg held **about $72 million in cash and investments**. Handing over $33.9 million cut that roughly in half: the company said in its press release that cash on a pro forma basis would have been **approximately $38 million**. The filing does not say how long that is expected to last. Shares **closed 18.31% higher at $0.9788** on September 4, after the filing, on dollar volume of about $8.8 million. "We have taken meaningful actions to reduce costs and improve cash flow," CFO David Longo said in the press release attached to the filing. "With no debt and a stronger financial foundation, we have the financial flexibility to execute on our strategy and create long-term value for our shareholders." The company has not said what that strategy costs, or how far $38 million takes it. ### SunPower's CEO Drove to Sand Hill Road and Came Back With Venture Capital URL: https://www.pennystocks.news/spwr-sunpower-s-ceo-drove-to-sand-hill-road-and-came-back-wi/ Last updated: 2026-09-04T16:20:34.000Z T.J. Rodgers had a solar stock trading under a dollar and a story he thought Silicon Valley would buy. So he got in his car. On a single day of presentations to venture investors along Sand Hill Road, Rodgers collected verbal commitments for most of what became a **$26.2 million private placement**. The round was anchored by **Foris Ventures, the family office of John Doerr**, chairman of venture firm Kleiner Perkins. SunPower Inc. NASDAQ: SPWR The pitch framed SunPower less like a public equity and more like a venture bet. According to the company's September 3 announcement, SunPower carries **about $300 million in annual revenue but trades at a market value of roughly $60 million** — about 0.20 times sales — and, unlike a typical start-up, the risks of product development and going public are already behind it. The announcement does not say at what price the placement shares were sold, so the dilutive impact on existing holders cannot be determined from it. Shares **closed 58.21% higher at $0.4020** the following session, on dollar volume of about $113 million. The low share price, Rodgers said, reflects two things: the loss of a federal solar tax credit that reset the market, and what the company calls a **misexecution in its SunPower Direct Division** during the second quarter of 2026\. The division has been handed to Kapil Rai, described by the company as its most experienced manager of that kind of operation. The Sand Hill Road pitch also drew on U.S. Energy Information Administration data: **only 6% of solar-capable American homes had installed solar as of 2026**, with the EIA projecting 30% market penetration by 2030. The release included return projections the company puts at **between 4x and 11x**, worked out four different ways from a presentation-day price of $0.30 a share. These are company estimates, not independent analysis. **Short volume in the following session reached 60.37% of reported activity.** The release does not address it. The company says it plans to grow revenue to $500 million next year and return to profitability "shortly." It did not say what shortly means. ### Mexico Clears the Way for Mining Americas' Zacatecas Gold Mine URL: https://www.pennystocks.news/maiff-mexico-clears-the-way-for-mining-americas-zacatecas-go/ Last updated: 2026-09-04T13:00:34.000Z For years, two federal environmental approvals stood between Mining Americas and any path forward at its Cerro de Oro gold project in northern Zacatecas, Mexico. Last week, Mexico's federal environmental agency granted both. MINING AMERICAS INC OTC: MAIFF The permits — a land-use change and an environmental impact assessment — were required by SEMARNAT, Mexico's federal environmental regulator, before construction planning could begin. Shares closed **15.44% higher at $4.71** after the announcement, on dollar volume of about $2.3 million. The approvals clear the main regulatory barrier the company had cited, but Mining Americas says additional licences and permits are still needed before construction can start. The company says it is now planning toward a **construction decision it has targeted for 2027**. Cerro de Oro is planned as an open-pit, heap-leach operation — a method that extracts gold by stacking crushed ore in large heaps and running a chemical solution through it to dissolve the metal, without a conventional mill. An early-stage economic study completed in 2023 put the project's **initial capital requirement at US$28 million** and projected average annual gold output of about **58,000 ounces** over an 8.2-year mine life. That study used a base case gold price of **US$1,600 per ounce**. CEO Darren Blasutti said in the company's September 3 release that the project will now be evaluated "in the context of significantly higher gold prices." No updated economic estimate was provided. Before any construction decision, the company says it plans to complete additional permitting, run detailed engineering, and carry out a new drill program. That program will test how far below the current resource depth — roughly 130 metres — mineralization continues. The project's early-stage resource estimate stands at **790,000 ounces of gold**, and the company says the deposit remains open at depth. ### CNH Is Outsourcing Its Seeding Equipment to a Canadian Rival URL: https://www.pennystocks.news/cnh-cnh-is-outsourcing-its-seeding-equipment-to-a-canadian-r/ Last updated: 2026-09-03T21:21:46.000Z Case IH and New Holland have long sold their own seeding equipment. Going forward, another company will build it. CNH INDUSTRIAL N.V. NYSE: CNH CNH said on August 31 that it has struck a supply agreement with Bourgault Industries, a maker of large-scale seeding equipment. Bourgault is based in Saskatchewan, according to trade publication RealAgriculture — the same province as CNH's Saskatoon manufacturing plant. Under the deal, **Bourgault will build precision air drills and high-capacity air carts carrying Case IH and New Holland branding**, and CNH will sell them through its dealer networks in North America, Australia, and what the company calls "other high-potential seeding markets." For a farmer buying Case IH or New Holland seeding equipment in those regions, the brand on the machine stays the same. The factory behind it does not. That matters because it resets which company's engineering decisions, parts inventory, and production choices determine what ends up in a customer's field. **CNH's Saskatoon plant will shift its focus to planters and headers for combine harvesters**, the company said. It will continue to support its existing seeding products through a transition period, without saying how long that period will last or what support will look like once it ends. Shares **closed 9.20% higher at $13.65 on September 3**, after the August 31 announcement, on dollar volume of about $734 million. "By combining complementary strengths, this alliance enhances our ability to compete, creates new opportunities for our dealers, and enables us to invest more in the technologies shaping the future of agriculture," chief executive Gerrit Marx said in the announcement. Bill Glanville, group president of Bourgault Industries, said the deal would make "Bourgault seeding technology available to more farmers in more markets." The release frames the deal as an expansion of CNH's portfolio. **The seeding work leaves Saskatoon**, and Bourgault fills the gap. ### The Miners Are Off. The Stock Fell Anyway. URL: https://www.pennystocks.news/gpus-the-miners-are-off-the-stock-fell-anyway/ Last updated: 2026-09-03T19:42:32.000Z Hyperscale Data turned off its last Bitcoin miner at the Michigan facility on September 1, 2026\. The company is clearing space for an AI data center under a long-term hosting contract. Its shares fell the following day and kept falling the day after that. Hyperscale Data, Inc. NYSEAMERICAN: GPUS The hosting contract is with an unnamed California-based neocloud provider — a company that rents out AI computing capacity to other businesses. It covers **20 megawatts** of computing capacity, with an initial 10-year term and two five-year extension options the customer may exercise. If the customer holds the contract to its maximum term, Hyperscale Data says it expects to collect **more than $1.2 billion** in revenue, according to its September 2 announcement. For shareholders, the big number is the conditional one. The customer holds a right to an additional 32 megawatts; if exercised and held through the full maximum term, total contract revenue could exceed **$3 billion** — but neither option has been taken yet. Even with both exercised, Hyperscale Data says the combined deployment would cover only about 20% of the roughly 340 megawatts it expects to eventually make available at the Michigan site. Shares **closed at $0.1984 on September 3, down 17.09%** from the previous close of $0.2393, on dollar volume of about $22.6 million. Shares have been falling for most of the year. The Block reported on September 2 that they had **lost more than 76%** of their value in 2026 alone. Hyperscale Data has executed two reverse stock splits in that span — a **1-for-35 consolidation** effective November 22, 2024, and a **1-for-5 consolidation** effective August 24, 2026, both according to SEC filings. A reverse split reduces the number of shares in circulation without changing each holder's proportional stake in the company. The company also said it intends to sell its Bitcoin mining servers, though the release did not say what it expects to receive for them. Hyperscale Data acknowledged in the announcement that its expansion plans remain preliminary and may not be financed or approved. The revenue potential rests on a customer it has not named exercising options it has not yet taken. ### The Offer Is $1.02. The Stock Closed Higher. URL: https://www.pennystocks.news/dh-the-offer-is-1-02-the-stock-closed-higher/ Last updated: 2026-09-03T18:00:20.000Z Advent International has offered **$1.02 a share in cash** for Definitive Healthcare's publicly held stock. The company's founder and executive chairman, **Jason Krantz**, is already aligned with Advent on the deal — his stake is excluded from the acquisition, so he keeps it if any deal closes. Definitive Healthcare Corp. NASDAQ: DH Advent submitted the **non-binding proposal on September 1**, targeting all Class A shares and equivalent limited liability company units not already owned by Advent or Krantz. A special committee of independent directors confirmed receipt the following day and said it is reviewing the offer with its advisors — Rothschild & Co on finance and Skadden, Arps, Slate, Meagher & Flom on legal. The publicly traded float is about 34.8% of total shares outstanding. The committee is negotiating on behalf of that minority; Advent and Krantz hold the rest and are on the other side. Krantz is not selling. The public shareholders are being offered $1.02 and a door. Shares closed at $1.0400 on September 3, up 15.26% from the prior session, on dollar volume of about $9.4 million. The close sits **above the stated offer price**. On the same day the committee confirmed the proposal, the company announced the appointment of **Clay Ritchey as chief executive officer**, effective September 8, according to a September 2 filing with the SEC. His predecessor, Kevin Coop, left on August 31 — **the day before the offer was submitted**. The committee has made no decision and says no shareholder action is required yet. Ritchey arrives as the company is deciding whether to remain public at all. ### An Antibody That Fights Tumors Three Ways Just Got a U.S. Patent Nod URL: https://www.pennystocks.news/ppbt-an-antibody-that-fights-tumors-three-ways-just-got-a-u/ Last updated: 2026-09-03T16:20:34.000Z The U.S. Patent and Trademark Office has agreed in principle to grant Purple Biotech a patent on the core design of its CAPTN-3 cancer antibody platform. The agency issued a Notice of Allowance — its determination that an application meets patentability requirements, ahead of formal issuance — for an application titled "Precursor Tri-Specific Antibody Constructs and Methods of Use Thereof," the company said in a **September 2 press release filed with the SEC**. Purple Biotech Ltd. NASDAQ: PPBT CAPTN-3 is built around antibodies that do three things at once: bind to a tumor and recruit both T cells and NK cells to attack it. Most approved cancer antibodies engage only one type of immune cell. The **allowed claims cover constructs with dual tumor-targeting binders** — the antibody grabs the tumor in two places simultaneously — alongside other features of the platform, according to the release. The platform also uses what the company calls capping technology, designed to confine immune activation to the area immediately around the tumor. The goal is to avoid the system-wide immune reactions that have limited conventional T-cell engager drugs, a class of cancer therapy that pulls immune cells toward tumors but can trigger dangerous inflammation elsewhere in the body. Shares closed **19.28% higher at $1.9800** after the announcement, on dollar volume of about $178 million. What the patent most directly protects is the platform's modular architecture. Rather than designing each new antibody candidate from scratch, CAPTN-3 is structured so the tumor-targeting component can be swapped in and out while the rest of the design stays the same. "This allows us to rapidly develop new multispecific antibody candidates by incorporating different targeting domains and functional components," CEO Gil Efron said in the release. The platform's **lead candidate, IM1240, is advancing toward the clinic**, according to the release. A second candidate, IM1305, is in preclinical development. The company gave no timeline for either. A Notice of Allowance is not a granted patent. The USPTO still requires payment of issue fees before the patent formally issues, and the protection it confers does not take effect until then. ### A Real Estate Company Now Wants to Build an AI Data Centre in Europe URL: https://www.pennystocks.news/lhai-a-real-estate-company-now-wants-to-build-an-ai-data-cen/ Last updated: 2026-09-03T14:41:34.000Z Linkhome Holdings manages real estate. On Tuesday it said it is looking at building AI data centres in Europe. According to a press release attached to an 8-K filed with the SEC on September 2, the company has formed a new wholly owned subsidiary, Linkhome Technologies Inc., and begun a preliminary evaluation of a potential GPU computing project somewhere on the continent. **The board approved the subsidiary. It did not approve the project itself.** No location has been chosen, no financing is in place, and the company has not entered any binding agreements — not with equipment suppliers, data centre operators, or customers. Linkhome Holdings Inc. NASDAQ: LHAI Shares closed **34.02% higher at $1.1000**, on dollar volume of about $105 million across 281,106 trades. About 55% of reported volume on the session was short volume, against a free float of about 8 million shares. The proposed project, if it goes ahead, could involve **up to 144 NVIDIA GB300 GPUs**, the company says. Those would serve cloud providers, enterprise AI clients and high-performance computing customers. The company says it has obtained non-binding indicative equipment quotes and started preliminary talks with potential European operators and customers. No counterparty has committed. Linkhome Technologies **has not started operations and has no revenue**. The company's longer-term stated aim is a decentralised global platform connecting distributed GPU capacity with enterprise demand across multiple markets. Between that aim and anything operational stands a list of unresolved conditions: site selection, equipment procurement, project financing, customer agreements, power and cooling arrangements, regulatory approvals, and a final board decision on whether to proceed at all. Before any GPU goes into a rack in Europe, the company still needs to pick a country, find a building, raise the money, sign a deal with a customer — and get its own board to say yes. \`\`\` ### A Junior Nevada Gold Miner Just Landed on the Nasdaq URL: https://www.pennystocks.news/srcrf-a-junior-nevada-gold-miner-just-landed-on-the-nasdaq/ Last updated: 2026-09-03T13:01:07.000Z Scorpio Gold started trading on a US exchange on September 1\. The next day, **trading across all its listings was halted**. The company said it was done in error and asked for trading to resume. SCORPIO GOLD CORP OTC: SRCRF The listing gives US investors a way to hold the stock through Nasdaq without going through a Canadian or German exchange. **Each American Depositary Share bundles 20 common shares** into a single unit, traded under the ticker SGLD. For existing holders, nothing changes — shares held on the TSX Venture Exchange, OTCQB, or Frankfurt Stock Exchange continue to trade under their current symbols, the company said in its September 1 announcement. Converting to ADSs is optional and currently free. The company said the issuance fee is waived through November 25; **after that, the fee is US$5.00 for every 100 ADSs issued**. Bank of New York Mellon administers the program. Common shares on the OTCQB **closed 44.25% higher at $0.3462 on September 3**, on dollar volume of about $1.76 million across 323 trades, after the company announced the listing and the erroneous halt. The company did not say what caused the September 2 halt — its first full trading day on the new exchange. ### Revenue Up Twentyfold. Still Losing More Than It Makes. URL: https://www.pennystocks.news/rzlv-revenue-up-twentyfold-still-losing-more-than-it-makes/ Last updated: 2026-09-02T23:02:25.000Z Rezolve AI grew first-half revenue **from $6.3 million to $130.8 million** in a single year — roughly a twentyfold increase. The net loss over the same period came to **$139.5 million**, more than the revenue itself. Rezolve AI PLC NASDAQ: RZLV The company's September 1 results release leads on a deal with Google. Following what it describes as an extensive technical evaluation, **Google selected Rezolve's proprietary distributed database technology for deployment inside Google Cloud**. According to the company's announcement, the initial rollout covers **roughly 100 terabytes of data across ten blockchain networks**, providing indexing and data pipelines for Google Cloud's Web3 datasets. The company says further infrastructure licensing agreements are expected soon, though none are named. The financial picture is harder to read. Rezolve **raised about $250 million in new equity** during the first half. The company says **$67.5 million of the operating loss reflects non-cash charges** — share-based pay, depreciation and an impairment write-down — rather than cash leaving the business. Gross margin for the half was 48.9%. Shares closed 17.30% lower at $2.3900 after the results were released, on dollar volume of about $153.7 million. Rezolve reaffirmed full-year revenue guidance of about **$360 million**. According to the release, hitting that number requires about **$229 million in H2 revenue** — driven, the company says, by peak retail trading, enterprise deployment timing and partner-led distribution. Rezolve entered that second half with **$33.2 million in unrestricted cash**. ### NIO's Margins Nearly Doubled. The Stock Fell Anyway. URL: https://www.pennystocks.news/nio-nio-s-margins-nearly-doubled-the-stock-fell-anyway/ Last updated: 2026-09-02T21:21:34.000Z One year ago, NIO kept about ten cents of every dollar it collected from vehicle sales. In the second quarter of 2026, it kept nearly nineteen. NIO Inc. American depositary shares, each representing one NYSE: NIO **Vehicle margin reached 18.5% in the quarter, against 10.3% a year earlier**, according to unaudited results NIO released on September 1\. Gross profit more than tripled year-over-year to about US$870 million. The company says the improvement came from a more favourable product mix, with higher-margin models making up a larger share of deliveries. For shareholders who have been waiting for NIO to stop losing money, the quarter produced a first: stripped of share-based compensation, **adjusted net profit came in at about US$3.8 million**. Under standard accounting NIO still reported a loss — US$77.8 million — but a year earlier that quarterly loss was close to RMB5 billion, and the gap has closed quickly. **Deliveries reached 107,658 vehicles**, up 49% from a year earlier, split across the flagship NIO line, the ONVO family brand, and the FIREFLY compact-car range. The company says each brand grew in both volume and average transaction price. Shares closed 4.14% lower at $4.0550 on September 2, on dollar volume of about $327 million. **Cash stood at about US$8.4 billion** at the end of June. For the third quarter, NIO guides for **108,000 to 111,000 deliveries**. The adjusted profit of US$3.8 million arrived on revenues of about US$4.7 billion — a thin enough margin that CFO Stanley Yu Qu flagged "rising cost pressures" as something the company had to work around to hold it. ### An Automotive Lidar Maker Just Won a Contract to Navigate the Moon URL: https://www.pennystocks.news/lidr-an-automotive-lidar-maker-just-won-a-contract-to-naviga/ Last updated: 2026-09-02T19:40:34.000Z The Pegasus Lunar Terrain Vehicle is built to carry Artemis astronauts across the Moon's surface. AEye said on Monday that its Apollo lidar sensor will handle the navigation. AEye, Inc. NASDAQ: LIDR The deal, which **AEye's September 1 press release describes as a multi-million-dollar contract**, marks the company's entry into the space mobility market after years focused on automotive, defence and industrial customers. Apollo will manage terrain perception, obstacle detection and autonomous navigation for Pegasus, the vehicle at the centre of NASA's Lunar Terrain Vehicle Services programme. Shares closed **27.83% higher at $1.4700**, on dollar volume of about $199 million across roughly 374,000 trades, after the announcement. Lunar Outpost picked Apollo for three properties the release names: a solid-state design with **no moving parts to fail in the lunar vacuum** or under the temperature swings and constant vibration of the Moon's surface; a software-defined architecture that lets operators adjust scan patterns in software without swapping hardware; and a compact form factor that preserves mass budget on a vehicle where every kilogram is accounted for. "Space mobility is a new market opportunity for AEye," chairman and chief executive Matt Fisch said in the release, "and the lunar environment represents the most demanding proving ground any sensor can face: no atmosphere, no margin for error, and no opportunity for in-mission repair." Lunar Outpost chief strategy officer Forrest Meyen said in the same release that the vehicle will help **"begin building NASA's Moon Base"** at the lunar South Pole, and that the programme required partners capable of scaling with it. The release carries no scheduled date for Pegasus's first crewed traverse. What it does make clear is that **once the vehicle reaches the surface, there is no way to repair or replace a sensor that fails**. ### The CEO Just Bought Nearly Half Her Company in a Single Private Deal URL: https://www.pennystocks.news/petz-the-ceo-just-bought-nearly-half-her-company-in-a-single/ Last updated: 2026-09-02T18:02:34.000Z On August 27, Dandan Liu bought **nearly 3 million shares from existing shareholders in a single privately arranged deal** — not through the open market. The SEC filing disclosing the purchase arrived four days later. TDH Holdings, Inc. NASDAQ: PETZ The deal cost **about $3.56 million in total**. It handed Liu — already TDH Holdings' chair and CEO — a stake of **49.11%**, covering 5,069,389 of the 10,323,268 shares outstanding. She is now just short of holding a majority of the company's votes. Because the purchase was private rather than open-market, the price was set by direct agreement between Liu and the sellers. The filing identifies her counterparties only as **"certain shareholders"** — no names, no per-share price, no explanation of how the deal came together. Shares **closed 28.70% higher at $1.4800** on September 2, after the filing was published, on dollar volume of about $17.3 million across 61,586 trades. TDH Holdings still trades under the ticker PETZ, a holdover from its years in pet food. According to a company press release on Nasdaq.com, **the company now operates and manages commercial real estate properties in China**. The filing says Liu **may increase her stake further** at any time — through open-market purchases or additional private transactions. ### The Action Camera Brand Is Becoming an AI Optics Company URL: https://www.pennystocks.news/gpro-the-action-camera-brand-is-becoming-an-ai-optics-compan/ Last updated: 2026-09-02T16:22:51.000Z The camera company that built its name on action sports footage agreed on September 1 to merge with a firm that makes optical components for AI data centers and defense systems. GoPro will stay on Nasdaq after the deal closes. It will also, the company says, add a product line it has never sold before. GoPro, Inc. NASDAQ: GPRO Shares **closed 40.38% higher at $1.2300**, on dollar volume of about $705 million across roughly 794,000 trades. Existing shareholders get **$1.14 per share in cash** — **about $285 million in aggregate** — and keep **roughly 10% of the combined company's outstanding shares**. GoPro's outstanding debt of **about $92 million gets repaid at closing**, leaving what the company's press release calls a "substantially debt-free balance sheet." The stock was trading at $0.8762 the day before the announcement, below the cash price; shares ended September 2 above that figure, which means the market is treating the retained stake as worth something on top of the cash. The deal still needs approval from GoPro's stockholders and from regulators. Both boards have already signed off. GoPro expects to **close by the end of 2026**. Under the merger structure, Starman Optical merges into GoPro, with GoPro surviving as a subsidiary of Action Acquisitions LLC, the holding company behind Starman. GoPro says it will keep selling cameras and its subscription service while adding Starman's products. Starman, according to the company's press release, focuses on the **development and domestic manufacturing of optical transceivers** — devices that send data as pulses of light rather than electrical signals, used inside high-speed AI data center networks — and targets defense and aerospace buyers as well. Nicholas Woodman, GoPro's founder and chief executive, said in the September 1 press release that the merger would position the combined company as "a leading American imaging and optical solutions company." Charles Tebele, chief executive of Starman Holding, cited domestic manufacturing in the same release: "much of the critical hardware supporting these technologies continues to be manufactured overseas." GoPro shareholders are not being bought out. They receive cash, keep a slice of the company, and will vote on a business that, by its own description, is heading somewhere most of them did not buy in expecting. What that 10% ends up being worth is not in the filing. ### A Former Solar-Car Startup Is Merging Into a Sports Franchise Fund URL: https://www.pennystocks.news/ssm-a-former-solar-car-startup-is-merging-into-a-sports-fran/ Last updated: 2026-09-02T14:40:58.000Z In 2023 Sono Group cancelled its solar car and let most of its workforce go. Three years later, it is proposing to hand its Nasdaq listing to a newly formed sports company that does not yet hold a single franchise interest. **On August 31, Sono signed a non-binding letter of intent to combine with Sports One**, according to an 8-K filed with the SEC that day. Sono Group N.V. NASDAQ: SSM The terms matter for anyone holding Sono shares now. **Sports One's existing holders would own a super-majority of the surviving public company**, leaving Sono's current shareholders with the remainder. If the deal closes, the combined company would be renamed Sports One, the parties said in a joint press release on August 31. Sports One describes itself, in that press release, as an AI-driven business that scores individual athletes' commercial value for sponsors, teams and brands, and says it intends to acquire and hold minority interests in NBA, NFL, MLB and NHL franchises. It is, by the filing's own description, recently formed. No franchise names appear in the filing, no acquisition prices are given, and no funding source for the planned purchases is disclosed. What Sono shareholders would be exchanging their majority position for is, so far, a stated intention. On the same day as the letter of intent, Sono sold **283,500 ordinary shares to private purchasers** at the prior day's closing bid price — a stake limited to **19.9% of shares outstanding** under Nasdaq rules, the 8-K says. Proceeds go to working capital. The purchasers agreed to a **180-day lock-up** on those shares. There is a separate arrangement involving Sono's preferred shares. YA II PN, Ltd., which holds all of the company's preferred stock, has granted Sports One affiliates a call option on **approximately half of those shares — 700 preferred shares** in total. The option can be exercised within **15 calendar days** of the deal closing. Until it expires, those 700 shares cannot be converted into ordinary shares or sold. Shares closed 77.43% higher at $4.7550 after the announcement, on dollar volume of about $145 million. The free float is about 1 million shares. The deal still requires a definitive agreement, shareholder approval and regulatory review. Sports One has not committed to buying any specific franchise at any stated price, and no timeline for any of those steps was given. ### A Junior Copper Miner's New Leadership Team Funded Its Own Hiring URL: https://www.pennystocks.news/badef-a-junior-copper-miner-s-new-leadership-team-funded-its/ Last updated: 2026-09-02T13:02:20.000Z The incoming leadership team at Hercules Metals formally took over on September 1\. Their **C$4.5 million investment** in the company had closed the day before. HERCULES METALS CORP OTC: BADEF Every share in the placement — about 7.3 million in total, **priced at C$0.62 each** — was bought by the former management team of Arizona Sonoran Copper Company, the group now stepping into Hercules's senior roles, the company said in an August 31 release. In a separate announcement on July 30, Hercules said George Ogilvie would become President and CEO effective September 1; founder Chris Paul would move to a senior exploration role. The Arizona Sonoran team left that company through a sale: Hudbay Minerals acquired it in a deal Hudbay valued at about US$1.5 billion, according to a Hudbay SEC filing from March 2026. For anyone already holding Hercules shares, those 7.3 million new shares make each existing one a smaller slice of the same company. The other side of that is that the new team's money is tied up: Canadian securities rules prohibit resale for **roughly four months from the date of issuance**, so the executives cannot exit quickly regardless of how the drilling goes. Hercules says the proceeds will go toward continued drilling and expansion of the **Leviathan porphyry copper system** in western Idaho, exploration of other porphyry targets, and general working capital. The release gave no timeline for the next round of results. Shares **closed 17.03% higher at $1.1180, on dollar volume of about $565,000**. The deal still needs the TSX Venture Exchange's sign-off. That approval had not come through as of the August 31 release. ### AIM ImmunoTech Gets Patent Pairing Its Cancer Drug With Keytruda URL: https://www.pennystocks.news/aim-aim-immunotech-gets-patent-pairing-its-cancer-drug-with/ Last updated: 2026-09-01T23:00:34.000Z The U.S. Patent and Trademark Office has granted AIM ImmunoTech a patent for using its experimental drug Ampligen alongside Merck's cancer immunotherapy Keytruda. The company said in an August 31 announcement that the **patent runs to December 2039**. AIM ImmunoTech Inc. NYSEAMERICAN: AIM **The patent's broadest claim covers any cancer** where giving the two drugs together works better than either drug alone — or better than simply adding their separate effects. Separately listed claims in the same patent name pancreatic, ovarian, colorectal, breast, lung, skin, bladder, melanoma, head and neck, and kidney cancers, but the broad claim is not restricted to any of them. For someone holding the stock, the catch is straightforward: a patent protects a method of treatment, but the method has to exist as an approved therapy before the protection has commercial meaning. **Ampligen has not received FDA approval to treat any cancer.** The company's own cautionary filings note that clinical trial results cannot be guaranteed, and significant work remains before any regulatory submission would be possible. Keytruda works by releasing a brake that cancer cells can use to hide from the immune system. AIM says in its release that it is not affiliated with or endorsed by Merck. Shares **closed 12.54% lower at $0.2260** after the company announced the patent grant, on dollar volume of about $28 million. The new patent joins related filings AIM says it already holds in the U.S., the Netherlands, and Japan, **all running to 2039**, covering Ampligen's use alongside similar immunotherapy classes. The company's stated clinical priority is late-stage pancreatic cancer — one of the specific diseases named in the new patent. Chief Executive Thomas Equels called it in the announcement "the central focus of our late-stage oncology strategy." ### A Rare Earth Magnet Maker Is Sextupling Its Power Supply in Korea URL: https://www.pennystocks.news/emat-a-rare-earth-magnet-maker-is-sextupling-its-power-suppl/ Last updated: 2026-09-01T21:22:34.000Z EM&T's Pohang magnet factory currently draws **130 megawatts of power** from the South Korean grid. Under principal terms it says it has agreed with Korea Electric Power Corporation, that rises to **750 megawatts** — nearly six times as much. The extra power is meant to do one thing: multiply output. Evolution Metals & Technologies Corp. NASDAQ: EMAT The company is targeting **10,000 metric tons of rare earth magnets a year**, up from around 1,000 metric tons currently, and says it wants to reach that level by the end of 2026\. The plan treats November 2026 as the critical moment: that is when ULVAC magnet manufacturing equipment is scheduled for delivery and installation, and when the expanded power supply is expected to be ready, according to the company's August 27 release. Housing all that equipment means a much larger building. EM&T says it plans to expand its manufacturing footprint from **24,000 to 482,000 square feet**. The new space would sit on roughly 1.3 million square feet of land the company says it intends to buy directly from Pohang City Government. Two pieces of outside funding are attached to the expansion. KEPCO is expected to cover roughly **90% of the substation, cabling, and civil works costs** under the power agreement, according to the release. Separately, EM&T says it has received conditional approval for a **$20.7 million grant** from Pohang City and Gyeongbuk Province — earmarked for construction and equipment — but execution is tied to completing the land acquisition. The release does not say what the land will cost. Shares closed 18.20% higher at $3.8650 on September 1, on dollar volume of about $4.8 million. The announcement was made August 27, five days before that close. As of the announcement date, the power supply agreement, the land deal, and the government grant were all still pending final execution. The company's release describes power, land, and equipment together as the essential infrastructure for the tenfold production increase — and November 2026 as when all three need to be in place. ### Ten Straight Quarters, and So-Young's Losses Are Shrinking URL: https://www.pennystocks.news/sy-ten-straight-quarters-and-so-young-s-losses-are-shrinking/ Last updated: 2026-09-01T19:42:12.000Z So-Young's clinic network has more than doubled its revenue every quarter for two and a half years running. In the second quarter of 2026, it pushed the whole company to a new high. So-Young International Inc. NASDAQ: SY **Total revenue reached about RMB505 million** in the quarter ended June 30 — the highest the company has recorded — up 33.4% from a year earlier, according to a 6-K filed with the SEC on August 31\. The clinic network drove the gain: **aesthetic treatment services revenue came to about RMB331 million, up 129.5% year-over-year**, marking the tenth consecutive quarter of triple-digit growth in that segment. The company still loses money. But the gap is closing: **net loss narrowed by 37%, to about RMB22.7 million**, from the same quarter a year earlier. Chief Financial Officer Shannon Shen said in the release that the company sees "a clear path toward profitability." She gave no timeline. Shares closed 21.25% higher at $2.9100, on dollar volume of about $40.5 million. **So-Young had 65 branded centers operating as of June 30**, the filing shows. **Of those, 47 were profitable at the clinic level** in the quarter — a measure that counts location-level costs but excludes any overhead allocated from head office. **Same-store sales grew 52%** year-over-year, a sign that existing locations are performing materially better than they were at the same point in 2025. Not all revenue lines grew. Fees from medical service providers paying for placement on So-Young's platform fell from a year earlier, as did other services revenue including insurance brokerage. The filing attributes both to lower activity volumes but does not say whether the company intends to rebuild those streams. For the third quarter, the company expects aesthetic treatment services revenue to grow between **91.7% and 97.2% from a year earlier** — still near-doubling, but just below the triple-digit threshold the past ten quarters cleared. By the company's own guidance, the streak is likely to end in three months. ### Investors Gave Up the Right to Buy Shares. They Got Nothing Back. URL: https://www.pennystocks.news/coot-investors-gave-up-the-right-to-buy-shares-they-got-noth/ Last updated: 2026-09-01T18:01:34.000Z Investors in Australian Oilseeds Holdings were entitled to buy company shares at either $2.00 or $0.70\. The stock now trades below either price. **They are handing those rights back for nothing.** Australian Oilseeds Holdings Limited NASDAQ: COOT The warrants came from two private placements completed earlier this year. The first, which closed in March, priced units at $1.00 each; every unit included one share and a warrant to buy two more at **$2.00**. The second closed in April at $0.50 a unit, with each warrant covering two more shares at **$0.70**. That second deal covered **up to 16.8 million units**, and the board voted to cancel every warrant on August 26 — two days before the company filed notice with the SEC. For existing shareholders, the cancellation removes a significant risk. Each warrant gave its holder the right to buy two new shares; every new share issued would have made existing holders' stakes a smaller piece of the same company — what traders call a dilution overhang. The second placement covered up to 16.8 million units, each carrying such a warrant, against a free float of 6.4 million shares. The holders receive no payment for surrendering these rights, and **the filing gives no reason for the arrangement**. Shares **closed 28.87% higher at $0.5928** on September 1 after the company filed notice, on dollar volume of about $48 million. The warrant cancellation follows the sale of the company's core business. According to a 6-K filed with the SEC on July 28, 2026, **Australian Oilseeds agreed to sell its oilseed processing and edible-oils subsidiary** — Australian Oilseeds Investments Pty Ltd — to Singapore-based Trusha Realty Pte. Ltd. That filing does not say what business, if any, the company plans to operate after the sale completes. No warrant from either placement had been exercised before the cancellation, according to the August 28 filing. The holders have also waived any registration rights they held for shares that might have been issued on exercise. **What the company becomes without its warrants and without its original oilseed operation, neither filing says.** ### RedHill Sells Its H. Pylori Drug to Fund Its Next Move URL: https://www.pennystocks.news/rdhl-redhill-sells-its-h-pylori-drug-to-fund-its-next-move/ Last updated: 2026-09-01T16:22:31.000Z Apotex already owned 30% of Talicia. On August 31, it bought the rest. **RedHill Biopharma sold its 70% stake** in Talicia — an antibiotic that treats *H. pylori*, the stomach infection behind most gastric ulcers — to a subsidiary of Apotex Health Corp. **for $18 million in cash**, with the potential for **up to $35 million more** tied to worldwide net sales milestones. Apotex had picked up its existing minority stake through its prior acquisition of Cumberland Pharmaceuticals' U.S. branded business, which included Cumberland's 30% share in the Talicia holding structure. Redhill Biopharma Ltd. NASDAQ: RDHL Shares closed 36.16% higher at $0.9000 after the announcement, on dollar volume of about $141 million across roughly 397,000 trades. For anyone holding the stock, the deal trades a revenue-generating asset for cash and a wager on what RedHill buys next. The company says it intends to use the proceeds to acquire new FDA-approved commercial products — but named no target, price range or timeline in the filing. The sale carries a **five-year non-compete** covering the U.S. and its territories: RedHill cannot sell a competing H. pylori product in its core market for the duration. RedHill will also provide transition services to Apotex for an initial six months, with an option to extend for three more months for limited services, according to the 6-K filed with the SEC on August 31. CEO Dror Ben-Asher said in the company's release that the transaction "unlocks the resources needed to scale RedHill's existing gastrointestinal commercial franchise into a stronger and larger one, including new, high-value, FDA-approved product opportunities." **No acquisition target was disclosed.** More than half of the session's reported volume — 55.99% — was short volume. The filing does not address the composition of the day's trading. The milestone payments depend on Apotex growing Talicia's sales — a product RedHill has now agreed not to compete against. Whether that upside materialises is entirely outside RedHill's control from here. ### Antelope Cut Its Share Count. Then It Sold More Shares Than It Had Left URL: https://www.pennystocks.news/aehl-antelope-cut-its-share-count-then-it-sold-more-shares-t/ Last updated: 2026-09-01T14:40:34.000Z The company turned every 16 of its shares into one on August 7, reducing its outstanding count to about 1.4 million. Seventeen days later, it agreed to sell 15 million new shares in a private transaction — more than it had after the consolidation — and to hand the buyers warrants to purchase 15 million more. Antelope Enterprise Holdings Limited NASDAQ: AEHL Under a securities purchase agreement filed with the SEC on August 28, **Antelope Enterprise Holdings sold 15 million Class A ordinary shares at $1.266 each**, raising just under $19 million in total. The buyers — described only as "certain non-U.S. investors" — also received **warrants to purchase another 15 million shares at $0.50 apiece**. Before the reverse split took effect, the company had about 20.9 million shares outstanding, according to a press release filed with the SEC on August 5. For someone holding a position, the placement alone would multiply the share count roughly tenfold from its post-split level: the same company, carved into far more pieces than existed a month ago. If the warrants are exercised, the buyers receive a second tranche identical in size to the first. The filing does not say what the proceeds will be used for. Shares closed 83.33% higher at $6.4900 on September 1, after the filing, on dollar volume of about $316 million. The shares are restricted securities, sold to non-U.S. investors without SEC registration; they may not be resold without an applicable exemption. The filing states that no broker fees or placement agent commissions were payable. Closing was expected in the third quarter of 2026, the filing said. The buyers paid $1.266 per placement share. **The warrants let them purchase the same number of additional shares at $0.50** — well below the price they had just agreed to pay. The filing gives no explanation for how the warrant price was set. ### First Deep Hole at Bonaparte Hits the Porphyry System Geologists Predicted URL: https://www.pennystocks.news/decxf-first-deep-hole-at-bonaparte-hits-the-porphyry-system/ Last updated: 2026-09-01T13:01:51.000Z Geologists with the British Columbia Geological Survey published a paper in 2013 suggesting the gold veins near the surface at the Bonaparte property might sit on top of a buried porphyry copper system. Last month, Decade Resources drilled the first hole deep enough to test that idea and found what the model predicted. DECADE RESOURCES LTD OTC: DECXF The hole, DDH 1, passed through two alteration zones before hitting **mineralized feldspar porphyry at 557 metres**, where it found chalcopyrite — the copper sulphide mineral common in porphyry deposits — along with occasional molybdenite. **The hole bottomed at 621.6 metres with mineralization still open below.** **DDH 1 is the first hole ever drilled to test beneath Bonaparte's chargeability anomaly** — a zone of elevated electrical response that geophysical surveys had traced to depth, and which the 2013 paper identified as a likely fingerprint of a buried porphyry system. The hole was sited 500 metres east of the historic Discovery area, where earlier trenching returned multi-ounce gold assays, to test a separate anomaly. For a shareholder, the confirmed alteration sequence is meaningful — but what the model predicted was a system worth testing, not a deposit. Core samples are heading to MSA LABS in Langley, BC for assay, and the company cautions that visual observations of sulphide minerals in drill core say nothing about grade. The company has also noted that the historic geophysical data has not been verified by its qualified geoscientist and is not being treated as current. President Ed Kruchkowski, who is also the company's qualified geoscientist, said DDH 1 delivered "the classic zonation pattern that vectors toward the heart of a porphyry system" and called it rare confirmation in a first hole. **Shares closed 41.98% higher at $0.1150** after the announcement, on dollar volume of about $505,000 across 229 trades. Results from a July soil sampling program covering more than 750 soil samples are also pending from the same lab. The company has not said how many holes are planned for Phase I or when assay results from DDH 1 are expected. ### BioXcel Is Bankrupt. Teva Is First in Line for IGALMI. URL: https://www.pennystocks.news/btai-bioxcel-is-bankrupt-teva-is-first-in-line-for-igalmi/ Last updated: 2026-08-30T14:40:51.000Z BioXcel Therapeutics has run out of road. On August 28, the company entered **voluntary Chapter 11 bankruptcy in Delaware** and simultaneously agreed to sell substantially all its assets to Teva Pharmaceuticals — with Teva already holding the opening bid. BioXcel Therapeutics, Inc. NASDAQ: BTAI The assets up for auction include **IGALMI, BioXcel's only approved drug** — a film that dissolves under the tongue to treat sudden, severe agitation in adults with schizophrenia or bipolar disorder — along with a pending application to expand its approved use to home settings. Teva, a subsidiary of Teva Pharmaceutical Industries Ltd., has agreed to serve as what bankruptcy law calls a stalking-horse bidder: it sets the floor price that any competing buyer must beat. The court process allows others to top it, but if nobody does, Teva takes the assets. Shares closed 74.76% lower at $0.1814, on dollar volume of about $10.4 million. For anyone holding the stock, the mechanics of a Chapter 11 asset sale are worth understanding. Secured creditors get paid first from whatever the auction produces. Equity holders stand at the back of that line and receive whatever, if anything, remains. The company's announcement did not state the dollar value of Teva's bid. To keep operating through the process, BioXcel locked in **$19 million in financing from its existing secured lenders** — funding that, once the court approves it, ranks ahead of most other claims and is meant to cover wages, supplier payments and the costs of the bankruptcy itself. The company says IGALMI will stay on the market and continue reaching patients throughout the proceedings. The pending application to allow IGALMI to be used at home — rather than only under direct clinical supervision — is still under FDA review, with a **decision date of November 14, 2026**, according to the company's August 28 announcement. Whoever wins the auction inherits that application, and whatever the FDA decides about it. ### A Gaming Giant Is Paying Cyabra to Police Its Player Community URL: https://www.pennystocks.news/cyab-a-gaming-giant-is-paying-cyabra-to-police-its-player-co/ Last updated: 2026-08-30T13:02:34.000Z An unnamed gaming publisher agreed to pay Cyabra a **six-figure annual fee** to watch its player community for fake accounts, coordinated campaigns, and manufactured reviews — activity that, the company says, can shape how a game is received before most players have formed their own opinion. Cyabra, Inc. NASDAQ: CYAB Cyabra announced the deal on August 28\. Under the agreement, the company says its managed service will monitor social and digital platforms on the publisher's behalf and flag inauthentic behavior at scale. The client's name was not disclosed in the release. For Cyabra, the deal is evidence that commercial buyers are starting to spend on what has until now been mostly a government and defense market. The contract's exact value sits somewhere in the six-figure range; the release does not narrow it further, and no revenue figures are provided. Shares **closed 45.36% higher at $0.4467** on August 30, on dollar volume of **about $99 million**. Short volume on the session was **53.88% of reported volume**. The announcement came roughly two months after Gartner included Cyabra in the inaugural edition of its Emerging Market Quadrant for narrative intelligence — which Gartner described, according to the company's release, as the first time it formally defined that market category. Cyabra's CEO, Dan Brahmy, said in the release that gaming is "one of the most consequential and increasingly important environments" for coordinated manipulation. The company says the deal is the latest in a series of high-profile customer wins — but **has not named any of them**. ### Blue Owl Puts Billions Behind IREN's GPU Buildout in Canada URL: https://www.pennystocks.news/iren-blue-owl-puts-billions-behind-iren-s-gpu-buildout-in-ca/ Last updated: 2026-08-29T23:02:51.000Z Funds managed by Blue Owl **committed $2.4 billion to finance IREN's purchase of NVIDIA Blackwell Ultra GPUs** for its Mackenzie data center campus in British Columbia. The structure is equipment finance, not corporate debt — the hardware itself stands as the collateral. IREN Limited NASDAQ: IREN The deal splits evenly between **a $1.2 billion senior secured term loan and $1.2 billion in senior secured notes**, according to an August 28 press release. Rather than releasing the full amount at once, the facility draws in tranches as hardware is delivered and commissioned. Shares **closed 12.53% lower** on August 29, the day after the announcement, on **dollar volume of about $3.2 billion**. The case for treating GPUs as lendable infrastructure rests on an argument about fungibility. NVIDIA's Nico Caprez said in the release that the company's software stack lets its chips serve any customer's workload, making them more interchangeable than purpose-built hardware. That, the release argues, makes NVIDIA infrastructure an investable asset class for long-term capital. Blue Owl's Kurt Tenenbaum, a senior managing director, said the firm drew on **operating experience across more than 100 data centers** to shape the facility's design. Blue Owl manages about **$319 billion** in assets across its three investment platforms. IREN says the deal extends a buildout backed by a global development pipeline the company puts at **more than 5 gigawatts**. IREN chief financial officer Anthony Lewis said in the release the company is expanding capacity for both AI training and inference customers. NVIDIA's Caprez described the transaction as **"a repeatable model for financing AI infrastructure at scale."** ### Shareholders Killed This Deal, So Now There's a Buyback URL: https://www.pennystocks.news/sols-shareholders-killed-this-deal-so-now-there-s-a-buyback/ Last updated: 2026-08-29T21:20:34.000Z Solstice Advanced Materials struck a deal to buy Element Solutions in early July. About seven weeks later, both sides agreed to walk away. Both boards terminated the merger on August 27\. Under the deal's terms, Solstice's existing shareholders would have owned **roughly 56% of the combined company**, with Element Solutions shareholders holding the other 44%, according to Solstice's quarterly filing with the SEC — meaning they would have shared nearly half of what is currently their company with incoming shareholders. Both companies say shareholder feedback drove the decision. Solstice Advanced Materials Inc. NASDAQ: SOLS The same day, Solstice's board approved **a $500 million share repurchase program** — the company's first. Instead of issuing shares to buy another business, Solstice will now buy back its own. No termination fee is owed by either party. Shares closed **12.76% higher at $63.53** on August 29, on dollar volume of about $1 billion. Alongside the termination, Solstice reaffirmed its guidance for the year: **full-year 2026 net sales of $4,125 million to $4,185 million**, and adjusted earnings of **$2.75 to $2.95 per share** — a non-GAAP figure that strips out certain one-time costs. For the third quarter it expects **net sales of $990 million to $1,030 million**. CEO David Sewell said cash flows and the balance sheet were strong enough to support both organic growth investments and returning capital to shareholders. Element Solutions chairman Ian G.H. Ashken said in an August 27 filing with the SEC that the deal's strategic and financial rationale "was compelling." Both companies walked away from it regardless. ### Pfizer and BioNTech Win FDA Clearance for This Fall's COVID Shot URL: https://www.pennystocks.news/bntx-pfizer-and-biontech-win-fda-clearance-for-this-fall-s-c/ Last updated: 2026-08-29T19:41:41.000Z The FDA on Thursday cleared Pfizer and BioNTech's updated COVID-19 vaccine for the 2026-2027 season, and shipping began the same day. The following morning BioNTech said it was ending a mid-stage cancer trial. Shares fell. BioNTech SE NASDAQ: BNTX The approved vaccine, **COMIRNATY XFG**, targets the XFG variant of SARS-CoV-2, the strain the FDA designated as the preferred composition for vaccines entering the U.S. market this fall, according to the companies' August 27 announcement. The companies say lab data show the shot generates immune responses against multiple currently circulating variants, including XFG.1.1, NB.1.8.1 and several others. Clearance covers **adults 65 and older**, and individuals aged **5 through 64** with at least one underlying condition that raises their risk of severe COVID-19 outcomes. The companies said the vaccine will be available at pharmacies, hospitals and clinics across the U.S. within days. The COVID approval was not what moved the stock. On Friday, BioNTech separately said it was terminating a Phase 2 study of autogene cevumeran — its experimental personalised mRNA cancer vaccine — in patients with resected colorectal cancer, after an independent data safety monitoring board recommended stopping the trial for futility, according to BioSpace, which cited BioNTech's own press release. Reuters reported that BioNTech's U.S.-listed shares fell close to 9% on the news. **Shares closed 8.37% lower at $102.0750**, on dollar volume of about $313 million. The colorectal cancer trial, known as BNT122-01, was testing autogene cevumeran as a standalone therapy — not in combination — to prevent disease recurrence in high-risk patients after surgery. The futility finding means the monitoring board determined the trial was unlikely to meet its goals even if it continued. No safety problems were cited as the reason for stopping, according to BioSpace. The COVID vaccine itself carries a longer record. The companies say **more than five billion doses** of COMIRNATY have been distributed globally to date, and the XFG adaptation follows the same annual reformulation process as prior seasons. BioNTech holds the marketing authorisation for the vaccine in the U.S., the EU, the United Kingdom and other countries, according to the August 27 announcement. Autogene cevumeran had been one of BioNTech's more closely watched oncology programmes. A standalone failure in colorectal cancer does not end the programme — the therapy has been studied in combination with other treatments in different tumour types — but it narrows the path for what the company had positioned as a flagship in personalised cancer immunotherapy. ### A Spine Biologics Company Just Broke Into the Dental Market URL: https://www.pennystocks.news/xtnt-a-spine-biologics-company-just-broke-into-the-dental-ma/ Last updated: 2026-08-29T18:02:34.000Z Xtant Medical makes bone grafts for spine and orthopedic surgeons. On August 27, the company **announced a move into dental and oral surgery markets across North America** — not through its own sales force, but through a partner's. Xtant Medical Holdings, Inc. NYSEAMERICAN: XTNT The company signed an **exclusive deal with BioHorizons, a unit of dental distributor Henry Schein**, making BioHorizons the sole channel for Xtant's allogeneic growth factor product — materials derived from donated human tissue, designed to encourage bone healing — in dental offices and oral surgery practices across the US and Canada. BioHorizons will sell the product under its own brand name, Prolifica™; Xtant markets the same technology as OsteoFactor Pro™. **No dollar value was disclosed** for the deal, and neither company gave revenue projections or sales targets. Two days after the announcement, shares **closed 16.36% higher at $0.3840**, on dollar volume of about $31.3 million. The agreement makes BioHorizons Xtant's **exclusive route into dental and oral surgery** in North America. Xtant supplies the product and handles manufacturing; BioHorizons owns every customer relationship in that channel. What Xtant earns per unit sold, the release does not say. Both companies called it a long-term relationship. Neither said how long. ### A Drug for an Untreatable Skin Disease Just Cleared Its First Clinical Hurdle URL: https://www.pennystocks.news/qnrx-a-drug-for-an-untreatable-skin-disease-just-cleared-its/ Last updated: 2026-08-29T16:20:51.000Z Netherton Syndrome is a rare genetic skin disease with **no approved treatment available in the United States**. On August 28, Quoin Pharmaceuticals said the first six patients to complete twelve weeks on its experimental lotion had cleared the statistical bar the company had set in advance for the interim review. Quoin Pharmaceuticals, Ltd. NASDAQ: QNRX **Four of those six patients improved by at least one grade** on the primary physician skin assessment, achieving statistical significance with a p-value of 0.0087 against a pre-set threshold of 0.0215\. A secondary measure of overall patient-rated change cleared the same bar. No treatment-related serious adverse events were reported. Two questions matter most to anyone holding the stock: does the drug work, and can the company afford to find out? The interim data offered a provisional answer to the first. On the same day, a separate announcement addressed the second. Quoin said it had agreed to raise **up to $50 million** from a group of healthcare-focused institutional investors, including Sirenia Capital Management, Sphera Healthcare, AIGH Capital Management, Nantahala Capital, StemPoint Capital, and Stonepine Capital Management, along with members of management and the board. **About $30.8 million arrives upfront.** The remaining roughly $19.2 million depends on whether investors choose to exercise the warrants included in the deal. The company says the combined net proceeds, assuming full exercise, are expected to **fund operations into the second half of 2029.** Shares closed 18.72% higher at $6.1200 after both announcements, on dollar volume of about $228.5 million. Those warrants carry a deadline tied directly to the trial's outcome. They expire on the earlier of five years from closing or **30 days after Quoin publicly announces that the full trial has met its primary endpoint** — which the company says it expects to report in the second quarter of 2027\. A positive readout starts a 30-day clock for investors to decide whether to exercise and deliver the remaining $19.2 million. The company says it expects to complete enrollment of all 20 participants by the end of 2026. ### A Hong Kong SaaS Minnow Is Selling Shares at a Steep Discount to Market URL: https://www.pennystocks.news/wct-a-hong-kong-saas-minnow-is-selling-shares-at-a-steep-dis/ Last updated: 2026-08-29T14:41:34.000Z Wellchange Holdings priced a share sale at $0.15 on Thursday. The stock it was selling closed above a dollar the following day. Wellchange Holdings Company Limited NASDAQ: WCT The company said it would sell **50 million new Class A shares at $0.15 each**, raising about $7.5 million before fees, in an offering set to close on or about August 31, according to the company's announcement on GlobeNewswire. Prime Number Capital is acting as exclusive placement agent. The free float currently stands at about 2.6 million shares. The 50 million shares being issued would be many times that number — and every new share printed makes the ones already out there worth a smaller slice of the same company. The pricing announcement gave no reason for the discount to the prevailing market. Shares closed **45.53% higher at $1.0900** on Friday, after the pricing was announced, on dollar volume of about $19.4 million across roughly 63,000 trades. Holders who bought at that close paid roughly seven times the offering price. An F-1 registration statement filed with the SEC sets out how the company intends to spend the net proceeds: 30% for business expansion and operational scaling, with the rest split among sales and marketing, research and development, strategic investments, and working capital. Short volume on Friday came to **56.5% of reported trading** — bets against the stock accounted for more than half of all activity on the session. The free float is about 2.6 million shares, and 6.6 million shares traded short, meaning short volume alone was more than twice the size of the float. The SEC declared the registration effective on August 27, the day before the pricing was set. Once the offering closes, the new shares will outnumber the existing float by a wide margin. ### A Chinese Payments App Is Now Building Gas-Powered AI Data Centres in Canada URL: https://www.pennystocks.news/fngr-a-chinese-payments-app-is-now-building-gas-powered-ai-d/ Last updated: 2026-08-29T13:01:42.000Z FingerMotion runs a mobile payments platform in China. Three weeks ago it hired a new chief executive. This week she said the company is building gas-powered AI data centres in Western Canada. FingerMotion, Inc. NASDAQ: FNGR The one executed step under that plan closed on August 17, when FingerMotion paid **1,674,480 of its own restricted shares — no cash — for a 9.9% stake in Lyken AI Computing Inc.** The company said the all-stock transaction was valued at **$500,000**. Alset AI Ventures Inc. retains a 90.1% controlling interest in Lyken. For anyone holding the stock, the gap between what has been done and what is planned is the story. **FingerMotion has no signed sites, no power agreements and no enterprise customers.** Everything beyond the Lyken stake is a framework that has not yet produced a binding contract. **Shares closed 129.53% higher at $0.3980,** on dollar volume of about $560 million. Short volume on the session was 56.04% of reported volume. New chief executive Jolie Kahn, appointed August 4, says the logic of the plan rests on a real constraint: grid interconnection queues in Western Canada and the United States have grown long enough that a connection request and actual delivered electricity have become different things. The company intends to generate power at each site from natural gas — including gas that would otherwise be flared — rather than wait for a grid connection. That work would fall to BlueFlare Energy Solutions, an Alberta developer, under a June 9 memorandum of understanding. BlueFlare would handle site origination, engineering, construction and field operations across Alberta, British Columbia and Saskatchewan, capabilities FingerMotion does not have internally and says it does not plan to build from scratch. Lyken sits between basic colocation and the large cloud providers, offering managed compute, storage and networking to enterprise customers who need more than a rack but cannot contract at hyperscale. On August 25 FingerMotion noted a separate non-binding memorandum of understanding between Lyken and Singapore-based Swarmnet Solutions, covering an indicative framework for a **128-node NVIDIA B300 compute cluster.** The company was clear that the agreement belongs to Lyken, not FingerMotion, that it is non-binding, and that no revenue figures have been agreed. The company's own August 27 release included a milestone table showing no site control, no power arrangement, no customer contract and no project financing — and said plainly that the release announced none of those things. The company says it intends to finance each site against contracted customer revenue rather than draw on its corporate balance sheet. **That depends on contracts it does not yet have.** ### A Truck Accessory Maker Says It Just Had Its Best Sales Month Ever URL: https://www.pennystocks.news/wksp-a-truck-accessory-maker-says-it-just-had-its-best-sales/ Last updated: 2026-08-28T23:02:29.000Z Worksport makes tonneau covers for pickup trucks, along with solar integrations and portable power systems designed to fit the same market. In July, the company says, customers ordered more of its products in a single month than at any point in its history. Worksport, Ltd. NASDAQ: WKSP The company said in an August 26 release that **July product orders reached about $2.52 million**, a new company record. That figure is an operating metric, not a recognized revenue number: of the total, about **$2.22 million became preliminary net sales** after fulfillment, while roughly **$300,000 remained in backlog** at month-end — firm orders that haven't yet cleared the revenue-recognition requirements under standard accounting rules. The $2.22 million in preliminary net sales was up roughly 60% from the approximately $1.38 million Worksport posted in March, and the company says net sales rose in every month of 2026 through July. **Gross margin came in at 30.8%**, the third consecutive month above 30%, which the company says reflects a materially stronger profit base than it had at the start of the year. Worksport put its **annualized revenue rate at $30 million** and, according to the release, anticipates that figure will keep rising. That projection is the company's own. All July results are preliminary and unaudited, pending the company's external financial reporting close. Shares **closed 23.53% higher at $0.6300** two days after the release, on dollar volume of about $138 million. Short volume on that session was reported at about 52.5 million shares against a free float of roughly 14.4 million — making the day's short volume more than three times the available float. The orders still in backlog at July's end will count as revenue only once those shipments go out and the applicable recognition conditions are satisfied — meaning a portion of the record order book is still waiting to clear. ### Biomerica's Own Board Funded Its Latest Raise — Now It's Hunting a Deal URL: https://www.pennystocks.news/bmra-biomerica-s-own-board-funded-its-latest-raise-now-it-s/ Last updated: 2026-08-28T21:22:51.000Z Everyone on Biomerica's board wrote a personal check. So did the chief executive. So did the bank they just hired to find them a deal. On August 27, the diagnostic test maker **raised $2.23 million by selling shares at $1.60 each**, with no warrants attached and no discount, according to the company's announcement. Buyers included B. Riley Principal Capital, executives from B. Riley Securities, Biomerica's CEO, and every member of the board. BIOMERICA INC NASDAQ: BMRA The same announcement said Biomerica has hired B. Riley as its **exclusive advisor to evaluate mergers, acquisitions, joint ventures and other combinations**. The company said it intends to use proceeds to strengthen its balance sheet and fund operations while the board works through that process. The new shares represent **about 30% of the company's share count** once the placement closes, the announcement said. Every new share issued makes the existing ones a smaller slice of the same company. The counterweight is that the people authorizing those shares also bought them. Shares closed 24.27% higher at $2.10 on August 28, after the announcement, on dollar volume of about $6.9 million. The placement price was $1.60\. The stock closed the following day at $2.10. ### A Chinese Skincare Tech Company Is Buying a Distributor to Feed Its AI Platform URL: https://www.pennystocks.news/wnw-a-chinese-skincare-tech-company-is-buying-a-distributor/ Last updated: 2026-08-28T19:42:14.000Z Meiwu Technology's AI skincare platform needs one thing above all: clients. On August 20, the company agreed to buy them. Meiwu Technology Company Limited NASDAQ: WNW The target is Xiamen Hemeitong, a functional skincare distributor active across southern and eastern China with access to roughly **1,600 brand owners, retailers and beauty salons**. In a 6-K filed with the SEC on August 26, Meiwu said that once the deal closes, Hemeitong's network will bring business clients into its MOBO platform and accelerate the collection of user interaction data the AI tools need to develop. For a shareholder, the thing to register is what MOBO is at this point. The filing describes its intended functions — skincare evaluation, product recommendations, e-commerce and data analytics for brand owners and salons — but discloses no current user count, no platform revenue, and no conversion rate from distributor contacts to active platform clients. The acquisition buys access to a network. Whether that network generates platform users is a question the agreement does not answer. Meiwu's subsidiary Xiamen Chunshang Health Technology is paying **RMB 235.2 million — about $35 million — in cash** for 100% of Xiamen Hemeitong's equity. An independent valuation by Beijing Yingyue Asset Appraisal, completed August 17, put Hemeitong's full equity at RMB 239.4 million; the agreed price sits just below that. Payment runs in two tranches, and the agreement notes that **RMB 34.251 million had already been transferred to the two sellers in May**, months before the formal contract was signed, and counts toward the first instalment. Shares closed 33.47% higher at $3.3100 on August 28, two days after the filing, on dollar volume of about $57 million. The parties aimed to complete the equity registration by August 31\. The closing remains subject to standard conditions including shareholder approval at the target company. At the time of filing, neither the number of active MOBO users nor any revenue from the platform had been disclosed. ### A New Crypto Company Paid Its SPAC Sponsors Almost Entirely in Warrants URL: https://www.pennystocks.news/usde-a-new-crypto-company-paid-its-spac-sponsors-almost-enti/ Last updated: 2026-08-28T18:02:31.000Z Three former SPAC sponsors were owed about **$6.9 million**. They settled for 5% in cash. The rest they accepted as warrants — the right to buy StablecoinX shares at prices the stock is not currently reaching. StablecoinX Inc. NASDAQ: USDE StablecoinX completed its merger with TLGY Acquisition Corp in June and inherited the debt along with it. TLGY had issued the notes to three entities — TLGY Sponsors LLC and two CPC Sponsor Opportunities funds — to cover working capital and extension loans while the blank-cheque company searched for a merger target. On August 21, the company and the three former sponsors signed a restructuring agreement, according to an 8-K filed with the SEC on August 24\. The terms: **5% of the original principal paid in cash**, 47.5% settled in Tranche A warrants exercisable at **$11.50 a share**, and the remaining 47.5% in Tranche B warrants exercisable at **$15.00**. The sponsors waived all remaining claims on the original notes. Both strike prices sit above where the stock is trading now, meaning neither tranche is currently worth exercising. But the Tranche A warrants run to **June 25, 2031**, and the Tranche B warrants for **eight years from issuance** — so the former sponsors have time to wait. If the share price does climb past those levels, existing holders would see new shares created: every new share issued makes the ones already outstanding a smaller slice of the same company. A further feature: while the former sponsors hold the warrants, they can receive shares by surrendering the warrants rather than sending cash to the company. StablecoinX conserves cash upfront, but collects no exercise proceeds from the sponsors if that right is used. **Shares closed 34.95% higher at $8.0700** on Thursday, on dollar volume of about $169 million. The filing does not state how many warrants were issued in total — the form documents attach placeholder counts rather than final figures. That number will determine the actual scale of potential dilution sitting on the table. ### The Blood Test That Predicts Sepsis Outcomes Gets Peer-Reviewed Backing URL: https://www.pennystocks.news/vnrx-the-blood-test-that-predicts-sepsis-outcomes-gets-peer/ Last updated: 2026-08-28T16:22:51.000Z Predicting which sepsis patients will deteriorate is one of the hardest calls in intensive care medicine. A study published this week in *Critical Care Medicine* found that a nucleosome blood test can predict — independently of other standard markers — which patients will die within 28 days or need machines to replace failing kidneys. VolitionRx Limited NYSEAMERICAN: VNRX The paper, a secondary analysis of the SISPCT randomised controlled trial, found that levels of **H3.1 nucleosomes — proteins released when immune cells self-destruct in the process known as NETosis — were significantly higher in patients with septic shock than in those with sepsis**, and tracked directly with the severity of acute kidney injury. An independent editorial published alongside it in the same journal said H3.1 may identify "a biologically distinct subgroup of patients with NET-mediated organ injury." **Shares closed 47.70% higher at $0.5010, on dollar volume of about $229 million**, against a free float of about 6.5 million shares. For a holder, the peer-reviewed paper does two concrete things: it gives the Nu.Q NETs biomarker a level of clinical credibility that internal company studies cannot, and it appears in a journal read by the intensivists who would order the test. The company says it is in active licensing discussions with more than a dozen diagnostic companies, but no dollar values or timelines are attached to any of them. One development worth separating from that finding: the company says it has built a **prototype that works on a finger-prick blood sample**, the way a home pregnancy test does, and has shown it correlates with the established CE-marked automated test in ICU patients. That prototype has not been peer-reviewed. In a corporate update released the same day, VolitionRx reported **$1.4 million in first-half 2026 revenue, more than double the prior-year period**, according to the company's release. No breakdown by product line was given. The company also said it has submitted a clinical manuscript for its feline lymphoma test — which, according to the release, detected 86% of feline lymphomas at 97% specificity — to a peer-reviewed journal. A **$5 million contractual milestone payment is expected to follow publication**. A government-backed program in France, budgeted at about **$7.3 million, is due to start enrolling patients in the third quarter of 2026**. That program, called DETECSEPS, would evaluate Nu.Q NETs in an interventional real-world setting — a step beyond the secondary trial analysis that produced this week's paper. The $5 million payment depends on publication, not on submission. The manuscript is still in review. ### This Hong Kong Cloud Company Wants Permission to Print a Hundred Trillion Shares URL: https://www.pennystocks.news/chow-this-hong-kong-cloud-company-wants-permission-to-print/ Last updated: 2026-08-28T14:42:10.000Z ChowChow Cloud is asking shareholders to vote for a reverse split — turning every 10 shares into one. Right after that, in the same set of proposals at the same meeting, it wants permission to authorize 100 trillion shares. ChowChow Cloud International Holdings Limited NYSEAMERICAN: CHOW The extraordinary general meeting is set for September 14 in Hong Kong. The full agenda runs through six linked resolutions: **a 10-for-1 reverse split**, the creation of two share classes with different voting rights, a redesignation of all existing shares into those classes, and then an increase in authorized shares **from 50 million to 100 trillion**. If all six pass, CEO Yee Kar Wing's holding company will control **95.7% of all votes** — up from a position today where it holds about 68.91% of ordinary shares. For anyone already holding shares, those two outcomes are related. The redesignation is the step that matters most. Under the proposal, Yee's company — Rainbow Sun Enterprises Limited, incorporated in the British Virgin Islands — would have its shares redesignated into Class B. Everyone else's shares become Class A. **Class B shares carry 10 votes each**; Class A shares carry one. Rainbow Sun's economic stake stays roughly where it is, but its say over every subsequent decision becomes nearly absolute. The proxy statement was filed with the SEC on August 26\. Shares closed 68.42% higher at $0.6400 on August 28, on dollar volume of about $93 million. The proxy says the dual-class structure would "enable the Company's key shareholders to maintain long-term voting control and stability." On the 100 trillion authorization, it says the additional headroom would allow for equity financings, strategic transactions and general corporate purposes. The filing does not say how many of those shares the company intends to issue, or on what timeline. Class A shares cannot be converted into any other class. Class B can convert into Class A, at the holder's option, on a one-for-one basis — but only Rainbow Sun would hold Class B. The decision of when, or whether, to give up that voting premium belongs entirely to Yee. ### A Tokyo Builder Moves Into Osaka URL: https://www.pennystocks.news/lgps-a-tokyo-builder-moves-into-osaka/ Last updated: 2026-08-28T13:01:16.000Z LogProstyle builds and sells homes in Tokyo. It has now agreed to buy an Osaka firm to enter the Kansai market, where it has not previously operated. LogProstyle Inc. NYSEAMERICAN: LGPS On August 27, the company signed an agreement to acquire **all 3,800 issued and outstanding shares of I-FLATZ**, a condominium sales and leasing firm headquartered in Osaka City, from its sole owner, Toshihide Suzuki. I-FLATZ is itself the sole shareholder of LAND-I Co., so the deal pulls both companies under LogProstyle's control. The price is **about JPY 612 million**, according to the 6-K filed with the SEC that day. Closing is targeted for **September 30, 2026**. I-FLATZ built its business selling new condominiums in the Kansai region before expanding into the resale of renovated pre-owned apartments and real estate leasing, according to LogProstyle's own IR page. LogProstyle says it wants to bring the business model it has developed in the Tokyo area into that region through this acquisition — giving it a revenue base outside the market it already knows. Suzuki will step down as representative director of I-FLATZ after closing but stays on the board. He departs both his roles at LAND-I entirely. A non-compete takes effect once he leaves. LogProstyle has agreed to release him from personal guarantees he gave on I-FLATZ's existing bank loans within two months of closing; until that is done, the company has agreed to handle any claims those creditors bring against him directly. Shares closed **74.85% higher at $1.5200** after the announcement, on dollar volume of about $57.7 million. The free float is about 6.3 million shares — roughly a quarter of shares outstanding — and **short volume on the session was 59.12% of reported volume**. If the deal has not closed by December 31, 2026, either party may terminate the agreement. ### A Tariff Refund More Than Doubled Abercrombie's Expected Earnings URL: https://www.pennystocks.news/anf-a-tariff-refund-more-than-doubled-abercrombie-s-expected/ Last updated: 2026-08-27T23:02:34.000Z Three months ago, Abercrombie & Fitch told investors to expect second-quarter earnings of **$1.80 to $2.00 a share**. The quarter came in at **$4.17**. Abercrombie & Fitch Co. NYSE: ANF The difference was a refund. The US government returned roughly **$100 million in tariffs** that Abercrombie had paid on imported goods — duties collected under a trade emergency authority known as IEEPA. Those refunds landed in the second quarter and flowed into operating income, adding about **$1.75 to per-share earnings** in one quarter. The company said in its August 26 release that the underlying result would have beaten guidance even without the refund, though the refund accounts for the bulk of the gap between the forecast and the outcome. Peel back the refund and the business looks like a steadily growing retailer. **Net sales reached $1.3 billion for the quarter, up 5%** from a year earlier, with both the Abercrombie and Hollister brand families posting record second-quarter figures and growth spread across regions. For a holder of the stock, the practical question is how much of that result belongs to the ongoing business and how much was a one-time government payment. After the company published results on August 26, shares closed 35.67% higher at $147.75 the following day, on dollar volume of about $2.5 billion. The windfall lifted the full-year outlook sharply. Abercrombie now expects fiscal 2026 earnings of **$13.10 to $13.60 a share**, up from a May forecast of **$10.20 to $11.00**. The company also raised its share-repurchase target to at least **$500 million** for the year. The company has built further refund estimates into its second-half outlook. Whether those refunds materialize depends on tariff policy that, as Abercrombie's own filing notes, remains uncertain in timing and amount. ### Urban Outfitters Strings Together Eight Straight Record Quarters URL: https://www.pennystocks.news/urbn-urban-outfitters-strings-together-eight-straight-record/ Last updated: 2026-08-27T21:21:25.000Z For the **eighth consecutive quarter of record sales**, Urban Outfitters delivered. Revenue for the three months ended July 31, 2026, **rose 10.4% to $1.66 billion**, and Chief Executive Richard Hayne said in the company's release that adjusted profits had reached the highest level in company history. Urban Outfitters Inc NASDAQ: URBN The reported figures carry a significant one-time lift. The company received a refund of **about $96 million for tariffs previously paid under trade emergency powers** — a program the filing calls IEEPA — and booked the money through cost of sales. Strip it out and the underlying gross margin was essentially unchanged from a year ago. The streak is real; the headline profit margin is not a clean read on where the core business stands. With or without the refund, the operational picture is broadly positive. Every retail brand posted comparable sales growth in the quarter, and overall **comparable retail net sales rose 6.2%**. The subscription segment — Nuuly, a rental service for women's clothing — was the standout, with net sales **up 28.6%**, driven by a 30.4% rise in average active subscribers compared with the same period a year earlier. In the first half of fiscal 2027, the company spent roughly **$300 million buying back its own stock**. Shares **closed 9.46% higher at $82.95**, on dollar volume of about $297 million. Hayne called it the **highest adjusted profit quarter in the company's history** — and that figure already excludes the tariff refund entirely. ### One Holder Controls All the Class B Shares. They Just Tripled Their Votes. URL: https://www.pennystocks.news/rpgl-one-holder-controls-all-the-class-b-shares-they-just-tr/ Last updated: 2026-08-27T19:40:34.000Z All of Republic Power Group's Class B shares are held by a single person or entity. Last week that holder voted to triple the voting power of each share — and to authorize a billion more of them. Republic Power Group Limited (Nasdaq: RPGL) NASDAQ: RPGL The vote took place at an extraordinary general meeting in Singapore on August 24\. The proposal to increase Class B voting rights was, according to the 6-K filed with the SEC on August 25, explicitly conditional on the sole Class B holder's approval. They gave it. Each Class B share now carries **100 votes instead of 30**. Only about 30,000 Class B shares exist today, set against roughly 16 million Class A shares outstanding, each carrying one vote. The arithmetic of that gap has just shifted considerably. And the bigger change may be structural: before the vote, the company was authorized to issue no more than 62,500 Class B shares in total. After it, that ceiling is **1 billion Class B shares** — a cap that is more than 16,000 times larger than the one it replaced. The total authorized share count now stands at **11 billion**, split between 10 billion Class A and 1 billion Class B. Every new Class B share issued would carry those same 100 votes. Shareholders also handed the board a standalone mandate to consolidate shares without a further vote. The board may, at its sole discretion, carry out one or more reverse splits at any ratio from 1-for-2 up to **1-for-50**, at any point within **180 days** of the August 24 meeting. If it acts, the articles will be amended to reflect whatever ratio it chooses. A sixth proposal approved moving the company's legal domicile from the British Virgin Islands to the Cayman Islands, subject to receiving government and regulatory approval, the filing states. A seventh approved the form of Cayman memorandum of association that would take effect on continuation. Shares closed 16.88% higher at $2.3200 on August 27, after the 6-K was filed, on dollar volume of about $4.9 million across 6,816 trades. Short volume that session was 957,779 shares, equal to 72.69% of reported volume. The filing does not say who holds the Class B shares, nor does it disclose any plans to issue additional Class B shares or execute a reverse split. The authorization exists; what the board does with it has not been stated. ### $0.20 a Share. $1.00 to Stay on Nasdaq. URL: https://www.pennystocks.news/nwgl-0-20-a-share-1-00-to-stay-on-nasdaq/ Last updated: 2026-08-27T18:02:34.000Z In July, CL Workshop Group **sold 12.3 million shares at $0.20 each**. Nasdaq has given the company until November 2 to get those shares trading above $1.00, or lose its listing. CL Workshop Group Limited NASDAQ: NWGL The gap between those two prices defines what the placement means for anyone already holding the stock. Each unit, sold under a purchase agreement dated July 14, bundled one ADS — a listed certificate representing eight ordinary shares — with a warrant to buy **three more ADSs at $0.25**. Those buyers can now sell publicly: a prospectus filed with the SEC on August 25 registered the shares for resale on their behalf. The company said it receives none of those proceeds. The warrants compound the picture. If all 12.3 million are exercised, the company would issue **up to 36.9 million additional ADSs** at $0.25 each. Every new share makes existing ones a smaller fraction of the same company — and the exercise price, like the placement price, sits well below the $1.00 minimum Nasdaq requires. Nasdaq notified the company in May that its ADSs had fallen below $1.00 and stayed there, putting it out of compliance. **November 2 is the first deadline.** If the company misses it, a further grace period is available — but only by committing to push the price above the minimum, most likely through a reverse split, where existing shares are consolidated into fewer, higher-priced ones. CEO Liying Wang effectively controls all decisions. Through her holding vehicle she owns all of the company's Class B ordinary shares, which carry 50 votes each against one for the Class A shares listed publicly. That gives her **roughly 97% of total voting power**, the prospectus states. Shares closed 26.26% higher at $0.8472 on August 27, on dollar volume of about $3.7 million. The placement buyers secured a position that works whether the stock reaches $1.00 or not. For existing holders, the listing depends on it. ### An Electric Boat Company Is Merging Into a Mystery Defense Drone Firm URL: https://www.pennystocks.news/vmar-an-electric-boat-company-is-merging-into-a-mystery-defe/ Last updated: 2026-08-27T16:21:22.000Z Vision Marine Technologies builds electric boats. The company it plans to hand control to builds defense drones. At closing, if the deal completes, existing Vision Marine shareholders would own **2.9% of the combined entity**. Vision Marine Technologies Inc. NASDAQ: VMAR On August 24, the company announced it had **signed a non-binding letter of intent for a reverse takeover** by a privately held defense-technology company focused on unmanned aerial and autonomous systems. The counterparty's name is not being disclosed. Vision Marine says the identity will remain confidential until due diligence is complete and definitive agreements are signed. The 2.9% is the base case, before any concurrent financing dilutes it further. There is contingent consideration tied to maritime autonomy and military or government sales milestones that, if fully earned, **could lift existing holders' combined stake to about 5.7%**. Even then, the counterparty's shareholders would hold the large majority of the combined company. Shares closed 29.49% higher at $9.30 on August 27, on dollar volume of about $36.2 million. Closing the deal has substantial preconditions. **A concurrent financing of at least $25 million** must be completed. The counterparty must also secure **at least $100 million in binding purchase orders for 2027 deliveries** before the transaction can close. Vision Marine's release states plainly that this threshold "does not represent purchase orders currently received, contracted backlog or guaranteed future revenue." The parties are aiming for definitive agreements by mid-October and a closed transaction by the end of the year. The reverse split sits alongside this. On the same day as the deal announcement, Vision Marine disclosed a **1-for-10 share consolidation**, combining every ten existing shares into one, effective August 26\. The stated purpose was to push the share price back above the **$1.00 minimum** Nasdaq requires for continued listing — a bar the stock had not cleared. Chief Executive Alexandre Mongeon framed the proposed merger in the release as a natural evolution, from electrification into "intelligence and autonomy." The release does not disclose the counterparty's revenues, contracts, or financial statements, and notes that the demand estimates the counterparty has provided remain subject to Vision Marine's own due-diligence review. Shareholders asked to vote on this deal would be approving a transaction that transfers the vast majority of the combined company to a buyer whose name they do not yet know. ### A Tiny-Float Nasdaq Stock Just Tore Up Half Its Debt Deal URL: https://www.pennystocks.news/yygh-a-tiny-float-nasdaq-stock-just-tore-up-half-its-debt-de/ Last updated: 2026-08-27T14:41:51.000Z YY Group signed a deal in February to raise money through two equal tranches of convertible notes. On Monday, it cancelled the second tranche before a dollar of it was ever drawn. YY Group Holding Limited NASDAQ: YYGH The company said in an August 25 announcement that it had entered into a supplemental agreement with the noteholder, effective August 20, cancelling the **$5.94 million second tranche** outright. In the same agreement, the holder surrendered all **11,284 warrants** it had received when the first tranche closed — for no separate payment. The first tranche had already been mostly repaid. YY Group agreed to clear the **remaining approximately $1.37 million** by December 31, after which it will carry no convertible debt or warrants at all. That matters to anyone already holding the stock. Warrants give their owner the right to buy new shares, and convertible notes can turn into equity — each time producing shares that make the existing ones a smaller piece of the same company. Cancelling the second tranche removes that source before it was ever tapped. The warrants disappear at no extra cost to the company. Shares closed **84.35% higher at $2.1200** after the announcement, on dollar volume of about $179.6 million. The free float — shares actually available to trade — stands at about 899,000\. Reported short volume on the same session was about 11.5 million shares against that float. One restriction in the supplemental agreement limits the company's options going forward: it places conditions on YY Group's ability to raise money through future equity financings. The specific terms were not disclosed in the announcement. Chief Executive Mike Fu said the company expects to settle the remaining balance by the year-end deadline. The noteholder gave up both the right to deploy the second tranche and its entire warrant position without receiving anything in return. The company did not say what led the holder to accept those terms. ### Junior Gold Miner Keeps Hitting Thick, High-Grade Gold in Quebec URL: https://www.pennystocks.news/emauf-junior-gold-miner-keeps-hitting-thick-high-grade-gold/ Last updated: 2026-08-27T13:02:34.000Z Emperor Metals' latest assay release from Duquesne West in Quebec includes a **20.1-metre intercept grading 5.0 grams of gold per tonne**, at a vertical depth of 375 metres. The interval sits inside a replacement-style lens — a broad zone where gold has replaced the surrounding rock — that the company says is more continuous and extensive than earlier, widely spaced drilling had shown. EMPEROR METALS INC OTC: EMAUF Shares closed 22.55% higher at $0.3199, on dollar volume of about $938,000 across 523 trades. Results are now in for **38 of the 66 holes** drilled this season at Duquesne West. A substantial portion of the total expected assays — including work on previously unsampled historical core — has not yet been reported, according to the company's August 25 release. The programme is part of Emperor Metals' push toward a preliminary economic assessment, an early study of whether the deposit can be mined profitably. The catch is that the intercepts being reported now sit partly outside the existing resource model. That model currently stands at **1.46 million ounces of gold at an average grade of 1.69 g/t**, per a resource estimate published in July 2025\. The company says the mineralised lenses the current programme is drilling are not fully captured in that figure — which means shareholders holding on the strength of the resource number are looking at a floor, not a ceiling, if the new holes hold up. This batch also returned a **12.4-metre interval at 1.6 g/t** and a **3.0-metre interval at 2.7 g/t** pulled from previously unsampled historical core. The historical core work turned up visible free gold — flecks or grains large enough to see with the naked eye — something that had not previously been recognised at this project. The company says it is now systematically targeting the zones where that characteristic appears. CEO John Florek said in the release that the results show "substantial thickness and grade" across several mineralised lenses and that a clearer understanding of the deposit's structure is allowing the team to drill these zones with greater precision. **More than half the programme's expected assays are still to come.** ### A Cloud-Seeding Stock Is Fighting to Stay on Nasdaq URL: https://www.pennystocks.news/rain-a-cloud-seeding-stock-is-fighting-to-stay-on-nasdaq/ Last updated: 2026-08-26T23:01:51.000Z Six months ago, Nasdaq set one condition for Rain Enhancement Technologies: bring the company's total market value above $35 million, or lose the listing. The deadline was August 17\. The company did not meet it. On August 18, the exchange told the company its stock would be **suspended and delisted starting August 27** unless it requested a panel hearing. The company filed that request three days later, on August 21, according to an 8-K filed with the SEC. The hearing request is expected to stay any suspension while the panel deliberates. Rain Enhancement Technologies Holdco, Inc. NASDAQ: RAIN For shareholders, the hearing is now the only decision point that matters. If the panel rules in the company's favor, trading continues while the company works toward compliance. If it does not, both the common shares and the company's warrants would be removed from the exchange. The company said it is "considering all options" to regain compliance, without naming them. Shares closed 26.13% higher at $1.1700 on August 26, after the filing, on dollar volume of about $2.3 million. The company's filing acknowledged there is **no assurance the panel will grant the request**, or that the company can achieve compliance within any timeframe the panel allows. ### A U.S. Federal Agency Just Bought This Israeli Drone Catcher URL: https://www.pennystocks.news/przo-a-u-s-federal-agency-just-bought-this-israeli-drone-cat/ Last updated: 2026-08-26T21:21:16.000Z Most drone-interception systems shoot. DefendAir throws a net. On August 25, a U.S. federal security agency **ordered the system for the first time** — marking ParaZero's first sale to any U.S. government customer. ParaZero Technologies Ltd. NASDAQ: PRZO The order, according to ParaZero's announcement, covers **DefendAir net launchers, Net Pods and on-site training** delivered by company personnel. No dollar value was disclosed, and the agency was not named. The training is part of the product, not an optional extra. ParaZero sends its own team to work through the system with the customer's operators — what CEO Ariel Alon described in the release as the difference between a box that arrives and a capability that works. "Counter-UAS capability is not created when a box arrives," Alon said. "It is created when trained operators can deploy the system confidently and act when seconds matter." The net-based approach is designed for settings where shooting down a drone is not viable — near crowds, confined spaces or sensitive infrastructure where a falling aircraft or debris would cause its own problems. The system stops a drone by catching it physically, without an explosive warhead or conventional gunfire. **Shares closed 31.03% higher at $0.8200** the session after the announcement, on dollar volume of about $64 million. The company says in its release that interest in DefendAir is growing across international defense and security markets, and that the U.S. federal order adds a new category of customer to that list. **How many orders that interest has produced is not disclosed.** ### Exyn's CEO Charged Personal Travel to the Company and Got Caught URL: https://www.pennystocks.news/exyn-exyn-s-ceo-charged-personal-travel-to-the-company-and-g/ Last updated: 2026-08-26T19:42:31.000Z The audit committee hired outside lawyers to look into how the company credit card was being used. What they found cost Brandon Torres Declet both of his jobs. Exyn Technologies, Inc. NASDAQ: EXYN Declet was Exyn's chief executive and chairman. The investigation, run by the audit committee with independent outside counsel, identified **about $286,000 in personal travel and other expenses** charged to a company-issued card over multiple periods and entered into Exyn's books as business costs, according to an 8-K filed with the SEC on August 25\. Declet **resigned from all positions on August 19**, effective immediately. Under a separation agreement dated August 25, he agreed to pay the money back. The company agreed not to pursue legal action immediately — the price it paid for a broad release of any claims Declet might bring against it. He gets no severance and no accelerated vesting of his equity. No repayment schedule is described in the filing. The board moved the same day as the resignation. Benjamin Williams, who has been the company's chief operating officer since May 2019, **became interim chief executive**. He has been here before: Williams held the same interim role from June 2023 through November 2023\. Director Gregory McNeal became non-executive chairman. **Williams's annual salary was raised to $355,000**, from $294,000, following the appointment. Shares **closed 40.00% higher at $3.2200** on August 26, after the filing, on dollar volume of about $5 million across 11,340 trades. Declet agreed to repay the $286,000\. The filing does not say when, or what the company does if he doesn't. ### A Nasdaq Media Company Buys Itself Weeks to Avoid Delisting URL: https://www.pennystocks.news/tnmg-a-nasdaq-media-company-buys-itself-weeks-to-avoid-delis/ Last updated: 2026-08-26T18:02:39.000Z Nasdaq moved to delist TNL Mediagene in June. After an appeals hearing in August, the company has won more time — but must clear two compliance tests before the end of October or face removal from the exchange. TNL Mediagene NASDAQ: TNMG The sequence that brought things to this point began on **June 22, when Nasdaq's listing qualifications staff determined to delist** TNL Mediagene, citing failure to regain compliance with the minimum bid price rule and existing non-compliance with the stockholders' equity rule. The company requested a hearing a week later. That hearing took place on **August 4**, and the Nasdaq Hearings Panel issued its ruling on August 23. The panel set two conditions. **By September 21, TNL Mediagene must demonstrate compliance with the minimum bid price requirement** — the rule that sets a floor on how low a listed stock can trade. **By October 30, it must show its stockholders' equity is sufficient** for continued listing. The filing does not say what the company has proposed to do to satisfy either condition. Shares closed **43.29% higher at $0.5700** after the panel's ruling became public, on dollar volume of about $129 million. The panel has kept the power to withdraw the exception at any point. If any development during the grace period makes continued listing inadvisable — in the panel's judgment — it can act. TNL Mediagene's own filing says there is no assurance the company will meet the conditions, and a failure on either would result in delisting. TNL Mediagene had already failed the bid price rule once before June 22 — that failure was what triggered the determination to delist. It now has until September 21 to fix that, and has not said how. ### Egypt's Sawiris Family Backs Swvl's Push Into the U.S. Market URL: https://www.pennystocks.news/swvl-egypt-s-sawiris-family-backs-swvl-s-push-into-the-u-s-m/ Last updated: 2026-08-26T16:22:34.000Z One of Egypt's most prominent business families has put money behind Swvl's first real push into the United States. On August 25, the Dubai-based transport-technology company said it had agreed to raise **$13 million in a private placement**, with the Sawiris family leading through a Houston investment firm called Coefficient LP. Swvl Holdings Corp NASDAQ: SWVL Coefficient committed **$10 million** of the total; an existing Swvl shareholder added the remaining **$3 million**. All shares were priced at **$1.446 each**. On closing, **Coefficient becomes Swvl's largest institutional shareholder**, and Coefficient founder Abdalla Ali joins the board. Shares closed 50.34% higher at $2.2100 the following session, after the announcement, on dollar volume of about $190 million across roughly 550,000 trades. The money has two stated destinations. The first is U.S. expansion — the company says it has only just begun American operations, and this is what funds the build-out. The second is new: Swvl intends to start extending credit to the bus and minibus operators already in its network, giving them access to financing rather than just bookings. The release gives no detail on rates, loan sizes, or how the proceeds are split between the two goals. The company points to first-quarter 2026 numbers to support the raise. Revenue reached **$8.2 million, up 68%** year on year. Operating expenses, the company says in the release, fell to **23% of revenue** in the same period, which it describes as approaching operating breakeven. The placement itself will expand the share count materially. Swvl is issuing **about 9 million new Class A shares** to a market where the free float currently stands at about 5.4 million. Those shares are restricted until Swvl files a resale registration statement, which it has agreed to do under the terms of the deal. Swvl has always made its money as a platform — software connecting operators to clients. Extending credit to those same operators is a different kind of business, and the release does not say how Swvl plans to fund or manage it once the initial capital is deployed. ### A Hong Kong Clothes Seller Is Pivoting Into Pharmaceutical Cannabis URL: https://www.pennystocks.news/jem-a-hong-kong-clothes-seller-is-pivoting-into-pharmaceutic/ Last updated: 2026-08-26T14:42:41.000Z 707 Cayman Holdings sells clothing and manages supply chains from Hong Kong. On Monday it said it intends to **acquire a pharmaceutical cannabis company**. 707 Cayman Holdings Limited NASDAQ: JEM The target is Crucial Innovation Inc., which describes itself as an integrated pharmaceutical botanical therapeutics platform. **Medical cannabis is its commercial foundation**; the company says it is also developing therapies in oncology, pain management and opioid replacement, and has established routes to market in the UK, Germany and Australia, according to the release. The **term sheet is non-binding**, and closing still requires satisfactory due diligence, delivery of audited financial statements, a fairness opinion, definitive agreements, and approval from shareholders, regulators and Nasdaq. The proposed deal would be backed by **$10.25 million in committed financing**, led by GeoNova Holdings, an Abu Dhabi-based investment group, together with co-investors. The release says the funds are intended to cover transaction and growth costs. The acquisition price, valuation and allocation of proceeds have not been disclosed and will be set out in the definitive agreements. Shares **closed 77.88% higher at $6.7950** after the announcement, on dollar volume of about $126.6 million against a free float of about 570,000 shares. No financial figures for Crucial Innovation appear in the release — **no revenue, no cash, no valuation**. The deal commits neither side to anything until definitive agreements are signed, a price is named and Nasdaq gives its approval. ### An SEC Settlement Barred a Netcapital Director From the Securities Business URL: https://www.pennystocks.news/ncpl-an-sec-settlement-barred-a-netcapital-director-from-the/ Last updated: 2026-08-26T13:01:04.000Z Cecilia Lenk sat on Netcapital's board and led its advisory subsidiary. Then a federal court approved her settlement with the SEC. She resigned the same day — **permanently barred from the securities business**. Netcapital Inc. NASDAQ: NCPL The United States District Court for the District of Massachusetts **approved Ms. Lenk's settlement on August 19**. Under its terms, she consented to be permanently enjoined from directly or indirectly participating in the purchase, offer or sale of any security — other than for her own account — and agreed to pay a **civil penalty of $50,000**, without admitting the SEC's allegations. She wrote in her resignation letter, filed as an exhibit to the 8-K, that the permanent injunction left her unable to continue serving as a director or to lead Netcapital Advisors Inc., the company's wholly owned subsidiary. That kind of bar does not narrow a career — it ends it, for any role that involves handling or recommending securities on behalf of others. For shareholders, the harder question is the case Ms. Lenk was part of, which **names Netcapital itself as a defendant** and has not resolved. Shares closed 126.83% higher at $0.5800 on August 26, on dollar volume of about $276 million. The free float is about 3.7 million shares; short volume was 55.48% of reported volume on the session. Bloomberg Law reported that the SEC's complaint alleges the company **overstated its revenue by 345%** between October 2021 and January 2024, inflating it by **about $14 million through consulting agreements** that the agency says were, in some cases, forged. The SEC's litigation release says the alleged scheme ran alongside a fundraise of **more than $25 million from investors**. The SEC filed the civil action on August 10, captioned *SEC v. John Fanning, et al.*, naming Netcapital and five individuals — including current and former officers and directors — as defendants, according to the agency's litigation release and the 8-K. Ms. Lenk, who previously served as Netcapital's chief executive before the company's current leadership, is the first of the defendants to settle. **The case against Netcapital and the remaining defendants is still pending.** ### Gogoro's Margin Problem Ended When Its Battery Program Did URL: https://www.pennystocks.news/ggr-gogoro-s-margin-problem-ended-when-its-battery-program-d/ Last updated: 2026-08-25T23:01:45.000Z A year ago, Gogoro's quarterly gross margin was 0.3% — essentially nothing. In the three months to June 30, 2026, it was **22.6%, the highest the company has recorded in more than five years**. Gogoro Inc. NASDAQ: GGR The difference was largely one program that is now finished. Gogoro spent two years voluntarily upgrading battery packs in its Taiwan swapping network, a process that loaded costs into the gross margin line and held it down. According to the company's August 24 results release, the program **finished in the fourth quarter of 2025**, removing about **$10.9 million in upgrade-related costs** from second-quarter cost of revenues alone. That matters because the battery program was not a permanent part of the business — it was a one-time drag, and it is done. Anyone holding the stock has watched margins sit near zero for two years while that drag was live. It is no longer live. Shares closed 29.07% higher at $2.9300 on August 25 after the company reported second-quarter results, on dollar volume of about $4 million. The free float is about 5.9 million shares, so that turnover represents meaningful activity against a thin base. **Net loss narrowed to $4.9 million** from **$26.5 million** a year earlier. **Revenue reached $70.6 million**, up 7.3% year-over-year. In the first half of 2026, the company generated **$26.0 million in operating cash**, compared with $15.2 million in the same period last year — the fifth consecutive quarter of positive operating cash flow, Gogoro said. Cash on hand at June 30 was $68.8 million. For the full year, Gogoro is guiding revenue of **$285 million to $305 million** and said the battery-swapping network business is on track to turn a profit this year on an adjusted basis. The CFO who managed the company's finances through the upgrade cycle, **Bruce Aitken, retires September 1** after more than eight years in the role. Gogoro named Jacky Lee, a former Deloitte auditor, as principal financial officer effective August 21\. The company has not said when it expects to appoint a permanent CFO. ### 3i Converted at $0.39. It Sold at $0.12. URL: https://www.pennystocks.news/vbio-3i-converted-at-0-39-it-sold-at-0-12/ Last updated: 2026-08-25T21:21:46.000Z 3i, LP converts preferred stock in Valion Bio into ordinary shares at a conversion price of $0.39 each. Then it sells those shares on the open market. On August 20, it was selling for about $0.12 a share. Valion Bio, Inc. NASDAQ: VBIO The conversion price sets the rate at which 3i's preferred stock becomes common shares: for every $0.39 of preferred value converted, one new common share is created. Between the July 7 record date and August 20, the company's total share count grew from about 4.15 million to about 20.9 million, with the new shares going almost entirely to 3i through a series of conversions, according to a Schedule 13D/A filed with the SEC on August 24\. Those new shares are then sold into the open market. For holders of ordinary shares, each conversion makes their stake a smaller slice of the same company. Every share created for 3i at $0.39 is one more share dividing whatever Valion Bio is worth. A contractual 9.9% ownership cap shapes how quickly this happens. 3i cannot hold more than a tenth of the company at any one time, so it converts a tranche of preferred into common shares, sells enough to fall back under the cap, and then converts another tranche. On August 20, 3i converted about 2 million Series C Preferred shares and sold 403,324 of them that same day at $0.1221\. It sold additional shares on August 21 and August 24, at prices up to $0.1763. Shares closed 35.40% higher at $0.1660 on August 25, on dollar volume of about $17 million. The free float stood at about 3.09 million shares; short volume on August 25 was about 35.3 million shares. Shareholders voted at a special meeting on August 14 to give the board the power to do a reverse stock split — at a ratio of anywhere between 1-for-5 and 1-for-50, at its discretion, within twelve months. A reverse split compresses the existing share count, giving each remaining share a larger slice of the company. It does not touch the preferred stock 3i still holds, or the conversion rights attached to it. How much preferred stock remains available to 3i — and therefore how many more common shares it can still create — was not disclosed in the August 24 filing. ### 12 Cents. $1.00. September 22. URL: https://www.pennystocks.news/ritr-12-cents-1-00-september-22/ Last updated: 2026-08-25T19:42:31.000Z Reitar Logtech has been trading below $1.00 long enough for Nasdaq to open a formal compliance review. On August 21, the company authorized spending up to **$3 million buying back its own Class A ordinary shares**, funded from existing cash — a move that arrived with a delisting deadline roughly four weeks away. Reitar Logtech Holdings Limited NASDAQ: RITR According to a Form 6-K the company filed with the SEC, Nasdaq notified Reitar on March 26 that its shares had been trading below the **$1.00 minimum bid price for 30 consecutive business days**, in breach of its listing rules. Nasdaq gave the company a 180-day window to fix it, and that window closes on September 22\. To satisfy the requirement, shares need to close at or above $1.00 for **10 consecutive business days** before then. For anyone holding the stock, the buyback program is softer than it sounds. The company's August 21 announcement says it carries **no minimum purchase obligation** and can be suspended, modified or discontinued at any time, at management's discretion. Funding comes from existing cash, but the release gives no figure for what those balances are. The company has not said how it expects the program to close the gap to $1.00. Shares closed 38.22% higher at $0.1150 on August 25, four days after the program was published, on dollar volume of about $40.8 million. On that session, reported short volume of about 29.4 million shares was higher than the free float of about 17.3 million shares. What the company plans if shares are still **below $1.00 when September 22 arrives**, the release does not say. ### The Building Is Done. Bitcoin Mining Starts in Two Months. URL: https://www.pennystocks.news/btct-the-building-is-done-bitcoin-mining-starts-in-two-month/ Last updated: 2026-08-25T18:02:31.000Z The construction crew has left. The mining machines have not arrived. BTC Digital said on August 24 that its **10-megawatt cryptocurrency mining facility in Georgia** is fully built, and that the company expects to begin deploying mining equipment **within about two months**. At full deployment, the company says the site is designed to handle **up to about 900 PH/s of computing power** — the measure of how fast a mining operation can run the calculations required to earn Bitcoin. BTC Digital Ltd. NASDAQ: BTCT The release does not say how many machines BTC Digital has ready to deploy, what they cost, or how the build-out is being financed. It also gives no timeline for reaching full capacity, saying the pace will be adjusted based on power progress, Bitcoin network difficulty, and digital-asset prices. Shares **closed 52.63% higher at $1.7400** after the announcement, on dollar volume of about $378 million. That figure deserves context. The company's free float is about 8.97 million shares. **Reported short volume on the same session was about 52 million shares** — several times the entire float — and made up about 56% of reported volume. Short volume at that scale relative to a float can reflect a range of activity, including market-maker hedging, and is not by itself evidence of one-sided pressure. The release gives no explanation for the price move. Alongside the new facility, BTC Digital describes a **"dual-engine" strategy**: cryptocurrency mining on one side, AI computing infrastructure on the other. According to the release, the company believes the two share common ground in power procurement, data centre construction, and equipment operations, with capabilities built through projects like the Georgia site carrying over into future AI work. Management said in the release that once operations begin, machines would be deployed "progressively" based on conditions including network difficulty and digital-asset prices — meaning the two-month window is the start of deployment, not the end of it. ### A Smart Eyewear Maker Lets a Partner Onto Its Shelves for the First Time URL: https://www.pennystocks.news/lucy-a-smart-eyewear-maker-lets-a-partner-onto-its-shelves-f/ Last updated: 2026-08-25T16:21:31.000Z Every frame ever sold on Lucyd.co has been designed and made by Innovative Eyewear. **That changes in September, when HTC's VIVE Eagle camera glasses go on sale there** — the first product on the platform that the company did not build itself. Innovative Eyewear, Inc. NASDAQ: LUCY Innovative Eyewear announced the arrangement on August 24, according to a company press release. HTC's glasses will be offered with **a free basic prescription upgrade** through Lucyd.co's US-based lens fulfillment service. No financial terms were disclosed. CEO Harrison Gross said in the release that quality standards had kept the platform exclusive to in-house products until now. "VIVE Eagle is the first product developed by a partner that we are offering on our site," he said, citing what he called all-day wearability, utility, audio quality, and award-winning design. Charles Huang, HTC's SVP of Global Sales and Marketing, said Innovative Eyewear had "consistently proven themselves in the smart eyewear space" and described the prescription fulfillment as part of the deal's appeal. The VIVE Eagle **competes in the AI camera glasses segment** — frames with a built-in camera for recording on the go. Privacy features stop recording when the glasses are not being worn or when the indicator light is blocked, the release says. The glasses work with HTC's VIVE Connect app for AI conversation recording, translation, and camera management. **Shares closed 63.77% higher at $1.1200** after the announcement, on dollar volume of about $200 million against a free float of roughly 5.8 million shares. Short volume on the session was **57.12% of reported volume**. In a separate release on August 20, the company also said it had added AI-generated personalised news reports to its Lucyd app, along with access to Google's Gemini service and improved Android features. Those updates apply to its own glasses, not the VIVE Eagle, and carry no disclosed revenue figures. What Innovative Eyewear receives in exchange for distributing HTC's glasses — a revenue share, a licensing fee, or something else — **the release does not say**. ### A Battery Company Just Became an Oil and Gas Explorer URL: https://www.pennystocks.news/xpon-a-battery-company-just-became-an-oil-and-gas-explorer/ Last updated: 2026-08-25T14:40:31.000Z Expion360 made lithium batteries for RVs and boats. On Sunday it said it had bought an oil and gas prospect in Louisiana, renamed itself, and replaced its chief executive. Expion360 Inc. NASDAQ: XPON The company, now called Expion Energy, paid **about $3.4 million** for a drill-ready prospect in Eastern Louisiana covering roughly 3,000 leased acres. An existing wellbore came with it. Under an exploration agreement signed at the same time, **a new lateral wellbore must be drilled by February 2027**. For shareholders, the pivot brings two immediate facts: the company is entering a business it has not previously operated, and the financing that made the acquisition possible carries conversion rights at a discount to where the stock now trades. Shares closed 80.49% higher at $6.2000 after the announcements, on dollar volume of about $645 million. The **$9 million raise used 8% convertible debentures** that will become preferred stock, convertible into common shares at $4.25 each. Because that conversion price sits below the current share price, each share created through conversion is issued at a discount — and every new share makes the ones already outstanding a smaller piece of the same company. The investors who provided the initial $9 million also have the option to put in **up to $91 million more** on similar terms, pending shareholder approval. The lead investor is Five Narrow Lane LP, a fund affiliated with Joseph Hammer. **Hammer resigned as chief executive the same day the deal closed** and now serves as interim chairman. The company says its disinterested board members approved the placement. Kevin Sellers, the new chief executive effective August 24, founded Cynergy, an oil and gas advisory firm, in 2009, according to the company's release. The company says the prospect sits near Gulf Coast infrastructure and analog formations in the same regional trend. Neither release disclosed a resource estimate. What the prospect holds, the company has not said. ### Agnico Eagle Is Backing Radisson's First Underground Access at O'Brien URL: https://www.pennystocks.news/rmrdf-agnico-eagle-is-backing-radisson-s-first-underground-a/ Last updated: 2026-08-25T13:00:31.000Z The O'Brien gold project in Quebec's Abitibi has been drilled from the surface for years, steadily building a mineral resource. No one has ever gone underground. **Agnico Eagle has agreed to fund that first step, committing roughly C$57 million to Radisson Mining Resources** in a deal announced August 24. RADISSON MINING RESOURCES OTC: RMRDF The units are **priced at C$1.07 each — a 19% premium to Radisson's 20-day average**. At closing, **Agnico Eagle will hold about 10.45% of Radisson** on an undiluted basis. No broker was involved and no fees are payable. Shares closed 22.40% higher at $0.9011, on dollar volume of about $1.6 million across 636 trades. The funds go toward cutting an underground access ramp, building the related surface and underground infrastructure, and installing water management. Engineering and permitting work begins immediately, the company says. **Radisson's 140,000-metre surface drilling program**, separately funded from existing cash, continues in parallel. Each unit includes half a warrant, with a full warrant exercisable at **C$1.39 per share for five years**. An acceleration clause fires after two years if the stock's 20-day average clears C$1.85. Agnico Eagle also gains governance rights. Under an investor rights agreement, it can seat a director on Radisson's board and participate in future equity raises to maintain its position. Until the end of 2028, it will have sign-off rights on certain property transactions — royalties, streaming deals and secured financing. After that date, it receives 60 days' notice of such moves for as long as it holds at least 5% of the company. CEO Matt Manson said in the announcement that the underground program is designed to "establish a development schedule for O'Brien." Recent drilling, he said, has traced **gold mineralization to at least 1.9 kilometres** below the old O'Brien mine, with plans to push **drilling targets to 2.5 kilometres**. An underground ramp is the tool that turns a geological model into something a producer can build a mine plan around. ### A Canadian Nutrition Start-Up Gets Its Product Behind Kroger's Pharmacy Counter URL: https://www.pennystocks.news/musl-a-canadian-nutrition-start-up-gets-its-product-behind-k/ Last updated: 2026-08-24T19:40:26.000Z Kroger built a program to test products that might appeal to customers taking weight-loss injections — drugs that reduce appetite but also accelerate muscle loss. Among the products it selected is a supplement made by a small Canadian company most investors have never heard of. Promino Nutritional Sciences CSE: MUSL Promino Nutritional Sciences said in an August 24 announcement that its Rejuvenate Muscle Health drink will appear on dedicated pharmacy counter displays at **662 Kroger stores** as part of a **90-day test**. Kroger has already issued the first purchase order, according to the release, and the company says product should reach shelves **before September 1**. The placement matters because Kroger designed the program and chose Rejuvenate for evaluation — the company did not simply negotiate shelf space in the supplement aisle. Kroger put it at the pharmacy counter, next to where customers pick up their prescriptions. That is where the conversation about the side effects of weight-loss drugs tends to happen, and muscle loss is one of them. Promino describes Rejuvenate as a plant-based, dairy-free amino acid drink with **five calories per serving**. The light format — as opposed to a dense protein shake — is the pitch to patients whose suppressed appetite makes heavier supplements hard to finish. The company says the agreement is material to its third-quarter revenue, without giving a figure. That matters: the 90-day window decides everything. Continued shelf space and customer reorders both depend on how the test performs, and Promino is a small Burlington, Ontario company for which a sustained listing at a retailer of this scale would represent a different kind of business from the one it operates today. Janice Day, Promino's Chief Sales Officer, said in the release that the program "puts Rejuvenate directly in front of GLP-1 consumers at a highly relevant point of purchase." The release carries no sales target for the test period and no figure for what a continued listing would mean to annual revenue. What Promino does have, for now, is a deadline: the shelves fill before September, and the results come back 90 days later. ### $825 Million in April. $1.1 Billion Now. URL: https://www.pennystocks.news/ie-825-million-in-april-1-1-billion-now/ Last updated: 2026-08-24T18:00:30.000Z The US Export-Import Bank offered Ivanhoe Electric **$825 million in potential backing** for its Arizona copper mine in April 2025\. The bank has now raised that figure to **$1.1 billion**. Ivanhoe Electric TSX: IE The new document — called a **Preliminary Project Letter** — is a step up from the Letter of Interest the bank issued four months ago. The company says the letter marks the completion of the bank's preliminary due diligence on the Santa Cruz Copper Project, which sits on private land in Arizona and is designed to produce copper metal on site without a smelting step. **The letter does not commit the bank to anything.** Any financing remains subject to the bank's full review and board approval. The company says it expects the **board to take up the question in the spring of 2027**. Ivanhoe Electric applied for the funding under the bank's Make More in America Initiative, which supports domestic projects aimed at expanding US production capacity and strengthening critical supply chains. Shares closed 10.20% higher at $15.78 after the announcement, on dollar volume of about $333,000. An **updated feasibility study for Santa Cruz is expected in September 2026**. The company says the new study will incorporate plans for underground access via tunnel boring machine, along with other engineering work completed since an earlier study. The bank's board consideration follows in the spring of 2027. ### The VR Portfolio Is Gone. The Pitch Is Now Defense AI. URL: https://www.pennystocks.news/btln-the-vr-portfolio-is-gone-the-pitch-is-now-defense-ai/ Last updated: 2026-08-25T23:17:00.000Z Three months ago, this company had a portfolio of virtual reality businesses. Now it has a single product and a pitch aimed squarely at the federal government. Brightline Interactive, Inc. NASDAQ: BTLN Brightline Interactive — the new name for The Glimpse Group, which began trading as BTLN on Nasdaq on August 21 — says in its company announcement that it has identified **a government opportunity pipeline exceeding $100 million**. The same announcement puts a ceiling on what that means in practice: the company believes it can compete for **up to $40 million of those opportunities** given its current resources. The rest requires cleared personnel, security infrastructure and government-cloud capabilities it does not yet have, the company says. That gap is what a shareholder needs to sit with. The $100 million is not booked business — the release explicitly describes it as "potential opportunities under evaluation and not contracted backlog." Converting any of those leads into signed contracts, starting with the $40 million slice, is the work still ahead. Shares closed at $1.07 on August 24, up 15.05% from the prior close, on about $528,000 in dollar volume. CEO Tyler Gates took the role on June 1 alongside a new board. He has laid out the transformation in a document he calls "The Brightline Letter," describing a two-stage model: first, revenue from connecting clients' systems into SpatialCore; then recurring revenue as those clients use the platform over time. The August 21 announcement says the company is divesting or discontinuing the old Glimpse businesses. A July 7 announcement on Access Newswire confirmed the sale of one subsidiary, Glimpse Learning, described there as a non-core legacy asset. Earlier this year, the company raised **about $1.85 million in new capital** to fund the pivot, according to a company announcement on Access Newswire. That is the balance sheet behind a pipeline the company says exceeds $100 million. ### Largo Pushes Its Brazilian Debt Deadline Out by Three and a Half Years URL: https://www.pennystocks.news/lgo-largo-pushes-its-brazilian-debt-deadline-out-by-three-an/ Last updated: 2026-08-24T14:40:15.000Z The debt was due this September. After reaching agreement with five Brazilian banks, Largo won't have to touch the principal for another six months after closing — and won't finish repaying until March 2030. Largo Inc. NASDAQ: LGO Largo and its Brazilian operating subsidiary, Largo Vanádio de Maracás S.A., signed a binding term sheet on August 20 to restructure **about $82 million owed to Banco do Brasil, BTG Pactual, Bradesco, Santander and Caixa Econômica Federal**, the company said in its release. The final maturity moves from September 2026 to March 2030\. For the first six months, no principal is due; after that, **quarterly principal payments run for 36 months**, with interest continuing monthly throughout. The extension matters because Largo is trying to build cash from two sources it is still ramping up. The company says it is increasing production of copper, gold, platinum and palladium concentrates at the Maracás Menchen Mine as by-products of its vanadium operations, and is preparing **the first shipment of high-purity vanadium pentoxide to the U.S. Defense Logistics Agency** under a **$60 million first order announced in July 2026**, according to the release. Neither stream is yet generating meaningful cash — the restructuring is designed to give Largo time before lenders start collecting principal. Shares closed 15.92% higher at $0.7440 after the announcement, on dollar volume of about $1.6 million. The term sheet is not a final agreement. Largo says the restructuring still requires definitive documentation, including settlement of the interest rate and the collateral package that Largo and its subsidiary will provide. Until those are in place and customary closing conditions are met, the deal is not done. The company is also conducting a strategic review of its tungsten assets in Canada and Brazil, which it mentioned as a separate path for unlocking value. No terms or timeline for that process were disclosed. \`\`\` ### First Drills at Andrei Find Two Distinct Mineral Systems URL: https://www.pennystocks.news/endr-first-drills-at-andrei-find-two-distinct-mineral-system/ Last updated: 2026-08-24T14:49:16.000Z Nobody had ever drilled at Andrei before this summer. Seven holes later, Enduro Metals says the target holds two separate types of mineral system — and the more interesting one appears to get stronger the deeper you go. Enduro Metals Corporation TSXV: ENDR The company's August 24 release said the **2,700-metre inaugural program** at Andrei tested two concentrations of elevated ground response within a combined geological anomaly stretching more than four kilometres across its Newmont Lake property in northern British Columbia. Both systems turned up in the northeast portion of that anomaly — the area the company now considers the more prospective of the two. The first system is a porphyry: a copper-gold deposit type that forms deep underground when metal-bearing fluids crystallise inside an intrusive rock body. Hole AD-03 cut **porphyry-style alteration and quartz-sulphide veining that grew more abundant with depth**, a pattern that suggests the core of the system lies further down or to one side. The hole was stopped at 491 metres because of drilling conditions, with the mineralisation still intensifying. The company says the system remains open to the northeast and southeast. The second system is a different animal. Holes AD-04 and AD-06 both intersected **low-sulphidation epithermal-style veining and breccias** — a shallower, lower-temperature type of gold-bearing mineralisation that forms in fractured rock closer to the surface, often near past volcanic activity. AD-04 hit an interval of intense veining and broken rock between 63 metres and 92 metres downhole before faulting closed the hole at 192 metres. AD-06 found a similar interval much deeper, between 436 metres and 444 metres, before drilling difficulties ended that hole too. Both systems in the same target, at different depths, is structurally unusual. What that means for grade and width is unknown: **all assay results are still pending**, and the company says it expects them later in the year. Until those numbers arrive, the geological observations carry no economic weight. The holes are mapped; the rock has been logged; nothing has been valued. The southwest portion of the target produced less. The four holes drilled there each hit mineralisation that either faded with depth or was displaced by faults. The company also noted that the program came in shorter than originally planned, citing difficult drilling conditions and limited availability of drill-contractor personnel. Phase 2 work is already under way. Enduro's next step at Andrei is a **planned 20-line-kilometre induced polarisation survey** — a geophysical technique that measures how rock responds to electrical current and is used here to extend coverage northeast of where the 2026 holes ended. That is the direction the porphyry system appears to be pointing. CEO Robert Cameron said in the release that the pending assay results, combined with the upcoming survey data, "will help us refine our geological model and prioritise the next phase of exploration at Andrei." The assays are the next material event for this target, and the company has not said when exactly they will be received. ### A CNS Drug Developer Sells Shares Without Saying What the Money Is For URL: https://www.pennystocks.news/juns-a-cns-drug-developer-sells-shares-without-saying-what-t/ Last updated: 2026-08-24T15:11:34.000Z Jupiter Neurosciences has agreed to sell **307,692 shares of common stock** to raise **about $2.0 million** in a registered direct offering — a sale to specific investors rather than through the open market. The announcement carries no use-of-proceeds statement. For a company running a Phase IIa clinical trial for Parkinson's disease, that is a notable omission. Jupiter Neurosciences, Inc. NASDAQ: JUNS D. Boral Capital is acting as exclusive placement agent. Closing is expected **on or about August 24, 2026**, under a shelf registration the SEC declared effective in April 2026\. A shelf registration lets a company pre-approve a set of securities and draw on it when cash is needed, without restarting the registration process from scratch each time. The announcement came out on August 21\. Shares **closed 19.92% higher at $6.2000** two days later, after a previous close of $5.1700, on dollar volume of about $444 million. The company's lead program is JOTROL, a formulation of resveratrol — a compound found in certain plants — that the company says has enhanced bioavailability. It is in a Phase IIa trial for Parkinson's disease, according to the release. The company also holds U.S. rights to ALA-002, which it describes as a next-generation psychedelic compound, and sells a consumer supplement called Nugevia. How long $2.0 million sustains a clinical-stage operation is a question the release does not answer: no cash position or burn rate appears in the announcement. ### NOAA Opens the Environmental Review That Precedes a U.S. Deep-Sea Mining License URL: https://www.pennystocks.news/tmc-noaa-opens-the-environmental-review-that-precedes-a-u-s/ Last updated: 2026-08-23T21:22:45.000Z The United States has never issued a domestic license for deep-sea mineral exploration. Last week, the formal process that could lead to the first one began — at least for TMC's U.S. subsidiary. NOAA published a Notice of Intent to prepare an Environmental Impact Statement for the subsidiary's application to explore roughly 122,000 km² of Pacific seafloor, an area about the size of England. TMC the metals company Inc. NASDAQ: TMC Shares closed 20.65% higher at $4.7900, on dollar volume of about $96.9 million, in the days after the company announced the development on August 17. For a shareholder, the distinction between what this is and what it is not matters. An exploration license is not permission to mine. If granted, it would allow TMC USA to send equipment to the seafloor to collect scientific and engineering data. What makes the licensing process meaningful is that it is moving — and that the area in question is large. The company's own technical report, published in August 2025 and cited in the filing, estimates the USA-B application area holds about 1.02 billion tonnes of polymetallic nodules containing nickel, cobalt, copper, manganese and meaningful quantities of rare earth elements. The process NOAA has started is a structured federal environmental study required before any major government action that could affect the environment. NOAA will publish a draft version of that study, along with proposed terms and conditions for the exploration activities, for public comment. After reviewing those comments, it will issue a final version, then decide whether to grant the license. There is no statutory deadline under U.S. deep-seabed mining law by which NOAA must finish. The USA-B application cleared an earlier hurdle on May 26, 2026, when NOAA certified it as formally complete. That certification opened the door to the substantive environmental review now underway. TMC is running a second U.S. track alongside it. A separate application covering the USA-A area — this one combining an exploration license request and a commercial recovery permit — was submitted to NOAA on January 22, 2026, and declared fully compliant on April 28, 2026\. The two applications cover different parts of the Clarion-Clipperton Zone, a stretch of Pacific seafloor between Hawaii and Mexico that has drawn commercial attention for decades because of its nodule density. The company says independent researchers have published 41 peer-reviewed studies based on data it collected from the eastern portion of the zone. It says the USA-B exploration activities, if licensed, would generate new data from the central and western sections, with academics free to publish their findings. What NOAA does next — and how long it takes — is the open question TMC's shareholders are now waiting on. ### A Greenland Miner Is Cutting Its Share Count to Hold Its Nasdaq Listing URL: https://www.pennystocks.news/grml-a-greenland-miner-is-cutting-its-share-count-to-hold-it/ Last updated: 2026-08-23T19:43:11.000Z Greenland Mines had too many shares trading at too low a price to satisfy Nasdaq's minimum bid requirement. On Sunday, it fixed that — by turning every fifty shares into one. Greenland Mines Ltd. NASDAQ: GRML The **1-for-50 reverse stock split**, approved by the board and effective at the open of trading on August 24, reduces the share count from **about 159 million to about 3.2 million**, the company said in an August 20 announcement on GlobeNewswire. The company expects the consolidation to bring it back into compliance with Nasdaq's continued-listing rules. Nasdaq has the final say on whether it does. Shares closed 22.11% higher at $0.2027 on August 23, the last session before the split took effect, on dollar volume of about $16.7 million. Short sales made up 59.35% of reported volume in that session. For existing holders, the split itself is neutral on paper: fifty shares become one, but the fraction of the company each holder owns stays the same. What does not change is the number of authorized shares — the board retains the full capacity to issue new stock in the future, and the release does not say how much of that capacity may be used. The announcement was paired with an operational update from Skaergaard, the company's **palladium, gold and platinum project on Greenland's east coast**. Field crews have completed the first blasting for a large bulk sample, and drilling is underway. A July 2026 resource estimate, prepared under current SEC reporting standards, lifted the project's indicated grade by **36%** and indicated contained metal by **31%** against the prior 2022 estimate. The updated figure puts the Skaergaard deposit's indicated category at **about 7.6 million ounces of palladium and about 3.2 million ounces of gold**, according to the release. Greenland Mines holds an **80% interest in Skaergaard**, with an option on the remaining 20%. A second project, Sarfartoq in west Greenland, targets neodymium-praseodymium rare earths — the materials used in the permanent magnets inside electric motors and wind turbines. A definitive agreement to acquire Sarfartoq had been signed, the company said, but had not yet closed as of the announcement. Field work there is expected to begin in September, subject to that closing. The split did not touch the authorized share count. With only about 3.2 million shares in circulation after the consolidation, any meaningful new issuance would hand each existing share a smaller slice of the same company — and the release says nothing about whether new issuances are planned. \`\`\` ### Critical Metals Rewrites Its European Lithium Deal Terms as Its Own Stock Slides URL: https://www.pennystocks.news/crml-critical-metals-rewrites-its-european-lithium-deal-term/ Last updated: 2026-08-23T18:01:08.000Z When Critical Metals Corp agreed in May to acquire Australian lithium developer European Lithium, it offered a fixed price: **0.035 of a CRML share for every European Lithium share held**. Three months and two amendments later, that number moves. Critical Metals Corp. NASDAQ: CRML The company said in an August 19 announcement that the exchange ratio will now float within a band. If CRML's 20-day average price before the shareholder vote falls at or below **$8.00, European Lithium shareholders receive the maximum of 0.045 CRML shares**. If CRML trades at or above $16.00, they receive the minimum of 0.025\. Between those two prices, the ratio adjusts on a straight-line basis. With CRML's 20-day average below $8.00 at the time of the announcement, **the ratio currently sits at its maximum**. The structure is designed to share price swings between both sets of shareholders rather than leaving one side fully exposed. If CRML's stock falls, European Lithium holders get more shares to compensate. If it rises, they get fewer, limiting the dilution for existing CRML holders. A fixed ratio of 0.035 left European Lithium shareholders bearing all the downside if CRML slid between signing and closing — which it did. For current CRML shareholders, a ratio of 0.045 rather than 0.035 means more new shares issued in the transaction. Every new share makes the existing ones a smaller slice of the combined company. The revised ratio also flows through to European Lithium's listed options and performance rights, which are priced by reference to the same exchange ratio. Shares **closed 22.59% higher at $7.1100** on August 23, on dollar volume of about $111 million. The stock remained below the $8.00 floor. Mike Hanson, the Critical Metals board director leading the special committee overseeing the deal, said in the announcement that "the strategic rationale for bringing European Lithium and its assets fully into the CRML group is unchanged." European Lithium expects to send shareholders the formal deal document — which will include an independent expert's assessment of whether the terms are fair — in early September. Subject to shareholder and court approval, **the deal is expected to close in October 2026**. ### A Singapore AI Hardware Firm Has Found a Big Japan Customer. Now It Needs More. URL: https://www.pennystocks.news/supx-a-singapore-ai-hardware-firm-has-found-a-big-japan-cust/ Last updated: 2026-08-23T16:22:45.000Z SuperX AI Technology's Japan warehousing and fulfillment hub has **shipped about $31 million of Pro6000 servers** to a single Japanese customer across four purchase orders since January. The company says cumulative shipments to that customer will reach **about $38 million by end of August**. SuperX AI Technology Limited NASDAQ: SUPX Shares closed **25.29% higher at $8.5200** on August 23, after the company issued the press release on August 19\. Dollar volume was about $4.4 million across 4,793 trades. The customer is Digital Dynamic Inc. (DDI), described in the release as a Japan-based AI infrastructure company with a nationwide computing network spanning data center operations, hardware cluster management, and commercial computing capacity. **Four orders arrived in January, April, July, and August**, each described in the release as a successive capacity expansion. SuperX supplies DDI through a local partner; an earlier press release on PRNewswire, dated April 10, identified that partner as eole Inc. Beyond the DDI figures, the August 19 release says projects worth **about $28 million are under phased production** and sequential delivery, and that new orders worth about $20 million have been secured. The release does not say whether those numbers overlap with the DDI total or represent other customers and contracts. The hub's pitch is local inventory. Rather than shipping from Singapore each time an order arrives, SuperX warehouses stock in Japan and fulfills orders on the ground. The company says this shortens lead times for large-volume server orders, though the release provides no delivery-time benchmarks. Its forward-looking projections carry the caveat that actual results "may vary based on customer data center readiness and supply chain conditions." The release is a company press release and its claims about production and order values are attributed to SuperX itself. No third-party verification of the shipment figures is included. SuperX says it is "actively onboarding more local computing clients" in Japan but names none and discloses no signed agreements beyond the DDI orders. **Every dollar of disclosed hub revenue runs through one relationship.** Whether that changes before the next update is the question the release does not answer. ### AMC Robotics Needed Factory Cash. It Cut Its Warrant Price to Get It. URL: https://www.pennystocks.news/amci-amc-robotics-needed-factory-cash-it-cut-its-warrant-pri/ Last updated: 2026-08-23T14:41:30.000Z Two investors held warrants to buy AMC Robotics shares at $4.017 each. The company cut that price to **$1.65 — less than half the original** — to make sure they exercised now rather than whenever they chose. AMC Robotics Corporation NASDAQ: AMCI The deal, announced August 21 on GlobeNewswire, **locks in $1 million immediately**. The same investors can exercise their remaining warrants at $1.65 within 30 trading days for up to about **$1.1 million more**, bringing the potential total to about $2.1 million. The company says the proceeds will go toward its NovaArm manufacturing facility in Bắc Ninh, Vietnam. That factory has a stated price tag. The company's second-quarter results, filed August 17, put planned buildout and equipment at **about $3.5 million**. Cash on hand as of June 30 was **$4.5 million**, down from about $7 million at year-end 2025\. The warrant proceeds are meant to fill part of that gap. Shares closed 32.65% higher at $6.5000 on August 23, on dollar volume of about $1.2 million. Getting the cash in hand early came with a commitment. In exchange for exercising immediately, **the two investors received new warrants covering up to 1,219,816 additional shares** — one new warrant for each share issued under the existing ones. Those new warrants carry an **exercise price of $5.775** and are exercisable straight away, running for just over four years. The free float stands at about 3.7 million shares; the new warrants would add roughly 1.2 million more if fully exercised. The **6,150-square-metre Bắc Ninh facility** was announced in June. The company said the lease was expected to take effect in the third quarter of 2026, with initial production targeted for the second half of the year. The remaining $1.1 million is an option, not a commitment. The investors have 30 trading days from the agreement to decide whether to exercise the rest. ### Myriad Uranium Takes Full Control of Its Wyoming Uranium Project URL: https://www.pennystocks.news/m-myriad-uranium-takes-full-control-of-its-wyoming-uranium-p/ Last updated: 2026-08-23T13:01:45.000Z Myriad Uranium previously held three-quarters of Copper Mountain, its main uranium project in Wyoming. As of August 21, it holds all of it. Myriad Uranium CSE: M The company completed its acquisition of Rush Rare Metals Corp. through a plan of arrangement, according to Myriad's August 21 announcement on Newsfile. Rush shareholders voted to approve the deal on August 17\. Two days later the Supreme Court of British Columbia issued the final order, and the transaction closed. Rush is now a wholly owned subsidiary of Myriad, and **Rush's shares have been delisted from the Canadian Securities Exchange.** To pay for it, Myriad issued **about 25 million new shares** to former Rush shareholders — roughly one Myriad share for every two Rush shares held. Each new share issued makes the ones already outstanding a smaller slice of the same company. About 2.1 million Myriad options were also created to replace outstanding Rush options. The deal came with a built-in asset separation. Rush's Boxi Property in Quebec — a rare-earths prospect with no connection to Wyoming uranium — was spun out into a new entity at closing. **Former Rush shareholders received one Spinco share for every four Rush shares they held,** and Myriad put $100,000 into the new company to capitalise it. Myriad exits Quebec entirely; former Rush holders keep their exposure to Boxi. Copper Mountain's history explains the strategic logic. Union Pacific ran **about 2,000 boreholes** across the district in the late 1970s and reached advanced mine planning before a collapse in uranium prices stopped the work, according to the company's announcement. The company estimates Union Pacific spent **roughly C$125 million in today's money** on the project. CEO Thomas Lamb said in the announcement that Myriad believes Copper Mountain "could become America's largest" uranium project. That claim is the company's own — no current resource estimate has been established, and the company states that historical estimates at the site have not been verified by a qualified person under current standards. Registered Rush shareholders who still hold paper share certificates need to submit them to TSX Trust Company to receive the Myriad shares owed to them under the arrangement. ### A Texas Family Office Just Paid Double Market Price for This Stock URL: https://www.pennystocks.news/mma-a-texas-family-office-just-paid-double-market-price-for/ Last updated: 2026-08-22T14:42:48.000Z The stock closed at $0.38 on August 19\. The next morning, a Texas family office paid **$1.00 a share — about 160% above that close** — for a block of new equity in the same company. The stock rose 49% on the day the deal was announced, and still finished well below what the investor paid. Mixed Martial Arts Group Limited NYSEAMERICAN: MMA MMA.INC said in an August 20 announcement on GlobeNewswire that **the placement raised $4 million in exchange for 4 million ordinary shares**. No warrants, options or convertible securities were attached, and no broker or placement agent commissions were paid, according to the announcement. The company said it received the full amount. The absence of warrants is the part that matters most to existing holders. A warrant gives an investor the right to buy additional shares later at a fixed price — when that price sits below the market at maturity, the investor converts and new shares enter circulation, making each existing share a smaller piece of the same company. **No such instrument was attached to this deal**: the 4 million new shares are the entirety of what was issued. Shares **closed 49.00% higher at $0.5662**, on dollar volume of about $247 million. The new shares were issued as restricted securities. Before the Texas family office can resell them, it must meet **applicable holding requirements under federal securities law**. The company said proceeds will go to working capital. The investor paid $1.00 a share. At the close on the day the deal was announced, the stock sat at $0.5662 — and the shares cannot yet be sold into that market. ### Centerra and Teck Top Up Their Stakes in a Junior Copper Explorer URL: https://www.pennystocks.news/merg-centerra-and-teck-top-up-their-stakes-in-a-junior-coppe/ Last updated: 2026-08-23T02:15:48.000Z Centerra Gold and Teck Resources each held a **9.9% stake in Metal Energy Corp.** Then the company issued new shares. Both chose to buy enough to stay exactly where they were. Metal Energy Corp. TSXV: MERG The mechanism is a top-up right — a provision written into each company's investor agreement that lets them subscribe for new shares whenever Metal Energy issues more, keeping their ownership percentage from shrinking. Together, the two companies took **550,000 shares at C$0.89 each**, putting roughly **C$490,000** into the junior's treasury, the company said in an August 21 announcement. The price was set by the terms of the existing agreements. No warrants were attached and no finder's fees were paid. For a holder watching from the outside, the dollars matter less than the decision. Centerra and Teck are not passive names on a cap table: they have formal rights baked into their agreements, and on Thursday both chose to use them. The release gives two different accounts of where the money goes — one paragraph says general working capital, while the "About" section says the proceeds are directed entirely toward drilling at the NIV project. The company did not reconcile the two. NIV is Metal Energy's flagship property, a copper-gold project in British Columbia's Toodoggone District where a **6,000-metre drill program** got underway in June — the first time anyone has drilled the ground. The property sits about **32 km south** of Centerra's own Kemess mine complex, in geology the company says mirrors what hosts the Kemess deposits to the north. The new shares carry a hold period of four months and one day. The issuance still requires final approval from the TSX Venture Exchange. ### A Bitcoin Treasury Firm Bought a Call Option From Its Own Controlling Shareholder URL: https://www.pennystocks.news/six-a-bitcoin-treasury-firm-bought-a-call-option-from-its-ow/ Last updated: 2026-08-22T13:49:57.000Z Sixty-Six Capital agreed to pay its controlling shareholder nearly $2 million for the right to buy Bitcoin. Minority shareholders did not vote on the deal. Sixty-Six Capital Inc. CSE: SIX The counterparty is K33 Holding AS, a subsidiary of K33 AB, which controls Sixty-Six. Under a 12-month agreement dated August 21, the company will pay a **non-refundable premium of US$1.93 million** for a call option giving it exposure to **up to 200 Bitcoin above a strike price of US$100,000 per coin**. The option runs until August 21, 2027, can be exercised once for between 100 and 200 Bitcoin, and settles through physical, on-chain delivery against payment of the strike price. Canadian securities rules normally require a formal valuation and a minority shareholder vote when a controlling party sits on the other side of a deal. **Sixty-Six is claiming exemptions from both requirements**: it says it is not listed on a specified market and that the premium it is paying K33 does not exceed 25% of the company's market value. The company also did not file a material change report 21 days before signing, as the rules would ordinarily require. The release says management wanted to move quickly. **Sixty-Six also sold its Purpose Bitcoin ETF holdings** and used part of the proceeds to repay about CAD 3 million in financing. The rest goes toward the option premium and direct on-chain Bitcoin purchases, shifting the company's exposure from ETF units to a mix of direct holdings and option exposure. K33 Markets AS — a separate entity within the same K33 group — will handle execution, custody and treasury administration for Sixty-Six's direct Bitcoin holdings. The company says it intends to exercise the option for the full 200 Bitcoin if it finishes in the money, subject to available funding. The US$1.93 million premium is non-refundable — **and it goes to the entity that controls the company**. ### SonicStrategy Walked Away From an AI Deal Over Counterparty Red Flags URL: https://www.pennystocks.news/soni-sonicstrategy-walked-away-from-an-ai-deal-over-counterp/ Last updated: 2026-08-24T14:51:07.000Z Five weeks after announcing a deal to buy AI infrastructure assets, SonicStrategy walked away. Due diligence on the target, ARKLAB AI, turned up problems with the counterparty's corporate standing — and both sides agreed not to proceed. SonicStrategy Inc. CSE: SONI The company said in an August 21 release that it had terminated the non-binding letter of intent, originally announced on July 14, 2026\. No definitive agreement had been signed, and the company says it did not incur any material costs or liabilities. The release does not name what, specifically, was wrong with ARKLAB AI's corporate standing. For anyone holding the stock, the question is straightforward: what did due diligence find? The company does not say. "Corporate standing" can mean anything from a lapsed registration to a more serious legal or ownership problem. SonicStrategy's release describes the termination as mutual and amicable, but the company is the one that flagged the issue — and chose to walk. The same release also covers the first half of 2026\. **Staking revenue — money earned by running validator nodes that help process transactions on proof-of-stake blockchains — came to $183,096 for the six months ended June 30, 2026**, with **$71,530 of that in the second quarter alone**. CEO Dustin Zinger said in the release that the figures reflect the scale of the company's validator operations on the Sonic network. On costs, **the company says it has cut its total monthly burn to about $30,000**. Burn rate is the amount a company spends each month beyond what it earns. Zinger said in the release that the reduction is meant to let more revenue reach shareholders rather than being consumed by overhead. SonicStrategy says it remains committed to expanding into decentralized AI computing alongside its validator business and will keep evaluating opportunities. What that means in practice, after the ARKLAB AI deal fell apart at the due diligence stage, is an open question the company does not address. ### Insolvent in Three Countries, a Smart-Glass Maker Needs Its Shareholders to Save Its Nasdaq Listing URL: https://www.pennystocks.news/gauz-insolvent-in-three-countries-a-smart-glass-maker-needs/ Last updated: 2026-08-22T13:00:30.000Z Gauzy Ltd. has **court-supervised insolvency proceedings running in France, Germany, and Israel** at the same time. On August 31, its shareholders vote on whether to give the board authority to consolidate the company's shares — and without a yes, **the financing lined up to repay those creditors falls away**. The proxy statement filed with the SEC on August 17 states the logic plainly. Keeping the Nasdaq listing is a condition of **a $7 million rescue financing**. That financing is a condition of the proposed debt settlement. And the settlement is the company's stated path to continued operations. Gauzy Ltd. NASDAQ: GAUZ For anyone holding the stock, the question is what happens if the vote fails, or if Nasdaq delists the company despite a yes. The filing says either outcome would block the rescue financing. It does not say what the company would do next. Shares **closed 20.30% higher at $0.3970** on August 22, on dollar volume of about $18.9 million across 100,009 trades. The company's total outstanding debt is **about $81 million, owed to roughly ten creditor groups**. They include a senior secured lender, a major Israeli bank, French and Israeli tax authorities, and current and former employees owed back wages. The filing does not break out individual amounts. Three of Gauzy's French subsidiaries entered court-supervised reorganization in November 2025\. In May 2026, the Commercial Court of Lyon ruled that **the assets of Vision Systems SAS and part of Gauzy SAS would go to Clayens Genas**, the winner of a public auction. Both companies have appealed; a hearing before the Court of Appeal of Lyon is set for September 17. In Israel, former employees filed to open insolvency proceedings against the company. Gauzy responded with a proposed debt settlement under Israeli law. That plan would repay creditors in full — but only after an exit transaction valued at more than $330 million, or through **25% of each profitable year's net profit** until the debt is cleared. The settlement still requires approval from more than half of creditors by number and more than three-quarters by value, followed by court confirmation. The rescue financing is structured as a **management buyout led by CEO and Chairman Eyal Peso**, along with other executives and investors including Chutzpah Holdings LP, according to the filing. Proceeds would go toward interim payments to creditors, back wages, and working capital. The share consolidation proposal would let the board pick any ratio from 1-for-2 up to 1-for-1,000, at any point before the end of 2027\. At the maximum, **every thousand shares a holder has today would become one**. The filing warns there is no assurance the share price would rise in proportion to the reduction in shares outstanding. The creditor vote and Nasdaq's decision on the company's filing-deadline extension are both still pending. The company has not said what it would do if either goes against it. ### 12 Million Shares in the Float. 150 Million More for the CEO. URL: https://www.pennystocks.news/goai-12-million-shares-in-the-float-150-million-more-for-the/ Last updated: 2026-08-21T23:02:45.000Z Eva Live's free float stands at about 12 million shares. The CEO's new pay package, if fully earned and converted, would produce **150 million more**. That is the central fact in a five-year executive employment agreement signed with CEO David Boulette on August 17, 2026, and disclosed in an 8-K filed with the SEC on August 20. Eva Live Inc. NASDAQ: GOAI Shares closed 15.34% higher at $2.0300 after the filing, on dollar volume of about $469,000. Under the agreement, Boulette can earn up to **1 million shares of a new class of preferred stock** — 200,000 shares per year over five years — by hitting performance milestones. Each preferred share converts into 150 ordinary shares of common stock. The filing states the full award is convertible into up to **150 million common shares**. The mechanics matter: every preferred share is a claim on 150 additional shares of the same company, and every new common share issued makes the existing ones a smaller portion of the whole. The **year one milestone is already met**. The agreement names it as the Nasdaq uplisting, which occurred on January 28, 2026\. The 200,000 preferred shares for that first year are effectively earned; what remains are procedural steps. The company must file a Schedule 14C disclosure with the SEC, wait at least **20 calendar days** after mailing it to shareholders, and have Nevada accept the certificate of designation for the new preferred stock. Stockholder approval was obtained in advance by written consent rather than a formal shareholder vote. The year two milestone requires an acquisition of at least **$5 million** in transaction value — or the commercial launch of a product projected to generate at least $5 million in incremental annual revenue — alongside **at least $15 million in annual sales**. Years three through five each require **30% year-over-year sales growth**. The preferred carries no mandatory dividends and no ordinary voting rights, so Boulette cannot use the preferred shares to influence shareholder votes. Common shares received on conversion would carry normal voting rights. Beyond the equity, the agreement pays a base salary of **$800,000 a year**, rising 10% on each anniversary of the effective date. If the company terminates Boulette without cause, it owes him a **$5 million lump-sum severance payment**. The filing does not state the company's current annual revenue — the baseline against which the year two and three milestones will eventually be measured. ### A Short Seller Says This Nasdaq Stock Is Weeks From Being Wound Up URL: https://www.pennystocks.news/troo-a-short-seller-says-this-nasdaq-stock-is-weeks-from-bei/ Last updated: 2026-08-21T22:49:34.000Z A firm called Muddy Insights published a report warning that an August 20 hearing in Hong Kong would lead to a winding-up order and a Nasdaq suspension for TROOPS, Inc. TROOPS replied the same day: the judgment is stayed, enforcement is blocked, and the hearing was a scheduling session — not a reckoning. TROOPS, Inc. NASDAQ: TROO The underlying judgment is real. Hong Kong's High Court ruled in June 2025 that TROOPS and two subsidiaries are, alongside other defendants, jointly and severally liable — meaning any one defendant can be held for the full amount if the others cannot pay — for **HK$163.4 million under one claim** and **HK$241.4 million under a second**. The company says it is one of **eleven defendants** named, and that others have already posted assets with the court as security. TROOPS filed a notice of appeal in July 2025\. The Hong Kong Court of Appeal **scheduled the hearing for February 2027**, and the court granted a stay of execution, so the judgment cannot currently be enforced. A related winding-up petition in the Cayman Islands continues to be adjourned pending the appeal outcome. For anyone holding the stock, the core tension is direct: Muddy Insights says the legal exposure threatens the company's survival near term, while TROOPS says enforcement is blocked and nothing changes until the 2027 appeal. The company's statement does not address what happens to its Nasdaq listing if the stay were lifted before the appeal concludes. Shares **closed 15.74% higher at $2.2800** on August 19, on dollar volume of about $1.1 million. Muddy Insights is a short-seller research firm, which means it benefits financially if the share price falls. That does not make the underlying judgment disappear. The appeal is the event that resolves the dispute, and it is not scheduled until early 2027. ### A Broken Turbine Just Knocked Out Algoma's Entire Steelmaking Operation URL: https://www.pennystocks.news/astl-a-broken-turbine-just-knocked-out-algoma-s-entire-steel/ Last updated: 2026-08-21T22:49:33.000Z One turbine at Algoma Steel's private power plant detected an abnormality on August 17 and shut itself off automatically. The rest of the plant kept running. The furnace that makes steel did not. Algoma Steel Group Inc. NASDAQ: ASTL Lake Superior Power, Algoma's on-site generating facility, supplies the electricity for the company's steelmaking operations. When the turbine went offline, the company **suspended production at its electric arc furnace** — the piece of equipment at the centre of its recently completed switch away from blast-furnace steelmaking. The other turbines at the plant were not affected. Downstream processing and shipping have continued, and the company says it does not expect to miss committed customer delivery dates. Future shipment volumes may be affected, the company says, without saying by how much. For a shareholder, the central question is how long the furnace stays cold. Algoma gives two possible answers. If the province's grid operator — the Independent Electricity System Operator — approves an alternative power arrangement, steelmaking could restart in about **10 days**. If that approval does not come, the fallback is commissioning a contracted spare turbine already on site under a long-term service agreement with GE Vernova, a process the company expects to take **no more than 21 days**. Having the spare pre-positioned matters: it puts a ceiling on the outage without Algoma needing to source replacement equipment under pressure. What it does not settle is which timeline shareholders are actually on, or what the financial cost will be. The company said it was still assessing both. Shares **closed 17.11% higher at $4.7900** on August 19, two days after the announcement, on dollar volume of about $25.7 million. Algoma said it would provide a further update once the assessment is complete and a restart timeline confirmed. ### This Singapore Pipe Driller Is About to Become a Drone-Ag Company URL: https://www.pennystocks.news/skk-this-singapore-pipe-driller-is-about-to-become-a-drone-a/ Last updated: 2026-08-21T22:49:33.000Z SKK Holdings drills underground pathways for pipes and cables beneath Singapore's streets. If the last approvals arrive, it will be a drone-agriculture technology company before the year is out. SKK Holdings Limited NASDAQ: SKK Shares **closed 36.43% higher at $5.7300**, on dollar volume of about $48.8 million, after the company announced six new drilling contracts totalling up to **$26.6 million** — the largest block of new work it has disclosed to date — and confirmed that its acquisition of drone-technology assets from Rantizo, Inc. is advancing toward closing. The deal is the part that changes what SKK Holdings is. **The stated valuation is $258.8 million**, but the cash going to Rantizo is just $759,047\. The rest of the consideration comes in newly issued shares. To generate enough of them, shareholders voted in June to approve a **tenfold increase in the company's authorized share capital**. Every new share issued to Rantizo makes the ones already out there a smaller slice of the same company. The asset purchase agreement, signed May 1, 2026, covers substantially all of Rantizo's drone-based technology used in agricultural spraying, seeding and monitoring. **Upon closing, SKK Holdings will rename itself Rantizo.** Rantizo Inc. — a Delaware corporation headquartered in Houston, Texas, according to the company's release — will hold a substantial equity position and the right to nominate two directors to the board. Marianne McInerney will join as President. The six new drilling contracts cover horizontal directional drilling — a method that lets utilities be laid underground with minimal surface disruption — and utility works. Five of the six are fixed-price subcontracts for building contractors and a telecommunications operator, worth about **$19.6 million combined**. **The sixth, at about $7.0 million**, covers utility works for a Singapore statutory board project. Short volume on the session came to 1,632,151 shares — more than double the free float of 756,287 shares. One condition stands between SKK Holdings and the closing: **Nasdaq must approve the listing of the additional shares.** Until it does, SKK Holdings is still a pipe driller. ### It Ships Steel. Now It Says It's Building an AI Data Center Campus. URL: https://www.pennystocks.news/sgly-it-ships-steel-now-it-says-it-s-building-an-ai-data-cen/ Last updated: 2026-08-21T21:21:55.000Z Singularity Future Technology describes itself one way in its stock offerings and another way in its announcements. This week it was a freight logistics provider. Then it signed an agreement to build an AI data center campus. Singularity Future Technology Ltd. NASDAQ: SGLY The two descriptions came within 48 hours. Offering documents published on GlobeNewswire on August 18 and 19 call the company "a global logistics integrated solution provider" whose core work is **shipping and logistical support for steel companies and e-commerce businesses**. The campus announcement on August 20 — from the company's own press release — calls the same entity "a Nasdaq-listed digital infrastructure and high-performance computing company." What that announcement describes is a **non-binding framework agreement with Florence Development LLC** for a roughly 900-acre industrial site in Florence, South Carolina. Non-binding means neither party is required to complete any transaction. About 25MW of near-term grid capacity has been identified at the site, subject to utility confirmation, with a potential expansion pathway to roughly 99MW — though the company's release stresses that no expansion is guaranteed. Any deal would still require financing, due diligence, government permits and a definitive agreement, none of which is in place. Shares **closed 15.44% higher at $3.4400** after the announcement, on dollar volume of about $262 million. Two days before the campus announcement, Singularity raised **about $1.8 million in a direct offering at $3.00 per share**, according to its August 18 and 19 press releases on GlobeNewswire. On the same day as the campus announcement, it priced a second offering targeting **$5.0 million at $3.20 per share**, according to the company's August 20 GlobeNewswire release, with proceeds earmarked for the data center business, RTTNews reported. The company has not disclosed what the project would cost, who would provide major financing, or whether it has prospective tenants. The framework agreement requires neither party to do anything. ### A Semiconductor Materials Firm Is Becoming a Critical Minerals Miner URL: https://www.pennystocks.news/smtk-a-semiconductor-materials-firm-is-becoming-a-critical-m/ Last updated: 2026-08-24T14:49:19.000Z SmartKem makes specialty materials for electronics manufacturers. Three weeks ago it agreed to buy a South African mining company with rights to titanium, iron, and vanadium. Then it **combined every 50 of its shares into one** to hold its Nasdaq listing — the listing that, if the deal closes, will belong to a fundamentally different business. SmartKem, Inc. NASDAQ: SMTK Shares **closed 17.55% higher at $5.1250**, on dollar volume of about $5.7 million. The merger, announced in an August 3 press release on SmartKem's investor relations page, **values Ferrox Critical Minerals at $125 million**, payable entirely in newly issued SmartKem stock. How many shares that amounts to will not be known until closing: the share count is calculated using SmartKem's average trading price over the 30 days before the deal completes. Any debt Ferrox already owes SmartKem under existing promissory notes reduces the $125 million figure, though the release does not say by how much. Ferrox's main asset is the Tivani deposit in Limpopo Province, South Africa, where it holds a **74% interest** and has mining rights for iron, titanium, and vanadium, the press release says. The deal requires shareholder approval from both companies, a registration statement filed with the SEC, and Nasdaq's sign-off before it can close. The company says the combined entity would mine minerals to supply its own materials manufacturing and sell the remainder to outside buyers. "With this merger we will now have the ability to source critical minerals for Smartkem as well as provide excess material to the global market," said Ian Jenks, Chairman and Chief Executive, in the August 3 press release on SmartKem's investor relations page. The reverse split has a simpler explanation. Shareholders authorized it at the June annual meeting and the board proceeded on August 19, per the SEC filing. Its stated purpose is to **lift the per-share price above Nasdaq's minimum bid requirement**. The split took effect at the close of trading on August 20; shares began trading on a split-adjusted basis the following morning. For today's SmartKem shareholders, the reverse split changes nothing about their ownership percentage. The merger, if it closes, changes what that ownership is in. ### This Property App Had Quintillions of Authorized Shares — Until Today URL: https://www.pennystocks.news/omh-this-property-app-had-quintillions-of-authorized-shares/ Last updated: 2026-08-24T14:50:03.000Z The authorized share count was measured in quintillions. On Wednesday, shareholders voted to bring it down. Ohmyhome Limited NASDAQ: OMH Ohmyhome held an extraordinary general meeting in Singapore on August 20 and **approved a fifty-for-one share consolidation**. Before the vote, the company was authorized to issue **9 quintillion Class A ordinary shares and 1 quintillion Class B ordinary shares**, each at a par value of a tenth of a millionth of a cent. The consolidation reduces those figures to **180 quadrillion Class A shares and 20 quadrillion Class B shares**. For a holder, fifty shares became one. The par value of each consolidated share rises fifty-fold to match. What does not shrink is the gap between what the company is authorized to issue and what it actually has out there — roughly 22 million shares outstanding. Every new share issued from that authorization would make existing ones a smaller slice of the same company. **Shares closed 25.91% higher at $0.1040**, on dollar volume of about $38 million across 221,154 trades. Short volume on the session was **14,564,116 shares, or 55.2% of reported volume**. The filing gives no indication of how many of the authorized hundreds of quadrillions the company intends to use. ### A Cancer Drug Company Is Becoming Something Completely Different URL: https://www.pennystocks.news/howl-a-cancer-drug-company-is-becoming-something-completely/ Last updated: 2026-08-21T17:15:04.000Z Werewolf Therapeutics built its pipeline around cancer. On Thursday it agreed to abandon that pipeline and merge with a company developing a treatment for a chronic pain condition that has no FDA-approved drug. Werewolf Therapeutics, Inc. NASDAQ: HOWL For anyone holding Werewolf stock, the arithmetic is blunt: after the deal closes, **existing shareholders will own about 6.8% of the combined company**. Ambros shareholders take roughly 71.7%, and investors providing the new financing get about 21.5%. The disease at the center of the new company is CRPS-1 — Complex Regional Pain Syndrome Type 1 — a condition that causes continuous, severe pain in a limb, typically following an injury. About 65,000 people in the United States are newly diagnosed each year, according to the companies' joint announcement, and **there is currently no FDA-approved medicine for it**. Ambros's drug, neridronate, is already approved in Italy for CRPS and has been given to roughly 600,000 patients there across approved conditions. The FDA has granted it three priority designations — fast-track review, orphan drug status, and an intensive development-support program the agency reserves for drugs targeting serious conditions with high unmet need — and has indicated that a single successful Phase 3 trial could support a U.S. approval application, according to the release. That trial, CRPS-RISE, is already running. Ambros expects **topline results in 2028**. The **$150 million raised in the concurrent financing** — co-led by RA Capital Management and Janus Henderson Investors — is expected to fund operations through those results and a planned application to the FDA, with **cash the companies say will last into the first half of 2029**. Under the deal terms, **Ambros was valued at $500 million and Werewolf at $47.5 million**, based on the merger agreement's exchange ratio. Werewolf shareholders also receive the right to collect any payments the combined company receives if it sells Werewolf's existing cancer drug assets — what the announcement calls a contingent value right. No value for those assets is stated in the release. The combined company will operate under the Ambros name and is expected to trade on Nasdaq under the ticker "AMBX." Every member of the incoming leadership team comes from Ambros. Werewolf's cancer programs do not follow. Shares closed 111.41% higher at $0.9116, on dollar volume of about $226 million. The deal requires shareholder approval from both companies and is **expected to close by the first quarter of 2027**. Whether Werewolf's legacy cancer assets ever produce a payment for former shareholders remains an open question; the release does not say whether any buyer has been approached. ### The Cancer Trials Are Over, and the New Chinese-Linked Owners Have Flooded the Float URL: https://www.pennystocks.news/indp-the-cancer-trials-are-over-and-the-new-chinese-linked-o/ Last updated: 2026-08-21T16:20:42.000Z Indaptus Therapeutics halted all enrollment in its cancer drug studies earlier this year and has no active clinical programs left. By March, a group of buyers that included **Sino Lion Ventures Limited** had purchased control of the company from its previous owner, according to an S-3 filed with the SEC on August 17\. In August, those new controlling shareholders registered **nearly 59 million shares for resale** — against a free float of under 10 million. Indaptus Therapeutics, Inc. NASDAQ: INDP Shares **closed 46.81% higher at $1.3800** on August 20, on dollar volume of about $14.7 million across 35,504 trades, after the company filed the resale registration statement. For existing holders, the disproportion is the point. The free float is 9,863,406 shares. The shares now registered for resale are roughly six times that number. The company receives nothing from any of those sales — all proceeds go to the selling stockholders identified in the prospectus. The control shift happened in stages, the S-3 states. In December 2025, investor David Lazar bought preferred stock from Indaptus for $6 million and became its chairman and co-chief executive. Three months later, Lazar sold those preferred shares to Yun Yao, Sino Lion Ventures Limited, Junyi Dai, Ting Yang, and Lina Deng for **$11.2 million**. Immediately after, the five buyers held **approximately 96.2% of the company's outstanding common stock**. Junyi Dai became chief executive and chairman. Lazar resigned from all board positions by June 5, 2026; the filing says his departure was not based on any disagreement with the company. The 58,895,000 shares now registered for resale came from two places. About 38.9 million were issued when the earlier preferred stock converted into common shares. The remaining **20 million shares were sold in June 2026 at $0.60 each** to seven non-U.S. accredited investors for gross proceeds of $12 million, the S-3 states. As of the filing date, the S-3 states that Indaptus has **no active clinical development programs** and no patients remaining in any Decoy20 study. The company says it is evaluating strategic alternatives, including potential acquisitions and research collaborations. One initiative it has already started is a research collaboration with Kunming University of Science and Technology in neurological research and sleep — a long way from the cancer immunotherapy the company was built around. ### Cypherpunk's Biggest Shareholder Sold It Mining Rigs. Now It Wants More Shares. URL: https://www.pennystocks.news/cyph-cypherpunk-s-biggest-shareholder-sold-it-mining-rigs-no/ Last updated: 2026-08-21T15:36:10.000Z The entity that already held nearly a fifth of Cypherpunk Technologies and had placed two people on its board sold the company nearly 5,000 Zcash mining computers last week. In return, it took a warrant to buy tens of millions of new Cypherpunk shares at a fraction of a cent each. Cypherpunk Technologies Inc. NASDAQ: CYPH Under the asset purchase agreement signed August 17, Cypherpunk's mining subsidiary agreed to buy **4,902 Bitmain Antminer Z15 Pro computers** along with three hosting contracts for data center facilities in Barstow, Texas; Morristown, Tennessee; and Fairview, West Virginia. The stated purchase price was **$33,333,333**, paid entirely through a pre-funded warrant issued to Winklevoss Treasury Investments covering **43,290,042 new shares** of Cypherpunk common stock. The warrant's exercise price is $0.001 per share — a fraction of a cent — making it, in practice, a near-certain equity grant rather than an option anyone is likely to walk away from. For anyone holding Cypherpunk stock today, that warrant is what the deal is about. It covers roughly 43 million shares against a free float of about 75 million. Every new share issued under it makes the existing ones a smaller piece of the same company. Whether it gets exercised in full depends on a shareholder vote that has not yet been scheduled. Shares **closed 32.85% higher at $1.0700** on August 19, after the company filed the deal, on dollar volume of about $10.8 million across 21,682 trades. The per-share purchase price was set at **$0.77**, pegged to a five-day average of Cypherpunk's Nasdaq closing price before the agreement was signed. Until shareholders approve the full issuance, WTI cannot hold **more than 19.99% of shares outstanding** — a cap built into the warrant's terms. The company has committed to putting the question to shareholders at its next annual meeting. The seller, Moria Mining LLC, is an affiliate of Winklevoss Treasury Investments, the warrant recipient. WTI had already held **19.9% of Cypherpunk's stock** before the deal and had previously exercised its right, under an agreement from October 2025, to appoint two directors to the board: William McEvoy and Khing Oei. The filing says the deal was reviewed and approved by the company's nominating and corporate governance committee, which it describes as consisting of disinterested directors. WTI has agreed to vote its existing shares in favor of approving the full warrant exercise at the annual meeting. The rest of the shareholder base will decide whether the entity that sold the equipment also gets to extend its stake well beyond the current cap. ### A Hedge Fund Bought Board Control of a Small Medical Device Company URL: https://www.pennystocks.news/femy-a-hedge-fund-bought-board-control-of-a-small-medical-de/ Last updated: 2026-08-21T15:36:10.000Z A hedge fund put money into Femasys. It also walked away with **two board seats, the right to veto major corporate decisions, and an agreement that two existing directors would step down within 60 days.** Femasys Inc. NASDAQ: FEMY Nantahala Capital, a Connecticut-based fund that focuses on small and micro-cap companies, paid **roughly $12 million** to participate in a **$30 million private placement** that closed on August 10, 2026, according to a Schedule 13D filed with the SEC on August 17\. Femasys described the broader deal in an August 7 press release published on GlobeNewswire. The terms, set out in a side letter signed alongside the purchase agreement, go well beyond a typical investment. Nantahala can block the decisions that most shape a small company's direction — and it did not have to wait to fill its second board seat. That seat was secured the moment the transaction closed. The side letter entitles Nantahala to one board designee as long as it holds at least 15% of Femasys's outstanding shares, and a second once it crosses 20%. The filing states that **the 20% threshold was met immediately after the purchase.** The veto provisions reach into decisions that small-company management teams usually make without outside approval. Borrowing more than **$2.5 million,** replacing the chief executive, declaring dividends, expanding the board, and adopting a rights plan — the kind of defensive measure designed to dilute hostile buyers — all require Nantahala's written consent. Alongside those provisions, Femasys agreed to use commercially reasonable efforts to facilitate the **voluntary resignation of two current board members within 60 days** of the closing. The filing does not name them. Shares closed 23.18% higher at $2.71 on August 19, after the Schedule 13D became public, on dollar volume of about $111 million. The side letter runs for **ten years from the date of the purchase.** Nantahala held no shares in Femasys before August. It now holds consent rights over who runs the company. ### An AI Heart Monitor Company Is About to Become a Crypto Miner URL: https://www.pennystocks.news/hscs-an-ai-heart-monitor-company-is-about-to-become-a-crypto/ Last updated: 2026-08-21T15:36:10.000Z HeartSciences reads heart signals. Fortitude Mining mines Zcash, a privacy-focused cryptocurrency, and is wholly owned by Digital Currency Group. If HeartSciences shareholders vote yes, those two things become one company — and the AI cardiac device business effectively disappears into a crypto miner. HeartSciences Inc. NASDAQ: HSCS Shares closed 19.48% higher at $2.5450 after HeartSciences filed two 8-Ks disclosing the latest step in that transformation, on dollar volume of about $559,000 across 2,002 trades. For anyone holding the stock, the question is simple: is this still the company they bought? The merger agreement was signed on June 23, 2026\. A preliminary proxy statement went to the SEC on July 27\. The vote has not yet been scheduled, and the deal is expected to close in the second half of the current calendar year, the company said in its August 19 press release. The filings disclosed that **Fortitude bought about $1 million of HeartSciences shares on August 12**, paying **$2.43 per share** — a **22% premium** to the closing price that day — in a private placement. That brought in **411,522 new shares**, and Fortitude now holds **about 9.4%** of HeartSciences' outstanding common stock ahead of the merger closing. HeartSciences said it will use the proceeds for operating expenses before the deal closes. The purchase price was set at the 30-day volume-weighted average price through August 11, according to the subscription agreement filed with the SEC. The investment is structured so it does not change the merger exchange ratio — Fortitude gets no extra consideration at closing in respect of the shares it bought. But those shares are voting shares, and Fortitude now holds nearly a tenth of the company going into the shareholder vote it needs to win. One detail buried in the subscription agreement warrants attention. The filing discloses that Nasdaq sent HeartSciences a deficiency letter on August 4, 2026 — fifteen days before the August 19 filings. The filing does not say what the deficiency relates to, and the company has not explained it further in the source material reviewed here. If the merger closes, shareholders in an AI cardiac device company will hold shares in a Zcash mining operation run by Digital Currency Group. What the combined entity does with the ECG business is not addressed in either filing. ### Edgemode Handed the Lender Shares Before the Loan Was Complete URL: https://www.pennystocks.news/edgm-edgemode-handed-the-lender-shares-before-the-loan-was-c/ Last updated: 2026-08-24T18:24:02.000Z Before a dollar of the loan arrived, Edgemode had already handed the lender the shares. Edgemode, Inc. OTC: EDGM On August 17, 2026, Edgemode signed a deal with ClearThink Capital Partners, LLC giving it a convertible note with a face value of up to **$1,150,000**, for which the company would receive **net proceeds of up to $1,000,000** — the gap being original-issue discount built into the note from the start, a guaranteed gain for the lender before interest is counted. As consideration for purchasing the note, ClearThink also received **200,000,000 restricted common shares** outright, as a fee for agreeing to lend the money at all, according to the 8-K Edgemode filed with the SEC on August 21. As of that filing date, **$625,000 of the available proceeds had been received**. The money did not stay long: Edgemode used roughly **$328,000 to retire existing promissory notes** and another **$225,000 to pay Blackberry AIF** under the joint venture agreement the two companies entered in January 2026\. The filing does not say when the remaining proceeds will arrive. The note carries a **12% interest rate**, applied to the principal on the issuance date, and matures December 31, 2027\. ClearThink cannot begin converting the note into Edgemode shares until **180 days** after issuance — or sooner if Edgemode defaults. When it does convert, the price resets to **70% of the lowest closing price** across the ten trading days before each conversion date. The lower the stock trades, the more shares ClearThink receives for each dollar of debt it cancels. The 200 million commitment shares increase the share count before any conversion has taken place. Every conversion that follows adds more at a sliding discount. The agreement caps ClearThink's ownership at **9.99%** of outstanding shares at any one time — limiting how much it can convert in a single tranche, but not the total it can accumulate over the life of the note by converting in stages. The filing states the company's obligation to deliver conversion shares is "absolute and unconditional regardless of the dilutive effect." ### The Trustee Looked for Buyers. Nobody Was Interested. URL: https://www.pennystocks.news/hgtxu-the-trustee-looked-for-buyers-nobody-was-interested/ Last updated: 2026-08-24T16:45:12.000Z Hugoton Royalty Trust **has paid nothing to its unitholders since July 2023**. The trustee reached out to potential buyers for the trust's assets. According to an August 21 filing with the SEC, no interest resulted from those discussions. HUGOTON ROYALTY TRUST OTC: HGTXU The filing describes a trust that has exhausted most of its options. Accumulated excess costs — meaning the operating and development expenses on the underlying properties have consistently outrun the royalty income they generate — have put all three of the trust's conveyances in the red. To cover basic expenses this month, Argent Trust Company **drew $8,000 from the cash reserve**. The trustee has also deferred its own fee since April 2024\. The filing says the trust may not survive the coming year, and the trustee now believes outside financing is unlikely to be a viable path forward. The trust has also lost its trading venue. On July 17, 2026, units **were moved off the OTCQB** and onto the Expert Market, where brokers can only execute trades at a customer's specific request — they cannot recommend the units to clients. The trust filed a notice with the SEC on August 14 saying it could not produce its quarterly report for the period ended June 30 because it cannot afford to hire an accounting firm. Without audited financials or reserve reports, the filing says, unitholders may have limited or no information on which to base investment decisions. The trustee explored a sale of the trust's net profits interests — the royalty claims burdened by the same excess costs that ended distributions. Potential buyers were approached. **None expressed interest**, and the filing describes a near-term sale as unlikely, though the trustee says it will keep considering all viable options. What comes next may be a vote to shut the trust down. That requires approval from holders of **at least 80% of all outstanding units** — a high bar for any scattered unitholder base. And even if a sale were somehow arranged, the filing cautions that there is no assurance any proceeds would reach unitholders after the trust's own financial obligations are settled first. The excess costs underlying the three conveyances are deep. Oklahoma's cumulative shortfall stands at about **$15.1 million**, Wyoming's at about **$12.7 million**, and Kansas at about **$3.3 million**. Sitting ahead of any future royalty income is also **$1 million in advances** that a prior operator can recoup before distributions resume. The trustee does not foresee distributions in the near term — and the near term is no longer the only thing at risk. ### The Merger Missed June. Gravitics Is Paying 50% Per Month to Bridge It. URL: https://www.pennystocks.news/nimud-the-merger-missed-june-gravitics-is-paying-50-per-mont/ Last updated: 2026-08-24T16:45:12.000Z The reverse merger between Non-Invasive Monitoring Systems and Gravitics was supposed to close by June 30\. It is now August, and the deal is still pending. To cover working capital in the meantime, **Gravitics borrowed $1 million** on August 18 — under terms that make the urgency plain. NON INVASIVE MONITORING SYSTEMS INC /FL/ OTC: NIMUD The loan, drawn from BZH SPO LLC under an agreement dated August 17, carries **stated interest of 4.0% per 30-day period** on the original principal. On top of that, an **original issue discount of 50% of principal accrues for each 30-day period**. The note matures 60 days after funding. If it is not repaid by then, a default premium of **3.0% per 30-day period starts accruing automatically**, with no action required by the lender. That is the cost of keeping the lights on while the merger registration clears the SEC. The loan must be repaid from the proceeds of a public offering that would close alongside the merger. Gravitics is required to direct any money from that offering, or from certain customer contracts, to the lender first. Non-Invasive Monitoring Systems has signed a guarantee covering all of Gravitics' obligations under the loan. The catch — and it matters — is that the guarantee takes effect only if the merger closes. **If the deal collapses before closing, the guarantee terminates automatically** and NIMS owes nothing. If it closes, NIMS steps in as co-obligor alongside Gravitics, equally liable. The merger was announced on **March 6, 2026**, according to a company press release. Under that agreement, Gravitics stockholders would hold **at least 95.5%** of the combined company, with existing NIMS shareholders owning **up to 4.5%**. Gravitics, based in Marysville, Washington, holds a contract with Axiom Space and has worked with the U.S. Space Force, according to CNBC. The filing does not say why the June 30 closing target was missed, nor when the merger is now expected to close. The long-stop date — the deadline after which the guarantee voids — is defined in the loan agreement but not disclosed in the 8-K. ### A Pharma Company Took a Billion in Meme Coins. A Meme Coin Principal Is Now Its President. URL: https://www.pennystocks.news/zstk-a-pharma-company-took-a-billion-in-meme-coins-a-meme-co/ Last updated: 2026-08-21T02:56:46.000Z ZeroStack Corp. distributes pharmaceuticals through a German subsidiary and calls itself a decentralized AI asset manager. On Tuesday it **agreed to accept $1 billion of a meme coin in exchange for new shares** — and appointed a principal of that meme coin as company president. ZeroStack Corp. NASDAQ: ZSTK The detail that stands out is the price. According to ZeroStack's August 19 announcement, the shares are being issued at **$25.19 each**. Before the deal was published, the stock had been trading at around $1.84\. The company says the agreed price — **more than twelve times the market rate** — reflects the Memecore principals' conviction in ZeroStack's strategy. The release does not say why a buyer would pay that premium rather than buying shares in the open market. Shares **closed 169.55% higher at $4.9600** after the announcement, on dollar volume of about $203 million. For existing holders this is mainly a question of how many new shares end up in circulation. ZeroStack has a free float of about 1.6 million shares. The **3.5 million shares being issued immediately** are already more than double that. Warrants for about **36 million additional shares require shareholder approval** under Nasdaq listing rules before a single one can be issued, and any shares that do come through carry a lock-up of up to **ten years**. The company has not said when that vote will be held. The $1 billion comes in the form of **about 926 million Memecore tokens** — traded as $M — valued at their prevailing market price of **$1.08 apiece**, the company says. Memecore describes itself as a blockchain built to turn internet memes into long-term economic assets rather than short-term speculation. Rudy Rong, identified in the release as a Memecore principal, is **joining ZeroStack as president** under the terms of the deal. CEO Daniel Reis-Faria stays in place. The release does not say what happens to the transaction if shareholders vote down the warrants — which represent the bulk of the billion-dollar contribution. ### An Eye Drug Failed Its Main Test — Now Its Maker Wants to Exclude Nine Patients URL: https://www.pennystocks.news/eypt-an-eye-drug-failed-its-main-test-now-its-maker-wants-to/ Last updated: 2026-08-21T02:47:48.000Z Nine patients in EyePoint's Phase 3 eye drug trial lost significant vision. The company says none of them should count. **The primary endpoint was not achieved in the full patient dataset**, EyePoint said in an August 17 press release — but it is pushing ahead toward an FDA filing anyway. EyePoint, Inc. NASDAQ: EYPT The LUGANO trial tested whether DURAVYU, an investigational implant delivered into the eye every six months, could match the vision outcomes of aflibercept, the standard injection treatment for wet age-related macular degeneration. Wet AMD damages central vision progressively and is a leading cause of blindness in people over fifty. **Nine patients in the DURAVYU arm lost significant vision** from geographic atrophy, glaucoma, and retinal detachment — not from wet AMD itself, according to EyePoint. All nine had their wet AMD controlled by the drug. **Not one patient in the aflibercept comparison arm experienced comparable losses.** What this means for someone holding the stock: the case for FDA approval now rests largely on whether regulators accept an argument that was not part of the original trial design. EyePoint ran what it calls an ad hoc analysis — conducted after the results came in, rather than planned in advance — stripping those nine patients out. With them removed, the drug was non-inferior to aflibercept. Regulators draw a clear line between pre-specified and after-the-fact analyses, and EyePoint has not said whether the FDA has given any indication it will accept this framing. Shares closed 15.17% higher at $6.3000 on August 19, on dollar volume of about $53 million. EyePoint points to its secondary results as supporting evidence. Patients receiving DURAVYU needed **42% fewer supplemental injections** than those on aflibercept — a statistically superior result, the company said. **More than half of DURAVYU patients went 56 weeks without any supplemental treatment at all**, and in those patients specifically, vision outcomes were non-inferior to aflibercept. The drug's six-month dosing interval compares to the roughly every-two-month standard in current U.S. practice, according to the release. EyePoint also argues the comparison arm performed better than expected historically — prior large trials showed roughly 3 to 5 percent of aflibercept patients typically lose significant vision, yet none did in LUGANO — which it says made the primary endpoint harder for DURAVYU to clear. A second, identical trial called LUCIA is now the critical variable. Results are expected in the fourth quarter of 2026, and EyePoint says it still plans to file for FDA approval in the first half of 2027, assuming LUCIA supports that path. The company has not said what it would do if LUCIA also misses the primary endpoint on the full dataset. ### CleanTech Vanadium Mining launches unit placement to raise fresh capital URL: https://www.pennystocks.news/cleantech-vanadium-mining-1-million-non-brokered-private-placement/ Last updated: 2026-08-25T01:39:55.000Z CleanTech Vanadium Mining Corp. TSXV: CTV | OTCQB: CTVFF CleanTech Vanadium Mining Corp. is seeking **up to $1,000,000 in a non-brokered private placement**, selling as many as 10,000,000 units at $0.10 each, according to an August 20, 2026 release. A non-brokered financing is one arranged by the company itself rather than through an investment dealer. Each unit combines one common share with **one transferable warrant exercisable at $0.15 for three years**. A warrant is the right, not the obligation, to buy an additional share at a set price. At full subscription the offering would issue 10 million shares immediately and put another 10 million shares in reserve against warrant exercise. The release does not state the company's current share count, so the resulting dilution cannot be calculated from the disclosure itself. The warrant strike sits 50 percent above the unit price, meaning the warrants only produce further cash for the company if the shares trade above $0.15 during the three-year window. **Insiders are expected to subscribe for 1.5 million units**, or $150,000 of the offering, representing 15 percent of the maximum raise. Because directors and officers are participating, the subscription is a related party transaction under Multilateral Instrument 61-101, the Canadian rule that protects minority shareholders in transactions involving insiders. The company says it **expects to rely on exemptions from minority shareholder approval and formal valuation** under sections 5.5(a) and 5.7(1)(a) of that instrument, on the basis that neither the value of the units the insiders acquire nor what they pay for them is anticipated to exceed 25 percent of CleanTech's market capitalization. A material change report will be filed in respect of the transaction. Net proceeds are earmarked for **general corporate purposes**, with no allocation to a specific project disclosed. For a company holding exploration-stage assets, that phrasing leaves open whether the money funds fieldwork, option payments or overhead. CleanTech may pay finders' fees under TSX Venture Exchange policy; no rate is given. The offering requires exchange approval and other consents, and securities issued, including any finder's units, carry the standard **four-month-and-one-day resale hold period**. ## Earlier financing closed below the new target In the same release, CleanTech said it has elected to close the private placement it had announced on June 16, July 6 and July 21, 2026\. That financing brought in **aggregate gross proceeds of $433,033.37**. The company did not restate the original size sought in that earlier offering, its pricing, or the terms of any securities issued under it, so the shortfall against target cannot be measured from this document. The sequence of three announcements over five weeks followed by a decision to close is the visible fact; the reason for closing is not given. Taken together, the two items describe a company raising in small increments. The prior round produced less than half of what the new round is attempting, and the new round has not yet received exchange approval or disclosed any subscriptions beyond the anticipated insider portion. ## The assets behind the raise CleanTech describes itself as focused on critical minerals in the United States. It holds **an option to acquire mineral rights over more than 17,550 acres** with historic fluorspar resources across several projects in the Illinois-Kentucky Fluorspar District, and owns a 100 percent interest in the Gibellini vanadium project in Nevada. The description of the fluorspar resources as historic means they have not been verified to current reporting standards, and the acreage is under option rather than owned. No exploration results, expenditure commitments, cash balance or burn rate are included in the release, and no timeline is given for closing the new offering beyond the conditions described. John Lee is chief executive officer. The shares trade on the TSX Venture Exchange and on the OTCQB market in the United States. Source: [Newsfile](https://www.newsfilecorp.com/release/310663/CleanTech-Announces-1-Million-NonBrokered-Private-Placement?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Canadian Chrome Company plans private placement to raise capital URL: https://www.pennystocks.news/canadian-chrome-company-private-placement-8-4-million-units/ Last updated: 2026-08-25T01:39:54.000Z The Canadian Chrome Company Inc. CSE: CACR | CSE: CACR.A The Canadian Chrome Company Inc. said it plans to sell **up to 1,400,000,000 units at $0.006 each, for gross proceeds of up to $8.4 million**. The Toronto-based exploration company, formerly known as KWG Resources, trades on the Canadian Securities Exchange under CACR and CACR.A. The structure is unusual. Each unit consists of one subordinate voting share plus one hundredth of a warrant — a right to buy shares later at a set price — exercisable for a multiple voting share. Because the two share classes convert into each other at a ratio of 100 to 1, **the warrant coverage works out to one warrant share for every unit sold**, with a stated exercise price of $1.00 per multiple voting share. On a subordinate-share basis that is the equivalent of $0.01, roughly 67 percent above the unit price. At the maximum size, the offering would create 14 million warrants. If all were exercised, the company would take in a further $14 million, and the shares issued would be convertible into **another 1.4 billion subordinate voting shares**. The release does not disclose the company's current share count, so the dilution the financing would cause cannot be measured from the announcement alone. The warrants run for five years from the first closing, or until two business days after a change of control of the company, whichever comes first. Fractional warrants will be rounded down. The two classes carry proportionate rights: **one vote per subordinate voting share and 100 votes per multiple voting share**, with dividend and liquidation entitlements scaled the same way. Holders can convert in either direction at any time at the 100-to-1 ratio. Finders may be paid **up to 5 percent of the amount they refer, settled in units rather than cash**, at the same deemed price of $0.006\. Buyers must be accredited investors or otherwise qualify for a prospectus exemption, and the securities carry a four-month hold period, standard for Canadian private placements. On use of proceeds, the company says the money will fund its business of acquiring, exploring, evaluating and developing large-scale chromite and other base metal and mineral deposits, and that this includes **overhead, operating expenses and the costs of the placement itself**. No breakdown between exploration spending and general corporate costs is given. The offering is described as proposed. The release does not state a closing date, a minimum size, or whether any portion has been subscribed. Nor does it name a lead agent; the only compensation mentioned is the finder's fee. Canadian Chrome describes itself as an exploration stage company focused on chromite deposits in the Ring of Fire region of northern Ontario, along with other base and strategic minerals, and on supporting transportation and electrification links to reach remote deposits. It reports no revenue in the release, and no cash position or burn rate is disclosed. ## Capital markets appointment Separately, the company said it intends to appoint **Michael Minas as Vice-President Capital Markets**. The appointment has not yet been made: management said it will put the proposal to the board of directors for approval at the next board meeting. According to chief executive Frank Smeenk, Minas traded treasuries at Cantor Fitzgerald in New York, was an executive director at CIBC World Markets, co-founded Genuity Capital Markets and later served as director of institutional sales at Canaccord Genuity Group. Until recently he was chief executive of The Ring of Fire GP Inc., which the company says was engaged by Canadian Chrome. Smeenk linked the hire to United States markets, saying the appointment comes "now that the path forward into the USA and its capital markets has been addressed for Canada's critical minerals." The release gives no detail on what that path consists of, and **no US listing, financing or regulatory step is identified**. Compensation terms for the position were not disclosed. Source: [Newsfile](https://www.newsfilecorp.com/release/310642/CCC-Announces-Proposed-Private-Placement-of-Units-and-Appointment-of-Michael-Minas-as-VP-Capital-Markets?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Leggett & Platt Shareholders Approve Merger With Somnigroup URL: https://www.pennystocks.news/leggett-platt-shareholders-approve-somnigroup-merger/ Last updated: 2026-08-25T01:39:52.000Z Somnigroup International Inc. NYSE: SGI **Leggett & Platt shareholders voted to approve the merger with Somnigroup International**, the Carthage, Missouri manufacturer said on 20 August 2026\. The company added that **one required regulatory approval is still outstanding** and that it expects the transaction to close once the remaining conditions are met. The deal rests on an agreement and plan of merger **dated 13 April 2026** between Somnigroup, Leggett & Platt and Sparrow Unity Corporation, a Missouri company wholly owned by Somnigroup. Under that structure, **Sparrow Unity merges into Leggett & Platt, which survives as a wholly owned subsidiary of Somnigroup**. That is a standard reverse triangular merger: the acquirer forms a shell subsidiary, the shell disappears into the target, and the target continues to exist under new ownership rather than being dissolved. The announcement is short on detail beyond the vote itself. **Leggett & Platt disclosed no vote totals, no transaction value and no expected closing date**. It did not name which regulator has yet to sign off. Readers looking for the consideration payable to Leggett shareholders would need to go to the Form S-4 and the proxy statement/prospectus that the two companies filed with the Securities and Exchange Commission; the release refers to those documents but does not summarise their terms. Both parties are New York Stock Exchange–listed rather than micro-caps. Leggett & Platt trades under LEG and describes itself as a 143-year-old diversified manufacturer of bedding components, automotive seat comfort systems, furniture components, geo components, flooring underlayment and hydraulic cylinders. Somnigroup trades under SGI. The company's own risk disclosure sets out what could still go wrong: conditions that may not be satisfied or waived, including governmental and regulatory approvals; events that could delay completion or lead to termination of the merger agreement; litigation that could produce an injunction blocking the deal or a damages award; and disruption to business relationships while the outcome is uncertain. It also flags **significant transaction and merger-related costs** tied to the deal, and the possibility that the expected benefits are not realised when expected or at all. For now, the shareholder condition is cleared and **the timing of closing depends on the remaining regulatory clearance**, which the company did not put a date on. Source: [PR Newswire](https://www.prnewswire.com/news-releases/leggett--platt-announces-shareholder-approval-of-merger-with-somnigroup-302856600.html?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Boot Hill's DraftKings Deal Runs Ten Years. Its State License Runs Three. URL: https://www.pennystocks.news/buks-boot-hill-s-draftkings-deal-runs-ten-years-its-state-li/ Last updated: 2026-08-24T18:24:03.000Z Boot Hill Casino's new arrangement with DraftKings runs for **ten years**. The government contract that makes it possible runs for three. BUTLER NATIONAL CORP OTC: BUKS Butler National Corporation's casino subsidiary BHCMC, LLC signed two agreements on August 17\. One extends Boot Hill Casino & Resort's management contract with the Kansas Lottery by **three years, beginning September 1, 2027**, running the state relationship through 2030\. The other amends and extends Boot Hill's existing arrangement with DraftKings — which handles online and mobile sports wagering — for a full decade. The DraftKings deal is explicitly conditional on Boot Hill continuing to hold its Kansas Lottery management authority. Under the Kansas Lottery renewal, Butler National Service Corporation receives **90% of all sports wagering revenue** it generates, according to the 8-K filed August 20\. That figure is subject to adjustment if state law requires changes. The original agreement was a five-year contract put in place after Kansas authorised lottery-owned sports wagering in 2022\. The new extension carries the same material terms, the filing states. The filing does not explain why the two contracts run for different lengths. DraftKings has committed for ten years; Boot Hill's underlying state-granted authority ends in 2030\. If Kansas does not extend Boot Hill's management contract again after that point, the DraftKings arrangement collapses with it — the filing states this condition plainly. The DraftKings extension includes updated commercial terms reflecting current market conditions, according to the company's August 20 press release, but **no dollar value for the arrangement was disclosed** in the 8-K or its exhibits. That dependency runs in one direction. DraftKings needs Boot Hill to keep its Kansas Lottery contract. Boot Hill needs Kansas to keep renewing. The first renewal took five years to arrive at a first extension; how the state decides in 2030 is not a question this filing addresses. ### IMA Tech Added a Second Director. He's Married to the First One. URL: https://www.pennystocks.news/imaa-ima-tech-added-a-second-director-he-s-married-to-the-fi/ Last updated: 2026-08-24T18:24:03.000Z IMA Tech's board had one seat. Then the person sitting in it appointed her husband to fill the second. IMA Tech OTC: IMAA An 8-K filed with the SEC on August 20 discloses that **the board expanded from one director to two on July 31**, and that Lucky Lakhvindar Janda was appointed to fill the new vacancy, effective immediately. The filing states plainly that Janda and IMA Tech's other director — Inderjit Mangat, who also serves as chief executive officer — are husband and wife. Janda, 71, has managed his own investments for more than a decade, according to the filing. **Since 2024 he has also served as a director and VP of Marketing and Capital Markets at Aapki Ventures**, a British Columbia company listed on the Canadian Securities Exchange under the symbol APKI. The Canadian Securities Exchange's own listing page shows Aapki Ventures' status as suspended. The 8-K gives the reason: the company failed to file required periodic financial reports. That detail matters for anyone holding IMA Tech stock. The new director's only disclosed outside board role is at a company regulators have shut out of trading for the same category of failure — late or missing filings — that small public companies most commonly stumble over. The 8-K does not say whether Janda has any relevant operating or governance experience beyond investment management and his role at Aapki Ventures. The filing was signed by Mangat as chief executive officer. With Janda's appointment, the board of IMA Tech is now two people who are married to each other. ### Scandium Canada Closes $5 Million Charity Flow-Through Financing for Crater Lake Drilling URL: https://www.pennystocks.news/scandium-canada-closes-5-million-charity-flow-through-offering/ Last updated: 2026-08-25T01:39:51.000Z Scandium Canada Ltd. TSXV: SCD Scandium Canada Ltd. (TSXV: SCD) said on August 20, 2026 that it had **closed a $5,000,000 non-brokered private placement**, issuing 25,000,000 charity flow-through units at $0.20 each. Each unit consists of one common share and one full warrant. The **warrants carry an exercise price of $0.22** and can be exercised from October 20, 2026 until August 20, 2028\. If all of them were exercised, the company would issue a further 25 million shares and take in an additional $5.5 million. The company did not disclose its share count before or after the placement, so the dilution cannot be measured from the release alone. Nor did it state a cash balance or a rate of spending. According to the company, the **proceeds are to fund diamond drilling, exploration work and the collection of environmental samples at the Crater Lake project**, with the spending to be incurred on or before December 31, 2027\. That date matters under flow-through rules: the structure lets an issuer transfer eligible Canadian exploration expenses to subscribers for tax purposes, and the money must be spent on qualifying exploration rather than on general corporate costs. ## Charity flow-through and the LIFE exemption These were charity flow-through units, a variant in which the subscriber typically donates the shares to a registered charity after purchase, layering a charitable tax receipt on top of the flow-through deduction. Investors in this financing were **sourced by Wealth Creation Preservation & Donation Inc. (WCPD)**, a firm that specialises in that structure. Because the tax treatment carries most of the economics for the buyer, the $0.20 unit price is not a straightforward read on what a cash buyer would pay. The units were sold under the listed issuer financing exemption, or LIFE, in the provinces of Canada. One practical consequence is that the **shares are not subject to a statutory hold period** for Canadian resident purchasers, meaning the new stock is free trading rather than locked up for four months. The offering document is filed on SEDAR+. The securities were not registered in the United States and cannot be offered or sold there absent registration or an exemption. ## What the money is meant to pay for Crater Lake sits in Nunavik, northern Quebec. Scandium Canada describes it as North America's only primary source of scandium, a claim that comes from the company rather than from an independent assessment in this release. Chief executive Guy Bourassa said the financing supports the drilling already under way. "It is important to take advantage of having the drilling equipment and team on site, lowering our costs," he said, adding that the campaign is aimed at confirming lateral extensions of the TG deposit and that the company expects to reflect the results in **an updated mineral resource estimate**. No timing was given for that estimate, and no drill results were included. The company also markets aluminum-scandium alloys through a wholly owned subsidiary, Scalium+. The release gives no revenue figure for that business. One caveat sits at the end of the announcement: despite the reference to closing, the **transaction still requires final approval from the TSX Venture Exchange**. Source: [Newsfile](https://www.newsfilecorp.com/release/310603/Scandium-Canada-Announces-Closing-of-5-Million-NonBrokered-Life-Offering-of-Charity-FlowThrough-Units?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### The Bid Is Dead. The Bill Is Not. URL: https://www.pennystocks.news/dpls-the-bid-is-dead-the-bill-is-not/ Last updated: 2026-08-24T16:45:13.000Z Aero Precision and Ballistic Advantage, two firearms manufacturers, were placed into receivership in May 2026, with a court-appointed receiver managing their assets toward a sale. In August, a company the SEC classifies as a prepackaged software firm put in a cash bid of **approximately $35 million** for substantially all of their assets. The receiver never signed the agreement. Someone else got the companies. DarkPulse, Inc. OTC: DPLS The bidder was DarkPulse, Inc. To participate, it needed a deposit — about **$2.77 million** — that it did not have. It solved this by borrowing from five private individuals. The five loans, formalised in promissory notes dated August 8, 2026, total **$2.78 million in aggregate**, carry interest at **8% per annum**, and mature no later than **October 1, 2026**. The two largest came from Douglas and Brenda Zink, who lent $1.4 million, and Loren Ellefson, who lent $1.1 million. DarkPulse wired the deposit on August 4, according to the 8-K filed with the SEC on August 20. The terms of the notes contain a clause worth reading carefully. Repayment of principal and accrued interest is due in full by October 1 *regardless of whether DarkPulse wins or loses the bid*. The filing states that the proposed asset purchase agreement was not executed by the receiver and that DarkPulse has not entered into a definitive agreement. The day after DarkPulse filed the 8-K, trade publication RECOIL reported that Aero Precision, Ballistic Advantage, and two related brands had been sold to a private ownership group, as confirmed by AllOutdoor.com on August 21\. DarkPulse was not named as the buyer. The filing also disclosed a financing commitment from N Advance LLC of **up to $40 million**, intended to support the transaction. That commitment was conditional on DarkPulse being confirmed as the successful bidder and on the execution of definitive transaction documents — conditions that were never met, based on what the filing and subsequent trade reporting show. DarkPulse now carries nearly $3 million in unsecured short-term debt taken on for a deal it did not win. The filing does not say where the money to repay it will come from. ### Kingsmen Drills 1.40 Metres of 433 g/t Silver Equivalent at Las Coloradas URL: https://www.pennystocks.news/kingsmen-resources-las-coloradas-drill-results-lc-26-014-015/ Last updated: 2026-08-25T01:39:49.000Z Kingsmen Resources Ltd. TSXV: KNG | OTCQB: KNGRF | FWB: TUY Kingsmen Resources reported **1.40 metres grading 433 g/t silver equivalent, including 239 g/t silver**, from 190.0 metres in hole LC-26-014 at its Las Coloradas project in the Parral district of Chihuahua, Mexico. Within that interval, a 0.75-metre sample returned 787 g/t silver equivalent (435 g/t silver). The second hole released, LC-26-015, cut **1.70 metres at 185 g/t silver equivalent (139 g/t silver)** from 201.65 metres, including a shorter interval at 438 g/t silver equivalent. Both holes were drilled as step-outs beneath old mine workings, targeting a 100-metre undercut. According to the company, they intersected the mineralized system **90 metres and 96 metres down-dip of previously mined ground**. The Mine zone has now been traced over a minimum strike length of 106 metres across three drill fences spaced 50 metres apart, to a vertical depth of 155 metres. Kingsmen says the zone remains open at depth and along strike. ## What the grades represent The reported widths are **drilled core lengths, not true widths**, which the company states have not yet been determined. Core length overstates the actual thickness of a zone when a hole cuts it at an angle. The mineralization is described as dipping east at roughly 40 degrees. Silver equivalent is a single number that rolls gold, lead and zinc into a silver-grade figure. In LC-26-014's headline interval, silver itself accounts for 239 of the 433 g/t; the rest comes from 0.41 g/t gold, 4.53 percent lead and 5.65 percent zinc. The calculation assumes prices of US$42 per ounce silver, US$3,675 per ounce gold, US$2,003 per tonne lead and US$2,960 per tonne zinc. The recovery assumptions behind the formula — 92 percent for silver, 91 percent lead, 85 percent zinc and 40 percent gold — are **taken from published figures for a different deposit**, Kootenay Silver's La Cigarra project in Chihuahua, which Kingsmen describes as having a similar mineralization style. No metallurgical testwork on Las Coloradas material is cited. There is also an internal inconsistency in the release. The highlight text gives LC-26-014's high-grade sub-interval as 0.75 metres from 190.4 to 191.5 metres, which extends beyond the stated 191.4-metre end of the parent interval. For LC-26-015, the highlights describe a 0.68-metre sub-interval from 202.17 to 202.85 metres while the accompanying table lists 0.78 metres from 201.17 metres. ## Where the programme stands Kingsmen has now published results from **three of the 19 holes drilled to date** at Las Coloradas. Earlier releases covered LC-26-013, which returned 5.20 metres at 257 g/t silver equivalent, and LC-25-010, which returned 13.4 metres at 138 g/t silver equivalent including 0.7 metres at 1,742 g/t. The company says the wide intercept in LC-25-010 sits in a structurally controlled dilatant zone — a gap opened by faulting that allowed thicker mineral deposition — and that this zone has not been drilled along strike in either of the fences reported here. By the company's own account, there has been **no infill drilling, no deep drilling and no testing of the wide zone** seen in LC-25-010\. The property covers 8.5 square kilometres and consolidates ground worked by ASARCO between 1942 and 1952. President and chief executive Scott Emerson said the drilling has "outlined a block of mineralization that remains open along strike and at depth," and pointed to untested ground between the intercepts shown in the release's sections. Kingsmen attaches a footnote to that interpretation, noting it rests on the company's current geological model and that there is no assurance further drilling will confirm or extend what has been found, or that such drilling will take place. Samples went to ALS Geochemistry in Chihuahua for four-acid multielement analysis and fire assay for gold, with standards, blanks and duplicates inserted into the sample stream. Remaining core is being logged and sampled, with further assays to be released as they are received. **Las Coloradas has no mineral resource estimate**, and the release gives no figures on cash on hand, the cost of the drill programme or how much drilling remains funded. Kingsmen trades on the TSX Venture Exchange, the OTCQB market and in Frankfurt. Source: [Newsfile](https://www.newsfilecorp.com/release/310557/Kingsmen-Drills-1.40-Metres-of-433-gt-AgEq-239-gt-Ag-at-Las-Coloradas-Expanding-a-HighGrade-Silver-Zone-Open-at-Depth-and-Along-Strike?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### An Electric Fleet Charging Company Just Won Its First Military Contract URL: https://www.pennystocks.news/xos-an-electric-fleet-charging-company-just-won-its-first-mi/ Last updated: 2026-08-25T01:39:46.000Z The U.S. Air Force awarded Xos its **first defense contract** on August 17, selecting the commercial fleet charging company to build a prototype deployable battery system. For Xos, which has sold electric trucks and mobile charging equipment to delivery fleets, ports, and municipalities, it is the company's first entry into the defense market. Xos, Inc. NASDAQ: XOS The award came through the Air Force Global Strike Command Rapid Capabilities Division 2026 Showcase, a program designed to move commercial technology into military use quickly. The agreement is a prototype Other Transaction Agreement — a contract type the Pentagon uses to engage vendors outside traditional defense procurement channels. Xos will adapt its Xos Hub™ mobile battery storage system for military field conditions, with assembly at its Byrdstown, Tennessee facility, according to the company's release. **The period of performance runs into late 2027.** The contract carries **no disclosed dollar value** and covers a single prototype. That is the catch for anyone holding the stock: a prototype agreement opens a vendor to the defense market but does not commit the Air Force to production orders. The company says it intends to pursue further defense opportunities, without specifying what or when. Shares **closed 112.44% higher at $4.4400** on August 18, after the announcement, on dollar volume of about $488 million across about 809,000 trades. The company's free float stood at about 7.9 million shares. Short volume on the session was about 19.1 million shares — **more than twice the float.** One prototype, no follow-on. The next move belongs to the Air Force. ### A Tiny Shipping Stock Is Folding Every Forty Shares Into One to Stay Listed URL: https://www.pennystocks.news/ciss-a-tiny-shipping-stock-is-folding-every-forty-shares-int/ Last updated: 2026-08-25T01:39:48.000Z Three weeks ago, C3is closed a $6 million offering bundled with warrants that could issue tens of millions of new shares at prices designed to reset lower after closing. By August 17, the share count had roughly quadrupled. On Monday, the board moved to undo it: **every forty shares become one**. C3is Inc. NASDAQ: CISS The offering, completed July 28, included Class F Warrants with the potential to issue **up to about 41.7 million additional shares**, depending on how their reset and cashless exercise features played out, according to a Form 6-K filed with the SEC on July 28\. A prospectus from the same date listed about 13 million shares outstanding, according to an amended Schedule 13G filed August 14 by L1 Capital Global Opportunities Master Fund. By August 17, the 6-K announcing the reverse split put the count at about 57.6 million. **Shares closed 15.32% higher at $2.7400** on August 18, on dollar volume of about $1.3 million. The split is the company's answer to Nasdaq's minimum bid price rule, which requires listed stocks to trade above $1\. The company's press release said the split "will increase the market price" and allow it to meet that threshold. After the split, the outstanding share count falls from about 57.6 million to **about 1.44 million**, according to the 6-K. Holders who end up with a fraction of a share will receive a cash equivalent rather than a fractional share. Combining shares does not change what fraction of the company each holder owns. But the mechanism that expanded the share count to where it stands now — the **resettable, cashless warrants — remains in place** and will itself be adjusted in proportion when the split takes effect. Not all of those adjustments are straightforward. The 6-K says the Class B and Class C Warrants will go through a further adjustment period lasting **five trading days after the split**, under terms set out in those warrants' own documents. The filing does not describe what range of outcomes that window produces, or what it means for the number of shares those warrants could eventually deliver. ### Shareholders Voted It Down. Two Weeks Later, the Board Asked Again. URL: https://www.pennystocks.news/uuu-shareholders-voted-it-down-two-weeks-later-the-board-ask/ Last updated: 2026-08-25T02:01:31.000Z Shareholders said no on July 31\. Two weeks later, the board asked again. At a special meeting that day, Universal Safety Products' stockholders **rejected two proposals**: one to authorize 25 million shares of preferred stock on terms the board could set without a further shareholder vote, and one to create a new class of common stock carrying 25 votes per share against one vote for ordinary shares. Both failed, according to an 8-K the company filed with the SEC afterward. Fourteen days later, on August 14, the company **filed a new preliminary proxy** containing the same two proposals, with the same board recommendation to vote for both. The filing gave no reason for resubmitting the defeated measures. Universal Safety Products, Inc. NYSEAMERICAN: UUU Shares **closed 18.95% higher at $4.5200** on August 18, on dollar volume of about $363,000. What that means for a shareholder: blank-check preferred, once authorized, can be issued by the board at any time on whatever terms directors choose — voting powers, conversion rights, liquidation preferences — without another vote. The 25-vote Class B structure would let whoever holds that stock outvote ordinary shareholders by a wide margin on any company decision. Both tools, if approved, reduce the weight of the ordinary share going forward. The quarterly filing the company submitted the same day as the new proxy fills in the backdrop. Its remaining products — ground-fault circuit interrupters and ventilation fans — brought in **about $110,000 in net sales** in the quarter ended June 30, 2026\. The filing states that the company may not survive the next year without new funding — what auditors call a **going-concern warning**. Cash on hand was about $3.7 million. The business meant to generate the next chapter of revenue is Universal DeFi, a subsidiary operating nodes on the Ault Blockchain network. As of June 30, it held about 425 million AULT Tokens — which the filing says were not traded on any exchange, with no observable market price, so no revenue has been recognized. Under an agreement signed June 30, Universal DeFi will pay 25% of any proceeds from token sales to Ault Capital Group, up to a cumulative total of **$93.75 million**. That cap applies to a token that, as of the filing date, had never been traded. The filing does not say what the board plans if shareholders reject the proposals a second time. ### A Private Equity Firm Is Taking This Healthcare Software Company Off the Market URL: https://www.pennystocks.news/weav-a-private-equity-firm-is-taking-this-healthcare-softwar/ Last updated: 2026-08-25T02:01:30.000Z Weave built its business around the small healthcare practices that larger software vendors tend to pass over. Francisco Partners has agreed to buy the company outright and take it off the stock market. Weave Communications, Inc. NYSE: WEAV Under the terms announced in the company's August 18 press release, **stockholders would receive $7.40 per share in cash**, putting the deal's equity value at roughly $650 million. That represents a 34% premium to where Weave's stock closed on August 17, the last full trading day before the announcement. The company says its software is used at more than 40,000 locations. For existing shareholders, the transaction is a clear-cut proposition: accept certain cash at a substantial premium, or vote it down and remain in a public company. The Weave board voted unanimously to approve the deal, and said it evaluated a range of strategic and financial alternatives before settling on Francisco Partners. Shares **closed 31.65% higher at $7.2800** after the deal was announced, on dollar volume of about $360 million. The merger agreement, as filed with the SEC on August 18, states that **no Weave executive has agreed to roll equity into the surviving private company** or invest alongside Francisco Partners. The management team is not publicly committed to a stake in the business after the transaction closes. The deal is expected to **close in the fourth quarter of 2026**, pending shareholder approval and regulatory clearance. The board has not yet called the special stockholder meeting that would put the offer to a vote. ### An Oncology Company Is Giving Away Its Old Business as a Dividend URL: https://www.pennystocks.news/chrs-an-oncology-company-is-giving-away-its-old-business-as/ Last updated: 2026-08-25T02:01:33.000Z Coherus Oncology is giving away its old drug business. On September 30, shareholders become entitled to any money the company collects from selling its remaining biosimilar patents, royalties, and cell lines. **They cannot sell those rights, and if nothing is sold within two years, they expire with nothing paid.** Coherus Oncology, Inc. NASDAQ: CHRS The instruments are called contingent value rights, or CVRs. For shareholders, the CVR dividend amounts to a claim on assets the company has decided it no longer wants, with an expiry date attached. Coherus said in its August 17 announcement that it has retained an investment bank to run the sale process, starting immediately. **No buyer has been named and no value has been placed on the assets.** The package being separated out includes **biosimilar patents, a royalty stream under an existing licence, cell lines, and regulatory filings.** CEO Denny Lanfear said in the announcement that the assets could appeal to an established biosimilars company or a new entrant, pointing to draft FDA guidance that would remove the requirement for comparative clinical trials in biosimilar approvals. The release attributed no dollar value to the assets. One further constraint: **the CVRs are expressly subject to a loan agreement Coherus signed with Innovatus Life Sciences Lending Fund I** on August 12, five days before the CVR announcement. That agreement restricts both the disposal of the biosimilar assets and payments to CVR holders. The release did not detail what those restrictions mean in practice. What Coherus is keeping is an oncology company built around **LOQTORZI (toripalimab-tpzi), an approved PD-1 inhibitor** — a class of cancer drug that helps the immune system identify tumour cells — and two mid-stage candidates targeting liver, head and neck, colorectal, and gastrointestinal cancers. Shares **closed 16.52% higher at $1.3400** on August 18, after the announcement, on dollar volume of about $4.5 million. The rights distribute on October 7 and **expire exactly two years later.** Any assets unsold by then produce nothing. ### FDA Clears Quantum BioPharma to Run First Human Efficacy Trial of Its Myelin-Protecting MS Drug URL: https://www.pennystocks.news/qntm-fda-clears-quantum-biopharma-to-run-first-human-efficac/ Last updated: 2026-08-25T01:39:45.000Z Most drugs approved for multiple sclerosis work by dialling down the immune system. Quantum BioPharma's Lucid-MS targets something else: the enzyme that strips the protective myelin sheath from nerve fibres. On August 10, the FDA cleared the company to test that approach in MS patients for the first time. Quantum Biopharma Ltd. NASDAQ: QNTM The FDA's approval of Quantum's Investigational New Drug application — a submission the company's CEO described as approximately 15,000 pages — **clears Lucid-MS for a Phase 2 trial in progressive MS**. Phase 2 is the stage that tests actual efficacy, not just safety. Prior Phase 1 trials were run in healthy volunteers and found the drug well tolerated, according to an August 10 press release filed with the SEC. Lucid-MS is designed to inhibit protein arginine deiminase 2, or PAD2 — **an enzyme the company says drives myelin degradation**, the process at the root of disability progression in MS. Most approved therapies try to slow the immune system's attack on myelin; this drug is designed to protect myelin directly, according to the company. That distinction matters most in progressive MS, where immune-targeting drugs have had limited reach and treatment options remain narrow. Shares **closed at $3.80 on August 14, up 17.65%** from the previous close of $3.23\. Dollar volume was about $1.0 million across 2,244 trades. The free float is about 3.5 million shares. Short volume on the session was 54,732 shares, 40.17% of reported volume. The trial will be **randomized, double-blind and placebo-controlled**, and will measure both clinical and radiological markers of disease progression. Site selection is already underway, and Quantum is working with a global clinical research organisation whose name it did not disclose. Patient enrolment timing was not given. Quantum held **about $9.5 million in combined cash and digital assets as of June 30**, and management says the current burn rate — operating expenses ran roughly 53% lower than a year earlier in the second quarter — gives the company a runway to at least October 2027\. In animal models, Lucid-MS both prevented and reversed myelin breakdown, the company says. The Phase 2 trial will be the first test of whether it does the same in people. ### NexGel Needs Shareholders to Save Its Nasdaq Listing URL: https://www.pennystocks.news/nxgl-nexgel-needs-shareholders-to-save-its-nasdaq-listing/ Last updated: 2026-08-25T01:39:43.000Z For 30 consecutive business days, NexGel's stock closed below a dollar. Nasdaq sent a deficiency notice on April 22\. Now the company has until October 19 to fix it — and it is asking shareholders for the tool to do so: **a reverse stock split that could combine as many as twenty shares into one**. NexGel, Inc NASDAQ: NXGL A reverse split does not change what the company is worth. It repackages the same value into fewer, higher-priced shares. At the maximum ratio the proxy requests, each shareholder would end up with one share for every twenty held, and **the price per share rises in proportion**. Nasdaq's continued-listing rules require a sustained closing price at or above $1.00; a large enough split achieves that mathematically, though it offers no guarantee the price holds afterward. The preliminary proxy, filed on August 14, calls a special shareholder meeting for September 23\. The board wants discretion to choose any split ratio between 1-for-2 and 1-for-20, at any point within the year following a vote. It can also choose not to act — or to wait and see whether the stock recovers on its own before the **October 19, 2026 compliance deadline**. A second proposal on the same ballot would **expand the authorized share count from 25 million to as many as 150 million**. The proxy says the company does not currently have enough authorized shares to cover all its existing obligations, including outstanding convertible notes, warrants and equity plan awards, each of which requires shares to be held in reserve. Every new share issued under an expanded authorization makes existing ones worth a smaller slice of the same company. The proxy does not specify the size of those pending obligations. NexGel shares **closed 15.61% higher** at $0.5650 on August 14, from a previous close of $0.4887\. Dollar volume was about $913,000 across 11,834 trades. The free float is about 7.1 million shares, or 76.6% of shares outstanding. Short volume on the session was 92,500 shares, representing 25.83% of reported volume. Both proposals require a majority of outstanding shares to pass. The shareholder vote is September 23; the Nasdaq compliance deadline is October 19. ### Steakholder Foods shareholders to vote on vast expansion of authorized share count URL: https://www.pennystocks.news/stkh-steakholder-foods-wants-to-raise-its-authorized-share-c/ Last updated: 2026-08-25T01:39:42.000Z Steakholder Foods wants to multiply its authorized share count 20,000 times over. Shareholders will vote on September 15 on a proposal to expand the company's authorized ordinary shares from 50 billion to one quadrillion — that is, a thousand trillion — a notice filed with the SEC on August 11 showed. The scale of the request points to a problem that predates the vote. As of August 5, the company had about **12.2 billion ordinary shares outstanding against a 50 billion authorized cap** — leaving apparent room. But total outstanding warrants, including two series issued in the July placement, represent about **72.8 billion ordinary shares**, well beyond what the company is currently authorized to issue in full. The two new warrant series cannot be exercised at all until shareholders approve the share increase. Those warrants came from a **$3.5 million private placement that closed August 3**. The company issued pre-funded warrants, Series E warrants, and Series F warrants to a single accredited investor, each series exercisable for up to 1,750,000 American depositary shares. Each ADS represents 12,000 ordinary shares. The pre-funded warrants carry an exercise price of $0.01 per ADS and are immediately exercisable. The Series E and F warrants have an exercise price of $2.00 per ADS but remain locked until the authorized share increase takes effect — which requires the September vote. Series E warrants expire 18 months after that date; Series F warrants expire five years out. Steakholder Foods Ltd. NASDAQ: STKH Shares closed at $3.60 on August 14, **up 25% from a previous close of $2.88**, after the company filed the special-meeting notice three days earlier. Dollar volume was about $164.1 million across roughly 377,800 trades. Short volume that session was about 4.8 million shares, representing 52.51% of reported volume. If both the Series E and Series F warrants are exercised in full for cash, the filing says the company could receive **up to $7.0 million in additional gross proceeds**. If they are not exercised, the company says it may be unable to fulfill its obligations to the warrant holders and could face claims or be required to negotiate alternative arrangements. H.C. Wainwright & Co. acted as placement agent and received a cash fee equal to 7.5% of gross proceeds, according to the proxy statement. The board is recommending a vote for both proposals at the September 15 meeting: the share-capital increase and the formal approval of the ADS issuance underlying the pre-funded warrants. Approval of each requires a simple majority of shares present and voting. ### MDxHealth nearly doubles its share count, then climbs 75% the following session URL: https://www.pennystocks.news/mdxh-mdxhealth-nearly-doubles-its-share-count-then-climbs-75/ Last updated: 2026-08-25T01:39:39.000Z MDxHealth SA nearly doubled its share count in a single offering on August 13\. The next trading session, shares closed about 75% higher. The company **sold about 44 million ordinary shares at $0.454 each**, directly to institutional investors with no placement agent, according to a prospectus supplement filed with the SEC on August 13\. Net proceeds were **about $20 million** before expenses. MDxHealth said it intends to use the funds for working capital, product development, and expanding its commercial operations. Before the offering, about 51 million shares were outstanding. After it, the count stood at **about 95 million** — every existing holder now owns a smaller piece of the same company. The proceeds arrived as MDxHealth was working against two separate Nasdaq compliance deadlines. MDxHealth SA NASDAQ: MDXH The largest buyer was Bleichroeder LP, a New York investment manager run by Chairman and CEO Andrew Gundlach. Funds managed by Bleichroeder **purchased about 24 million of the offered shares** and, including earlier open-market purchases, now hold **33.2% of the company's outstanding stock**, according to a Schedule 13D that Gundlach signed on August 14\. The shares acquired in the offering are subject to a **90-day lock-up**. MDxHealth disclosed in the prospectus that on July 2, 2026, Nasdaq notified the company its closing bid price had been **below $1.00 for 30 consecutive trading days**, with a compliance deadline of December 28, 2026\. A second notice, dated July 20, flagged that the company's market value of listed securities had fallen below Nasdaq's **$35 million minimum**, with a separate compliance window closing January 19, 2027. MDxHealth closed at $0.8080 on August 14, up 74.89% from the prior close of $0.4620\. Dollar volume for the session was about $297 million across 623,344 trades. Short volume was 123,731,925 shares, representing 54.76% of reported volume. Even after the day's gain, the stock at $0.8080 still sat below the $1.00 minimum Nasdaq requires. ### Digital Asset Acquisition scraps its Old Glory bank merger the day before the shareholder vote URL: https://www.pennystocks.news/daaq-digital-asset-acquisition-scraps-its-old-glory-bank-mer/ Last updated: 2026-08-25T01:39:41.000Z Digital Asset Acquisition Corp. terminated its planned merger with Old Glory Holding Company on August 13 — the day before shareholders were scheduled to vote on it. Shares **closed 43.53% higher** the following session. Old Glory's president and CEO, Mike Ring, told customers in an email that **the Federal Reserve would not approve the transaction**, Banking Dive reported. The parties had submitted a Federal Reserve application in February to register the combined holding company. The termination agreement gives no reason for the decision and does not describe a formal denial. For holders of DAAQ shares, the collapse of the deal reopens a standard path out: shareholders in a blank-check SPAC can redeem their stakes from the trust at roughly the per-share value held there. These shares tend to trade at a discount to trust value while a deal is open, because the outcome of the deal remains uncertain. With no deal pending, that uncertainty is removed. Digital Asset Acquisition Corp. NASDAQ: DAAQ DAAQ closed at $10.42 on August 14, up from a previous close of $7.26, on dollar volume of about $1.2 million across 1,652 trades. The float is 17,250,000 shares; short volume on the session was 9,694 shares. The deal had been announced January 13\. It assigned Old Glory **a $250 million pre-money valuation** and was intended to take the bank's holding company public on Nasdaq under the ticker OGB, according to a Business Wire announcement that day. DAAQ held about $176 million in its trust account. The parties planned to raise at least $50 million in additional financing, though none had been secured as of the final prospectus filed with the SEC. Under the termination agreement, no fee is owed by either party. That prospectus had flagged serious problems at Old Glory. The company carried **an accumulated deficit of $51.8 million** as of March 31, 2026, and recorded net losses of $14.8 million in 2025 and $4.5 million in the first quarter of 2026\. The filing said the company's capital was not expected to cover operating losses and minimum regulatory capital requirements over the next 12 months — a going-concern warning. The merger had been Old Glory's primary route to new capital; Ring's customer email did not identify an alternative, Dallas Express reported. DAAQ said it will postpone the shareholder meeting indefinitely. Ring told customers he intends to sue the Federal Reserve personally — "on his dime, not the company's" — according to Banking Dive. ### Aurora Cannabis buys two UK cannabis distributors in cash transaction URL: https://www.pennystocks.news/aurora-cannabis-acquires-internode-hap-pharma-uk/ Last updated: 2026-08-25T01:39:38.000Z Aurora Cannabis Inc. NASDAQ: ACB | TSX: ACB Aurora Cannabis has acquired two UK businesses — licensed importer and wholesaler Internode Pharma Limited and licensed pharmacy HAP Pharma Limited — for **GBP 2.1 million in cash paid at closing**, according to the company's announcement dated 19 August 2026. The purchase was made indirectly through a wholly owned subsidiary, which bought 100% of the shares of both companies. The release states the cash consideration is **contingent on the satisfaction of certain post-closing conditions**, without specifying what those conditions are. No earn-out, share issuance or debt component was disclosed, and Aurora did not publish revenue, earnings or asset figures for either acquired business. Both entities are based in Birmingham. Between them they operate a licensed import and distribution facility and a virtual pharmacy — that is, a dispensing operation that fulfils prescriptions remotely rather than over a shop counter. Aurora says the combination gives it ownership of the chain from cultivation through to delivery to the patient, replacing arrangements in which third parties handled the final steps. Aurora frames the deal around market size rather than current sales. The company describes the United Kingdom as one of Europe's largest medical cannabis markets and cites a **population of roughly 70 million people**. It does not give a figure for the value of that market, its own current UK revenue, or the number of patients served. On the financial effect, the release says the transaction is **expected to be accretive to adjusted EBITDA in future quarters**, attributing that to operational efficiencies and less reliance on outside distributors. Adjusted EBITDA is a non-standard earnings measure that Aurora defines itself and that is not recognised under IFRS accounting rules; the company points readers to its FY27 Q1 management discussion and analysis for the definition. No quantified contribution and no timeframe were provided, so the claim cannot be checked against a number at this stage. Executive Chairman and Chief Executive Miguel Martin said the acquisition would let Aurora "expand our market share, while also supporting a consistent and reliable supply of high-quality medical cannabis products to UK patients." He also pointed to what he called increasingly prescriptive regulatory standards in the UK as part of the rationale. Aurora added that it **intends to evaluate further UK distribution acquisitions** to add capacity, without naming targets, budgets or timing. ## What the release does and does not establish The verifiable content of the announcement is narrow: a completed share purchase, a stated cash price, the licences held by the two targets, and their location. Everything concerning market share gains, supply reliability and earnings contribution is presented as company expectation, and Aurora lists integration risk — specifically "the risk of successful integration of acquired business and operations" — among the factors that could affect the outcome. For context on scale, GBP 2.1 million is a small outlay for a company listed on both Nasdaq and the Toronto Stock Exchange, and the release contains **no information on Aurora's cash position or how the payment was funded**. Nor does it disclose whether the acquired businesses were already distributing Aurora product before the deal, which would determine whether the transaction adds revenue or internalises margin that Aurora was previously paying away. Aurora sells into medical and consumer markets in Canada, Europe, Australia and New Zealand, and holds GMP-certified manufacturing sites in Canada and Germany. GMP, or good manufacturing practice, is the pharmaceutical quality standard required for medical cannabis supply in most European markets, including the UK. Readers looking for the financial follow-through will need Aurora's next quarterly filing, where any UK distribution revenue and the acquisition accounting would first appear. Source: [PR Newswire](https://www.prnewswire.com/news-releases/aurora-cannabis-furthers-global-medical-cannabis-growth-with-accretive-acquisition-of-internode-pharma-limited-and-hap-pharma-limited-expanding-distribution-access-to-the-uk-medical-cannabis-market-302855564.html?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Marvel Biosciences Extends Its Private Placement to Quebec Investors URL: https://www.pennystocks.news/marvel-biosciences-extends-private-placement-quebec/ Last updated: 2026-08-25T01:39:36.000Z Marvel Biosciences Corp. TSXV: MRVL | OTCQB: MBCOF Marvel Biosciences Corp. said on August 19, 2026 that it has **expanded its previously announced private placement to investors resident in Quebec**. The financing was first announced in a release dated July 16, 2026. The announcement is procedural in nature. Extending an offering into an additional Canadian province requires the issuer to file offering material that meets that province's requirements, including French-language disclosure. Marvel said an **amended and restated offering document dated August 19, 2026** has been filed under its profile on SEDAR+ and posted on the company website, and that it is available in English and in French. What the release does not contain is the substance of the deal. **No dollar size, share or unit price, closing date or use of proceeds is stated** in the August 19 announcement, and the terms set out in the July release are not repeated. Readers who want those figures have to go to the offering document itself, which Marvel notes prospective investors should read before making an investment decision. The company also flags that the offering remains subject to TSX Venture Exchange approval, and that the securities are not registered under U.S. securities law and may not be offered or sold to U.S. persons absent an exemption. Marvel, based in Calgary, describes itself as a **pre-clinical stage pharmaceutical developer** — meaning it has no drug in human trials and, on the basis of this release, no product revenue. Its stated approach is to make new chemical derivatives of known off-patent drugs and seek fresh patent protection for use in different diseases. According to the company, its subsidiary has produced several new chemical entities that inhibit the A2a adenosine receptor, aimed at neurological conditions including depression and anxiety, Alzheimer's and ADHD, as well as cancer and non-alcoholic steatohepatitis. Those claims are the company's own and are not accompanied by clinical data in the release. For a company at this stage, financing terms are the material variable, because equity issued at a discount adds to the share count. **None of those terms are disclosed here**; the only new information is the widened geographic reach of the offering. Source: [Newsfile](https://www.newsfilecorp.com/release/310470/Marvel-Biosciences-Expands-Private-Placement-to-Quebec?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### VisionWave walks away from Meteor Aerospace deal after due diligence review URL: https://www.pennystocks.news/vwav-visionwave-walks-away-from-40-million-meteor-aerospace/ Last updated: 2026-08-25T01:39:35.000Z VisionWave Holdings signed a binding deal to buy a controlling stake in Israeli aerospace firm Meteor Aerospace in late June, then cancelled it six weeks later after reviewing the target in due diligence. **Shares closed 44.72% higher** the day the exit was disclosed. VisionWave Holdings, Inc. NASDAQ: VWAV The agreement, dated June 28, called for VisionWave to acquire **51% of Meteor Aerospace at a pre-money equity valuation of $40 million**. On August 13, the company sent Meteor a written termination notice, effective immediately. The 8-K filed the following day says the decision followed due diligence but does not give a reason for the finding. The exit carried no financial cost. **No shares were issued and no money changed hands**, and VisionWave said it faces no early termination penalties. The deal had not closed at the time it was cancelled. Shares closed at $1.78 on August 14 against a previous close of $1.23\. **Dollar volume was about $45.9 million across 120,586 trades.** The free float is 11,244,414 shares, representing 41.1% of shares outstanding. Short volume on the session was 9,367,090 shares, or 62.46% of reported volume. ### Star Equity agrees to acquire Harte-Hanks in cash and preferred stock deal URL: https://www.pennystocks.news/hhs-harte-hanks-shares-close-53-higher-after-star-equity-agr/ Last updated: 2026-08-25T01:39:32.000Z Harte-Hanks shares closed 53% higher on August 14 after Star Equity Holdings announced it had agreed to acquire the company at **$5.00 per share in a combination of cash and preferred stock**, according to an 8-K Star Equity filed with the SEC that morning. Harte-Hanks, Inc. NASDAQ: HHS Shares **closed at $4.30, up from a previous close of $2.81**, on dollar volume of about $20.8 million across 46,269 trades. The free float stood at about 3.9 million shares. Short volume on the session was 515,283 shares, representing 44.15% of reported volume. The offer values Harte-Hanks at roughly $38.4 million in total equity, according to Star's 8-K. **Up to 50% of the consideration — about $19.2 million — will be paid in cash**, with the balance going to Star's 10% Series A Cumulative Perpetual Preferred Stock, a fixed-dividend instrument listed on Nasdaq. No Star common stock will be issued in the deal. The agreement includes a **30-day go-shop period** — a window in which Harte-Hanks and its advisers may solicit competing offers — running to September 13, 2026\. Closing also requires a Harte-Hanks stockholder vote and SEC approval of a Form S-4 registration statement for the preferred shares. Star says it expects the deal to close before year-end 2026, with Harte-Hanks continuing to operate under its own name. The $4.30 close sits below the $5.00 offer, which reflects the conditions still to be met. Harte-Hanks' 10-Q for the period ended June 30, 2026, filed the same day, showed cash of about $5.2 million and a **net loss of about $5.6 million for the first half of the year**. ### EMA accepts Pfizer-Valneva Lyme disease vaccine for review URL: https://www.pennystocks.news/valn-ema-accepts-pfizer-valneva-lyme-disease-vaccine-for-rev/ Last updated: 2026-08-25T01:39:33.000Z The European Medicines Agency has accepted for formal review a marketing authorisation application for a Lyme disease vaccine developed by Pfizer and Valneva — a step that, if it ends in approval, would produce the first licensed Lyme vaccine for humans. Valneva shares closed 26.19% higher on August 14 after the companies announced the EMA's decision. Valneva closed at $7.13, up from a previous close of $5.65\. Dollar volume was about $21.3 million across 44,722 trades. Short volume on the session was 217,892 shares, representing 53.74% of reported volume. Valneva SE NASDAQ: VALN The application covers the vaccine candidate known as LB6V, a **six-valent OspA-based vaccine** — meaning it targets six distinct proteins found on the outer surface of the *Borrelia* bacteria that cause Lyme disease. The mechanism works at the tick stage: antibodies produced by a vaccinated person are ingested by the tick during feeding and block the bacterium from leaving the tick before it can be transmitted. The companies submitted the application on the basis of results from the Phase 3 VALOR trial, announced in March 2026, which reported **efficacy of more than 70%** against Lyme disease, with the vaccine described as well tolerated and with no safety concerns identified. VALOR enrolled **9,437 participants aged five and older** at sites across the United States, Canada, and Europe in areas of high Lyme disease incidence. It was a randomised, placebo-controlled trial that gave participants four doses over two tick seasons. The EMA previously granted the vaccine candidate PRIME designation, a status reserved for medicines that may offer a major advantage over existing treatments — or, as here, address a condition with no approved therapy at all. There is currently no approved human Lyme disease vaccine anywhere in the world, according to the companies' release. The disease burden in Europe is the core of the companies' case for approval. According to the August 14 release, Lyme disease is the most common vector-borne illness in Europe, with **about 132,000 cases reported annually** from countries with surveillance systems, and **more than 200 million people** living in areas of elevated risk. Left untreated, the disease can affect the joints, skin, nervous system, and heart. Pfizer and Valneva have collaborated on the vaccine since **April 2020**, under an agreement that gives Pfizer exclusive rights to manufacture and commercialise the product if it receives regulatory clearance. Valneva reported its first-half 2026 financial results the day before the EMA announcement. The company held a **cash position of €121.5 million** as of June 30, 2026, supported in part by **about €37 million in gross proceeds** from a capital raise completed in the second quarter. The company recorded a **net loss of €63.3 million** for the half, widened from the same period in 2025, driven partly by one-time charges related to its chikungunya vaccine IXCHIQ, including manufacturing contract cancellation fees and inventory write-offs. Valneva reaffirmed its full-year 2026 product sales guidance in the same release, and said regulatory decisions on the Lyme vaccine candidate are expected within the next twelve months. ### Oxbridge Re launches AI GridWorks platform to develop and operate data centers URL: https://www.pennystocks.news/oxbr-oxbridge-re-pivots-to-ai-data-center-development-under/ Last updated: 2026-08-25T02:01:28.000Z Oxbridge Re Holdings, a holding company whose subsidiaries write Gulf Coast property reinsurance, **launched AI GridWorks on August 12** — a new platform it says will develop, own and operate AI data centers. The announcement named no customers, no financing and no specific locations. The company is a small reinsurer moving into a capital-intensive industry with nothing yet committed on paper. Oxbridge Re Holdings Limited NASDAQ: OXBR Shares closed 17.69% higher two days after the announcement, at $1.53 against a previous close of $1.30\. Dollar volume was about $298,000 across 1,630 trades. The free float is about 5.9 million shares, or 73.3% of shares outstanding. Short volume in the session was 39,224 shares, representing 35.73% of reported volume. According to the August 12 release, **AI GridWorks will target projects ranging from 10 MW to 100 MW** in power capacity — megawatts of electricity draw, the standard measure of data center scale — with an initial focus on roughly 50 MW facilities. The company says it will hire engineering, construction and technology firms as projects advance, but gave no timeline or budget for doing so. A separate earnings release filed by Oxbridge on August 13 reported **about $19.8 million in restricted cash** — funds set aside under contractual or regulatory requirements and not freely deployable — at June 30, up from about $7.0 million at December 31, 2025\. The company said in that release that the balance "places Oxbridge in a strong position as it advances its AI infrastructure strategy," but did not say how much, if any, is available for AI GridWorks specifically. Chairman and CEO Jay Madhu said in the August 12 release that "owning and developing these critical AI infrastructure assets has the potential to create significant long-term value for our shareholders." The company described AI GridWorks as **"the first phase" of a broader AI infrastructure strategy** and cited SurancePlus — which tokenizes reinsurance contracts on the Solana blockchain — as evidence of its ability to build new business lines. Its regulated reinsurance subsidiaries continue to operate. ### Unifi sells North Carolina warehouse land to data center company to cut debt URL: https://www.pennystocks.news/ufi-unifi-sells-north-carolina-warehouse-space-to-data-cente/ Last updated: 2026-08-25T01:39:31.000Z Unifi, a yarn and recycled-fiber maker, **closed 24.50% higher** after agreeing to sell roughly 500,000 square feet of warehouse space and about 120 acres of land in North Carolina to a data center company for $60 million. The property sat on Unifi's balance sheet at **under $5 million as of late June 2026**—making the sale price more than 12 times its book value. The proceeds go to pay down debt. Shares closed at $8.03, up from a previous close of $6.45\. Dollar volume was about $5.8 million across 6,839 trades. The free float stands at about 14.1 million shares, or 76% of shares outstanding. Short volume on the session was 75,183 shares, 28.81% of reported volume. UNIFI, Inc. New NYSE: UFI The buyer is **Enovum Data Centers Corp., a Canadian corporation**, according to an 8-K filed with the SEC on August 17, 2026\. The two properties are in Yadkin County, North Carolina. Data Center Dynamics reported that Enovum is a subsidiary of WhiteFiber, a data center developer founded by Bitcoin mining company Bit Digital. WhiteFiber said it has received non-binding letters of intent with investment-grade credit support around the Yadkin sites, Data Center Dynamics reported. The filing states the **net proceeds will repay a portion of outstanding term loans** under Unifi's existing credit agreement, with Wells Fargo as agent. The property's net book value was less than $5 million as of June 28, 2026, the filing notes—though no reason for the gap between book value and sale price was given. A **$2.25 million earnest money deposit** goes into escrow. Of that, $1 million may become non-refundable if Enovum exercises its option to extend an inspection period that otherwise expires September 15, 2026\. Closing is scheduled about 45 days after the inspection period ends. Before closing, Enovum must confirm available energy capacity at the sites, and both parties must agree on documents separating the sold property from Unifi's remaining holdings. The deal also requires agreement on a **partial lease-back**, under which Unifi will continue using portions of the sold space after the transaction closes. "This carve out of assets is expected to have minimal operational impact to our business," Chief Executive Eddie Ingle said in the company's press release, adding that production capacity and customer service at the Yadkin County campus would remain unchanged. ### List by October or Pay It Back URL: https://www.pennystocks.news/dror-list-by-october-or-pay-it-back/ Last updated: 2026-08-24T18:24:04.000Z The lenders get shares or they get their money back. There is no other outcome. Dror Ortho-Design, Inc. OTC: DROR On August 19, Dror Ortho-Design signed a securities purchase agreement and took in **$275,000 from private investors**. The money came in the form of debentures — short-term debt that **carries no interest** and **matures on October 19, 2026**. Whether those debentures ever convert into stock depends entirely on something that has not happened yet. The structure is tied to a public offering the company is working toward. If that offering closes before the maturity date, the $275,000 **converts into shares at whatever price public investors pay** — and the debenture holders receive the same warrants and registration rights as everyone else in that offering. If the offering does not close in time, the company **owes the principal in cash on October 19**. Holders can extend that deadline in 60-day increments by giving written notice, but the company cannot compel them to do so. An **S-1 registration statement filed with the SEC** shows the company is pursuing a listing on Nasdaq. Dror, which operates from Jerusalem, **received FDA clearance in February 2026** for its ZSmile aligner platform, according to a company announcement on GlobeNewswire. The company trades on OTC Pink under the symbol DROR. Warrants are also part of the August 19 deal, but they exist only if the public offering closes. Their number and exercise price are both determined by terms that do not yet exist — the offering has not been priced. Without the offering, the warrants are never issued. Until the debentures are paid off or converted, the company cannot take on significant new debt, cannot pay dividends, and cannot sell assets outside of ordinary inventory. A default — including failure to repay on the maturity date — lets the holders demand immediate repayment of the full principal. **October 19 is now the date everything runs toward.** ### Athena Gold Drills 23.85 g/t Gold Over 5 Metres at Laird Lake in Red Lake URL: https://www.pennystocks.news/athena-gold-laird-lake-scooby-zone-drill-results/ Last updated: 2026-08-25T01:39:29.000Z Athena Gold Corporation CSE: ATHA | OTCQB: AHNRF Athena Gold Corporation reported **23.85 grams per tonne gold over 5 metres from 21 metres downhole** in hole LL-26-006A at its Laird Lake project in Ontario's Red Lake district. The intercept, which the company has named the Scooby Zone, came from the first drill program ever completed on the property. Within that interval, two one-metre samples carried the bulk of the metal: **62.88 g/t gold from 21 metres and 54.08 g/t from 23 metres**. Deeper in the same hole, Athena reported 0.27 g/t over 32 metres from 227 metres. The same zone was cut in two other holes. LL-26-005 returned 2.18 g/t over 2 metres from 30 metres, in core that the company had earlier said contained visible gold. LL-26-008 returned **8.03 g/t over 0.62 metres roughly 400 vertical metres below hole 6**, inside a wider interval of 1.37 g/t over 4.5 metres from 609.5 metres. That deeper hit is the basis for the company's statement that mineralisation continues at depth, though a single sub-metre sample 400 metres away establishes little about the size or continuity of anything between the two points. Results were mixed across the program. **Four of the nine holes — LL-26-001, 003A, 004 and 007 — returned no significant results.** Hole LL-26-002 returned 2.17 g/t over 2.6 metres from 118.3 metres while testing the historical Gold-Bearing Zone (GBZ), a banded iron formation occurrence about a kilometre east of the Scooby Zone. Hole LL-26-009, drilled to test the GBZ down plunge, returned 0.89 g/t over 5 metres from 168 metres. The program consisted of **nine holes totalling 5,134 metres, completed in early July 2026**. Athena optioned the project in 2024 and says it spent two years on surface sampling, a till survey of more than 2,000 samples and 3D inversion of historical geophysics before drilling. Hole LL-26-006A was aimed at a geophysical target designated G4 and a structural corridor associated with a previously reported 373 g/t gold grab sample — a surface rock chip, which is a selective sample and not representative of any volume of rock. Athena cautions in its own table that the reported intervals are **core lengths rather than true widths**, and that it does not yet have enough information to determine true thickness. That matters for a near-surface intercept in a structurally controlled system: a 5-metre core length across a steeply dipping structure can represent considerably less real width. On analytical work, samples were assayed by two-cycle PhotonAssay at Paragon Geochemical Laboratories, a method the company notes is better suited to coarse gold than conventional fire assay. Athena re-assayed selected samples by 30-gram fire assay and submitted hole LL-26-006 material for screen metallics. According to the release, the **re-assays showed some variation against the original PhotonAssay values**, which the company attributes to the nugget effect, while remaining consistent in tenor and distribution. Athena says it considers the PhotonAssay results representative. Vice President of Exploration Ben Kuzmich described hole 6 as "the best gram-metre hit within a roughly 10 kilometre radius," with the nearest comparisons being the Madsen mine and the Great Bear project. Gram-metres multiply grade by intercept length; hole 6 works out to about 119\. The release also states that Athena treats an interval above 100 gram-metres as its own threshold for calling something a discovery, so the label is applied against a company-set benchmark rather than an industry standard. Laird Lake covers more than 7,000 hectares along over 10 kilometres of the Balmer-Confederation assemblage contact. The company cites published work indicating 94 percent of Red Lake's gold — production, reserves and resources combined — sits in the Balmer assemblage near that unconformity. The district has produced more than 30 million ounces since the late 1920s. Nearby ground includes West Red Lake Gold's Madsen mine, about 10 kilometres east, and Kinross Gold's Great Bear project, 34 kilometres to the southeast. Athena plans to send field crews back this fall for prospecting, trench work near LL-26-001 and follow-up on a gold-in-till anomaly called Nemo, followed by **about 10,000 metres of drilling using oriented core** in the fall and winter. **The release gives no budget for that program and no figures on the company's cash position or share count**, so how the work will be funded is not addressed. Source: [Newsfile](https://www.newsfilecorp.com/release/310430/Athena-Announces-Red-Lakes-Newest-Grassroots-Discovery-Drills-23.85-Grams-per-Tonne-Gold-over-5-Metres-at-Laird?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### The IPO Didn't Happen. Aditxt Sold Pearsanta for Nothing Upfront. URL: https://www.pennystocks.news/adtx-the-ipo-didn-t-happen-aditxt-sold-pearsanta-for-nothing/ Last updated: 2026-08-24T16:45:14.000Z As recently as July 2025, Aditxt was telling shareholders that **Pearsanta, its precision diagnostics subsidiary, had engaged a lead underwriter for a planned IPO**, according to a Business Wire announcement the company issued that month. That offering never came. On August 12, 2026, Aditxt signed over substantially all of Pearsanta's shares to MDNA Holdings Inc., a Florida corporation, for no upfront payment. Aditxt, Inc. OTC: ADTX The deal, disclosed in an 8-K filed with the SEC on August 19, left Aditxt with a set of conditions to be met before any money moves rather than cash in hand. The buyer assumed Pearsanta's outside liabilities — with amounts owed between Aditxt and Pearsanta carved out — but paid nothing at closing. The filing gives no reason for the terms. What Aditxt retained is a royalty: **2.5% of Pearsanta's net revenue, capped at $2.5 million in total**, running for up to ten years from Pearsanta's first commercial sale. The clock does not start until Pearsanta actually sells something. The filing does not say when that might be, or whether any product is currently on the market. On top of the royalty, **two milestone payments of $250,000 each** could follow. One falls due if Pearsanta closes a financing round of **$10 million or more**. The other is triggered by a liquidity event — an IPO, a reverse merger, an acquisition, or a sale of Pearsanta's assets. Neither is payable until the condition is met. One of those triggers is the IPO that Aditxt said, in its July 2025 Business Wire announcement, Pearsanta was already preparing for. Under the terms of the August sale, Aditxt would collect $250,000 if that offering ever happens — now as a creditor of its former subsidiary rather than as its parent. ### A Luxembourg Firm Is Buying a Water-Tech Company. The Deal Hinges on a Beverage Company Too. URL: https://www.pennystocks.news/cvat-a-luxembourg-firm-is-buying-a-water-tech-company-the-de/ Last updated: 2026-08-24T16:45:15.000Z A Luxembourg financial firm has agreed to buy all outstanding shares of Cavitation Technologies for **$35 million in cash**. The offer has an unusual condition attached: the same buyer must also close a simultaneous purchase of a private beverage company, and each deal is written so that neither can proceed without the other. Cavitation Technologies, Inc. OTC: CVAT The buyer, European Guarantee Services S.à.r.l., is described in the August 14 agreement as a private financial and wealth management company based in Luxembourg. Under a concurrent agreement, it would pay **$7 million in cash for Alchemy Beverages Inc.**, a privately held Delaware company in which Cavitation holds about **17% of outstanding common stock**, according to the tender offer agreement filed with the SEC on August 19\. The filing does not explain why a Luxembourg wealth-management firm wants to acquire a California water-treatment company, or what ties it to Alchemy beyond Cavitation's minority stake. For holders of Cavitation shares, the deal opens at **$0.108 a share** — a figure stated in the agreement, arrived at by dividing the net proceeds after deducting the company's roughly **$646,000 in combined debt and accrued liabilities** from the $35 million price, across about **317 million shares outstanding**. That number is not final. A revised price will be set 45 business days after the offer launches, based on however many shares are outstanding on that date. If warrants, convertible rights or a limited private placement that the agreement permits add shares before then, the same pool of cash gets divided across more of them. The company's board **unanimously recommended the offer**, according to the August 17 press release filed with the SEC as Exhibit 99.1\. No shareholder vote is required. Holders decide by choosing whether to tender their shares, and the offer must stay open long enough to give them at least 30 business days to review the final price once it is set. Two conditions could prevent closing. **At least 90% of outstanding shares must be tendered** — below that threshold, the buyer has no obligation to proceed. And because European Guarantee Services is a foreign entity, the parties must submit the transaction for review by the Committee on Foreign Investment in the United States, the body that examines whether foreign acquisitions raise national-security concerns. If CFIUS takes adverse action, the deal cannot close. The money to fund both purchases is to come from **Bright Wealth Banking Consultant**, a Dubai-based affiliate of the buyer, according to the agreement. The filing gives no explanation of why the Alchemy Beverages transaction is a condition of Cavitation's deal rather than a standalone arrangement — or what happens to Cavitation's 17% stake in Alchemy if, for any reason, only one of the two offers succeeds. ### Six Days, Two Sales, No Prices URL: https://www.pennystocks.news/etst-six-days-two-sales-no-prices/ Last updated: 2026-08-24T16:45:16.000Z Six days before this deal closed, **ETST's chief operating officer, Mario G. Tabraue, sold the company a compounding pharmacy in California.** On August 17 he sold it another business — this one a drug ingredient distributor in Florida. Earth Science Tech, Inc. OTC: ETST The second transaction, reported in an 8-K filed with the SEC on August 19, was the acquisition of **Zoolzy LLC, a wholesale distributor based in Doral, Florida** that supplies raw pharmaceutical ingredients — the active compounds used in compounding — alongside finished FDA-approved prescription products. The company says Zoolzy operates from a **3,684-square-foot facility.** As with the pharmacy deal six days earlier, **no price was disclosed.** Both filings describe the amount as immaterial. Both sellers were Tabraue. In each case, the independent members of ETST's board reviewed and approved the transaction and determined the terms were fair and no less favourable than what could be obtained from an outside party, according to the respective filings. But fair relative to what is not stated, because the price is not stated. In its press release issued August 19, the company says buying Zoolzy will let its compounding pharmacies source raw ingredients at wholesale rather than retail, expanding profit margins. The company also describes Zoolzy as a route into the veterinary medication market, saying it plans to formulate flavoured and easy-to-administer products for animals. **No revenue figures for Zoolzy were provided**, and no timeline was given for the veterinary initiative. The release's claim that the acquisition is "highly accretive" comes from the company's own marketing language, not from a disclosed financial figure. Tabraue's earlier deal, an 8-K filed with the SEC on August 12 covering the acquisition of Meduvo LLC, was also structured as a related-party transaction with terms withheld as immaterial. Two companies from the same seller in less than a week, and shareholders still do not know what either one cost. ### A Deal Three Years in the Making — and It Still Can't Close URL: https://www.pennystocks.news/fchs-a-deal-three-years-in-the-making-and-it-still-can-t-clo/ Last updated: 2026-08-24T16:45:16.000Z The agreement to buy four Florida medical and pharmacy businesses from Gary C. Bernard, M.D., was first signed in July 2023\. First Choice Healthcare Solutions has now rewritten it entirely — and the deal still cannot close. First Choice Healthcare Solutions, Inc. OTC: FCHS On July 22, 2026, First Choice entered into an amended and restated stock purchase agreement to acquire all of the equity in Pointe Medical Services, Pointe Med Pharmacy, Livewell MD, and Live Well Drugstore, which operates as Trulife Pharmacy. The filing, made with the SEC on August 19, states that the maximum purchase price is **about $21 million**. The price breaks into several pieces. At closing, First Choice would pay **$7.0 million in cash** — reduced by the **$300,000 in advances** already sent to Bernard before the agreement was signed. A further **$3.0 million in cash** follows within roughly 45 to 90 days of closing, evidenced by a promissory note that is non-interest bearing unless First Choice defaults. Bernard's existing business debt of **about $4.3 million** stays on the books of the acquired companies and becomes First Choice's responsibility. The remaining **$6.0 million** comes in shares of the new holding company rather than cash. A further **$1.0 million** is contingent on post-acquisition operating performance and may never be paid. That holding company does not yet exist, and that is the central problem. The acquisition is conditioned on First Choice first completing a separate merger with Westin Acquisition Corp., a Cayman Islands special-purpose company that will re-incorporate in Nevada and rename itself Wellgevity 360\. Under that structure, First Choice becomes a wholly owned subsidiary of Wellgevity 360, and Wellgevity 360's shares are what Bernard receives as part of his payment. None of that can happen until the SEC declares the related registration statement effective. The cash itself also depends on deals not yet in place. The agreement requires that an equity credit line of **up to $100 million** — which Wellgevity 360 is expected to establish — be available in amounts sufficient to fund the closing payment. The filing states plainly that there is no assurance the conditions will be satisfied. If the acquisition has not closed within **120 days** of July 22, 2026, either party may walk away, according to the filing. That window extends automatically if the registration statement is still under SEC review at the deadline, but not beyond 180 days from the same date. First Choice has already paid Bernard $300,000 of non-refundable advances; the filing notes that money is only refundable if Bernard himself fails to deliver. The deal requires Bernard to obtain all of the membership interests in Live Well Drugstore from minority holders before closing, then immediately transfer the whole business to First Choice. As of the filing date, the company said each minority holder had already signed on. What a shareholder holds today is stock in a company that has agreed to merge with a SPAC, simultaneously agreed to buy four businesses using the SPAC's not-yet-issued shares, and needs a nine-figure credit line it has not yet drawn on to pay the cash portion of the bill. The 120-day clock is running. ### Someone Else Does the Drilling. Evolution Collects the Royalties. URL: https://www.pennystocks.news/evolution-petroleum-midland-basin-mineral-royalty-acquisition/ Last updated: 2026-08-25T01:39:28.000Z On August 20, Evolution Petroleum **paid $16 million for royalties on 832 Permian Basin wells**. The operators drill; Evolution collects. Royalty interests work differently from working interests, where a company shares both the upside and the costs. Here, Evolution **owes nothing toward drilling costs, lifting expenses, or overhead** on any of those wells — every barrel someone else pumps runs through Evolution's account without a matching cost. According to an August 20 press release filed with the SEC, the acquired interests cover about 3,420 net royalty acres across five west Texas counties: Reagan, Upton, Glasscock, Midland, and Martin. The company says it expects the interests to generate **about $3.9 million in cash flow over the next twelve months**, representing what it calls a 4.1 times acquisition multiple. Current production from the acquired acres runs at about 210 barrels of oil equivalent per day, roughly 65% of it liquids. The deal was **funded through a public stock offering, cash on hand, and credit facility borrowings**, the company said. Issuing new shares to fund an acquisition gives existing holders a smaller claim on the same company. Evolution says the deal is immediately accretive to cash flow per share — meaning it believes the added royalty income more than offsets the new share count. The press release does not size those pieces, but a separate filing does: Evolution sold **4,255,000 shares at $3.25 each** — 3,700,000 plus a 555,000-share underwriters' option exercised in full on August 19 — for net proceeds of about **$12.4 million**. Against the 35,872,725 shares outstanding at its last quarterly report, that is roughly **12% more stock**, and it covers about three-quarters of the $16 million price. Cash and the credit facility made up the rest; the company has not said in what proportion. The royalty interests are expected to account for **about 20% of Evolution's pro forma fiscal 2027 asset cash flow**, up from less than 10% in fiscal 2026, according to the company's release. How that cash flow is distributed shifts, but the total depends on what the rest of the portfolio produces. The company says it **expects daily production to more than double by the end of fiscal 2029**, on an assumption it states plainly: 125 newly completed wells a year. Behind that sit 34 wells already drilled but not yet completed, 27 permitted, and some 1,257 locations the company counts as upside. Evolution would not spend anything to make that happen — it also cannot make it happen. ### Jefferson Capital prices add-on offering to its existing senior notes due 2030 URL: https://www.pennystocks.news/jefferson-capital-prices-100-million-add-on-notes-2030/ Last updated: 2026-08-25T01:39:26.000Z Jefferson Capital, Inc. NASDAQ: JCAP Jefferson Capital, Inc. said on August 18, 2026 that its indirect wholly-owned subsidiary Jefferson Capital Holdings, LLC has **priced $100 million of 8.250% senior notes due 2030**. The paper is not a new series. It is being sold as additional notes under an indenture dated May 2, 2025 — the same contract governing an existing **$500 million of 8.250% notes due 2030**. An indenture is the agreement that sets the terms of a bond, including its coupon, maturity and the restrictions placed on the borrower. Assuming the offering closes as priced, the series would total **$600 million of 8.250% notes maturing in 2030**. Because the add-on carries the same coupon and maturity as the existing debt, the company is not resetting its borrowing terms on this series; it is enlarging it. The notes will initially be **guaranteed on a senior unsecured basis** by certain of the issuer's wholly-owned domestic restricted subsidiaries. Unsecured means the holders have no specific collateral behind their claim and rank behind any secured lenders if the borrower fails. Several details investors would normally look for are absent from the announcement. **No issue price or yield to maturity was disclosed**, so it is not possible to tell from the release whether the add-on was sold above, at or below par — the figure that determines what the additional $100 million actually costs Jefferson Capital relative to the original tranche. The company also **did not state how it intends to use the proceeds**, whether for refinancing, portfolio purchases or general corporate purposes, and **gave no expected closing date** for the offering. Pricing and settlement are separate steps; an offering that has priced has not yet funded. Jefferson Capital, based in Minneapolis, trades on Nasdaq under JCAP. The release did not include a balance-sheet update, so the add-on cannot be measured here against the company's existing leverage or liquidity. What the announcement establishes is narrow but concrete: the amount, the coupon, the maturity, the guarantee structure, and the fact that the debt slots into an existing 2025 indenture rather than a new one. Source: [GlobeNewswire](https://www.globenewswire.com/news-release/2026/08/18/3347184/0/en/jefferson-capital-announces-pricing-of-100-million-of-senior-notes-due-2030.html?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Purecore Metals Begins OTCQB Trading Under PPURF, No Shares Issued URL: https://www.pennystocks.news/purecore-metals-otcqb-trading-ppurf/ Last updated: 2026-08-25T01:39:25.000Z VANCOUVER, BC, Aug. 18, 2026 /PRNewswire/ -- Purecore Metals Inc. CSE: PURE | FWB: J8Y | OTCQB: PPURF Purecore Metals' common shares **began trading on the OTCQB Venture Market under the symbol PPURF**, giving the Vancouver-based company a US-dollar quotation alongside its existing listings. The Canadian Securities Exchange remains the primary listing, where the shares trade as PURE, and the company is also quoted in Frankfurt under J8Y. The OTCQB is a US over-the-counter tier operated by OTC Markets Group for early-stage and developing companies. A quotation there is not a stock exchange listing and does not involve an offering of securities. Purecore states that **no capital was raised and no new shares were issued** in connection with the quotation, and that its issued and outstanding share count is unchanged. The release does not disclose what that share count is, nor does it give a cash position, budget or planned work programme. The company says the OTCQB quotation allows US broker-dealers to participate in trading and provides so-called Blue Sky recognition in a number of US states — meaning the shares can be offered to retail and institutional investors in those states under state securities rules. A second step is still outstanding. Purecore says it **has applied for Depository Trust Company eligibility and expects a determination in the coming weeks**. DTC eligibility allows shares to clear and settle electronically inside US brokerage accounts; without it, trades typically have to be settled manually, which brokers often discourage. The company notes there is no assurance eligibility will be granted. ## What the company holds Purecore's main asset is **an option to earn up to a 100% interest in the 35,029-hectare Yurchison Uranium Property** in the Wollaston Domain of northern Saskatchewan, in the Athabasca Basin region. The release's own cautionary language is explicit on the status of that asset: as at the date of the announcement, **Purecore holds no ownership interest in Yurchison**, only the option, and the option carries conditions the company must satisfy. Purecore also owns a 100% interest in the Bankier Property, a critical minerals project in British Columbia. No exploration results, resource estimates or drill data for either property are included in the release. ## The market backdrop cited Most of the announcement is devoted to US uranium supply figures rather than to company activity. Citing the US Energy Information Administration's 2024 Uranium Marketing Annual Report, Purecore says **US civilian utilities carry 184 million pounds of unfilled uranium requirements for 2025 to 2034**, against a maximum anticipated market need of 418 million pounds over the same period. The release adds that domestic-origin material accounted for 8% of uranium delivered to US reactors in 2024, and that **Canada was the largest single supplier at 18.6 million pounds, or 36% of deliveries**. It also points to Russian sanctions and export restrictions narrowing alternative sources, with the US importer waiver set to expire at the end of 2027, and to federal targets calling for a quadrupling of domestic nuclear capacity. Those figures describe the uranium market, not Purecore's position in it. The company has no production, and the property it links to that demand is held under option. Chief executive Peter Berdusco framed the move in terms of access rather than funding: "Listing on the OTCQB puts our shares in front of these investors in their own currency, on their own market hours, without issuing an additional share to do it." For shareholders, the practical content of the announcement is narrow. A US-dollar quotation broadens who can trade the stock during US hours, and the company says it did so **without any change to its capital structure**. It does not add cash, advance the Yurchison option, or produce exploration results. The next disclosed milestone is the DTC determination. Source: [PR Newswire](https://www.prnewswire.com/news-releases/purecore-commences-trading-on-otcqb-to-expand-us-investor-access-302854279.html?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### $1,533 in Cash. Borrowing $20,000 at a Time. URL: https://www.pennystocks.news/miti-1-533-in-cash-borrowing-20-000-at-a-time/ Last updated: 2026-08-24T18:24:04.000Z Mitesco had **about $1,533 in cash at the end of the first quarter**, according to a 10-Q filed with the SEC for the period ended March 31, 2026\. By August, it was **borrowing $20,000 at a time**. Mitesco, Inc. OTC: MITI An 8-K filed August 18 shows what that position looks like in practice: new loans carrying built-in fees before any interest accrues, existing bridge-note holders accepting extensions rather than payment, and preferred shareholders whose quarterly exit route has been halted. The latest cash came from AJB Capital Investments, a Florida investment firm the company has borrowed from before. AJB put in $20,000, but the note it received carries a face value of **$22,000 — a $2,000 fee built into the instrument before a single day of interest runs**. The note also carries **10% annual interest and matures in February 2027**. If Mitesco cannot pay at maturity, AJB can convert the outstanding balance into shares at a 30% discount to the five-day average trading price. That was not the only new debt. On August 14, two additional lenders provided a combined **$160,000 in 60-day term loans**, according to the filing. Those maturities fall around mid-October. Older debts are not being retired either. **Holders of $200,000 in bridge notes agreed to extend their terms** rather than be repaid. Two of those notes, covering a combined **$78,000, were extended only to September 1** — less than two weeks after the filing date. The rest run to December 31. Preferred shareholders face a different constraint. The board halted all quarterly redemptions of Series A Preferred stock on August 9, with the consent of a majority of those holders. Under the previous arrangement, five institutional investors could convert their preferred position into common stock each quarter at a discount. In an August 10 press release distributed through GlobeNewswire, Chairman Mack Leath said the predictable quarterly share issuances may have let traders time their activity against retail investors, and that prospective institutional backers viewed the structure as a barrier to new investment. A replacement arrangement is expected by September 30. To cover software development costs, Mitesco agreed to issue **1,000,000 restricted common shares to a consulting firm in Boca Raton**, with no dollar value for the work stated in the filing. On the same day the 8-K was filed, the company also put out a press release about a future home automation offering, according to the filing. No customers, revenue or committed funding were mentioned. The company expects a new preferred arrangement by September 30\. The bridge notes it just extended **to September 1 come due three weeks before that**. ### A Vitamin Company Gets an Oil Report the SEC Does Not Recognize URL: https://www.pennystocks.news/bfnh-a-vitamin-company-gets-an-oil-report-the-sec-does-not-r/ Last updated: 2026-08-24T16:45:17.000Z A petroleum engineering firm spent six weeks studying oil and gas potential in the Nevada desert. The company that hired them makes vitamins. BIOFORCE NANOSCIENCES HOLDINGS, INC. OTC: BFNH On August 13, BioForce Nanosciences Holdings received a **Prospective Resources Report from Ryder Scott Company, L.P.**, covering what the filing calls the Fox Mountain and South Lund assets — **about 19,957 acres** of federally leased land in the White River Valley, Nye County, Nevada. The company disclosed the report in an 8-K filed with the SEC on August 18. The leases themselves came from an entity connected to BioForce's own majority shareholder. According to BioForce's quarterly report for the period ended June 30, 2026, filed with the SEC, the company received its **11 oil and gas leases from Natural Minerals Trust, LLC** — a Delaware company controlled by Nexus Capital Investments, BioForce's majority shareholder — for only the cost of the assignment. The resource category Ryder Scott used matters. "Prospective resources" is a term **the SEC does not recognize**. Under SEC rules, oil and gas companies may disclose only "reserves" — a standard requiring geological and engineering data to show with reasonable certainty that quantities can be economically produced. BioForce stated in the 8-K that the Ryder Scott estimates "do not comply with the SEC Oil and Gas Industry Disclosures." The company went further. No drilling, seismic interpretation, pressure testing or core analysis has been done. BioForce said plainly that **there is no certainty any portion of the prospective resources will ever be discovered** — and that commercial viability would remain unproven even if something were found. Ryder Scott's analysis, the company noted, used tools that can identify surface structures but cannot confirm whether hydrocarbons are actually present in them. The filing does not say who would fund exploration or when any drilling might begin. What BioForce does today is unchanged: its annual report filed with the SEC describes the company's mission as providing vitamins, minerals and nutritional supplements. ### Fewer Than 300 Shareholders. No More SEC Filings. URL: https://www.pennystocks.news/dway-fewer-than-300-shareholders-no-more-sec-filings/ Last updated: 2026-08-24T16:45:18.000Z The decision came on August 17\. The next day, DriveItAway Holdings filed the paperwork that suspended its SEC reporting obligations on the spot. Driveitaway Holdings, Inc. OTC: DWAY The document filed was a Form 15, which a company uses to exit the federal securities reporting system. From the moment it landed, DriveItAway is no longer required to file annual reports, quarterly financials or current-event disclosures with the SEC. Full deregistration is expected **90 days after the August 18 filing**. The company qualified because its common stock is held of record by **fewer than 300 persons** — a threshold in federal securities law that lets small companies leave the reporting system. The board decided the cost of staying in was no longer justified for a company of its size. For a shareholder, that shift is concrete. SEC filings — audited annual accounts, quarterly results, disclosures of material events — are the standard tools for tracking what a company is doing with its money. Once deregistration takes effect, those are gone. DriveItAway says it will continue to provide financial information through the OTC Markets Alternative Reporting Standard, which would allow its shares to remain quoted on the OTC Markets current-information tier. That is a separate, lighter system, and it is not reviewed by the SEC. The filing does not specify how frequently reports will come or whether they will be audited. "Our focus is on building the business, and we intend to maintain transparent, current disclosure for our investors," CEO John Possumato said in the company's August 18 press release. The 8-K filed to announce the Form 15 may be the last current report DriveItAway ever files with the SEC. ### Eight Concessions Were Being Cancelled Without Notice. A Court Just Intervened. URL: https://www.pennystocks.news/dynr-eight-concessions-were-being-cancelled-without-notice-a/ Last updated: 2026-08-24T16:45:18.000Z Eight of DynaResource's mining concessions in Mexico were being cancelled by the country's mining authorities. The company says it was never properly told. On August 5, a federal court in Mexico ruled in DynaResource's favour in an Amparo proceeding — a constitutional challenge — brought by its Mexican subsidiary. The court found that **DynaResource had been denied its constitutional right to due process** during the administrative proceedings that led to the claimed cancellation of **eight concessions associated with the San José de Gracia mine**. It ordered authorities to restart the notification process before taking any further administrative action, according to the company's August 5 announcement. DYNARESOURCE, INC. OTC: DYNR That is a procedural win, not a final one. The company said in its August 17 press release that the ruling **does not finally resolve the underlying administrative matter** — the concessions remain subject to unfinished proceedings, and the respondent authorities may still appeal the decision. For shareholders, that means the question of whether the company retains the legal basis to operate eight parts of its only mine has been returned to the starting line rather than answered. Six days after the court ruled, DynaResource went to its existing shareholders for cash. An August 11 company announcement disclosed a non-brokered private placement targeting **$3.0 million in gross proceeds**, or up to $6.4 million if all warrants are exercised. Units are priced at $0.45 each; each unit includes one common share and one warrant with an exercise price of $0.51\. The company listed intended uses as working capital, capital spending, and **overdue debt repayments** — the announcement does not name the lender or say how much is past due. The warrants cannot be exercised until the company increases its authorised share count to accommodate them. That vote has not yet been scheduled. Against this backdrop, Q2 2026 production at San José de Gracia came in at **3,703 ounces of gold**, down from 5,701 ounces in the same quarter a year earlier. The primary cause, the company says, was a fall in ore grade: the average head grade processed in Q2 2026 was **2.45 grams per tonne**, against 3.63 grams per tonne in Q2 2025\. Revenue for the quarter came to about $11.4 million, compared with about $15.9 million in Q2 2025. The grade decline coincided with a contractor change. The company terminated one of its two underground mining contractors during Q2 after identifying persistent safety and performance failures. The remaining contractor is now absorbing the full workload, and CEO Rohan Hazelton said the transition is expected to take three to six months. The company described its **full-year 2026 production outlook as uncertain**, conditional on how quickly the new team establishes itself underground. The eight concessions at the centre of the court ruling are the same ground the company is betting on to support that recovery. How the administrative proceedings ultimately conclude will determine whether it has the right to mine them at all. ### OneMeta's Cash Flow Turned Positive. Its Revenue Did Not. URL: https://www.pennystocks.news/onei-onemeta-s-cash-flow-turned-positive-its-revenue-did-not/ Last updated: 2026-08-24T16:45:19.000Z OneMeta says its **operating cash flow turned positive in the first half of 2026**, reaching $2.4 million — against about $1.0 million used in the same period a year earlier. At the same time, the company's own press release acknowledges that reported revenue for the period fell from the prior year. It attributes the drop to a large one-time licensing fee that inflated the prior-year comparison, not to a decline in current activity. OneMeta Inc. OTC: ONEI Context matters, though. In April 2026, Avaya LLC signed a three-year global reseller agreement for OneMeta's translation and transcription services, and **paid $3.0 million as a prepaid credit balance** for future service — money received before a dollar of that usage is delivered. That prepayment landed in the same six-month window the company is calling cash-flow positive. The release does not say how much of the $2.4 million the Avaya payment accounts for. VerbumCall, the company's real-time translation product for contact centres, saw its weekly consumption run rate **climb more than 500%** between the first week of January and the last week of June, according to the release. **More than 20 new enterprise clients went live** in the second quarter, across insurance, aerospace, healthcare, financial services and other sectors. Several were Fortune 500 companies, the release says. In April, OneMeta also bought back **about 4.2 million shares of Series B-1 Convertible Preferred Stock for $2.85 million**. Those preferred shares could have converted into roughly 45.8 million common shares, so removing them reduces the potential dilution existing holders were facing — each common share now represents a slightly larger slice of the company. The release closes with a note that complete results, risk factors, and a going concern disclosure sit in the company's Form 10-Q filed with the SEC. A going concern disclosure flags doubt about whether a company can keep operating without new funding. OneMeta did not say what conditions would need to change for that warning to be lifted. ### Dryden Gold closes first tranche of Lost Lake Option with cash and share payment URL: https://www.pennystocks.news/dryden-gold-closes-lost-lake-option-agreement/ Last updated: 2026-08-25T01:39:23.000Z Dryden Gold Corp. TSXV: DRY | OTCQX: DRYGF | FWB: X7W Dryden Gold Corp. has closed the first tranche of consideration under its option to acquire the Lost Lake Property in northwestern Ontario, **paying $10,000 in cash and issuing 25,000 common shares** at a deemed price of $0.21 per share. The vendor is Orebot Inc., described in the release as an arm's length party. The payment follows approval by the TSX Venture Exchange for filing of the option agreement, which is dated June 29, 2026\. The company had previously disclosed the transaction in releases on July 6 and August 12, 2026. The property consists of **122 tenured mineral claims in the Gold Rock Mining Camp**, northwestern Ontario. The release does not disclose the size of the land package in hectares, any historical exploration results from the claims, or a planned work programme or budget for the ground. To earn the full 100% interest, Dryden Gold must make two further payments. On or before the first anniversary of the agreement's effective date, it owes **$40,000 in cash and 50,000 shares**. On or before the second anniversary, a further **$50,000 in cash and an aggregate of 50,000 shares** are due. That puts the total staged cost of the option at $100,000 in cash and 125,000 shares — a small transaction by the standards of exploration property deals, and one with limited dilution for existing holders at the deemed share price used for the first tranche. The payments are structured as options rather than firm commitments, meaning the company can walk away at either anniversary date without making the remaining payments. On exercise, Orebot would receive a **3% net smelter returns royalty on the property**. A net smelter returns royalty, or NSR, is a share of revenue from metal sold, calculated after smelting and refining charges are deducted. The royalty is payable only after commercial production begins — a stage the release gives no timeline for and which, for an early-stage exploration claim block, is not a near-term prospect. Dryden Gold holds a right, exercisable at any time and at its sole discretion, to **buy back half of the NSR for $1,000,000** in cash. According to the release, there are no other royalties outstanding on the property. The 25,000 shares issued in the first tranche carry a hold period expiring four months and one day from the date of issuance, the standard restriction on Canadian private placements and share-based consideration. The release contains no financial information about Dryden Gold itself — no cash balance, no share count, and no indication of how the remaining cash payments would be funded. It also contains no drill results or sampling data for Lost Lake, so the transaction should be read as a land acquisition rather than the addition of a defined target. The company describes itself as an exploration company focused on high-grade gold, with claims along the Manitou-Dinorwic deformation zone in the Dryden District. Dryden Gold trades on the TSX Venture Exchange under DRY, on the OTCQX as DRYGF and on the Frankfurt exchange as X7W. Source: [Newsfile](https://www.newsfilecorp.com/release/310267/Dryden-Gold-Closes-Option-Agreement-for-Lost-Lake-Property?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### GreenPower Motor closes fourth tranche of preferred share financing URL: https://www.pennystocks.news/greenpower-motor-fourth-tranche-preferred-share-financing/ Last updated: 2026-08-25T01:39:22.000Z GreenPower Motor Company Inc. NASDAQ: GP GreenPower Motor Company has issued **1,500 Series A Convertible Preferred Shares for gross proceeds of US$1,425,000**, the fourth tranche drawn under a private placement facility with a single institutional investor. The company announced the closing on August 18, 2026. The financing runs off a Securities Purchase Agreement dated November 14, 2025, which was **amended on June 30, 2026**. The release does not describe what the amendment changed, does not name the investor, and does not disclose how much has been raised across the four tranches in total or how much capacity remains under the facility. The proceeds work out to US$950 per preferred share. GreenPower did not state the stated value assigned to each share, which matters because the conversion mechanics are anchored to that figure rather than to the cash paid. According to the release, each preferred share converts into common shares at a rate calculated as **105% of the stated value, plus any additional amounts owed to the investor**, divided by **125% of the closing price of the common shares on Nasdaq the day before the tranche was issued**. In plain terms, the investor receives a 5% uplift on the stated value on conversion, but converts at a price set 25% above the market price used as the reference. The release gives no reference price, so the number of common shares the tranche could produce cannot be calculated from the disclosure. The reference to "additional amounts owing" indicates the instrument can accrue further claims — dividends, fees or similar — that increase the numerator and therefore the share count on conversion. The release does not specify what those amounts are or at what rate they accrue. GreenPower will pay **a cash placement fee of 5% of the proceeds to Digital Offering LLC**, which amounts to US$71,250 on this tranche, under an engagement letter dated October 29, 2025\. That reduces the net cash from the drawdown to roughly US$1.35 million before other expenses. The company said nothing about how the money will be used. Its forward-looking statements section refers to **whether it will continue to meet the requirements to maintain its Nasdaq listing**, a risk factor the company chose to identify by name. GreenPower, based in Vancouver, builds all-electric medium- and heavy-duty vehicles including transit and school buses, shuttles and cargo vans. Convertible preferred financings drawn in tranches are a common structure for small-cap issuers because they provide cash without a single large equity issuance, but each conversion adds to the common share count. The release contains no updated share count, cash balance or operating figures. Source: [Newsfile](https://www.newsfilecorp.com/release/310264/GreenPower-Announces-Completion-of-Fourth-Tranche-of-Preferred-Share-Financing?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Great Atlantic's Option Partner Starts Electromagnetic Surveys at Pilley's Island URL: https://www.pennystocks.news/great-atlantic-resources-hm-exploration-tdem-surveys-pilleys-island/ Last updated: 2026-08-25T01:39:20.000Z GREAT ATLANTIC RESOURCES CORP. TSXV: GR HM Exploration Corp. has started **borehole and surface time-domain electromagnetic surveys at Pilley's Island**, the north-central Newfoundland property on which it holds an option from Great Atlantic Resources Corp. The work was announced by Great Atlantic on August 18, 2026. Time-domain electromagnetics, or TDEM, involves sending an electromagnetic pulse into the ground and measuring how the resulting response decays over time. Conductive material — including the sulphide minerals that make up volcanogenic massive sulphide (VMS) deposits — responds differently from surrounding rock, which is why the method is commonly used to screen for that deposit type. According to the release, **Crone Geophysics has been contracted** to carry out the programme. Borehole surveys are being run in holes from the Phase One drill campaign, which HM Exploration says was **completed in May 2026 at the Clifford Jones (Bull Road) Zone**. Once those are finished, Crone is to move to a surface survey of **roughly 13 line kilometres covering about one square kilometre** around the Phase One holes. The stated purpose is to look for extensions of known mineralised zones and for additional conductive targets nearby. HM Exploration says the data will feed into drill planning for a **Phase Two programme planned for late 2026**. "Phase One drilling confirmed continuity within both the Upper and Lower lenses," said Nick Rodway, President and CEO of HM Exploration. "The borehole and surface EM data will help us evaluate their potential extensions and identify additional conductive targets that may represent massive sulphide mineralization." Rodway, a professional geologist, is named as the qualified person who reviewed the technical content on the HM side. David Martin, VP Exploration at Great Atlantic, approved the technical information for Great Atlantic. ## What the release does not contain No assay results, intercept widths or grades from Phase One appear in the announcement, and **no cost figure is given for the surveys**. The release also does not set out the terms of HM Exploration's option — the payments, share issuances or expenditure commitments required for it to earn its stated 100 percent interest — nor does it say what, if anything, Great Atlantic is spending on the current work. HM Exploration is listed on the Canadian Securities Exchange and refers to the ground as the Lewis Pilley's Project. For a shareholder in Great Atlantic, that leaves the news as a work-programme update on an optioned asset being advanced by another party, rather than a change in the company's own financial or resource position. Descriptions of the property's prospectivity in the release are attributed to HM Exploration. ## Background on the ground The project sits in the Notre Dame Subzone of the Dunnage Zone, largely underlain by Ordovician submarine volcanic rocks of the Roberts Arm Group. HM Exploration notes the belt also hosts the historic Buchans mine, and describes mineralisation at Pilley's Island as bimodal-felsic VMS style, with zinc-lead-copper-silver and locally gold intersections reported historically at the 3B Zone and Clifford Jones areas. The property has a long production history: **about 450,000 tonnes of massive pyritic ore was mined from the Pilley's Island Mine-Old Mines** by the Pilley's Island Pyrite Company beginning in the late 1800s, per a 1996 Geological Survey report cited in the release. HM Exploration says many of the historic showings on the property have not been systematically explored, and that older drill holes were shallow and vertically oriented, limiting what is known about mineralisation at depth. Targets flagged for future work include the 3B Zone, the Clifford Jones (Bull Road) Extension, Bouzanne Shaft, Henderson, Mansfield and Pilley's Cove. The property is road accessible, about 25 kilometres east of Springdale, 55 kilometres southeast of Firefly Metals' Green Bay project and roughly 150 kilometres from the Pine Cove mill and port. HM Exploration says results will be reported once the surveys and interpretation are complete. **No date was given for the release of that data**. Source: [Newsfile](https://www.newsfilecorp.com/release/310064/Great-Atlantic-Resources-Partner-Commences-Borehole-and-EM-Surveys-to-Define-Mineralized-Zones-at-Pilleys-Island-Project?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Metalsource Mining intersects high-grade silver equivalent at Silver Hill URL: https://www.pennystocks.news/metalsource-mining-silver-hill-sh26-20-sh26-21-assays/ Last updated: 2026-08-25T01:39:19.000Z Metalsource Mining Inc. CSE: MSM | OTCQB: MSMMF | FWB: E9Z Metalsource Mining reported that hole SH26-20 at its Silver Hill project in North Carolina cut **9.57 metres grading 364 g/t silver equivalent**, including a 2.26-metre interval at 913 g/t silver equivalent. The higher-grade section carried 8.4 g/t gold, 37.0 g/t silver, 1.9% lead, 12.8% zinc and 0.6% copper. A second hole, SH26-21, drilled as a down-dip step-out beneath SH26-20, returned **15.3 metres at 207 g/t silver equivalent**, with a 2.44-metre interval at 515 g/t including 7.3% lead and 47.4 g/t silver. The company says the two holes are step-outs of roughly 55 metres down plunge and extend drilling at the project to approximately **335 metres below surface**. Silver equivalent is a single number that rolls gold, silver, lead, zinc and copper into one figure. The calculation here uses 200-day moving average metal prices as of 6 February 2026 and, more notably, **metal recoveries taken from batch metallurgical testing completed in 1988**. Recoveries applied range from 89.2% for lead to 95.5% for gold. Investors reading the equivalent grades should treat them as a company estimate rather than a measured result. Metalsource also states that the reported widths are core lengths, not true widths, because it does not yet have enough data to estimate the true thickness of the intercepts. The release adds that the results are **preliminary and insufficient to define a mineral resource**, and that further drilling is needed to establish continuity, geometry and grade distribution. ## Why the second hole was drilled According to the company, SH26-20 was a follow-up to SH26-19, drilled specifically to characterise the grade of material lost in that earlier hole — a data-continuity issue that matters for any future resource estimate. Metalsource says the combination of the two holes shows that grade can vary substantially over short distances along strike and down dip, meaning a weak intercept can sit close to a strong one. In SH26-21, the company says elevated silver accompanied higher lead values, which it reads as evidence that the galena — lead sulphide — at Silver Hill is silver-bearing, and that silver tracks lead-enriched zones. Chief executive Joe Cullen said the distribution of metals is not random. "We're beginning to see patterns that can help us vector toward the higher-grade portions of the system," he said in the release. ## Drilling still outstanding The collar table published with the results lists 27 holes drilled at Silver Hill since 2025\. One, SH26-09, was abandoned at 15 metres. **Ten holes are still awaiting assay results**, including seven of the eight most recent holes collared at the same setup as SH26-20 and SH26-21\. Collar surveying is described as in progress, and reported collar elevations are expected to change. Metalsource says recently completed induced polarisation surveys — a geophysical method that measures how rock responds to an electrical current — have flagged additional targets inside and outside the historic mine footprint that have not been drilled. The company says it intends to expand drilling capacity to test those targets while continuing to step out from known mineralisation, and that it is evaluating additional land. No budget, drill metreage or timeline was attached to the expanded programme, and the release contains no financial information: no cash position, no spending rate and no financing details. Samples were assayed by ALS Geochemistry in Reno and ALS Canada in Vancouver, using four-acid digestion with ICP-AES, ICP-MS and fire assay. Standards, blanks and duplicates were inserted into the sample stream. Separately, the company granted **450,000 restricted share units to consultants and certain officers**, with a five-year term. Of these, 300,000 vest over three months and 150,000 over one year, with a statutory hold of four months and one day. No total share count was given, so the dilution effect cannot be measured from the release. Silver Hill covers 1,225 acres in Davidson County, North Carolina. Metalsource says known mineralisation extends to 550 metres from surface in a series of steeply dipping lenses. Source: [Newsfile](https://www.newsfilecorp.com/release/310204/Metalsource-Mining-Intersects-High-Grade-Silver-Hill-Mineralization-to-335-Metres-Below-Surface-with-55-Metre-Down-Plunge-Step-Outs?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Super League Enterprise posts sequential revenue growth and narrower adjusted EBITDA loss in Q2 URL: https://www.pennystocks.news/sle-super-league-enterprise-reports-q2-net-revenue-up-16-seq/ Last updated: 2026-08-25T01:39:12.000Z Super League Enterprise, Inc. **closed 33.04% higher at $3.02** on August 17 after the company reported second-quarter 2026 financial results, with dollar volume of $70,595,403 across 214,624 trades. The stock's free float stands at 1,604,606 shares, representing 99.7% of shares outstanding. Short volume on the session was 3,134,371 shares, equal to 59.14% of reported volume. Super League Enterprise, Inc. NASDAQ: SLE The results, published August 14, show **Q2 net revenue of approximately $1.24 million**, up 16% from approximately $1.08 million in the first quarter of 2026\. Gross revenue for the quarter was approximately $3.0 million, which the company says was roughly flat both year-over-year and sequentially. Gross margin expanded to 41% from 36% in Q1 2026. Adjusted EBITDA — a non-GAAP measure that strips out interest, taxes, depreciation, amortization and certain other items — showed **a loss of approximately $1.7 million**, compared with a loss of approximately $2.1 million in the second quarter of 2025, an improvement the company characterizes as approximately 20% year-over-year. On the balance sheet, Super League ended Q2 with **approximately $6.7 million in cash and investments**, against approximately $475,000 as of June 30, 2025\. The company also redeemed its remaining preferred stock during the quarter, leaving no preferred shares outstanding. The release states the company does not anticipate needing to raise additional capital to support the operating business, though that is a forward-looking claim and not a guarantee. The company completed its **acquisition of the Misfits Ads assets on May 1, 2026**, adding programmatic advertising and turnkey media capabilities, according to the release. Super League says the integration was completed without increasing the overall cost base. No purchase price was disclosed in the release. The company also launched a Youth and Family Marketplace during the period, described as providing advertisers access to kid-safe media across gaming channels. No revenue figure was attached to the launch. As of July 31, **weighted pipeline per seller reached approximately $2.8 million** for opportunities through year-end, up from approximately $1.78 million reported after Q1\. The company says it is targeting Adjusted EBITDA profitability in the fourth quarter of 2026, though that target is a projection and subject to the risks noted in its filings. ### OSR Health posted falling revenue and a thin cash position in its second quarter URL: https://www.pennystocks.news/osrh-osr-health-reports-falling-revenue-and-1-5-million-cash/ Last updated: 2026-08-25T01:39:13.000Z Shares of OSR Health, Inc. closed at $0.5900 on August 17, up 86.71% from a previous close of $0.3160, after the company filed its quarterly report for the period ended June 30, 2026\. Dollar volume was $208,235,745 across 576,466 trades. The company's free float stands at 19,424,149 shares, representing 55.3% of shares outstanding. Short volume on the session was 149,593,848 shares, equal to 58.51% of reported volume. OSR Health, Inc. NASDAQ: OSRH The 10-Q, filed August 14, shows **net sales of $315,669 in the second quarter of 2026**, compared with $1,135,517 in the same period a year earlier. For the first six months of 2026, net sales were $799,727, against $1,896,789 in the first half of 2025\. The filing gives no explanation for the decline. Despite lower revenue, the net loss narrowed. **The second-quarter net loss was $1,004,038**, compared with $5,225,198 in the second quarter of 2025\. For the first six months, the net loss was $4,471,212, against $16,618,012 a year earlier. The prior-year figure included $8,611,114 in merger and acquisition costs related to the business combination completed in February 2025. **Cash at June 30, 2026 stood at $1,499,603**, down from $1,700,273 at December 31, 2025\. Operating activities consumed $3,422,481 in cash during the first half of the year. At that pace, the cash on hand covers a fraction of one quarter of operating outflows. The filing does not state how the company intends to fund ongoing operations beyond what is noted about existing financing activities. The share count has grown materially. **Shares outstanding were 35,118,692 as of August 10, 2026**, up from 26,597,769 at December 31, 2025\. The increase reflects two tranches of issuances under an equity line of credit — a financing arrangement in which a company draws cash by issuing shares to a committed buyer — as well as shares issued to acquire Woori-IO Co., Ltd., a Korean medical device developer added to the group in January 2026\. The ELOC issuances in the first half raised a combined $2,526,699 in gross proceeds, according to the filing. The accumulated deficit reached **$40,950,247 at June 30, 2026**, compared with $37,169,881 at December 31, 2025\. Total current liabilities of $15,733,716 exceeded total current assets of $2,865,536\. Short-term borrowings, corporate bonds, and trade payables together account for the bulk of current obligations. The company changed its name from OSR Holdings, Inc. to OSR Health, Inc. effective June 11, 2026\. The filing states the name change did not alter any other provision of the certificate of incorporation or the terms of the common stock or warrants. ### TruGolf's Class A share count has more than quadrupled since year-end as preferred stock converts at a reset price URL: https://www.pennystocks.news/trug-trugolf-s-class-a-share-count-has-more-than-quadrupled/ Last updated: 2026-08-25T01:39:15.000Z TruGolf Holdings, which makes indoor golf simulators and related software, has seen its **Class A share count more than quadruple since year-end** as Series A Convertible Preferred Stock converts into common shares at a conversion price that was reset sharply lower in April. Shares closed 58.84% higher on August 17 after the company filed its second-quarter 10-Q. The stock closed at $1.5400, up from a previous close of $0.9695\. Dollar volume was $103,736,818 across 272,319 trades. The free float stood at 1,074,438 shares. Short volume on the same session was 14,418,105 shares, equal to 57.46% of reported volume. TruGolf Holdings, Inc. NASDAQ: TRUG The driver of the share count growth is a conversion price reset. Following a 1-for-10 reverse stock split in March 2026, the Series A Preferred's conversion price stood at $21.60 per share. On April 22, 2026, the company's articles of incorporation **reset that conversion price to $2.76 per share** under periodic reset provisions tied to the market price of the Class A common stock. Converting at $2.76 instead of $21.60 produces roughly eight times as many Class A shares for the same stated value of preferred stock — the same economic interest converts into a far larger portion of the total share count. Class A shares outstanding were **422,899 at December 31, 2025**. By June 30 the count had risen to 1,569,534, and the filing states **1,903,708 Class A shares as of August 12** — more than four times the year-end figure. Preferred holders who convert also receive a make-whole amount representing dividends that would have accrued to the five-year anniversary of issuance, itself convertible into additional Class A shares, adding further to the dilution. Cash stood at **$6,374,349 at June 30**, down from $10,469,263 at December 31\. The company consumed cash in both operating and investing activities during the first half, with the largest investing outflow directed to capitalized software development. Two related-party notes — one owed to ARJ Trust, a trust the filing says is indirectly controlled by the chief executive, and one a no-interest loan from the chief executive himself — carry a combined balance of **$2,100,000 and both mature on September 30, 2026**. The filing does not disclose a repayment plan. **Second-quarter revenue was $5,792,180** and the net loss was $447,808, against a net loss of $3,321,470 in the same quarter of 2025\. The filing does not attribute the year-on-year improvement to any specific factor. ### Profusa Executes 1-for-4 Reverse Stock Split URL: https://www.pennystocks.news/pfsa-profusa-executes-1-for-4-reverse-stock-split/ Last updated: 2026-08-25T01:39:16.000Z Profusa, Inc. shares **closed 25.86% higher at $4.5300** on August 17, 2026, after the company's 1-for-4 reverse stock split took effect that morning. Dollar volume for the session came to $8,077,988 across 19,848 trades. Profusa, Inc. NASDAQ: PFSA The split was announced on August 13\. The company filed an amendment to its restated certificate of incorporation with the State of Delaware and said the change took effect at **12:01 a.m. Eastern Time on August 17**. Shares continued trading on the Nasdaq Capital Market under the existing ticker symbol PFSA, but with a new CUSIP number, 74319X405. Under the terms of the consolidation, **every four shares of common stock outstanding** before the opening of trading on August 17 were combined into one share. Par value per share was unchanged at $0.0001\. Stockholders who would otherwise have been entitled to a fractional share received a cash payment in lieu. The company said the reverse split **reduced shares outstanding from 2,422,906 to approximately 605,726**. The number of authorized shares of common stock remains at 601 million. The free float on the session was **604,359 shares, equal to 11.3% of shares outstanding**. Short volume was 490,128 shares, representing 55.93% of reported volume on the same session. ### NeOnc Technologies shares climb after Phase 2a brain-cancer trial results URL: https://www.pennystocks.news/nthi-neonc-technologies-shares-climb-after-phase-2a-brain-ca/ Last updated: 2026-08-25T01:39:18.000Z NeOnc Technologies Holdings shares **closed at $4.91, up 16.35%** from a previous close of $4.22 on August 17, after Phase 2a results for its lead drug candidate circulated alongside several pieces of investor-relations content. Dollar volume was $1,716,903 across 3,469 trades. The free float stands at 10,520,556 shares, representing 40.6% of shares outstanding. Short volume on the session was 78,713 shares, or 40.95% of reported volume. Two of the three items in circulation originate from 24/7 Market News, which discloses in both releases that it **is compensated by NTHI** for ongoing news coverage and market outreach services. A third piece comes from Stonegate Capital Partners, an investor relations and capital markets advisory firm. All three should be read as attributed company-side material rather than independent analysis. NeOnc Technologies Holdings, Inc. NASDAQ: NTHI The clinical data come from the company's own reporting. NEO100 is an intranasally administered formulation of purified perillyl alcohol, studied in recurrent IDH1-mutant high-grade glioma — a brain cancer in which the IDH1 gene carries a specific mutation. The trial's primary result was a **six-month progression-free survival rate of 48.9%**, measured against a pre-specified historical benchmark of 20%, with a reported p-value of 0.0047\. Progression-free survival tracks the proportion of patients whose cancer has not advanced and who have not died by a set point in time. Median overall survival was reported at approximately 26.09 months. Six-, 12- and 24-month overall survival rates were approximately 86.7%, 60.9% and 54.1%, respectively. Five of 24 patients remained on treatment at the time of reporting, including one who had been progression-free for approximately 19 months. No major toxicities were reported. The study was open-label and single-arm, with no randomised control group. Stonegate notes that **confirmation in a randomised study remains the next test**. Comparison against a historical benchmark carries inherent limitations that a randomised design would address. The company says it intends to request a **Type B FDA meeting** to discuss the design of a registrational trial. NEO100 holds FDA Orphan Drug, Fast Track and Rare Pediatric Disease designations. A second candidate, NEO212, has completed Phase 1 dose escalation at a recommended Phase 2 dose of 610 mg, according to the company's filings, and has received FDA feedback indicating a potential accelerated approval pathway, according to Stonegate. On financing, the company has an at-the-market programme — a facility that allows it to sell shares into the open market incrementally over time — authorising up to $75 million of common stock through BTIG and A.G.P./Alliance Global Partners. The company has stated this is a financing facility, not cash already on hand. The company's SEC filings describe a USC patent portfolio covering **28 issued and 14 pending U.S. patents**, plus 65 issued and 28 pending internationally, across NEO100, NEO212 and related programmes. Second-quarter R&D expense was reported at **approximately $2.6 million**, compared with approximately $0.7 million in the same period a year earlier, reflecting increased clinical activity, manufacturing and development work, according to the company. ### Freightos appoints Yaron Eldad as chief financial officer URL: https://www.pennystocks.news/crgo-freightos-appoints-yaron-eldad-as-chief-financial-offic/ Last updated: 2026-08-25T01:39:06.000Z Freightos Limited closed at $1.6700 on August 17, **up 23.70% from a previous close of $1.3500**, after the company announced a new chief financial officer. Dollar volume on the session was $11,365,807 across 42,777 trades. The company's free float stands at 26,931,766 shares, or 52.4% of shares outstanding. Short volume on the session was 1,142,939 shares, representing 46.35% of reported volume. The company says **Yaron Eldad will join as CFO effective September 1, 2026**, reporting to chief executive officer Pablo Pinillos. Freightos describes itself as a freight pricing, booking and procurement platform. Freightos Limited NASDAQ: CRGO According to the release, Eldad has more than 25 years of CFO and senior financial leadership experience across technology and life sciences. His most recent role was **CFO of Evogene Ltd.**, where the company says he oversaw financing rounds, mergers and acquisitions activity, and organizational restructuring. Before Evogene, the release says Eldad served as CFO of e-SIM, a technology company, where he led its initial public offering — a process by which a private company lists its shares on a public stock exchange — and its subsequent years as a Nasdaq-listed company. He also co-founded Yamba Group, according to the release. "Yaron brings extensive public-company financial leadership experience, together with strong operational discipline and strategic business judgement," Pinillos said in the release. "His appointment strengthens our leadership as we continue to focus on execution, profitability, and scalable growth." The release carries no financial figures for Freightos — **no revenue, cash position, or earnings data were disclosed**. Whether the company is profitable or the rate at which it is using cash was not stated. ### Focus Universal earns first rental revenue from building acquired earlier this year URL: https://www.pennystocks.news/fcuv-focus-universal-reports-first-rental-revenue-after-buil/ Last updated: 2026-08-25T01:39:07.000Z Focus Universal Inc. **closed 15.48% higher at $6.49** on August 17, after the company filed its second-quarter 10-Q with the Securities and Exchange Commission. Dollar volume was $583,656 across 1,363 trades. The most significant development in the filing was a property acquisition completed in January 2026\. The company recorded a bank loan of **$11,050,000 tied to the building purchase**, which lifted net property and equipment from $66,705 at December 31, 2025 to $17,575,589 at June 30, 2026\. The acquisition was made through Lusher Holding LLC, a wholly owned subsidiary the company founded on February 2, 2026, to provide commercial real estate property management services. Focus Universal Inc. NASDAQ: FCUV That purchase produced the quarter's most notable revenue line. **Rental revenue of $651,950 appeared for the first time** in the second quarter of 2026; there was no comparable figure in the second quarter of 2025\. Total revenue for the three months ended June 30, 2026 came in at $675,170, against $35,330 in the same period of 2025\. For the six months ended June 30, 2026, total revenue was $723,143, compared with $225,585 a year earlier. Despite the revenue increase, the company remained unprofitable. **Net loss for the second quarter was $1,518,958**, roughly in line with the $1,505,648 loss recorded in the second quarter of 2025\. For the first six months, the net loss was $2,765,036 against $2,757,026 a year earlier. The accumulated deficit stood at $34,015,113 as of June 30, 2026. Cash fell sharply during the period. **The cash balance was $1,600,258 at June 30, 2026**, down from $7,934,958 at December 31, 2025\. Net cash used in operating activities was $1,889,277 for the six months, while investing activities consumed an additional $6,632,052, the bulk of which went to property purchases. The share count has risen materially. **Common shares outstanding grew to 702,745** from 228,774 at December 31, 2025\. The increase came from conversion of all outstanding Series B convertible redeemable preferred stock into common shares, issuance of pre-funded warrant units that raised $3,547,348 in cash, and shares issued under employment and award agreements. The company also repurchased $354,143 of its own stock during the period. The free float is 1,247,456 shares, equal to 60.3% of shares outstanding. Short volume on the session was 33,608 shares, representing 79.12% of reported volume. The company also disclosed that on May 18, 2026, it entered a cross-border e-commerce cooperation agreement through Lusher LLC, in which Focus Universal holds a 51% interest and Avantgarde Service Inc. holds the remaining 49%. **No transactions involving Lusher LLC were recorded** through June 30, 2026. ### Armistice Capital takes beneficial ownership stake above five percent in Intelligent Bio Solutions URL: https://www.pennystocks.news/inbs-armistice-capital-reports-5-91-stake-in-intelligent-bio/ Last updated: 2026-08-25T01:39:09.000Z Intelligent Bio Solutions Inc. **closed 21.66% higher at $3.3700** on August 17, after Armistice Capital, LLC filed an amended Schedule 13G — a beneficial ownership disclosure required of passive investors holding more than 5% of a company's shares — with the Securities and Exchange Commission. Dollar volume for the session was $779,288 across 2,031 trades. Intelligent Bio Solutions Inc. NASDAQ: INBS The filing, dated August 14, 2026, shows that **Armistice Capital reports beneficial ownership of 141,397 shares** of Intelligent Bio Solutions common stock, representing 5.91% of shares outstanding. The shares are directly held by Armistice Capital Master Fund Ltd., a Cayman Islands exempted company. Armistice Capital, LLC acts as the Master Fund's investment manager and, under an Investment Management Agreement, exercises voting and investment power over those shares. Steven Boyd, the managing member of Armistice Capital, is named as a co-reporting person. The filing is an amendment to a prior Schedule 13G. **No earlier share count was included in the current document**, so the direction and size of any change from the previous position cannot be determined from this filing alone. The reporting persons certified that the shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the company. The company's **free float stands at 2,364,340 shares**, equal to 98.9% of shares outstanding. Short volume on the August 17 session was 90,215 shares, representing 63.09% of reported volume for that day. ### INVO Fertility's share count has roughly quintupled since December while its Q2 profit rests on a one-time gain URL: https://www.pennystocks.news/ivf-invo-fertility-s-share-count-has-roughly-quintupled-sinc/ Last updated: 2026-08-25T01:39:10.000Z INVO Fertility, which operates fertility clinics and makes an intravaginal culture device, **closed 57% higher on August 17 after releasing second-quarter 2026 results** — results that showed a swing to net profit driven almost entirely by a one-time accounting gain, not by operating improvement. INVO Fertility, Inc. NASDAQ: IVF Shares closed at $1.53, up from a previous close of $0.9716\. Dollar volume was $277,057,422 across 745,853 trades. The free float was 1,778,532 shares; short volume on the session was 20,615,242 shares, equal to 56.08% of reported volume. The company said in an August 17 press release via GlobeNewswire that **second-quarter revenue was $2,175,485, up 17% year over year**. Net income for the quarter came to approximately $0.9 million, compared with a net loss of approximately $3.6 million in the second quarter of 2025. The quarterly profit depended on a non-operating item. The company recognised an **approximate $2.5 million gain on remeasurement related to the Birmingham clinic acquisition**, which it completed in June 2026 — a one-time item, not recurring operating income. Separately, the loss from operations was **approximately $1.3 million for the quarter**, narrower than the year-earlier period but still a loss, the press release said. A structural change visible in the 10-Q filed with the SEC on August 14 is the scale of share issuance over the first half of 2026\. **Common shares outstanding stood at 477,366 at December 31, 2025**, and **had risen to 2,295,035 by June 30**, roughly five times the year-end count. By the filing date of August 14, the count had increased further to 2,506,969\. The 10-Q shows the expansion came through a combination of preferred stock conversions, warrant exercises, and other equity issuances. Each such transaction reduces the fraction of the company that existing common holders own. The 10-Q balance sheet showed **cash of $3,732,945 at June 30, 2026**, against $2,077,842 at December 31, 2025. ### IP Strategy Holdings expects a large first-half net loss as crypto token holdings fell URL: https://www.pennystocks.news/ipst-ip-strategy-holdings-expects-up-to-86-million-first-hal/ Last updated: 2026-08-25T02:01:27.000Z IP Strategy Holdings, a Washington state company that pivoted from spirits distilling to holding $DATA cryptocurrency tokens, filed notice with the SEC on August 17, 2026 that it expects a net loss of **about $80 to $86 million for the first six months of 2026**, driven mainly by a fall in the value of those tokens. Shares closed **235.89% higher** at $7.39 after the filing, from a previous close of $2.20\. Dollar volume was about $767 million across roughly 1.3 million trades. The free float is about 10.2 million shares, representing 96.3% of shares outstanding. Short volume on the session was about 17.9 million shares, 57.24% of reported volume. IP Strategy Holdings, Inc. NASDAQ: IPST The token losses account for most of the anticipated result. The notice states that **$64 to $68 million of the expected loss** reflects the fall in the fair value of $DATA tokens the company holds on its balance sheet — the tokens remain held, but are now marked at a much lower value. A further **$9.7 to $11.7 million** came from realised losses on actual sales of digital assets. For context, the company's net loss over the same period a year earlier, when it was still primarily a distiller, was **$10.3 million**. Revenue tells a parallel story. Total net revenue for the first half of 2026 is expected to be **roughly $2.2 to $2.6 million**, roughly flat with the year-ago period — but almost none of it now comes from spirits. The filing says about **$1.8 to $2.2 million** in new revenue came from the company's $IP token validator service, which launched in September 2025, and from premiums earned under a covered-call program started in January 2026\. A covered call is the sale of the right to buy shares the seller already owns; the seller keeps the premium whether or not the option is exercised. The filing says spirits revenue fell by a roughly equal amount over the same period. The figures are preliminary and unaudited. The company says it expects to file the full quarterly report within five days of the original due date. No press release or other SEC filing explaining the stock's move on August 17 was found beyond the late-filing notice itself. The move may reflect short covering or momentum buying in a low-float stock. ### Adial September vote will decide whether preferred shares convert to common stock URL: https://www.pennystocks.news/adil-adial-s-september-vote-will-decide-whether-12-9-million/ Last updated: 2026-08-25T01:39:03.000Z Adial Pharmaceuticals, which spent years developing addiction treatments, completed a pivot in June 2026 when it acquired Azora Therapeutics and took on a drug candidate for ulcerative colitis. A September 17 stockholder vote will determine whether **12.9 million shares of Series A convertible preferred stock convert to common** — against a current common share count of about 2.6 million — and whether the company's top two executives keep their jobs. Adial Pharmaceuticals, Inc. NASDAQ: ADIL **Shares closed 25.38% higher at $4.99** on August 17, from a previous close of $3.98\. Dollar volume was $673,937 across 1,561 trades. The free float is about 2.1 million shares; short volume on the session was 23,634 shares, equal to 44.19% of reported volume. The preferred shares were issued in connection with the Azora acquisition and cannot convert to common without stockholder approval, according to the 10-Q Adial filed with the SEC on August 14\. If that approval is not obtained before December 11, 2026, holders may demand cash equal to the fair value of undelivered shares. The 10-Q states that this exposure **raises substantial doubt about the company's ability to continue as a going concern**. An 8-K filed August 13 states that **CEO Cary Claiborne and CFO Vinay Shah are each expected to be terminated** promptly after the annual meeting, provided the stockholder proposals pass. Matthew Davidson, currently chief development officer and a board member, is named in that filing as the expected replacement for the chief executive role. No replacement CFO has been named. Funding for the Azora deal came partly through a private placement. The company closed a **$32 million initial tranche** — including the conversion of $5.5 million in notes — of a financing that could total up to $64 million, according to the company's second-quarter press release. Cash stood at $28.7 million as of June 30, 2026, compared with $4.6 million three months earlier. The company says in its press release that this is enough to **fund operations into the second half of 2027**, not counting the second tranche. AT177, the drug brought in through the acquisition, is described in company materials as an oral treatment designed to release its active compound in the colon. The company says in its press release that an investigational new drug application — a required step before human trials begin — is planned for the first half of 2027. ### Acurx Pharmaceuticals receives FDA conditional acceptance for ibezapolstat brand name CIFBEZY URL: https://www.pennystocks.news/acxp-acurx-pharmaceuticals-receives-fda-conditional-acceptan/ Last updated: 2026-08-25T01:39:05.000Z Acurx Pharmaceuticals closed at **$1.6500 on August 17, up 18.28%** from a previous close of $1.3950, on dollar volume of $1,796,725 across 4,593 trades. The move came after the company released two announcements: FDA conditional acceptance of the proposed brand name for its lead antibiotic candidate, and second-quarter financial results showing a widening operating loss. The FDA conditionally accepted **the proprietary name CIFBEZY** (pronounced "sif-BEZ-ee") for ibezapolstat, the company's antibiotic candidate targeting *Clostridioides difficile* infection (CDI), a bacterial infection of the gut. The U.S. Patent and Trademark Office also allowed a trademark application for the same name. According to the company, final FDA approval of the brand name will be sought only at the time of a New Drug Application (NDA) filing, which itself requires successful completion of Phase 3 clinical trials. Acurx Pharmaceuticals, Inc. NASDAQ: ACXP Ibezapolstat is described by Acurx as a DNA polymerase IIIC inhibitor — a class of antibiotic that works by blocking a bacterial enzyme involved in DNA replication. The company says the drug is Phase 3 ready, subject to financing, and **patient enrollment in a recurrent CDI trial is expected to begin** in the coming months. On the financial side, Acurx reported a **net loss of $2.3 million for the second quarter ended June 30, 2026**, compared with a net loss of $2.2 million in the same period of 2025\. Research and development expenses rose to $1.1 million from $0.5 million in the prior-year quarter, with the company attributing the increase to higher manufacturing and consulting costs tied to the recurrent CDI trial program. General and administrative expenses fell to $1.2 million from $1.7 million, due in part to lower professional fees and legal costs. The company ended the second quarter with **cash of $10.7 million**, up from $7.6 million at December 31, 2025\. During the quarter it raised approximately $2.5 million gross through a registered direct offering of 825,085 shares at $3.03 per share, and a further $0.8 million under an equity line of credit. A concurrent private placement added warrants to purchase up to 1,650,170 shares at an exercise price of $2.78 per share, exercisable immediately and expiring 24 months after the effective date of the related registration statement. Common shares outstanding stood at **4,683,253 at June 30, 2026**, compared with 2,348,113 at December 31, 2025\. The free float on the day of the move was 3,797,912 shares, equal to 88.4% of shares outstanding. Short volume on August 17 was 459,862 shares, representing 56.53% of reported volume for the session. ### The Loan Was Gone. The Warrants Stayed. URL: https://www.pennystocks.news/glxz-the-loan-was-gone-the-warrants-stayed/ Last updated: 2026-08-24T18:24:05.000Z Galaxy Gaming paid off a senior secured loan from Fortress Credit Corp. in January 2025\. The warrants that Fortress received alongside that loan in 2021 were a different matter — they stayed outstanding for another 18 months, until the company bought them out. Galaxy Gaming, Inc. OTC: GLXZ On August 12, 2026, Galaxy Gaming signed cancellation agreements with three Fortress affiliates — Drawbridge Special Opportunities Fund LP, Fortress Lending II Holdings LP, and Fortress Lending Fund II MA-CRPTF LP — and paid **about $1.2 million in cash in total to retire warrants covering 778,320 shares**, according to an 8-K filed with the SEC on August 17\. The cash came from the company's existing holdings. Following the transaction, Galaxy Gaming says it has no warrants outstanding. A warrant gives its holder the right to buy shares at a fixed price. If that price sits below the market price, exercising the warrant creates new shares — and every new share makes the ones already held worth a smaller slice of the same company. Paying to cancel them eliminates that possibility. The filing does not state the original exercise price of the Fortress warrants, so it is not possible to determine from the filing whether Fortress would have exercised them or let them expire. The filing also does not say when the warrants would have expired, or why the company chose August 2026 — rather than any earlier point — to retire them. The gap between loan repayment and warrant cancellation is not explained. ### Leatt's Preferred Stock Count Has Been Wrong for Nearly 14 Years URL: https://www.pennystocks.news/leat-leatt-s-preferred-stock-count-has-been-wrong-for-nearly/ Last updated: 2026-08-24T18:24:05.000Z In September 2012, Leatt Corporation turned every 25 of its common shares into one. The same split was supposed to apply to its Series A Preferred Stock. It didn't — and the preferred share count has been wrong ever since. Leatt Corp OTC: LEAT A Certificate of Correction filed with Nevada's Secretary of State on **August 11, 2026** applies the missing split retroactively, reducing the Series A preferred share count from **3 million shares to 120,000**. Each of those preferred shares carries 100 votes, cast alongside common stockholders on every company matter, so the correction shrinks the voting weight attached to the preferred class by the same 25-to-1 ratio the common split used. For common shareholders, there is a secondary effect. The Series A converts into common stock on a one-for-one basis. At 3 million shares, that was a meaningful ceiling on potential dilution; at 120,000, it is not. The filing does not say whether any conversion is planned. The preferred stock is held by the company's founders. Earlier SEC filings show that Dr. Christopher Leatt and Jean-Pierre De Villiers received their Series A shares as founding consideration. The correction was approved by **written consent of the principal holder** of the Series A — the person whose voting power it reduces. That holder controlled **96,000 shares**, representing **80%** of the preferred voting power at the time of the vote. The filing also rewrites the conversion-rate adjustment mechanism. The old rules included a provision that adjusted the preferred-to-common conversion rate whenever the common stock was split or consolidated — a clause designed to protect preferred holders if the common moved without a corresponding preferred adjustment. That clause is now removed, since the correction eliminates the mismatch it was written to address. A replacement provision requires that any future common split or reverse split be mirrored automatically in the preferred stock, so the gap cannot open again. The filing gives no explanation for why the omission went undetected for nearly 14 years. ### A Year Ago This Texas Refinery Lost Money. Last Quarter It Made Millions. URL: https://www.pennystocks.news/bdco-blue-dolphin-s-cash-holdings-rose-fifteenfold-in-six-mo-2/ Last updated: 2026-08-24T19:03:04.000Z A year ago, Blue Dolphin's Nixon refinery ran at a net loss. In the three months ended June 30, 2026, it posted **net income of $17.7 million**. BLUE DOLPHIN ENERGY CO OTC: BDCO The swing in gross profit — the gap between what crude oil costs and what finished products sell for — carries most of the story. In the second quarter of 2025, that margin was $0.6 million. A year on, it was **gross profit of $25.1 million**, according to a press release Blue Dolphin attached to an 8-K filed with the SEC on August 17\. The filing does not specify which factors widened the margin. The cash position moved sharply over the same stretch. At the end of 2025, Blue Dolphin held **about $2 million in cash** and restricted cash combined. By June 30, **that figure had risen to $31.7 million**. The press release attributes the build to strong first-half operating results but provides no further breakdown. For the six months ended June 30, the company reported **net income of $32.5 million**, against roughly half a million dollars in the same period a year earlier. Second-quarter revenue came to **about $144 million**. "Blue Dolphin's disciplined operational execution within the continuing environment of geopolitical and market volatility drove strong financial results and significant cash generation," Chief Executive Jonathan P. Carroll said in the release. Earnings before interest, taxes, depreciation and amortisation — a measure of operating cash generation — came to **$24.4 million for the quarter**. In the same quarter a year earlier, the figure was **$88,000**. ### The First CMD Buyer Walked Away. Now There Are Four. URL: https://www.pennystocks.news/lbra-the-first-cmd-buyer-walked-away-now-there-are-four/ Last updated: 2026-08-24T18:24:06.000Z The company lined up to buy CMD walked away before the deal closed. 1847 Holdings went back to market and, according to a press release filed with the SEC on August 14, now has **four separate non-binding offers** — expressions of interest, not committed purchases — each contemplating a price of about **$65 million**. 1847 Holdings LLC OTC: LBRA **1847 Holdings bought CMD in December 2024 for about $18.8 million**. Bids at the offered price would represent **roughly 3.5 times what it paid** in less than two years — a ratio the company itself cited in the release. CMD is a construction business the board approved for sale in early 2026. While the CMD process plays out, the rest of the business — Kyle's, Wolo and ICD — kept improving. Operating loss from those continuing operations fell by about **57%** year-over-year in the second quarter, as the company earned more gross profit on a smaller revenue base. Gross margin widened to about **45%**, and total operating expenses fell by about **29%**. The headline loss number takes explanation. Net loss from continuing operations came to about **$5.9 million** for the quarter, while a year earlier the same line showed net income of about $21 million. Both figures are dominated by changes in the accounting value of the company's warrant liabilities — a non-cash item that produced a large paper gain a year ago and a loss this time around. The operating improvement is the cleaner read of how the business is actually running. Operating cash flow from continuing operations for the first half of 2026 was about **$712,000**. Chief Executive Ellery W. Roberts said in the release that proceeds from a CMD sale would go first toward repaying outstanding debt, with whatever remains evaluated for reinvestment in the continuing businesses. The four current offers are non-binding. The previous buyer had already been announced before falling away without completing the deal. ### Backstageplay Closes $146,000 Share Placement, Nearly Half Taken by an Insider URL: https://www.pennystocks.news/backstageplay-closes-146000-private-placement-insider-participation/ Last updated: 2026-08-25T01:39:02.000Z Backstageplay Inc. TSXV: BP.H Backstageplay Inc. has closed a non-brokered private placement, issuing **1,825,000 common shares at $0.08 each for gross proceeds of $146,000**. The offering was first announced on July 13, 2026, and the closing was disclosed on August 14, 2026. The company paid **cash finder's fees of $10,220**, equal to seven percent of gross proceeds, split between BMO Nesbitt Burns Inc. and Leede Financial Inc. Backstageplay states both finders are at arm's length. After those fees, net cash from the raise is roughly $135,800 before any other closing costs. A notable share of the money came from inside the company. **One insider subscribed for 850,000 shares, or $68,000** — just under half of the total offering. That makes the placement a "related party transaction" under Multilateral Instrument 61-101, the Canadian rule that governs deals between an issuer and its own insiders. Backstageplay is relying on two exemptions in that instrument to avoid a **formal valuation and minority shareholder approval**. It cites section 5.5(b), on the basis that it is a NEX Issuer and none of its securities trade on the markets specified in that provision, and section 5.7(1)(a), on the basis that neither the value of the shares issued to the insider nor the amount the insider paid exceeds 25 percent of the company's market capitalization. The release says no new Control Person was created by the financing. NEX is a separate board of the TSX Venture Exchange for companies that no longer meet the exchange's ongoing listing requirements. Backstageplay trades there under BP.H, with the ".H" suffix marking the NEX listing. The shares carry a **statutory hold period of four months and a day, expiring December 15, 2026**, meaning they cannot be resold in Canada before that date. The offering also remains **subject to final acceptance by the TSX Venture Exchange**. According to the company, proceeds will go toward developing a new social gaming platform and content, integrating third-party solutions, and general corporate working capital. Backstageplay describes itself as relaunching its social gaming platform in 2026, aimed at linking brands, fans and live entertainment through engagement and loyalty features. No launch date, budget or revenue figures are given, and the platform description comes from the company's own release rather than any disclosed contract or booked business. Two figures a reader would want are **absent from the release: total shares outstanding and the company's cash position**. Without the share count, the dilution from the 1,825,000 new shares cannot be calculated from this document alone. Without a cash figure or burn rate, it is not possible to say how far $146,000 in gross proceeds carries a platform build. For context on scale: at the $0.08 issue price, the entire raise is smaller than the annual salary of a single mid-level developer in most markets. Whether it functions as a bridge to a larger financing or as the full budget for the described work is not addressed in the release. Source: [Newsfile](https://www.newsfilecorp.com/release/309660/Backstageplay-Closes-Private-Placement-of-Common-Shares?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Brookfield and La Caisse complete acquisition of Boralex URL: https://www.pennystocks.news/brookfield-la-caisse-complete-acquisition-boralex/ Last updated: 2026-08-25T01:39:00.000Z Boralex Inc. TSX: BLX **Brookfield and La Caisse have closed their acquisition of Boralex Inc.**, the Montreal-based renewable power producer listed on the Toronto Stock Exchange under BLX, the parties said on August 14, 2026. The buyer group consists of **Brookfield together with institutional partners including Brookfield Renewable Partners, and La Caisse**, the Quebec institutional investor formerly known as CDPQ. The transaction had been announced previously; the statement confirms only that it has now been completed. The deal was carried out **as a plan of arrangement under the Canada Business Corporations Act**. A plan of arrangement is a court-approved procedure used in Canada to acquire all of a company's outstanding shares, which requires shareholder and court approval and results in the target being taken private. **No purchase price, share consideration or ownership split between the buyers was disclosed** in the announcement, and it gives no detail on regulatory approvals, closing conditions or the timetable for Boralex's delisting from the TSX. Source: [GlobeNewswire](https://www.globenewswire.com/news-release/2026/08/14/3345371/0/en/brookfield-and-la-caisse-complete-acquisition-of-boralex.html?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### St. Joseph Inc. buys Fastbase AI and plans to change its name URL: https://www.pennystocks.news/st-joseph-inc-acquires-fastbase-ai-corporation/ Last updated: 2026-08-25T01:38:59.000Z St. Joseph Inc. OTCID: STJO St. Joseph Inc. (OTCID: STJO) said on August 14, 2026 that it has **acquired U.S.-based Fastbase AI Corporation**, a company that identifies anonymous website visitors and converts them into named company and contact records for sales and advertising use. **No purchase price, share issuance or other financial terms were disclosed** in the announcement. The release also contains no revenue, profit or customer figures for Fastbase, and no information on St. Joseph's cash position or share count following the transaction. Investors therefore cannot assess from the release how much of the company was given away, if any, to fund the deal. Alongside the acquisition, the company said it **intends to apply to FINRA to change its corporate name to Fastbase AI Inc**, describing this as a strategic shift toward a primary focus on artificial intelligence. FINRA, the Financial Industry Regulatory Authority, processes corporate action requests such as name and symbol changes for over-the-counter issuers. **The trading symbol is not currently expected to change.** No timeline for the application or its approval was given. The company also said that **a Mr. Ortiz will be appointed as a director and officer**. The release does not give his first name, his background, or which officer role he will hold. It does not say whether any existing directors or officers are leaving. ## What the acquired business does According to the release, Fastbase sells website visitor identification and lead generation tools. Its products include InMarket Leads, described as a Google Analytics-based tool that flags companies searching for specified keywords along with location and contact details; Web Leads, a visitor tracking and benchmarking tool; and a set of customer interaction features such as popups, in-product tours and chat. The company says Fastbase is **developing an AI-powered business search platform drawing on data covering roughly 350 million companies**. That platform is described as still in development, not in commercial release. The descriptions of Fastbase's products in the announcement come from the company's own materials and are not independently verified. ## A change of business, not an extension of one The shift is substantial rather than incremental. St. Joseph's own description of itself in the same release is **a specialty medical device, medical equipment, medical supply and nutritional products company**, selling FDA-approved devices and formulated products for rehabilitation, remote patient monitoring and critical care monitoring. The release does not say what happens to that business — whether it will be retained, wound down or sold — after the intended name change to an AI-focused identity. Chief Executive Christopher Studinger said the acquisition "fits perfectly within our current mandate to expand our presence in artificial intelligence and data intelligence technologies," and referred to building a portfolio of brands in the sector. The release does not identify the other AI or data assets in that portfolio, or when they were acquired. Readers assessing the announcement are left with the elements that usually determine whether an acquisition of this kind matters: consideration paid, the acquired company's booked revenue, and the effect on the outstanding share count. **None of those three are addressed in the release.** Until the company files financial statements covering the transaction, the size and cost of the deal remain unstated. Source: [Newsfile](https://www.newsfilecorp.com/release/309486/St.-Joseph-Inc.-STJO-Announces-Acquisition-of-Fastbase-AI-Corporation?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Fairchild Gold Closes Golden Arrow Purchase From Emergent Metals URL: https://www.pennystocks.news/fairchild-gold-closes-golden-arrow-acquisition-emergent-metals/ Last updated: 2026-08-25T01:38:57.000Z Fairchild Gold Corp. TSXV: FAIR Fairchild Gold Corp. has closed the purchase of a 100% interest in the Golden Arrow property in Nevada from Emergent Metals Corp., paying **US$600,000 in cash, 12.5 million shares and a US$3.5 million secured note**, plus a royalty. The property covers 17 patented and 494 unpatented mineral claims near Tonopah, and the two parties dealt at arm's length. Of the cash portion, US$250,000 had already been handed over earlier as a non-refundable deposit. The share component consists of **12,500,000 Fairchild shares at a deemed price of C$0.055**, worth roughly C$688,000 at that value, and the shares carry a four-month statutory hold period. No finder's fees were paid. Shareholders approved the transaction on June 9, 2026. The largest single element of the price is deferred. Fairchild issued Emergent a **non-convertible senior secured promissory note of US$3.5 million bearing 8.5% annual interest**, payable semi-annually in cash and maturing on March 23, 2031 — five years from the date of the definitive asset purchase agreement. The note is secured by a first-ranking interest over the property and related assets, and Emergent keeps a registered security interest until the principal and accrued interest are retired. ## Repayment incentives and penalties The note's terms push Fairchild toward early repayment. If the company pays at least US$500,000 of principal immediately on closing a financing raising at least US$3 million gross, and then repays a further US$2.5 million plus accrued interest within six months of the acquisition closing, **Emergent waives the remaining US$500,000 of principal** and discharges its security. If the note stays outstanding, the balance grows. The principal **steps up automatically to US$4 million after the third anniversary** of the purchase agreement and to US$5 million after the fourth. Interest does not accrue on a step-up amount for periods before it takes effect. Fairchild has not disclosed in this release what cash it holds or whether the US$3 million financing that triggers the discount has been arranged, so the path to the reduced payout remains unfunded on the information given. ## Royalties stacked on the property Emergent also received a **0.5% net smelter returns royalty** — a payment calculated on revenue from metal sold, after smelting and refining deductions. Fairchild can buy it back for US$1 million if it acts before the fourth anniversary of the purchase agreement, or US$1.5 million between the fourth and seventh anniversaries. The buyback right lapses after the seventh anniversary. On top of that, Fairchild has taken on pre-existing royalty obligations attached to Golden Arrow. These include a **US$25,000 annual advance minimum royalty plus a 3% NSR on six unpatented lode claims**, split among three owners, a second US$25,000 annual advance minimum royalty plus a 3% NSR covering all the unpatented lode claims and any claims caught by an area-of-interest provision, and a 1% NSR on all 17 patented claims. The advance minimum royalties are payable regardless of whether the property produces anything. The company is also required to post a financial guarantee of about US$40,000 with the U.S. Bureau of Land Management under the property's plan of operations and reclamation permit. Fairchild says Golden Arrow, in the Walker Lane belt, contains two resource areas, Gold Coin and Hidden Hill, with a combined measured, indicated and inferred resource set out in an NI 43-101 technical report prepared by RESPEC. **No tonnage or grade figures were included in the release**. Executive Chairman Nikolas Perrault said the company expects to provide updates on its plans for the property, without giving a timetable or a budget. ## Paid investor awareness spending The same release discloses two promotional contracts, both subject to TSX Venture Exchange approval. Montreal-based IMPAQ Capital Inc. was retained effective August 10, 2026 for investor relations outreach at **C$8,500 a month plus 450,000 immediately vesting stock options**, on an initial six-month term that renews in three-month increments. Separately, Outside the Box Capital Inc. was engaged from August 10, 2026 to February 4, 2027 to handle marketing, social media engagement and distribution of company-approved material, for a **one-time fee of C$75,000 paid at the start of the term**, with no securities issued. Both firms are described as arm's length and as holding no Fairchild securities at present. Readers should treat material appearing about the company through those channels as paid promotion rather than independent coverage. Source: [Newsfile](https://www.newsfilecorp.com/release/309649/Fairchild-Gold-Completes-Acquisition-of-Golden-Arrow-Property?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Tier One Silver launches private placement to fund Ecuador copper option URL: https://www.pennystocks.news/tier-one-silver-c12-c17-million-financing-ruta-de-cobre/ Last updated: 2026-08-25T01:38:56.000Z Tier One Silver Inc. TSXV: TSLV | OTCQB: TSLVF | FWB: TOV0 Tier One Silver plans to raise **a minimum of C$12 million and up to C$17 million at C$0.07 per unit**, with part of the money going to the first payment on an option to acquire control of a copper-molybdenum project in Ecuador. The company announced the private placement on August 13, 2026. Each unit consists of one common share and one full warrant. The **warrant is exercisable at C$0.15 for three years** from the closing of the offering, which the company is targeting for early September 2026\. A warrant is a right to buy an additional share at a fixed price; if exercised, it issues new shares and further dilutes existing holders. The agents have also been granted an over-allotment option for up to **an additional C$8.5 million of units, taking the maximum to C$25.5 million**. That option can be exercised in whole or in part until 48 hours before closing. At the C$0.07 issue price, the C$12 million minimum implies roughly 171 million units, the C$17 million upper end roughly 243 million, and a fully exercised over-allotment about 364 million — each accompanied by a matching warrant. The release does not state the company's current share count, so **the dilution cannot be measured from the release alone**. Of the minimum net proceeds, the company says **US$1.8 million will fund the initial purchase payment** under an option to acquire a 70% controlling interest in Compañía Minera Ruta de Cobre S.A. A letter of intent for that transaction was announced on June 29, 2026\. The release does not disclose the total consideration payable for the 70% interest, nor the schedule of any further payments. The Ruta de Cobre project is in Azuay Province, Ecuador. Tier One describes it as one of South America's largest greenfield mineral projects; the release gives no resource estimate, drill results or other technical figures to support that characterisation, and it should be read as a company claim rather than a verified fact. Remaining proceeds are to be used to set up exploration operations in Ecuador, begin a first phase of exploration at Ruta de Cobre and provide working capital, according to the release. Anything raised above the C$12 million minimum would go toward accelerating exploration and additional working capital. No exploration budget or timeline has been disclosed. ## Terms and conditions 3L Capital Inc. is lead agent and sole bookrunner. Its compensation is **a 7% cash fee plus warrants equal to 7% of the offering**, exercisable at the issue price for three years from closing. On the C$12 million minimum, the cash fee alone would be C$840,000. Closing of the financing is conditional on the **concurrent execution and closing of the Ruta de Cobre share purchase**. Both transactions remain subject to customary conditions, including signed subscription agreements, professional opinions and approval from the TSX Venture Exchange. Neither is complete as of the announcement. The shares, warrants and any shares issued on exercise of the warrants will carry a four-month-and-one-day hold period in Canada from closing, applied separately to any later tranches. The company also notes that insiders may participate in the offering, relying on exemptions from the formal valuation and minority shareholder approval requirements of Multilateral Instrument 61-101\. It says the exemptions apply because **neither the value of securities issued to insiders nor the consideration they pay will exceed 25% of market capitalisation**. The release does not say which insiders intend to subscribe or for how much. Tier One's existing asset is the Curibaya project in Peru. The company says that on completion of the Ruta de Cobre transaction, the Ecuadorian project becomes its flagship. The financing is an offering announcement, not a completed raise: **no funds have been received and no subscription agreements were reported as signed**. Whether the exploration programme proceeds depends on both the placement and the Ecuador acquisition closing together. Source: [Newsfile](https://www.newsfilecorp.com/release/309590/Tier-One-Silver-Announces-C12-C17-Million-Financing-to-Fund-Ruta-de-Cobre-Acquisition-and-Exploration?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Lockheed Martin completes static fire test of Next Generation Interceptor Stage Two motor URL: https://www.pennystocks.news/lockheed-martin-ngi-stage-2-motor-static-fire-test/ Last updated: 2026-08-25T01:38:55.000Z HUNTSVILLE, Ala., Aug. 10, 2026 /PRNewswire/ -- Lockheed Martin NYSE: LMT Lockheed Martin said on Aug. 10, 2026 that the **Stage 2 rocket motor for its Next Generation Interceptor completed a static fire test** inside a high-vacuum chamber built to reproduce the conditions of low-Earth orbit. A static fire test holds a rocket motor in place and ignites it, measuring performance without launching anything. The motor was supplied by **L3Harris Technologies**, which conducted the hot fire. According to the release, the test confirmed the motor can withstand the thermal and pressure loads expected during an interception and verified thrust, chamber pressure and combustion stability. The Next Generation Interceptor, or NGI, is the replacement interceptor being developed for the U.S. Ground-Based Midcourse Defense system, the architecture intended to destroy long-range ballistic missiles in flight. Lockheed Martin describes the test as a step toward Critical Design Review, the point at which a program's design is judged mature enough to move into production. "This successful static fire test is a significant milestone on the path to the Critical Design Review and confirms our confidence that the NGI motor will meet the demanding performance envelope required for **fielding by 2030**," said Christopher Jewell, Lockheed Martin's vice president for NGI. Jewell said the data collected will feed into the final interceptor design and speed up integration with the existing midcourse defense architecture. The company also said it is **investing in new and expanded manufacturing capacity in Alabama** for the program, including production lines, tooling and plant layouts intended to meet what it calls urgent production demand. The release characterized the spending only as "millions" and **did not give a dollar figure, a site or a completion date**. Lockheed Martin further stated that NGI's "born-digital" design approach has compressed development cycles that previously took years into months, and that it is drawing on suppliers across the country. **No supporting figures were provided for either claim**. The announcement contains no contract value, no delivery schedule beyond the 2030 fielding goal, and no financial information. Readers should treat the performance descriptions as the company's own account of the test; **no independent or government confirmation was included**. The Missile Defense Agency, the customer for the program, was not quoted. Lockheed Martin trades on the New York Stock Exchange under the ticker LMT. The next verifiable checkpoint identified in the release is the Critical Design Review, for which **no date was announced**. Source: [PR Newswire](https://www.prnewswire.com/news-releases/lockheed-martin-announces-successful-static-fire-test-of-next-generation-interceptors-stage-2-motor-302847234.html?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Predictiv AI Inc. Hires Aktien Media for Internet Advertising Services URL: https://www.pennystocks.news/predictiv-ai-inc-hires-aktien-media-for-internet-advertising-services-2/ Last updated: 2026-08-06T23:31:01.000Z Predictiv AI Inc. CSE: PAI | FWB: 7IT TORONTO, ON / [ACCESS Newswire](https://www.accessnewswire.com/?ref=pennystocks.news) / August 6, 2026 / Predictiv AI Inc. (CSE:PAI)(FWB:7IT) (the "Company" or "Predictiv AI"), has engaged **Aktien Media Inc** ("Aktien") to provide internet advertising and market awareness services to the company. The parties entered into a **3-month, consulting services agreement dated July 30, 2026**. Aktien will focus on communicating the Predictiv AI story to German and European investors, by disseminating public information and news items through multiple internet channels. Aktien will be paid **5,000 euros per month** and the agreement can be extended beyond the initial 3 months by mutual agreement of the parties. Predictiv AI's common shares trade on the **Frankfurt Stock Exchange under the symbol 7IT** and on the **Canadian Securities Exchange under the symbol PAI**. **About Predictiv AI Inc.** Predictiv AI Inc. is a Canadian artificial intelligence company focused on developing vertical AI applications for defined industries. The Company's products address fleet operations and communications, including fleet management software, AI-based agents for voice, chat, and SMS, and tools designed to support structured operational workflows. For more information, please visit [www.predictiv.ai](https://www.predictiv.ai/?ref=pennystocks.news). **Company Contact** Suman Pushparajah Chief Executive Officer and Director 416-388-8886 **Forward-Looking Statements** This news release includes forward looking statements that are subject to assumptions, risks and uncertainties. Statements in this news release which are not purely historical are forward looking statements, including without limitation any statements concerning the expected future operating performance of the Company's business. Although the Company believes that any forward-looking statements in this news release are reasonable, there can be no assurance that any such forward looking statements will prove to be accurate. The Company cautions readers that all forward looking statements, are based on assumptions none of which can be assured and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from those indicated in the forward-looking statements. Readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance on forward-looking statements. The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the CSE. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement. SOURCE: Predictiv AI Inc. View the original [press release](https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/predictiv-ai-inc.-hires-aktien-media-for-internet-advertising-ser-1201700?ref=pennystocks.news) on ACCESS Newswire ### Solidion Technology Lifts Cash to $27.7 Million After $35 Million Placement URL: https://www.pennystocks.news/solidion-technology-q2-2026-results-cash-private-placement/ Last updated: 2026-08-25T01:38:53.000Z Solidion Technology Inc. NASDAQ: STI Solidion Technology closed the second quarter of 2026 with **$27.7 million in cash and cash equivalents**, compared with $0.2 million at December 31, 2025\. The Dallas-based battery materials developer said the increase came from a private placement completed in June and that the substantial doubt about its ability to continue as a going concern, disclosed in earlier filings, has been alleviated. The financing, announced June 7 and closed June 9, raised **$35 million in gross proceeds** from a single new institutional investor. Solidion issued 750,000 common shares and pre-funded warrants covering a further 1,583,000 shares — 2,333,000 shares in total, or roughly $15 per share — at a price the company describes as above market under Nasdaq rules. Titan Partners, a division of American Capital Partners, acted as sole placement agent. The company says proceeds are intended for commercialisation of its Extreme-Climate Battery technology, inventory, prototype work and working capital. Revenue for the three months to June 30 was **$124,914, against $4,000 a year earlier**. Solidion attributes almost all of the increase to government grant revenue recognised in the period, with the remainder from deliveries of its silicon anode products. Cost of goods sold was nil in the quarter. The prior-year figures in the release are marked as restated. Operating expenses fell by $296,546 to $1,492,251, which the company links to lower general and administrative costs, reduced personnel and professional services spending, and lower research and development outlays. The loss from continuing operations was $1.4 million. Below the operating line, the picture was worse. Total other expense rose to $1,519,419 from $326,735\. It included a **$917,780 non-cash loss on derivative fair values** tied to a forward purchase agreement and warrants from the March private placement, a $549,915 write-off of deferred offering costs relating to a registration statement Solidion withdrew in June 2026, and $153,597 of interest expense, mainly on short-term notes. The **net loss came to $2,886,756, or $0.35 per basic share**, wider than the $2,113,859 loss a year earlier. Separately, Solidion said it restructured its August 2024 equity financing, **cancelling all Series C and D pre-funded warrants** and the associated derivative liability. Madison Bond LLC and Bayside Project LLC converted their full warrant allocations into common stock and agreed to lock-up restrictions on those shares, subject to unspecified exceptions. The company presents this as reducing future dilution risk; the release does not state how many shares were involved or what the current share count is. The rest of the announcement repeats previously disclosed development items, none of which carry a stated dollar value. Solidion says it demonstrated a 9.5Ah pouch cell for industrial and military drones that retained about 95 percent of capacity at a 10C discharge rate, which it compares with a market average of 78 percent at 5C. The release states the company expects the cell to be commercially available in the second quarter of 2026 and, in the following sentence, that it is still working toward commercial availability — a date that has already passed as written. A second product, the PEAK Series uninterruptible power supply for AI data centres, is built on the company's 5500 silicon-carbon anode cell. Solidion claims up to 30 percent space savings and up to three times the life of conventional backup systems, with commercial availability expected in 2026 and **early integration work under way with unnamed data centre partners**. In June the company also unveiled Gen-ECB, a graphene-based platform aimed at satellites, spacecraft and lunar infrastructure. It says the technology operates between −80°C and +60°C and has completed more than 500 charge cycles at −40°C, and that it targets energy densities above 380 Wh/kg when paired with its solid-state, lithium-metal and lithium-sulfur chemistries. Solidion cites a portfolio of more than 385 patents. Other items listed include three government research grants — from ARPA-E's OPEN programme, the Department of Energy for a molten-salt reactor additive, and an Army STTR award for a fibre-based battery — and a **non-binding memorandum of understanding with an unnamed energy storage manufacturer**. No contract values, volumes or counterparties were given for any of them, and none of the product programmes had generated product revenue in the quarter beyond the $124,914 reported. Source: [PR Newswire](https://www.prnewswire.com/news-releases/solidion-technology-achieves-dramatic-balance-sheet-improvement-increased-revenues-302845393.html?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.* ### Predictiv AI Says First Shiftmatics Hardware Order Received, No Value Disclosed URL: https://www.pennystocks.news/predictiv-ai-shiftmatics-first-client-order/ Last updated: 2026-08-06T23:59:35.000Z Predictiv AI, Inc. CSE: PAI | FWB: 7IT Predictiv AI Inc. said on April 14, 2026 that it has received its first client order for Shiftmatics, a vehicle-mounted data device it has been building in stages, and that **stages 1 and 2 of the platform are complete**. The company did not disclose the customer, the number of devices, or any dollar value attached to the order. Predictiv AI Inc. FWB: 7IT CSE: PAI OTC: PCIVF [Zur Aktie ↗ ](https://www.tradingview.com/symbols/FWB-7IT/?ref=pennystocks.news) Shiftmatics is a telematics unit — hardware installed in a vehicle to record and transmit operating data. According to the release, the completed stages cover a production-ready device that captures high-frequency location data, vehicle telemetry such as speed, fuel consumption and driving behaviour, and environmental readings including temperature, pressure and humidity. The unit has onboard memory and backup power so that data survives connectivity or power loss. Two further stages remain. Stage 3, described as in development, would add onboard cameras and local video storage. Stage 4, described only as future work, would move processing onto the device itself so that events can be detected and acted on without routing data through a cloud service. The company gave no timeline or budget for either stage. On the order, the release says a request has been received from an initial client to deploy a first set of devices, with installation expected to begin shortly. Predictiv AI calls this the platform's first commercial use in a live operating environment. Because no unit count, contract value or delivery schedule is given, the order cannot be assessed as booked revenue on the basis of this disclosure. The company positions Shiftmatics alongside two existing software products, ShiftFleet.ai and CloudRep.ai, and says the data the devices generate is expected to feed AI applications elsewhere in its product range. That is an expectation stated by the company, not a described arrangement. "Shiftmatics was designed from the outset as more than a tracking device," said B.H. Sudantha, head of hardware and engineering. Much of the announcement is framed around what the platform is intended to support later — predictive maintenance, driver behaviour analysis, semi-autonomous workflows and possible extensions into robotics. None of that is described as delivered. The release contains **no financial information at all**: no cash position, no development spend on the hardware programme, no share count and no financing detail. Moving from software into hardware typically carries inventory, tooling and warranty costs, and the announcement does not address how those are funded. Predictiv AI is based in Toronto and lists its shares in Canada and on the Frankfurt exchange under the ticker 7IT. The release refers to the Canadian listing as CSE:PAI, while the accompanying summary uses CVE:PAI. Source: [www.finanzwire.com](https://www.finanzwire.com/press-release/predictiv-ai-inc-cve-pai-predictiv-ai-expands-into-hardware-with-shiftmatics-platform-and-secures-initial-client-order-YCsOLDFjNWl?ref=pennystocks.news) *This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.*